Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AAMDC	"C11orf67, CK067, FLJ21035, PTD015"	ENSG00000087884	"Adipogenesis associated Mth938 domain containing"	Q9H7C9	11	77821109-77918432	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 656.7"	"Cell type enhanced"	"Detected in all"		"Theca cells: 385.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 143.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 280.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA037918, HPA037919"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA037918: AB_2675737, HPA037919: AB_2675738"	"unprognostic (3.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (6.02e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.84e-2)"	75.8	180.9	30.1	13.0	35.8	21.0	62.5	35.2	42.6	51.0	31.4	66.6	37.4	41.4	27.9	24.6	47.5	23.4	178.9	30.5	31.7	56.0	57.9	46.9	13.8	37.2	34.4	56.7	34.4	27.4	28.6	21.7	35.9	46.0	29.2	20.1	36.6	34.6	656.7	55.4	47.5	40.2	31.9	31.7	62.4	42.2	34.3	23.7	42.2	173.0	13.6	48.1	42.7	42.7	30.3	24.3	37.2	26.5	106.0	73.3	10.0	49.2	33.4	43.8	54.1	280.1	44.6	20.3	46.5	83.0	43.2	16.9	56.4	32.9	51.9	47.1	45.3	19.5	43.5	52.4	52.2	11.2	17.1	98.3	22.2	46.0	24.2	40.2	131.3	27.0	23.1	32.0	93.2	35.6	23.8	44.3	17.3	84.5	41.4	22.3	63.6	19.6	58.2	18.1	13.1	49.2	62.4	26.7	36.0	55.1	41.2	21.1	138.2	45.5	24.7	87.5	16.5	34.2	58.4	37.8	17.7	18.0	26.2	143.1	28.9	33.3	14.6	17.7	18.8	18.3	28.4	24.2	32.6	25.2	24.8	18.4	16.9	35.9	17.5	33.8	47.3	16.3	30.1	35.8	35.2	42.6	30.5	31.7	37.2	34.4	35.9	31.9	34.3	42.7	68.4	83.3	25.4	19.6	10.0	64.2	82.7	51.0	24.5	10.0	58.7	67.2	114.1	62.9	42.5	79.1	4.2	29.1	11.8	70.2	144.8	60.0	100.1	37.7	27.8	55.7	22.7	19.1	6.9	73.1	43.1	64.5	39.3	35.8	41.2	53.4	93.9	122.2	46.9	11.8	8.9	48.7	44.7	29.9	35.9	36.3	68.3	22.5	83.6	8.4	56.2	101.3	16.5	18.1	24.8	70.2	132.2	64.3	10.2	46.6	160.3	200.8	50.1	13.9	46.0	53.5	65.8	154.0	85.4	29.2	100.7	15.7	14.8	385.5	61.0	71.2
ABRA	STARS	ENSG00000174429	"Actin binding Rho activating protein"	Q8N0Z2	8	106759483-106770244	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Translocation, Transport"	"Actin-binding, Activator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 31.5;skeletal muscle: 145.0;tongue: 63.8"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 206.4;Early spermatids: 132.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (9.08e-3)"	"unprognostic (1.61e-2)"	"unprognostic (3.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.35e-2)"		"unprognostic (6.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.15e-2)"		"unprognostic (4.34e-1)"	"unprognostic (6.21e-3)"	0.4	0.3	0.0	0.1	0.1	0.0	0.1	1.9	0.3	0.4	0.0	0.1	0.0	1.1	0.1	3.0	0.4	0.1	31.5	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	1.2	0.1	145.0	0.1	0.0	0.9	0.0	0.1	0.1	2.2	0.0	0.0	0.1	63.8	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.3	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	206.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	132.8	0.1	0.0	0.9	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	14.8	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	22.5	3.6	3.3	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0
AC006538.2		ENSG00000267001	"Novel protein"		19	2717769-2740048	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA058526	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"				"HPA058526: AB_2683743"																		5.0	0.0	0.4	0.7	0.4	1.3	1.0	0.2	1.4	1.1	0.3	2.7	2.6	0.7	0.0	0.2	1.2	0.3	0.2	0.5	0.5	1.2	1.8	1.6	0.7	0.4	0.3	0.0	0.0	2.6	0.0	0.3	0.4	1.4	0.6	0.1	2.2	2.3	6.5	1.2	0.7	2.4	0.5	1.2	1.8	2.8	0.5	0.9	0.1	2.9	0.3	0.9	0.0	0.6	9.8	13.0	2.3	0.0	10.4	11.1	7.1	7.1	5.2	6.2	11.4	12.7	0.7	7.7	8.6	6.0	4.8	3.6	0.0	3.1	0.0	0.0	9.3	24.6	9.1	17.4	22.0	6.4	3.4	6.0	7.2	11.5	0.4	1.8	2.7	8.5	23.5	4.1	1.7	11.7	3.2	3.4	2.1	1.3	16.2	3.9	2.2	7.9	0.0	5.9	3.6	6.1	10.1	1.8	9.5	0.0	3.2	17.8	1.9	1.6	2.8	11.2	8.2	11.6	16.4	5.0	1.0	26.0	1.7	7.1	8.8	12.5	8.0	8.0	7.9	7.7	7.4	7.6	12.5	6.9	5.5	6.7	3.1	6.5	8.5	15.0	4.5	7.4	0.4	0.4	0.2	1.4	0.5	0.5	0.4	0.3	0.4	0.5	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC015802.6		ENSG00000284526	"Novel protein"		17	76563710-76570544	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Alveolar cells type 2: 7.8;Endometrial ciliated cells: 17.7;Endometrial stromal cells: 17.9;Glandular and luminal cells: 12.7;Respiratory ciliated cells: 8.0"					"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 58.7;SK-MEL-30: 72.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"																					3.4	5.0	0.7	4.8	0.9	7.0	1.0	1.0	0.6	1.8	9.9	1.9	4.3	3.5	0.8	6.1	2.7	3.8	8.8	1.8	1.0	2.7	3.0	4.5	4.7	1.5	1.1	4.5	10.9	0.3	0.7	3.6	0.7	2.6	0.3	16.5	10.0	0.5	25.1	16.0	2.9	0.1	0.7	3.9	5.2	15.2	0.9	0.0	5.0	0.1	0.2	2.6	2.5	0.4	14.9	11.7	9.2	20.5	0.0	0.0	12.2	6.5	0.0	0.0	0.0	25.5	11.3	15.7	7.7	0.0	7.2	15.2	0.1	0.8	0.0	4.1	13.1	21.9	9.8	58.7	0.0	20.5	13.6	0.0	1.2	0.0	0.1	13.2	0.0	9.3	18.3	17.3	0.0	20.4	18.1	36.0	16.0	16.7	14.6	10.6	24.9	14.4	0.2	13.7	19.6	24.5	8.7	46.7	72.7	18.6	33.5	17.6	10.1	26.4	18.9	18.3	28.3	22.3	9.4	12.6	15.6	16.1	33.4	1.4	7.3	1.8	11.8	7.5	19.4	9.9	12.7	12.9	6.3	7.4	11.6	12.0	16.9	6.5	4.6	6.1	7.1	8.1	0.7	0.9	1.0	0.6	1.8	1.0	1.5	1.1	0.7	0.7	0.9	0.4	0.3	16.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.4	0.0	0.0	4.3	0.0	0.0	0.0	0.5	0.0	0.0	4.2	0.0	17.7	17.9	0.7	0.0	0.0	0.0	0.2	0.0	1.1	0.0	12.7	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.1	8.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.7	2.6	0.0	0.0
AC026464.4		ENSG00000260914	"Novel protein"		16	69299682-69322700	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"skeletal muscle: 156.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA060092			Approved	Midbody		Yes	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Midbody		"HPA060092: AB_2684203"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-1)"			"unprognostic (7.34e-2)"	"unprognostic (8.50e-2)"		"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"		"unprognostic (3.50e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.51e-4)"	"unprognostic (1.69e-1)"		"unprognostic (2.76e-1)"	"unprognostic (5.11e-2)"	44.1	30.4	24.3	29.1	27.0	28.6	31.8	26.0	37.3	28.4	14.9	36.4	30.5	32.6	12.3	41.7	29.4	22.0	43.2	28.4	27.4	30.3	20.7	28.8	28.0	28.5	25.1	33.7	47.2	47.6	16.1	29.4	29.1	27.7	26.4	35.4	36.1	26.6	156.6	34.6	35.1	31.7	25.2	29.9	31.7	18.7	27.4	26.2	30.3	97.2	30.0	32.2	28.3	30.1	64.9	56.5	65.5	62.3	48.9	51.3	36.9	80.1	53.7	83.6	54.6	72.3	35.1	61.6	81.7	64.5	42.9	49.7	62.2	54.6	52.9	38.2	30.0	48.9	30.1	37.3	61.5	62.3	49.8	43.7	73.8	69.2	75.7	47.9	70.0	52.4	63.2	29.6	68.7	84.5	62.1	30.8	53.1	42.7	27.0	94.3	37.4	82.1	38.7	41.2	67.7	38.1	107.8	35.6	47.7	39.9	50.7	43.0	74.0	77.7	55.5	67.8	61.3	101.4	78.6	147.0	78.7	23.3	94.8	16.1	25.4	36.1	31.0	20.7	28.4	23.0	27.4	36.9	26.8	20.2	27.7	27.4	17.1	22.5	28.3	18.5	28.5	33.7	24.3	27.0	26.0	37.3	28.4	27.4	28.5	25.1	29.1	25.2	27.4	30.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACACB	"ACC2, ACCB, HACC275"	ENSG00000076555	"Acetyl-CoA carboxylase beta"	O00763	12	109116595-109268226	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 183.3;skeletal muscle: 173.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 128.7;Astrocytes: 136.8;Hepatocytes: 216.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 17.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 17.5"	"Cell line enriched"	"Detected in many"	18	"ASC diff: 222.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA006554	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA006554: AB_1844495"	"unprognostic (2.24e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.97e-2)"	"unprognostic (4.54e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.63e-2)"	"prognostic favorable (1.15e-5)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.58e-2)"	183.3	19.8	19.6	3.3	21.7	3.6	100.5	7.6	11.4	12.9	26.9	37.2	8.4	12.0	3.5	10.6	12.1	10.9	35.4	10.1	11.2	12.6	54.3	6.7	3.8	12.7	19.4	14.3	19.2	17.9	11.2	2.5	11.6	11.8	8.2	1.7	12.5	11.7	173.2	9.5	15.5	9.4	6.7	7.8	18.6	4.9	19.1	4.5	18.1	61.5	3.0	23.0	11.5	13.2	0.9	5.7	3.6	6.9	222.6	1.7	2.6	0.9	1.5	1.0	0.6	4.1	1.1	2.9	1.6	1.2	2.4	4.8	3.0	1.5	0.6	3.8	5.3	6.6	6.2	4.3	1.0	5.7	1.6	2.6	1.5	2.3	0.6	1.7	0.5	4.9	0.7	0.3	0.7	1.7	4.1	5.3	3.9	0.4	12.4	2.2	4.8	1.5	1.8	2.0	2.3	5.4	5.9	2.8	3.4	1.5	2.6	5.9	0.4	2.2	1.3	2.5	1.9	8.8	5.3	4.0	5.3	4.5	1.7	4.6	0.4	17.5	1.1	0.1	0.6	2.2	1.0	0.3	0.2	3.0	1.8	0.9	0.7	0.1	0.2	0.3	0.6	0.1	19.6	21.7	7.6	11.4	10.1	11.2	12.7	19.4	11.6	6.7	19.1	13.2	128.7	6.4	1.1	136.8	3.7	2.3	2.6	1.0	3.4	3.1	32.5	5.0	35.3	25.8	1.7	23.9	0.0	0.6	2.4	13.9	1.9	2.1	34.3	3.3	3.4	26.0	10.2	25.7	5.1	4.0	0.5	16.0	18.3	1.3	1.3	20.0	41.4	216.5	1.7	23.5	6.4	9.6	0.0	12.6	2.4	36.4	29.2	3.7	5.4	28.1	1.2	5.2	2.1	29.7	25.8	2.7	7.3	50.4	2.5	0.9	17.9	6.5	2.3	4.1	6.6	29.3	12.0	2.3	3.0	2.5	1.6	0.1	3.5	21.8	11.8	1.1
ACSS2	"ACAS2, AceCS, ACS, ACSA, dJ1161H23.1"	ENSG00000131069	"Acyl-CoA synthetase short chain family member 2"	Q9NR19	20	34872146-34927962	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 117.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 137.7;Hepatocytes: 138.9;Intestinal goblet cells: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 22.6;granulocytes: 34.3;monocytes: 21.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 132.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004141	Approved					NA	NA		16000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA004141: AB_1078094"	"unprognostic (1.97e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.42e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.54e-1)"	69.3	23.7	4.0	10.7	9.3	7.5	27.2	6.8	7.8	15.1	6.0	54.6	64.2	13.7	34.3	18.6	22.1	10.7	49.8	3.3	6.4	22.0	46.9	23.2	4.0	12.1	5.9	13.0	14.8	19.6	3.8	17.2	12.7	12.2	32.9	5.3	38.1	16.2	117.3	17.1	46.8	11.3	5.1	8.1	37.7	10.6	7.2	4.0	9.6	99.2	7.0	9.3	11.9	16.3	32.8	11.6	17.1	10.7	69.5	59.1	25.5	14.5	32.4	13.9	21.7	27.3	40.6	0.1	18.6	24.1	50.2	26.0	20.1	132.4	9.5	0.1	7.1	37.2	6.6	18.5	46.2	6.6	28.1	50.3	34.2	24.8	34.5	27.8	27.7	4.2	22.0	7.1	15.8	13.3	2.4	18.8	3.3	27.6	44.1	15.9	20.3	83.4	62.5	9.0	2.9	14.5	24.7	49.1	32.1	21.2	19.6	24.4	23.5	12.3	7.8	12.4	7.9	24.0	19.7	9.1	32.3	9.3	9.1	34.3	21.8	6.6	1.2	13.3	1.2	0.7	3.0	1.3	22.6	1.1	5.3	2.9	12.2	0.7	6.4	4.2	2.0	9.2	4.0	9.3	6.8	7.8	3.3	6.4	12.1	5.9	12.7	5.1	7.2	16.3	8.8	12.8	41.1	17.6	4.2	7.8	9.4	13.5	10.2	6.4	27.6	10.9	82.2	20.0	16.6	11.0	6.2	15.5	3.7	137.7	11.7	20.8	9.0	8.0	8.2	13.5	7.8	29.0	18.5	33.7	11.2	11.4	58.1	13.0	9.5	35.3	13.6	138.9	16.4	8.4	18.2	100.6	18.3	17.9	13.9	7.2	11.5	15.6	14.2	17.8	19.4	9.1	1.0	5.5	86.5	23.4	66.4	4.5	14.6	11.2	70.4	60.5	7.6	4.1	13.1	7.2	9.8	32.1	20.3	12.3	10.9	20.9	5.1	7.8	75.1	13.0
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236664141-236764631	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	53	"heart muscle: 772.7;skeletal muscle: 2134.7;tongue: 1262.2"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 1762.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HEK 293: 1.3;HSkMC: 5.9;hTEC/SVTERT24-B: 2.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 66.6"	"Region enhanced"	"Detected in all"		"basal ganglia: 44.5"	"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		NA	NA		25000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	0.7	0.2	12.0	0.0	26.3	0.1	0.9	8.0	20.1	0.3	11.0	0.4	0.0	0.5	0.0	21.8	0.5	0.7	772.7	13.2	12.1	0.5	0.3	3.9	0.2	9.7	8.1	1.1	1.6	0.1	0.5	0.1	10.7	16.1	0.0	1.3	18.4	0.1	2134.7	1.3	0.5	1.8	8.0	0.2	3.8	4.2	8.7	0.5	0.7	1262.2	0.1	3.5	0.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.2	0.0	0.0	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	26.3	8.0	20.1	13.2	12.1	9.7	8.1	10.7	8.0	8.7	14.2	0.3	0.0	0.6	18.6	0.0	0.3	0.4	0.0	1.2	2.6	0.4	0.5	1762.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.6	0.5	1.2	10.4	0.0	0.0	40.9	0.7	0.0	43.7	3.6	1.4	0.0	0.1	1.8	0.2	0.1	0.0	11.3	0.0	0.0	0.0	0.3	24.6	0.6	1.2	0.0	11.2	0.0	0.0	0.0	24.6	156.9	0.2	0.0	0.4	0.0	0.2	0.0	1.4	0.0	1.2	0.0	66.3	12.4	3.1	2.0	1.2	0.1	0.0	0.4	0.4	0.0	0.2
ADAMTSL4	"DKFZP434K1772, TSRC1"	ENSG00000143382	"ADAMTS like 4"	Q6UY14	1	150549369-150560937	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 146.7;Endometrial stromal cells: 36.9;Extravillous trophoblasts: 46.4;Fibroblasts: 34.5;Hofbauer cells: 34.0;Syncytiotrophoblasts: 99.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 11.1"	"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 92.0;BEWO: 200.3;HSkMC: 43.8;K-562: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA006279	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA006279: AB_1078102"	"unprognostic (2.00e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (8.09e-4)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.40e-3)"	32.0	5.1	1.1	14.9	1.0	4.2	24.7	0.8	11.1	22.9	7.9	19.3	3.6	20.0	1.6	33.3	29.2	7.7	22.3	0.8	1.4	6.4	17.3	26.1	1.8	4.4	2.8	17.1	3.0	0.5	3.0	62.9	2.9	9.0	3.8	0.6	11.8	3.4	37.7	11.8	13.7	11.4	1.2	5.4	17.2	2.4	3.6	0.8	6.1	47.9	1.2	32.8	23.3	1.5	22.0	0.6	0.3	3.9	19.1	92.0	200.3	20.8	18.0	12.1	7.0	1.8	8.5	0.2	4.3	14.4	0.2	11.0	0.8	3.2	4.9	1.7	0.4	6.2	2.6	8.9	15.3	0.3	3.0	43.8	0.9	3.0	6.8	10.3	0.1	0.0	67.7	0.7	2.2	0.5	0.0	1.1	3.5	0.6	0.7	0.0	0.0	0.1	2.1	0.8	0.1	0.6	6.7	15.9	0.1	10.0	4.5	11.5	3.8	0.7	5.5	8.6	0.3	1.9	0.6	4.5	0.8	4.0	0.5	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.3	1.1	1.0	0.8	11.1	0.8	1.4	4.4	2.8	2.9	1.2	3.6	1.5	2.8	0.0	1.5	1.0	0.5	2.4	2.3	0.2	0.6	1.7	1.3	1.8	2.2	10.0	0.6	0.0	0.0	146.7	1.0	0.2	0.0	1.7	0.6	2.6	36.9	5.3	0.0	0.0	0.3	0.6	46.4	34.5	0.0	5.4	2.5	0.9	1.8	10.6	34.0	0.0	0.1	0.2	0.0	24.0	12.5	0.7	30.1	20.0	3.6	0.0	23.1	1.4	1.0	0.0	0.0	12.3	0.1	3.4	3.2	2.2	0.0	0.2	0.9	2.2	0.0	14.3	3.8	0.1	1.6	5.5	2.8	99.5	1.7	0.5	0.3	2.5
ADCY9	AC9	ENSG00000162104	"Adenylate cyclase 9"	O60503	16	3953387-4116442	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 45.4;skeletal muscle: 52.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 95.3;Inhibitory neurons: 72.7;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041328, HPA044225"	Approved		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA041328: AB_2677414, HPA044225: AB_2678863"	"unprognostic (1.78e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (6.62e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (5.24e-8)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-2)"	6.9	5.6	5.1	4.4	7.6	1.5	6.1	3.2	7.5	8.2	45.4	8.2	8.2	8.0	2.4	8.4	9.2	6.9	14.9	10.7	0.0	9.4	11.9	14.0	1.9	3.0	0.6	11.2	15.8	9.1	5.1	9.9	0.9	4.4	6.8	2.9	11.9	5.8	52.9	5.9	9.6	7.9	0.1	4.4	6.4	4.0	1.3	2.1	18.8	28.6	2.6	9.7	6.1	5.2	8.5	12.9	3.8	7.0	13.3	16.0	5.6	14.5	15.1	8.0	6.3	10.6	7.2	0.0	21.8	40.1	4.8	8.0	14.9	9.1	5.4	10.4	14.3	0.3	29.4	20.3	14.2	1.1	6.4	17.1	13.6	9.3	4.9	6.6	5.4	2.7	4.7	0.0	8.3	15.3	0.1	4.4	6.9	3.6	6.9	13.3	18.0	0.4	2.9	2.3	8.7	3.8	11.3	13.2	9.6	4.2	33.5	15.0	4.9	15.8	4.3	15.6	6.4	3.2	2.1	1.7	3.4	4.4	6.3	0.8	0.3	0.2	0.4	0.3	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.3	5.1	7.6	3.2	7.5	10.7	0.0	3.0	0.6	0.9	0.1	1.3	5.2	7.0	12.8	12.8	33.3	1.0	6.4	1.1	3.9	5.2	10.6	4.2	3.7	17.3	22.8	7.1	12.9	12.5	1.8	5.8	19.5	0.0	4.5	0.8	6.1	10.5	6.3	1.2	0.4	95.3	5.3	1.8	8.1	1.5	5.7	0.0	15.3	8.2	19.9	1.5	1.7	72.7	7.6	2.0	4.7	2.0	2.2	8.4	3.3	7.2	31.9	2.6	5.5	4.1	42.3	12.5	3.5	4.3	7.5	2.5	1.1	15.0	5.6	9.5	14.9	0.0	9.4	12.5	1.1	5.0	0.9	3.8	1.0	3.4	4.8	7.2	1.3
ADPRM	"C17orf48, MDS006"	ENSG00000170222	"ADP-ribose/CDP-alcohol diphosphatase, manganese dependent"	Q3LIE5	17	10697594-10711558	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023265, HPA023820"	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"			"HPA023265: AB_1845590, HPA023820: AB_1845591"	"unprognostic (7.58e-3)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.38e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.97e-2)"	6.7	4.6	1.9	4.9	2.2	6.6	6.6	2.0	2.3	6.8	1.7	5.1	3.1	6.4	3.7	4.4	4.8	4.7	3.6	1.9	2.1	4.5	6.8	3.9	6.9	1.9	1.8	7.8	6.9	3.1	3.9	2.6	1.9	7.7	3.2	9.9	4.7	3.5	9.2	5.4	6.0	2.8	2.0	5.8	7.9	4.0	2.2	7.0	6.5	6.4	5.6	4.8	5.2	2.4	3.8	2.8	3.9	5.0	8.8	11.1	1.9	7.2	7.7	5.2	7.5	1.5	1.7	7.1	3.3	7.5	2.2	3.0	1.8	5.2	6.4	4.4	5.4	3.5	2.9	4.3	14.7	2.6	4.3	13.7	7.5	5.6	7.8	8.0	9.6	7.8	3.4	0.6	6.8	1.1	2.8	4.5	4.2	2.5	1.5	3.1	2.7	1.9	9.1	2.5	0.7	5.2	3.5	1.3	8.2	4.7	3.6	5.0	9.8	2.9	2.3	3.6	4.2	1.6	1.1	1.1	6.9	3.6	6.1	2.6	2.5	4.7	2.4	2.6	3.5	5.9	6.2	4.1	3.1	7.2	13.0	8.5	2.3	4.1	2.3	1.7	5.9	3.9	1.9	2.2	2.0	2.3	1.9	2.1	1.9	1.8	1.9	2.0	2.2	2.4	5.8	3.2	2.0	6.5	17.6	5.2	11.7	17.4	8.0	11.7	5.9	6.0	2.7	4.3	8.9	1.8	18.8	7.2	6.4	3.8	3.9	8.4	10.2	1.9	3.9	5.7	4.8	6.7	6.0	8.3	7.3	6.6	4.6	2.4	14.0	4.4	7.1	9.8	6.7	3.3	6.9	7.5	2.0	9.5	5.1	5.2	15.8	6.0	10.6	1.9	11.1	13.5	6.2	8.0	8.1	8.1	4.6	8.2	3.6	12.7	14.9	8.5	4.1	34.3	6.6	6.6	14.0	12.5	10.2	4.4	4.7	8.2	13.0	4.4	5.6	11.4
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346461-40390463	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Lyase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 345.1;tongue: 242.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol		NA	NA		440000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavorable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	29.8	33.9	10.6	31.1	11.2	40.6	33.1	12.5	13.3	30.7	12.9	36.5	22.7	34.9	21.9	29.8	33.5	20.6	47.4	10.9	10.6	33.6	32.1	22.7	46.9	10.5	11.7	33.5	45.2	29.3	22.0	30.2	10.9	23.8	35.4	10.3	25.7	22.3	345.1	22.2	28.8	41.1	10.0	33.5	28.0	29.2	10.5	50.5	29.6	242.3	48.5	36.0	25.2	10.8	98.0	110.2	88.3	124.9	62.6	89.5	106.5	82.0	85.2	187.3	138.1	189.0	51.9	279.0	73.2	102.3	84.9	67.3	203.5	137.4	187.7	75.3	197.5	126.5	98.4	166.5	134.6	423.0	96.3	97.7	76.5	161.5	169.8	91.3	138.9	127.3	153.1	114.3	136.4	105.0	130.2	131.2	152.5	121.3	119.3	195.1	203.6	198.2	118.9	67.8	58.8	54.4	106.2	54.1	170.7	78.5	76.8	134.7	91.2	93.3	173.7	85.3	168.8	109.0	212.6	218.2	80.9	149.5	97.7	29.0	47.2	19.9	35.5	55.2	49.5	34.6	76.1	48.5	68.1	33.5	58.3	45.0	4.1	48.2	49.7	34.4	81.7	62.3	10.6	11.2	12.5	13.3	10.9	10.6	10.5	11.7	10.9	10.0	10.5	10.8	10.0	12.8	10.8	9.4	28.3	18.1	18.8	48.6	23.9	16.1	14.8	15.0	30.0	30.0	20.8	3.7	37.5	85.3	15.5	13.0	7.9	61.3	44.0	5.6	9.2	21.6	13.8	54.6	11.4	43.7	78.9	21.2	21.4	5.6	36.8	8.8	28.9	25.6	60.3	6.7	10.7	24.1	24.4	44.8	26.7	25.2	24.8	22.7	12.4	1.0	41.9	45.1	19.6	9.5	9.8	33.7	15.6	14.3	52.4	21.3	21.4	19.7	12.3	18.1	26.3	38.5	20.8	61.2	82.8	35.7	15.2	33.1	32.2	8.7	37.7	14.1
AFF1	"AF-4, AF4, MLLT2, PBM1"	ENSG00000172493	"AF4/FMR2 family member 1"	P51825	4	86935002-87141054	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 225.2;Microglial cells: 202.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069947			Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Mitochondria"		"HPA069947: AB_2686219"	"unprognostic (1.01e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-2)"	33.2	18.0	10.7	18.1	11.8	35.0	22.8	8.1	13.0	24.8	51.4	25.9	18.2	25.6	11.8	19.1	21.4	19.6	19.6	10.2	10.0	32.8	24.8	20.7	16.3	16.3	9.8	28.8	28.2	31.8	12.5	26.8	11.8	18.2	22.5	63.6	24.0	22.8	55.6	23.4	19.4	31.9	9.1	19.4	19.0	6.9	14.2	22.8	54.9	41.8	13.4	18.5	19.0	12.0	15.3	13.5	11.3	12.0	18.3	21.6	15.9	15.1	22.2	11.3	16.7	14.7	27.8	17.3	20.2	18.7	14.4	6.8	18.0	22.8	15.7	29.8	7.2	36.0	38.3	12.3	14.1	35.0	27.4	17.7	16.1	19.4	17.0	16.4	42.1	14.1	22.5	47.5	4.8	4.1	31.6	10.1	15.0	25.6	4.8	24.7	6.7	22.2	33.1	14.5	25.6	4.7	23.1	15.0	7.2	23.5	9.0	28.9	21.3	20.9	18.8	12.9	8.5	41.0	24.8	29.6	17.1	39.5	7.7	5.4	7.4	17.6	8.8	5.4	9.8	12.0	11.8	8.9	8.5	14.5	6.0	5.8	28.4	7.7	3.3	20.7	11.3	4.2	10.7	11.8	8.1	13.0	10.2	10.0	16.3	9.8	11.8	9.1	14.2	12.0	88.0	41.7	55.6	125.7	29.3	24.1	20.2	17.8	33.6	41.7	20.6	11.6	119.8	40.0	28.4	92.0	225.2	1.4	29.1	40.7	3.9	11.9	7.2	32.4	39.1	50.2	32.3	54.5	69.2	12.6	4.2	36.3	42.8	46.2	25.2	40.3	65.0	34.2	13.0	18.5	47.5	35.8	16.2	41.7	32.8	9.3	29.2	34.8	23.2	202.4	16.5	21.4	16.5	74.4	84.0	13.1	31.4	28.6	53.9	21.9	29.8	50.3	36.0	147.2	26.3	41.9	31.2	3.8	11.3	45.3	31.7	32.8	26.4	13.3	29.0	15.8
AGBL1	"CCP4, FLJ32310"	ENSG00000273540	"ATP/GTP binding protein like 1"	Q96MI9	15	86079871-87049169	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 7.8;tongue: 23.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 16.7;Astrocytes: 28.7;Excitatory neurons: 15.6;Inhibitory neurons: 25.6;Oligodendrocyte precursor cells: 47.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 68: Oligodendrocytes - Mixed function"								"unprognostic (3.70e-2)"	"unprognostic (4.46e-2)"		"unprognostic (1.06e-1)"										0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.7	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.7	0.0	7.8	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.4	0.0	0.0	23.2	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.0	0.7	1.0	0.3	1.0	0.8	0.3	0.9	0.4	0.4	0.0	3.2	16.7	28.7	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	1.9	0.0	0.0	0.0	47.3	6.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850361-99924023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 257.6;tongue: 212.0"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 160.5;Theca cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		450000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	11.9	6.7	4.1	7.1	4.9	6.1	9.1	6.9	5.6	6.1	6.0	10.0	8.8	7.3	7.6	16.4	5.4	5.2	22.8	3.7	5.1	13.3	42.8	5.9	7.3	4.7	5.6	5.9	4.3	17.6	4.5	11.7	4.4	13.8	10.6	23.3	7.7	9.6	257.6	5.3	7.1	9.7	4.9	8.0	7.7	4.7	4.8	7.9	10.5	212.0	8.5	8.9	5.0	5.6	20.4	5.9	7.0	11.4	11.0	10.4	23.4	6.3	9.2	5.5	9.8	22.3	6.8	26.4	11.7	10.8	4.9	11.3	40.5	12.4	10.2	14.2	12.9	15.5	18.9	12.4	7.3	13.7	8.9	12.8	7.9	7.5	6.2	7.5	8.5	9.2	26.3	2.0	5.5	6.2	16.3	4.3	10.9	8.9	7.7	0.0	2.3	1.3	16.3	26.7	17.2	12.1	18.2	17.3	9.9	12.8	12.6	9.0	9.4	6.6	9.3	8.9	6.3	7.3	6.1	30.5	11.7	3.6	3.5	0.0	0.4	1.4	1.5	0.6	1.4	1.0	1.1	1.0	0.9	1.0	1.1	1.1	0.5	2.4	0.3	0.8	1.3	0.8	4.1	4.9	6.9	5.6	3.7	5.1	4.7	5.6	4.4	4.9	4.8	5.6	12.8	22.4	26.8	96.6	28.5	10.6	18.1	24.6	18.2	34.6	18.8	18.0	119.6	18.6	25.8	16.5	54.2	107.9	18.8	23.2	23.5	13.7	1.2	18.8	23.6	13.9	16.8	15.6	45.6	12.9	20.3	28.5	31.1	18.6	10.8	45.0	14.6	111.0	17.9	52.2	56.0	15.8	12.2	19.1	8.8	2.5	10.2	13.5	16.0	23.4	14.1	160.5	21.6	36.2	34.4	17.7	14.3	21.4	20.4	13.0	15.2	19.2	26.0	46.9	6.6	41.4	18.4	8.7	11.9	40.0	9.2	29.1	25.7	159.1	23.5	20.1
AIMP2	"JTV-1, JTV1, p38, PRO0992"	ENSG00000106305	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 2"	Q13155	7	6009255-6023834	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Protein biosynthesis"	"Developmental protein"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.9;tongue: 102.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 134.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019098, HPA020057"	Supported		Approved	Cytosol		NA	Yes		35000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA019098: AB_1852040, HPA020057: AB_1852042"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (9.29e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.96e-1)"	"prognostic favorable (1.38e-5)"	"unprognostic (7.44e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.09e-4)"	19.2	21.0	13.6	14.3	15.1	12.4	17.3	15.6	17.0	11.0	12.8	25.8	47.7	16.7	16.7	22.0	14.4	8.8	45.3	15.4	14.6	25.7	33.8	12.6	14.3	14.9	14.5	7.4	17.0	28.7	7.8	13.4	14.7	11.9	24.4	11.9	16.4	15.2	154.9	21.6	27.8	19.3	15.2	13.0	14.6	44.1	15.1	15.4	25.8	102.5	19.5	17.0	13.7	16.2	90.3	100.2	33.1	48.3	34.5	37.3	113.7	49.5	33.3	79.9	59.4	110.1	58.5	109.6	46.2	51.4	90.1	98.6	113.6	74.2	49.6	35.6	84.0	61.2	54.8	84.2	106.2	86.7	53.1	57.4	109.1	72.3	117.9	13.3	60.2	43.8	86.7	35.6	59.4	142.6	37.4	157.2	136.0	44.3	70.4	83.5	73.8	93.3	119.1	41.7	66.1	62.6	50.4	101.3	72.9	41.9	94.5	70.1	51.8	46.0	112.9	77.0	111.2	44.5	73.9	95.5	38.5	122.3	75.6	46.7	61.4	19.5	41.5	77.5	34.9	47.3	27.7	32.5	92.4	31.9	27.1	28.9	6.0	48.3	57.9	58.7	32.3	43.4	13.6	15.1	15.6	17.0	15.4	14.6	14.9	14.5	14.7	15.2	15.1	16.2	15.0	9.6	10.3	8.1	13.0	10.8	22.5	58.5	24.5	10.2	11.8	15.1	2.2	28.6	40.2	12.9	6.2	50.8	10.1	17.6	70.5	52.6	134.7	25.3	23.9	20.0	6.7	24.2	5.8	57.3	64.0	15.1	23.4	20.6	12.6	16.7	13.2	38.8	50.0	6.7	6.7	18.2	57.0	19.1	14.3	84.5	19.9	18.1	19.6	1.9	40.3	17.8	17.5	5.0	10.4	40.1	14.5	18.0	23.8	23.0	59.3	67.7	34.9	11.2	13.1	16.0	24.5	91.1	26.8	37.1	11.6	39.5	12.6	38.0	39.8	17.8
AKAP1	"AKAP121, AKAP149, AKAP84, D-AKAP1, PPP1R43, PRKA1, S-AKAP84, SAKAP84, TDRD17"	ENSG00000121057	"A-kinase anchoring protein 1"	Q92667	17	57085092-57121346	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.8"	"Group enriched"	"Detected in all"	9	"Early spermatids: 584.7;Late spermatids: 2219.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008620, HPA008691, CAB019286"	Supported		Supported	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"CAB019286: , HPA008620: AB_2668104, HPA008691: AB_1078119"	"unprognostic (5.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.38e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.86e-9)"	"unprognostic (6.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.38e-1)"	40.6	15.5	31.6	17.8	35.2	6.9	35.2	29.1	35.2	23.7	17.2	76.1	54.8	24.5	19.7	36.4	31.5	18.0	82.6	28.5	26.5	26.2	49.9	19.6	10.8	26.7	27.1	20.0	22.2	48.1	17.1	7.1	26.9	34.7	48.9	34.7	33.6	24.8	207.8	27.3	55.8	26.3	21.9	11.3	55.4	112.9	29.8	11.4	36.3	137.9	9.5	46.8	25.5	28.0	46.1	54.3	80.7	27.5	18.2	12.8	46.8	19.0	18.3	24.2	16.8	61.2	42.2	74.1	52.3	14.5	26.5	74.6	50.1	44.4	24.7	40.6	63.5	63.1	51.4	118.1	19.4	59.9	23.8	11.7	41.8	26.2	39.2	14.4	25.7	22.9	42.3	28.6	14.8	39.8	76.1	24.1	28.7	97.9	61.7	58.2	32.8	61.0	17.1	61.9	58.9	40.3	15.8	45.1	23.9	16.6	31.4	61.4	18.8	24.3	24.2	28.3	45.0	28.9	36.9	55.8	14.0	47.5	19.7	1.6	1.0	0.4	2.6	2.0	2.3	1.8	2.0	2.1	2.3	1.2	4.0	2.1	0.1	3.3	0.5	4.0	1.7	1.3	31.6	35.2	29.1	35.2	28.5	26.5	26.7	27.1	26.9	21.9	29.8	28.0	34.5	35.3	49.9	26.4	16.6	22.6	23.5	11.9	32.5	33.0	29.4	42.3	154.9	28.6	32.1	5.5	47.9	21.5	10.6	89.1	1.9	16.3	584.7	16.8	12.6	16.4	45.9	12.6	14.9	16.3	13.8	12.2	54.0	37.8	3.8	21.0	11.4	60.2	9.5	37.0	26.3	86.6	8.2	9.0	9.5	2219.5	19.6	10.9	7.2	4.7	8.7	8.2	3.1	10.6	9.6	12.7	68.5	13.9	13.2	32.3	65.6	7.4	6.5	77.1	46.0	17.9	54.4	18.3	14.9	44.9	19.7	6.8	11.5	13.3	117.6	17.0
AKAP13	"AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB"	ENSG00000170776	"A-kinase anchoring protein 13"	Q12802	15	85380571-85749358	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 161.8"	"Low region specificity"	"Detected in all"							HPA019773	Approved		Supported	Cytosol		NA	NA		14000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA019773: AB_1844686"	"unprognostic (4.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.69e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.81e-3)"	37.7	18.9	10.0	38.7	9.2	56.1	32.1	1.7	9.3	28.5	66.1	25.9	16.7	83.0	20.7	25.6	22.7	44.6	66.6	11.0	17.7	14.4	22.2	54.1	47.6	16.7	17.6	26.7	54.5	11.8	18.5	26.0	13.9	20.3	21.3	8.3	23.9	23.5	83.9	24.7	32.5	40.3	9.7	38.3	34.4	20.0	15.0	46.3	32.7	60.3	46.5	32.9	26.7	16.3	13.2	29.0	20.8	7.8	31.3	34.6	11.2	10.6	23.5	9.4	9.0	11.3	11.0	62.0	14.6	19.2	23.8	26.5	23.9	9.9	9.0	45.2	11.0	83.8	20.0	8.6	17.3	17.2	161.8	25.6	25.5	11.6	39.8	10.6	25.2	22.4	5.5	29.6	14.7	6.3	24.7	12.8	13.5	22.8	11.5	16.7	20.6	23.5	15.3	27.0	13.1	23.4	27.9	8.3	14.5	22.7	6.0	14.3	30.2	11.4	7.8	6.7	10.7	46.1	30.1	48.9	6.8	55.2	9.0	282.9	66.0	181.4	122.2	54.9	68.3	74.9	81.6	93.3	38.8	68.8	68.2	75.5	104.3	108.2	77.5	100.6	73.2	48.0	10.0	9.2	1.7	9.3	11.0	17.7	16.7	17.6	13.9	9.7	15.0	16.3	110.5	125.0	431.2	88.2	186.8	75.7	105.2	29.1	57.5	18.6	50.2	39.9	215.2	91.5	71.6	40.5	41.7	36.7	336.8	143.3	5.9	83.4	258.9	155.6	327.0	121.5	63.5	37.0	51.2	69.6	27.6	119.6	170.2	323.6	279.5	65.6	75.7	53.7	79.2	13.5	13.0	57.8	36.7	147.1	276.3	166.3	77.6	257.9	99.6	290.4	197.3	45.8	252.4	123.6	13.2	101.2	118.7	63.6	205.8	77.0	68.6	10.5	60.1	17.9	85.5	139.6	117.4	23.3	37.2	77.6	79.0	23.4	269.7	30.5	61.7	179.6
AL139300.1		ENSG00000256500	"Novel protein"		14	103562962-103685924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.7;tongue: 16.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;granulocytes: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA044617, HPA052450"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044617: AB_2679024, HPA052450: AB_2681838"					"unprognostic (1.56e-1)"													4.3	2.6	0.9	2.9	1.0	0.8	1.3	0.9	5.2	1.2	0.2	1.4	0.0	0.8	0.2	1.6	0.9	0.1	12.8	1.4	1.6	0.5	0.5	1.0	1.6	1.0	1.7	1.0	2.5	7.5	3.8	0.1	1.6	1.4	0.0	3.5	1.6	1.1	31.7	0.6	0.7	3.1	0.7	0.4	0.7	9.4	1.1	2.9	0.1	16.5	1.7	3.4	0.5	1.2	8.1	15.9	18.5	0.6	8.2	7.8	5.6	25.7	19.7	29.3	17.0	9.5	12.1	22.0	17.2	19.2	19.3	5.5	12.4	13.3	17.4	6.7	0.0	8.7	6.1	8.7	9.7	10.8	3.4	8.6	0.6	13.5	11.0	14.5	15.2	13.7	11.6	3.4	21.4	15.4	18.9	1.2	12.1	19.5	13.9	7.7	12.1	11.4	13.6	9.0	22.1	12.2	14.6	5.7	12.1	6.2	13.0	6.6	8.4	11.3	9.2	16.9	10.4	6.4	8.6	25.6	19.6	3.4	9.8	0.2	0.8	1.1	0.5	1.3	0.7	0.3	0.7	0.9	0.4	1.3	1.0	0.4	0.7	0.6	1.6	1.5	1.4	0.3	0.9	1.0	0.9	5.2	1.4	1.6	1.0	1.7	1.6	0.7	1.1	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
ALPK3	"KIAA1330, MAK, Midori"	ENSG00000136383	"Alpha kinase 3"	Q96L96	15	84817356-84873479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 62.7;skeletal muscle: 195.8;tongue: 59.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 64.1;Exocrine glandular cells: 20.5;Skeletal myocytes: 51.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;HDLM-2: 10.7;HUVEC TERT2: 15.5;LHCN-M2: 21.2;NTERA-2: 12.9;RH-30: 37.7;THP-1: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA026558	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA026558: AB_1844774"	"unprognostic (2.69e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.95e-7)"	"unprognostic (1.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.87e-2)"	12.5	9.6	1.2	0.9	1.6	0.1	4.4	1.0	2.2	2.2	9.3	7.5	0.6	1.5	5.4	3.0	1.7	1.8	62.7	1.3	3.8	13.5	5.9	5.5	0.6	2.2	3.4	0.8	7.7	11.2	26.1	2.5	4.5	2.4	0.8	2.5	2.6	1.3	195.8	1.0	2.1	3.1	1.6	0.5	5.2	0.9	3.9	0.6	3.6	59.1	0.4	3.6	1.4	1.1	1.8	0.1	0.1	0.2	0.3	0.1	14.3	0.0	0.0	0.0	0.1	0.1	6.3	0.0	0.4	0.0	0.1	1.1	0.0	0.0	0.1	10.7	1.7	1.8	0.3	0.0	0.2	0.0	0.1	1.3	0.2	0.0	0.0	0.1	15.5	0.1	0.0	0.1	21.2	0.9	0.0	0.2	12.9	0.3	0.1	0.0	37.7	0.2	0.0	4.0	0.0	0.2	0.0	2.0	0.1	1.9	0.1	9.6	0.3	0.1	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.6	1.0	2.2	1.3	3.8	2.2	3.4	4.5	1.6	3.9	1.1	3.3	6.4	2.7	2.6	0.2	0.9	0.1	0.6	1.2	4.1	1.3	0.8	64.1	17.2	2.4	9.2	16.7	0.3	0.2	0.5	0.0	2.9	0.3	11.5	1.0	8.7	9.1	0.0	3.0	20.5	0.7	3.8	0.5	8.9	1.3	8.7	1.8	1.7	10.2	0.0	3.4	0.3	0.0	0.3	12.0	0.0	0.0	5.2	3.6	9.4	4.7	1.0	1.0	0.5	0.3	10.4	1.2	0.0	1.5	0.7	0.1	2.2	4.2	3.4	0.0	51.9	8.4	0.5	3.2	0.2	0.1	0.7	0.5	0.2	0.3	1.6
AMER1	"FAM123B, FLJ39827, RP11-403E24.2, WTX"	ENSG00000184675	"APC membrane recruitment protein 1"	Q5JTC6	X	64185117-64205708	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 15.3"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 6.6;Theca cells: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065214, HPA065265"	Approved		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 10: Non-specific - Unknown function"	"Nuclear bodies"	"Vesicles, Plasma membrane"	"HPA065214: AB_2685435, HPA065265: AB_2685450"	"unprognostic (1.56e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.89e-1)"	1.1	1.4	1.6	1.3	1.5	1.2	1.3	1.8	1.6	1.9	0.1	1.5	1.5	1.9	4.0	2.8	2.2	1.0	1.3	1.0	1.6	1.8	2.1	1.2	1.2	1.5	1.4	6.3	2.0	1.6	0.7	0.8	1.5	1.7	1.3	1.3	2.2	2.2	4.1	2.2	1.3	2.8	0.7	1.3	1.6	0.4	1.9	1.6	1.4	15.3	1.6	1.3	1.3	1.0	3.1	2.2	5.8	4.6	2.2	2.1	4.7	1.4	1.2	2.1	1.3	7.3	1.1	5.9	1.8	3.0	1.6	4.3	12.5	4.1	2.0	2.5	2.5	3.7	4.9	4.9	1.6	7.7	0.9	3.0	5.3	1.6	3.2	1.7	1.2	4.6	5.6	5.9	1.1	3.7	5.2	4.0	15.6	4.0	4.4	11.7	9.4	4.3	0.9	1.0	2.6	3.9	3.7	5.0	1.9	4.8	1.6	2.1	0.8	2.5	5.8	6.7	1.9	3.0	2.2	4.4	1.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	1.5	1.8	1.6	1.0	1.6	1.5	1.4	1.5	0.7	1.9	1.0	0.9	0.0	0.0	1.0	1.5	2.2	0.6	0.9	2.8	5.0	1.7	1.5	2.6	4.3	0.3	0.0	2.1	1.1	3.4	1.1	0.0	1.2	0.1	3.3	2.6	1.5	1.2	0.8	0.8	1.6	0.8	1.8	3.6	2.0	0.0	3.9	1.4	2.6	0.4	0.0	1.3	1.0	0.0	1.0	0.3	0.2	2.5	0.5	1.8	1.0	1.2	0.2	0.0	1.0	0.6	0.7	0.5	4.1	2.4	1.2	0.8	0.8	0.0	1.0	6.6	2.3	4.4	0.0	0.2	3.6	2.6	0.7	0.9	6.4	1.6	0.7
AMOTL1	JEAP	ENSG00000166025	"Angiomotin like 1"	Q8IY63	11	94706431-94876748	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 111.4;WM-115: 105.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001196	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		59000	"Cluster 24: B-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	"Cell Junctions"	"HPA001196: AB_1078147"	"unprognostic (2.21e-1)"	"unprognostic (5.25e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (5.03e-6)"	"unprognostic (7.47e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.29e-2)"	15.4	10.3	15.1	7.6	9.8	1.7	15.0	7.8	7.2	11.7	8.7	36.5	4.5	14.2	5.9	30.4	13.3	13.3	19.1	12.2	12.4	6.4	7.8	15.8	3.5	12.0	28.8	4.8	15.6	13.8	14.1	24.1	13.2	32.4	7.3	6.6	10.9	23.1	112.0	21.7	8.4	20.5	7.3	9.2	12.4	11.7	30.4	27.9	9.7	71.7	9.7	27.5	14.0	6.2	57.1	16.0	41.9	0.0	44.1	38.1	19.9	31.0	53.7	13.9	16.2	29.7	1.5	2.7	14.9	42.2	11.4	72.4	20.1	111.4	14.6	4.6	15.4	30.7	16.2	0.1	10.2	6.8	0.2	22.7	67.3	47.7	78.9	35.9	29.3	11.9	79.0	2.9	33.1	16.6	21.3	4.1	6.3	0.1	10.5	0.0	76.2	4.9	19.4	23.6	31.7	38.3	2.0	42.4	11.2	28.1	2.2	9.6	27.1	38.0	27.6	0.8	21.6	1.5	0.0	16.0	10.6	0.1	105.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	15.1	9.8	7.8	7.2	12.2	12.4	12.0	28.8	13.2	7.3	30.4	6.2	28.4	35.3	35.0	17.0	0.8	35.4	19.7	11.7	29.0	4.7	6.9	14.9	51.0	10.0	10.1	7.3	4.2	30.1	1.0	0.0	0.0	17.3	127.0	22.3	12.7	31.1	0.0	6.3	26.8	17.0	15.6	30.9	0.5	27.4	2.5	4.9	36.4	17.0	4.9	15.2	61.3	0.0	4.1	4.0	10.0	62.9	8.1	3.2	10.6	46.9	1.4	14.4	0.0	20.6	1.4	10.8	0.0	12.4	0.7	19.4	0.0	4.0	4.2	1.1	13.1	32.7	30.2	16.7	11.4	21.7	26.9	27.9	1.4	3.4	0.0	8.4
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 993.4;tongue: 629.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 164.7;Cone photoreceptor cells: 87.6;Erythroid cells: 250.2;Inhibitory neurons: 176.8;Skeletal myocytes: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.2;naive B-cell: 7.8;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;dendritic cells: 3.4"	"Group enriched"	"Detected in many"	4	"HEL: 125.2;K-562: 134.3;RH-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	NA	NA		4200000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.8	1.1	0.4	1.6	2.0	95.2	1.0	34.1	17.3	0.3	0.0	0.5	1.5	0.1	0.1	8.7	0.4	0.8	98.0	0.3	12.5	0.6	0.3	0.7	4.4	26.8	32.6	0.3	0.8	62.1	1.1	2.1	27.1	4.2	0.2	6.3	8.1	0.7	993.4	0.6	0.9	0.3	10.6	2.2	4.4	0.6	8.4	0.7	0.6	629.0	4.0	1.8	0.5	5.4	0.0	16.8	0.5	0.0	0.2	2.9	0.0	4.9	32.8	1.5	0.7	0.1	0.0	7.7	1.5	3.5	0.6	2.8	0.8	0.5	0.7	3.2	0.1	125.2	0.7	0.0	0.1	0.3	0.4	4.2	0.6	0.4	0.0	0.7	0.1	0.0	134.3	2.8	2.1	0.3	0.0	1.6	1.7	0.1	0.1	0.9	160.2	0.8	0.7	0.5	2.2	1.4	0.1	2.3	0.0	5.9	2.0	3.2	0.8	0.5	0.9	27.6	0.2	0.0	0.2	4.7	2.9	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.4	9.2	0.3	0.4	0.1	7.8	0.0	0.0	0.4	0.1	0.0	3.4	1.0	0.7	0.4	2.0	34.1	17.3	0.3	12.5	26.8	32.6	27.1	10.6	8.4	5.4	5.5	0.0	0.0	1.3	8.3	0.6	1.4	2.2	0.6	15.4	0.3	0.1	164.7	0.0	1.0	0.0	87.6	1.1	0.2	0.1	1.9	0.1	7.0	0.1	0.1	4.6	1.2	250.2	12.9	0.0	0.5	2.9	5.6	0.5	0.0	2.2	0.4	0.1	19.7	3.3	176.8	0.7	2.0	0.8	3.7	6.3	0.3	2.6	0.0	3.7	0.4	1.0	0.0	7.1	2.0	1.1	1.2	0.4	5.7	1.3	0.1	0.3	0.6	5.5	0.0	51.6	5.7	0.2	1.0	0.1	0.0	0.4	1.7	0.1	0.0	1.8
ANKRD2	ARPP	ENSG00000165887	"Ankyrin repeat domain 2"	Q9GZV1	10	97572499-97583884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	63	"heart muscle: 437.1;skeletal muscle: 981.2;tongue: 823.8"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 218.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.9;testis cancer: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 17.6;BJ hTERT+ SV40 Large T+: 7.3;HaCaT: 13.0;RPTEC TERT1: 17.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040842, HPA040884"	Enhanced		Enhanced	Vesicles		NA	NA		110000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA040842: AB_10963794, HPA040884: AB_10969453"	"unprognostic (1.27e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	0.4	0.8	2.5	0.1	2.3	0.0	0.5	2.5	3.7	0.2	2.0	0.3	0.0	0.3	0.3	1.0	0.1	0.3	437.1	2.5	2.7	11.8	0.3	0.8	0.2	2.5	2.4	0.1	0.9	0.0	0.6	0.0	2.5	2.9	0.0	0.3	3.4	0.9	981.2	2.7	0.2	0.2	1.9	0.1	0.2	0.5	2.7	0.0	0.5	823.8	0.1	0.1	0.4	2.5	17.6	5.4	0.0	0.0	0.2	0.0	0.4	0.9	0.0	7.3	4.7	0.3	5.3	0.0	0.6	0.2	0.4	13.0	0.0	4.7	5.0	0.2	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.8	2.1	4.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	17.4	0.8	0.0	0.0	0.0	4.4	0.0	0.4	2.1	0.3	0.0	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.5	2.3	2.5	3.7	2.5	2.7	2.5	2.4	2.5	1.9	2.7	2.5	0.1	0.0	0.0	1.3	0.0	0.1	0.7	1.7	1.2	0.0	0.2	0.4	218.3	2.8	0.2	3.7	0.0	0.2	0.0	0.0	31.3	1.2	0.6	0.1	0.3	1.6	0.0	0.0	1.3	0.2	0.4	1.0	0.0	0.1	0.0	0.7	0.4	0.2	0.1	0.0	1.5	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.5	0.4	0.9	0.0	1.9	0.0	0.1	0.0	19.1	0.0	0.1	0.0	13.6	1.1	2.5	3.5	0.6	0.3	0.3	0.2	0.1	0.0	0.5
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100706-151157785	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 343.8;monocytes: 445.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 861.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol		NA	NA		1800000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	292.9	135.4	98.1	164.2	104.1	109.7	188.3	94.0	150.6	148.9	151.8	196.0	44.5	181.5	105.0	94.7	149.9	108.7	188.7	102.5	123.1	82.6	214.4	131.6	161.8	144.2	109.4	181.7	78.3	29.6	161.9	141.1	146.2	124.9	78.2	133.6	70.3	208.6	331.3	62.7	119.9	300.1	92.3	150.9	111.4	52.5	127.4	160.8	86.7	371.5	176.4	206.5	107.4	104.8	3.0	30.4	212.8	317.1	861.2	417.8	55.1	397.4	526.4	323.5	477.6	106.7	15.6	26.9	138.5	578.6	268.1	0.5	165.9	200.2	300.3	110.5	52.1	15.3	62.1	204.7	295.0	97.6	94.7	508.6	1.5	282.3	42.0	476.9	420.6	197.5	22.0	396.1	737.6	100.4	181.8	151.7	56.2	1.2	92.4	120.4	592.9	31.0	42.2	0.3	12.2	49.3	39.9	282.7	175.6	308.4	488.3	201.1	326.8	296.6	84.2	19.4	107.1	205.4	289.5	4.5	154.5	459.7	46.2	89.7	89.4	82.9	290.4	54.7	190.4	175.4	213.4	263.3	118.3	179.0	145.8	181.6	17.6	261.9	25.0	30.2	190.9	331.7	98.1	104.1	94.0	150.6	102.5	123.1	144.2	109.4	146.2	92.3	127.4	104.8	90.3	16.0	17.3	19.2	146.8	11.0	11.5	2.2	1.8	16.5	30.7	24.0	59.5	12.8	1.1	23.9	6.2	64.3	110.3	0.3	25.4	6.5	56.9	1.8	38.5	45.6	21.4	36.4	36.5	17.8	33.7	105.9	9.2	1.7	57.5	343.8	57.1	147.1	85.4	15.2	36.3	2.4	0.0	41.0	77.8	46.8	123.3	41.2	55.2	10.3	445.2	45.6	187.4	18.6	5.6	12.1	1.2	211.4	120.3	7.3	1.0	48.4	4.7	125.8	230.1	55.3	150.6	2.5	1.5	0.6	8.1	177.2	143.4	149.4	2.5	1.5
APIP	"APIP2, CGI-29, Mmrp19"	ENSG00000149089	"APAF1 interacting protein"	Q96GX9	11	34853094-34916379	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021188, HPA024131"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		52000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA021188: AB_10610977, HPA024131: AB_10602171"	"unprognostic (2.80e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.74e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.58e-2)"	30.4	25.4	14.7	20.7	17.1	14.4	20.7	17.3	17.1	18.0	14.2	19.9	13.6	15.0	15.0	13.8	17.2	18.5	20.0	13.9	16.3	27.0	19.4	21.2	20.2	18.7	16.4	12.3	17.2	15.8	9.1	13.3	18.4	16.8	19.5	16.8	31.7	23.6	65.6	10.0	16.3	12.3	17.1	15.5	18.8	10.7	16.0	31.3	24.6	38.3	16.3	19.1	9.6	20.9	25.1	27.3	33.5	8.3	27.7	26.8	14.5	36.8	38.0	38.9	44.4	15.6	21.3	77.1	21.7	15.5	40.3	28.8	56.1	24.9	53.3	49.9	56.3	39.5	27.8	42.6	41.2	111.3	28.9	23.6	20.6	22.1	40.7	19.1	29.8	49.8	94.2	45.2	27.6	24.2	59.7	57.7	25.1	39.6	61.7	36.4	89.1	29.6	46.8	36.3	28.5	13.6	45.0	37.2	50.2	17.4	38.9	34.3	24.1	29.2	26.9	68.1	9.0	43.9	36.1	89.4	32.2	27.3	37.2	11.3	27.3	25.4	17.2	30.0	21.3	24.5	21.1	18.8	42.7	24.3	21.4	18.3	6.7	31.4	36.8	27.2	27.2	18.4	14.7	17.1	17.3	17.1	13.9	16.3	18.7	16.4	18.4	17.1	16.0	20.9	24.7	35.3	30.1	42.4	27.9	25.0	37.5	62.7	19.4	28.8	73.8	36.2	23.1	37.1	63.0	18.4	4.2	37.2	25.5	49.5	187.9	30.2	8.0	33.4	23.9	22.8	35.5	42.5	28.4	32.4	23.4	24.4	29.6	24.8	20.3	22.0	21.0	26.0	76.5	18.5	35.2	41.3	87.5	47.1	31.8	8.3	23.9	47.6	21.4	17.8	59.4	23.1	25.7	51.3	108.8	25.4	28.4	24.8	44.2	33.0	35.0	101.7	56.8	21.6	39.5	37.8	30.1	32.4	22.3	31.4	26.3	26.4	25.8	27.1	50.1	50.4
APOBEC2	"ARCD1, ARP1"	ENSG00000124701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 2"	Q9Y235	6	41053202-41064891	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 203.7;skeletal muscle: 853.2;tongue: 288.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 15.8;Cardiomyocytes: 103.5;Early spermatids: 25.7;Exocrine glandular cells: 21.8;Extravillous trophoblasts: 18.1;Late spermatids: 25.1;Skeletal myocytes: 36.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.7;pancreatic cancer: 4.9"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"CACO-2: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA014252, HPA017957"	Enhanced					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"			"HPA014252: AB_1844932, HPA017957: AB_1844933"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.01e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.19e-2)"	0.2	0.8	0.3	0.3	0.9	1.1	0.3	0.4	0.7	0.0	0.2	0.8	1.4	0.1	0.0	12.0	0.1	0.1	203.7	0.2	0.4	0.4	0.1	0.5	0.3	1.0	0.6	0.1	12.7	0.0	0.1	0.7	0.8	7.7	0.1	5.7	12.7	0.0	853.2	1.1	1.2	2.1	0.5	0.2	12.6	2.7	0.7	10.9	0.3	288.0	0.0	0.3	0.1	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.7	0.1	0.3	0.1	0.1	0.0	0.8	0.6	1.3	1.6	0.5	1.4	2.1	1.5	1.7	0.4	1.9	1.6	1.8	0.6	0.6	0.9	2.2	1.6	0.1	0.3	0.9	0.4	0.7	0.2	0.4	1.0	0.6	0.8	0.5	0.7	1.7	0.0	0.0	0.0	1.0	0.0	0.3	0.7	1.0	0.0	15.8	0.0	0.0	103.5	0.0	0.0	0.0	2.1	1.6	0.1	0.0	0.0	8.0	25.7	0.0	0.0	1.2	0.0	0.0	0.5	21.8	18.1	2.3	8.6	0.1	0.0	0.0	0.0	0.0	0.4	1.7	0.5	0.1	0.0	0.3	0.3	25.1	0.3	0.1	1.8	0.0	0.0	0.9	0.0	2.0	3.7	2.2	0.0	0.0	0.0	0.0	0.5	2.0	0.0	3.1	0.0	36.7	2.0	1.1	0.2	0.0	0.0	1.4	0.1	0.0	0.0	0.0
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901684-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 968.2;Syncytiotrophoblasts: 920.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 115.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	50.0	8.1	2.9	21.2	5.8	6.9	34.3	3.2	11.3	37.2	20.7	17.5	10.2	39.0	4.6	20.2	20.6	39.3	18.3	4.4	1.6	21.4	8.3	18.3	18.8	7.8	6.9	17.5	6.2	13.3	10.0	21.0	11.4	18.3	11.7	4.1	15.8	10.2	87.2	18.1	14.2	42.5	0.9	16.9	11.5	6.9	9.0	13.1	7.8	11.9	16.7	30.9	19.6	9.7	2.2	0.9	6.0	14.7	13.0	34.0	1.2	42.9	115.2	29.9	23.3	52.7	2.3	3.9	10.1	41.4	4.3	14.3	20.6	6.5	36.0	13.7	6.1	2.1	10.4	13.5	23.9	0.6	25.2	43.3	3.4	17.6	20.2	26.2	3.9	7.5	1.9	5.7	9.9	7.7	14.4	1.1	1.1	10.2	13.5	17.7	9.8	1.1	20.1	23.9	3.3	4.4	19.2	10.6	12.8	13.1	8.7	0.7	3.3	16.5	22.0	25.1	10.9	0.4	0.0	11.4	14.3	0.8	5.4	9.6	1.2	0.8	13.3	2.8	1.8	37.5	19.7	11.8	2.2	41.2	12.8	8.4	2.2	12.3	8.2	1.0	30.9	5.4	2.9	5.8	3.2	11.3	4.4	1.6	7.8	6.9	11.4	0.9	9.0	9.7	86.2	131.4	70.7	54.5	199.8	968.2	453.9	111.3	105.9	54.4	112.8	96.6	72.8	27.1	96.3	51.5	0.0	187.8	89.1	7.5	99.7	56.1	31.7	164.7	231.0	134.1	36.4	5.2	167.8	14.6	150.7	343.6	21.4	457.7	24.6	37.6	119.2	7.4	51.0	74.0	181.9	18.7	22.4	44.1	162.4	20.1	151.6	43.6	138.7	34.7	39.0	17.2	58.7	74.4	155.8	41.1	25.2	60.5	234.5	193.7	5.4	304.8	38.4	3.6	131.5	496.3	463.9	8.2	5.8	65.7	477.8	920.4	178.2	24.3	41.7	233.9
ARIH2	TRIAD1	ENSG00000177479	"Ariadne RBR E3 ubiquitin protein ligase 2"	O95376	3	48918821-48986382	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067381, HPA069715, HPA070963"			Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329"	"unprognostic (7.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (5.01e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (1.15e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.39e-2)"	20.6	22.9	21.4	16.0	24.5	23.0	19.8	24.2	23.7	21.4	24.7	29.4	11.7	24.5	33.8	19.5	21.3	15.0	53.9	21.3	23.4	22.7	21.3	19.7	20.7	22.9	22.9	20.7	24.1	24.4	26.0	18.4	23.8	23.1	17.7	32.4	18.6	21.9	100.4	16.5	21.2	24.4	22.0	24.3	22.5	27.0	22.8	26.1	22.0	79.6	21.4	23.6	17.4	27.7	40.4	39.6	37.6	53.2	54.3	29.7	52.4	46.3	53.5	56.5	62.1	42.0	35.0	84.1	21.4	49.8	82.0	23.5	77.9	47.2	68.7	57.0	48.1	85.3	51.7	34.5	48.9	63.4	39.5	31.9	70.2	70.9	94.9	32.2	43.1	38.3	68.4	54.6	50.7	27.8	65.4	25.8	64.3	43.3	59.5	23.5	42.8	70.2	32.9	54.1	16.4	44.8	47.7	56.1	45.0	44.1	28.6	43.8	41.4	34.1	49.4	52.5	74.0	72.8	148.1	103.3	37.3	51.9	43.7	53.1	34.6	39.9	44.2	32.2	30.5	28.8	28.2	37.1	32.3	34.2	29.2	37.3	25.6	25.8	20.9	29.9	35.5	39.3	21.4	24.5	24.2	23.7	21.3	23.4	22.9	22.9	23.8	22.0	22.8	27.7	37.0	35.3	31.4	54.9	50.2	50.9	51.5	27.3	68.3	57.0	35.5	35.3	74.6	32.9	44.0	29.5	87.6	36.4	76.0	31.3	29.4	33.8	15.3	33.5	48.3	38.4	16.7	76.2	50.0	43.2	36.2	40.1	42.3	38.1	45.5	42.3	28.5	44.6	26.6	57.2	59.1	26.2	14.2	32.8	35.7	11.3	41.7	44.6	30.2	38.4	45.2	42.2	95.8	42.3	128.6	42.1	23.0	43.2	85.0	78.9	20.8	34.3	30.6	82.5	26.3	51.5	48.6	165.7	89.7	59.4	54.0	53.4	66.8	37.7	31.6	67.0
ART1	"ART2, ARTC1, CD296"	ENSG00000129744	"ADP-ribosyltransferase 1"	P52961	11	3645128-3664416	"CD markers, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	57	"skeletal muscle: 47.4;tongue: 36.8"	"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051148	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA051148: AB_2681363"	"unprognostic (3.73e-1)"							"unprognostic (4.58e-2)"		"unprognostic (3.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"		"unprognostic (1.73e-1)"		0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	47.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	36.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.5	0.3	0.2	0.3	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASB10	GLC1F	ENSG00000146926	"Ankyrin repeat and SOCS box containing 10"	Q8WXI3	7	151175698-151187832	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 26.7;skeletal muscle: 77.9;tongue: 14.2"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079685	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"			"HPA079685: "						"unprognostic (6.72e-3)"				"unprognostic (1.96e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	77.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASB11	DKFZp779E2460	ENSG00000165192	"Ankyrin repeat and SOCS box containing 11"	Q8WXH4	X	15281697-15315640	"Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"heart muscle: 33.4;skeletal muscle: 114.7;tongue: 61.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.7;Ionocytes: 6.1;Melanocytes: 7.2"	"Cancer enriched"	"Detected in single"	20	"melanoma: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (5.89e-3)"				"unprognostic (1.04e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.54e-2)"		"unprognostic (2.04e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"		"unprognostic (6.21e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.7	0.0	114.7	0.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.2	0.0	0.2	0.2	0.1	8.7	0.0	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.4	0.1	0.3	1.7	0.3	0.1	6.1	0.3	0.8	0.3	0.3	0.2	7.2	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.3	0.0	1.9	0.2	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.4
ASB12	FLJ39577	ENSG00000198881	"Ankyrin repeat and SOCS box containing 12"	Q8WXK4	X	64224194-64230607	"Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"skeletal muscle: 90.5;tongue: 52.1"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 21.1"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;THP-1: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049542	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA049542: AB_2680810"	"unprognostic (6.52e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.76e-2)"	"unprognostic (4.23e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (6.75e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.63e-2)"	0.2	0.3	0.2	0.1	0.2	0.2	0.2	0.2	0.4	0.3	0.2	0.4	0.0	0.4	0.5	0.9	1.4	0.2	3.4	0.2	0.2	0.4	0.1	0.2	0.1	0.2	0.3	0.6	0.2	0.3	0.2	0.0	0.2	0.4	0.5	0.2	0.7	0.6	90.5	0.3	0.2	0.3	0.2	0.2	0.3	1.6	0.2	0.1	0.2	52.1	0.2	0.6	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.6	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.2	0.7	0.7	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	4.6	0.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	21.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1
ASB14	DKFZp313L0121	ENSG00000239388	"Ankyrin repeat and SOCS box containing 14"	A6NK59	3	57268342-57292685	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 28.1;tongue: 18.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Cardiomyocytes: 8.2;Excitatory neurons: 4.8;Inhibitory neurons: 4.3;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (2.14e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.14e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.81e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.69e-2)"	"unprognostic (6.87e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.71e-3)"	0.6	0.3	0.1	0.5	0.3	1.9	0.6	1.4	0.4	0.6	0.4	0.4	0.2	0.3	0.0	0.4	0.5	0.2	3.9	0.1	0.2	0.3	0.3	0.6	0.7	0.6	0.3	0.5	1.5	0.0	0.4	0.1	0.4	0.3	0.0	1.6	0.7	0.0	28.1	0.8	0.5	0.0	0.4	0.6	0.5	0.3	0.3	0.0	0.4	18.0	0.0	0.4	0.6	0.5	0.2	0.1	0.1	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.7	0.9	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.2	0.4	1.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.6	0.0	0.1	0.7	0.9	0.1	0.1	0.3	0.1	0.2	0.2	0.0	0.6	0.2	0.7	0.1	0.3	0.1	0.4	0.3	0.1	0.3	0.1	0.2	0.7	0.6	0.4	0.6	0.4	0.7	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	1.4	0.4	0.1	0.2	0.6	0.3	0.4	0.4	0.3	0.5	0.1	3.2	0.5	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.2	0.2	0.0	0.0	4.8	0.0	0.0	0.2	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
ASB15	FLJ43370	ENSG00000146809	"Ankyrin repeat and SOCS box containing 15"	Q8WXK1	7	123567010-123639481	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 27.3;skeletal muscle: 119.3;tongue: 84.1"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 54.2;Early spermatids: 35.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.19e-1)"					"unprognostic (7.45e-2)"	"unprognostic (1.37e-1)"					"unprognostic (5.98e-1)"	"unprognostic (6.09e-6)"	"unprognostic (7.31e-2)"	"unprognostic (6.39e-2)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	27.3	0.1	0.1	7.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.5	0.0	119.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	84.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.4	0.0	1.7	0.3	0.3	54.2	0.0	0.2	0.0	0.0	0.2	0.2	0.3	1.9	0.2	35.0	0.8	0.4	0.4	0.0	0.0	0.4	0.4	1.4	0.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	5.6	0.6	0.0	3.6	0.0	0.0	0.3	0.0	0.5	0.1	0.7	0.0	0.0	0.0	0.7	0.1	10.4	0.1	0.1	0.0	6.9	0.8	1.2	0.4	0.0	0.1	1.1	0.2	0.3	0.2	0.3
ASB2	ASB-2	ENSG00000100628	"Ankyrin repeat and SOCS box containing 2"	Q96Q27	14	93934166-93976739	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 522.2;tongue: 157.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 51.1;Early spermatids: 26.4;Late spermatids: 29.9;Skeletal myocytes: 27.6;T-cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	7	"eosinophil: 50.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 50.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 12.8;RPMI-8226: 12.4;SK-MEL-30: 5.9;U-266/70: 42.1;U-266/84: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001546			Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA001546: AB_1078224"	"unprognostic (5.65e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.62e-6)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.49e-7)"	"unprognostic (2.51e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.27e-1)"	2.9	0.8	0.8	5.6	2.1	0.5	1.5	0.0	1.9	12.0	0.0	66.5	4.0	31.6	0.3	4.0	26.6	0.5	78.5	0.6	0.0	0.5	0.5	3.0	7.4	0.1	0.0	2.9	0.3	0.2	0.2	0.2	0.3	14.4	0.4	0.0	6.6	0.9	522.2	2.3	18.3	1.6	0.0	4.2	17.2	0.4	0.3	0.4	1.2	157.6	3.2	30.4	8.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.4	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.0	12.4	0.0	0.2	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.9	0.0	0.0	0.0	0.2	0.0	42.1	8.6	1.7	0.5	2.6	0.5	0.0	0.2	50.8	1.9	2.7	0.3	1.9	1.7	3.8	4.2	0.4	0.2	0.5	0.1	0.0	7.8	0.4	2.3	1.3	0.8	2.1	0.0	1.9	0.6	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.0	0.3	3.3	0.4	0.1	8.4	0.0	0.2	0.2	0.9	51.1	0.0	2.9	0.0	0.0	0.1	3.0	0.0	0.0	1.4	26.4	1.7	0.3	0.5	0.0	2.7	4.7	0.0	0.5	1.9	1.1	2.5	0.0	0.0	0.0	0.0	0.6	0.0	1.9	0.0	0.0	0.0	0.3	29.9	0.3	5.3	1.8	1.9	5.8	0.8	2.1	0.0	0.7	0.2	0.0	0.4	10.7	0.1	0.0	0.0	0.4	1.1	0.0	27.6	5.0	0.8	8.4	0.1	0.1	2.9	14.5	0.1	0.1	0.3
ASB8	"FLJ21255, MGC5540"	ENSG00000177981	"Ankyrin repeat and SOCS box containing 8"	Q9H765	12	48147789-48181213	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 291.9;tongue: 184.4"	"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003299	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA003299: AB_1845072"	"unprognostic (1.35e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.40e-3)"	"unprognostic (3.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.82e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (6.57e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.26e-2)"	19.7	22.6	21.1	20.1	22.9	61.6	21.2	35.1	28.2	15.8	18.3	22.0	21.6	19.2	21.5	22.7	18.6	15.9	45.4	22.6	22.5	27.8	28.2	17.4	23.1	21.4	20.2	22.1	21.8	33.4	16.7	15.5	23.1	20.7	26.6	73.1	21.2	21.8	291.9	21.4	20.5	24.4	20.9	22.7	21.4	17.2	20.9	29.4	18.7	184.4	26.8	17.8	13.2	24.7	19.3	16.1	17.6	26.9	26.9	23.9	12.7	33.1	23.1	23.1	20.6	24.4	23.4	31.5	26.6	30.4	12.7	16.5	28.3	19.8	26.2	37.3	24.9	38.9	22.1	12.8	20.4	36.5	33.9	23.4	18.8	29.5	17.1	39.6	23.3	35.5	29.5	38.6	20.9	18.2	33.8	25.8	6.6	24.1	28.4	21.7	27.1	32.6	18.3	19.6	27.6	17.6	18.9	24.5	21.2	16.3	45.7	24.8	17.9	19.4	14.0	19.9	15.0	33.1	41.4	27.1	24.6	81.6	11.0	91.7	23.2	117.0	30.8	26.3	28.5	28.6	32.8	31.4	22.8	20.9	32.9	34.3	53.5	36.7	35.8	24.4	33.7	23.1	21.1	22.9	35.1	28.2	22.6	22.5	21.4	20.2	23.1	20.9	20.9	24.7	26.7	22.4	22.6	11.8	26.9	7.0	9.1	15.4	17.6	63.4	18.5	22.4	68.4	27.1	16.1	16.5	62.6	23.2	35.3	29.5	41.1	22.6	24.0	10.4	17.0	23.1	18.6	40.8	19.2	21.8	12.8	22.5	20.9	12.4	20.3	25.5	23.2	31.7	24.6	40.4	21.0	24.3	12.2	24.8	11.8	75.3	24.2	22.9	21.4	7.5	33.5	55.8	46.4	15.6	19.1	19.1	24.3	27.8	25.4	10.8	31.2	42.0	16.0	120.0	52.6	37.4	24.0	35.9	21.1	22.9	11.1	17.1	29.3	37.0	22.1	9.2
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 386.9"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 468.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 34.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 890.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	386.9	160.3	64.7	50.6	69.2	16.9	106.9	102.3	88.9	65.6	84.4	78.8	45.6	49.3	44.7	71.4	46.9	61.0	111.3	64.5	58.4	59.5	74.9	74.1	20.3	54.0	69.2	62.2	44.7	38.7	36.3	47.9	52.2	48.3	84.9	219.5	101.9	70.2	357.6	35.2	45.5	67.5	44.8	28.6	105.0	16.5	71.8	16.7	97.0	182.7	28.5	112.2	43.8	60.4	460.3	652.3	89.9	55.1	392.1	370.1	31.2	804.0	741.3	336.3	350.1	113.1	594.2	35.3	54.3	474.6	270.3	167.5	56.2	281.1	570.0	13.6	57.0	81.1	372.5	310.3	251.2	12.5	12.9	306.5	61.9	187.6	237.4	657.2	144.8	18.0	22.2	32.1	300.2	97.4	3.3	16.6	51.7	441.6	383.4	22.3	97.0	7.3	206.2	374.0	93.1	32.1	249.9	116.1	101.7	49.0	47.7	22.2	456.7	338.0	174.3	313.0	288.0	20.2	27.1	1.5	890.1	7.5	231.4	1.9	8.3	0.3	2.5	2.9	4.7	5.5	3.5	2.4	10.0	5.0	4.9	2.5	25.4	8.7	1.8	34.0	4.0	4.1	64.7	69.2	102.3	88.9	64.5	58.4	54.0	69.2	52.2	44.8	71.8	60.4	79.1	195.5	244.0	366.6	13.8	47.0	160.7	126.0	68.9	138.3	83.7	58.4	228.6	37.1	157.5	86.5	294.0	118.1	40.3	57.0	15.6	144.2	1.6	51.4	65.8	85.9	116.5	13.0	93.1	180.4	107.1	132.0	73.9	115.4	8.2	34.5	42.8	62.6	72.2	127.9	98.9	215.1	52.9	26.6	44.1	3.1	70.8	48.1	42.7	61.8	20.0	468.8	2.1	154.8	53.5	257.7	32.3	57.6	15.9	148.2	34.3	34.6	66.6	158.8	46.0	114.4	92.7	3.4	16.8	101.7	50.3	48.0	13.6	131.2	67.3	254.2
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"heart muscle: 1005.8;skeletal muscle: 2856.8;tongue: 2768.8"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 2119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					NA	NA		2500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA062605: AB_2684805"	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	60.4	49.6	26.2	57.8	34.6	46.0	34.1	36.0	28.0	43.4	23.2	64.2	47.5	46.6	39.0	181.2	67.0	60.5	1005.8	39.0	28.8	34.4	54.7	49.0	36.0	32.5	46.3	42.0	38.1	56.1	24.5	55.4	29.8	93.4	69.0	19.1	92.2	70.0	2856.8	46.5	56.4	74.4	29.8	30.5	47.2	74.1	57.6	36.2	73.3	2768.8	48.1	90.9	57.9	36.1	129.7	305.7	135.4	106.5	95.3	111.7	185.1	154.9	197.2	163.6	102.1	229.1	131.3	155.4	129.2	165.4	115.4	185.0	215.9	264.4	157.3	130.0	127.2	148.0	115.6	121.5	164.7	151.1	130.6	130.3	170.7	202.3	190.1	165.4	134.9	82.6	162.9	74.9	118.6	131.3	76.0	53.2	139.7	126.6	134.8	96.8	130.2	128.6	59.5	279.2	138.2	101.5	207.8	151.1	87.0	113.9	213.7	95.6	159.8	147.8	69.3	93.9	127.4	140.6	189.5	169.0	152.3	70.9	168.8	0.0	0.6	0.0	0.5	1.3	0.2	0.1	0.3	0.2	0.5	0.2	0.3	0.3	0.0	0.3	0.6	0.5	0.3	0.2	26.2	34.6	36.0	28.0	39.0	28.8	32.5	46.3	29.8	29.8	57.6	36.1	48.9	44.8	57.5	85.5	26.3	114.5	95.2	134.5	68.9	63.6	70.2	64.6	2119.9	41.5	103.5	51.5	64.6	33.4	37.4	155.1	1.9	43.7	14.8	291.6	90.8	59.7	137.3	14.1	161.0	71.0	37.6	104.2	49.5	258.1	45.0	47.3	40.7	122.2	64.3	84.1	146.1	109.6	65.1	54.6	64.9	13.4	30.4	65.3	67.6	63.7	33.8	27.5	15.5	119.6	96.4	98.0	89.4	83.1	56.8	117.4	78.0	25.3	176.4	42.9	52.6	88.0	110.2	80.3	47.7	142.3	109.0	30.6	32.7	40.0	97.7	126.4
ATXN1	"ATX1, D6S504E, SCA1"	ENSG00000124788	"Ataxin 1"	P54253	6	16299112-16761491	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 582.5;Inhibitory neurons: 519.0;Oligodendrocyte precursor cells: 318.2;Oligodendrocytes: 466.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 14.4"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008335, HPA070756"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA008335: AB_1845129, HPA070756: AB_2686306"	"unprognostic (1.01e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-3)"	4.1	4.0	3.2	5.9	5.3	2.6	4.1	0.0	14.4	8.4	0.0	8.8	3.8	10.9	4.3	5.0	6.2	5.7	5.8	8.4	0.0	4.1	4.7	6.9	4.2	0.0	1.3	5.4	4.8	5.5	6.5	4.9	0.0	7.4	3.8	13.9	4.6	6.2	14.6	5.7	4.8	7.5	0.0	5.7	5.3	3.0	3.9	2.6	6.1	14.8	3.1	6.7	6.6	0.8	4.5	2.6	0.9	0.0	4.4	5.9	5.8	4.8	11.2	2.9	3.3	2.8	2.8	0.2	6.3	9.3	3.7	4.2	0.3	3.0	4.2	2.6	4.7	0.7	4.4	9.0	7.0	4.2	7.0	4.6	5.7	6.1	5.1	11.2	5.9	0.9	0.0	5.3	2.4	2.3	0.3	4.8	0.9	1.4	4.3	0.3	5.8	4.0	4.0	7.6	0.3	2.5	4.4	5.5	9.1	8.4	3.6	7.2	9.1	4.0	6.1	4.8	4.4	30.7	19.2	0.2	2.6	4.3	10.0	0.2	0.5	0.1	0.7	0.4	0.5	0.1	0.5	0.7	0.2	0.0	0.0	0.4	1.3	0.0	0.2	0.1	0.4	0.3	3.2	5.3	0.0	14.4	8.4	0.0	0.0	1.3	0.0	0.0	3.9	0.8	16.0	48.1	25.9	206.3	20.7	91.4	72.2	22.8	48.9	39.8	20.7	14.4	35.9	25.8	26.0	11.0	100.1	0.6	48.4	23.6	7.9	16.7	4.3	80.5	144.4	21.7	1.2	5.7	582.5	8.5	4.0	32.9	22.4	75.8	38.7	67.4	17.2	25.2	22.4	38.7	519.0	16.5	2.0	39.6	79.1	3.3	10.5	41.7	32.0	217.4	42.3	24.1	33.0	318.2	466.8	32.3	16.3	28.2	82.6	56.6	13.9	8.8	33.2	99.9	52.6	19.0	41.6	1.0	6.9	60.9	48.7	0.4	61.5	6.4	7.7	63.8
AVEN	PDCD12	ENSG00000169857	"Apoptosis and caspase activation inhibitor"	Q9NQS1	15	33858782-34075155	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 44.0;Oligodendrocytes: 86.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020863	Approved		Approved	"Plasma membrane,Actin filaments,Centrosome"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Actin filaments"	Centrosome	"HPA020863: AB_1845219"	"unprognostic (1.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.93e-2)"	"unprognostic (5.77e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (5.29e-10)"	"unprognostic (7.66e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-3)"	13.7	11.4	8.5	7.2	8.6	4.4	10.8	8.9	10.1	11.4	10.5	15.2	7.4	12.5	5.2	12.3	11.3	6.4	28.5	8.2	9.2	5.5	16.9	7.2	4.8	9.2	9.0	10.5	20.8	3.0	5.8	12.4	9.4	9.4	9.4	2.5	7.9	9.1	31.1	11.2	7.5	12.5	8.8	6.5	12.3	10.7	9.0	6.9	5.6	13.6	7.9	16.2	10.8	9.1	16.4	26.3	26.0	8.6	21.4	24.1	14.7	41.1	36.2	31.9	19.9	7.2	11.3	15.2	24.8	34.8	24.2	10.4	12.2	26.9	25.7	14.6	7.7	26.1	15.9	20.5	31.5	26.6	18.2	19.8	50.9	18.4	45.8	38.6	35.2	7.6	26.6	21.1	45.6	17.3	10.5	46.1	11.9	22.2	8.5	15.7	14.6	32.2	26.4	21.0	13.4	16.8	22.6	11.6	11.4	10.7	12.6	29.4	24.5	27.7	9.5	12.0	34.6	21.2	17.7	31.1	13.3	31.0	15.2	0.0	0.2	0.0	0.5	0.6	0.6	0.4	0.5	0.2	0.2	0.1	0.2	0.3	0.0	0.5	0.2	2.3	0.9	0.1	8.5	8.6	8.9	10.1	8.2	9.2	9.2	9.0	9.4	8.8	9.0	9.1	9.0	3.2	5.3	16.6	5.6	5.7	8.7	1.8	3.4	5.6	7.5	9.0	32.7	2.8	0.8	0.0	6.2	11.0	10.5	7.4	0.0	2.9	13.8	4.4	14.3	10.2	4.8	9.5	21.8	8.6	44.0	8.5	5.6	5.6	0.0	14.7	8.6	19.1	7.4	8.4	24.1	7.7	0.0	4.1	4.4	6.5	7.5	5.0	3.6	22.5	3.5	10.9	7.2	26.7	86.6	7.0	5.2	10.5	15.6	21.5	9.4	4.6	1.5	5.3	6.6	4.9	9.7	6.2	7.4	12.9	9.7	9.4	6.5	23.1	6.0	14.7
BCL2L13	"BCL-RAMBO, MIL1"	ENSG00000099968	"BCL2 like 13"	Q9BXK5	22	17628855-17730855	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 180.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002052, HPA030994, HPA050377"	Uncertain		Enhanced	Mitochondria		NA	NA		100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: AB_2681107"	"unprognostic (1.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.81e-1)"	13.4	13.3	8.7	5.7	11.6	10.8	11.5	8.4	12.8	7.7	1.4	10.0	6.0	7.9	8.8	12.3	7.4	6.8	19.7	9.4	9.9	14.0	16.4	8.4	7.6	11.6	13.7	7.5	11.8	14.8	7.8	9.2	12.1	8.2	10.3	43.8	10.0	6.8	59.6	14.1	7.8	7.6	9.2	6.4	9.5	10.7	9.7	9.2	9.6	40.5	8.7	10.3	8.7	9.4	16.2	6.1	10.6	11.1	19.6	18.8	17.2	11.4	21.3	17.1	19.8	8.3	11.7	14.6	7.5	15.4	13.9	21.3	12.6	18.4	20.9	12.2	12.3	14.5	7.5	6.1	22.3	21.3	10.0	14.5	21.1	14.0	40.1	24.2	14.7	11.3	34.5	15.2	18.9	11.6	11.7	8.9	10.7	26.8	9.7	10.9	20.7	5.3	20.1	12.4	15.6	11.5	16.4	15.6	31.0	38.0	11.9	18.0	17.2	9.9	5.0	15.3	10.5	11.9	10.5	14.7	14.9	16.1	16.4	5.1	9.5	2.3	2.3	8.0	2.8	3.1	3.1	2.7	5.4	3.2	2.8	2.3	3.6	6.5	6.4	2.9	4.5	4.7	8.7	11.6	8.4	12.8	9.4	9.9	11.6	13.7	12.1	9.2	9.7	9.4	18.7	22.4	16.7	32.3	21.5	24.6	33.6	22.7	30.1	180.5	21.8	22.4	42.7	12.8	25.3	18.4	12.5	48.5	19.7	31.7	52.8	29.1	34.8	17.7	16.0	17.5	23.4	19.8	41.9	31.6	35.0	20.0	13.3	23.5	8.8	19.7	15.7	36.0	26.0	48.8	38.1	25.4	18.3	30.8	19.8	15.5	14.0	26.3	16.0	27.2	54.7	57.9	12.3	27.6	45.4	36.4	17.8	15.4	15.4	40.3	32.6	44.4	19.6	35.2	0.0	21.3	15.6	33.1	22.6	32.1	27.1	95.9	19.3	22.9	24.0	43.1
BZW2	"HSPC028, MST017, MSTP017"	ENSG00000136261	"Basic leucine zipper and W2 domains 2"	Q9Y6E2	7	16646131-16706523	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 265.5;skeletal muscle: 367.7;tongue: 258.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 278.2;Extravillous trophoblasts: 875.6;Syncytiotrophoblasts: 762.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022813, HPA026709"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Actin filaments, Cytosol"		"HPA022813: AB_1845511, HPA026709: AB_10600752"	"unprognostic (2.27e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.91e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavorable (7.86e-8)"	"unprognostic (9.13e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.25e-1)"	26.1	18.1	8.5	26.8	10.1	45.7	49.7	6.9	14.3	19.1	9.7	51.2	28.9	18.4	9.9	42.6	20.2	17.2	265.5	10.2	6.3	37.8	18.4	20.0	30.0	5.2	6.3	16.0	30.0	6.7	10.4	80.4	6.5	19.3	56.8	88.0	23.8	34.3	367.7	55.5	30.0	39.0	5.6	16.5	50.2	11.6	6.9	33.0	36.5	258.9	38.4	59.5	26.2	8.8	91.7	81.3	138.2	201.7	67.5	118.3	125.7	126.0	156.3	117.6	124.9	201.8	129.7	208.0	143.7	96.9	87.6	181.6	164.8	141.5	152.0	27.8	99.8	129.6	84.4	117.0	70.5	180.3	79.1	90.6	74.6	104.0	187.7	92.4	171.6	149.7	251.9	43.5	96.9	105.0	90.0	210.4	143.9	259.5	174.1	111.0	91.2	216.6	113.4	152.6	179.9	106.8	50.8	419.9	67.7	156.7	187.8	149.5	97.6	93.1	119.1	141.5	136.3	89.5	92.8	288.1	45.5	220.6	340.3	2.6	46.0	5.0	27.3	55.2	44.6	44.6	39.8	36.9	98.8	42.9	56.8	47.1	2.1	56.8	41.6	38.5	31.8	44.0	8.5	10.1	6.9	14.3	10.2	6.3	5.2	6.3	6.5	5.6	6.9	8.8	32.8	22.4	60.5	3.9	30.0	57.6	69.9	60.5	82.6	55.9	52.3	57.0	278.2	17.2	53.9	47.8	64.6	214.3	26.8	42.4	58.7	47.5	9.8	31.9	43.2	42.9	30.5	63.5	48.6	65.6	875.6	43.5	110.1	40.6	21.0	33.3	8.9	13.7	65.0	6.7	32.0	49.5	61.1	33.4	46.0	6.4	12.2	30.7	24.9	12.2	47.5	19.7	19.6	19.1	17.9	47.0	42.9	9.8	31.9	52.0	19.2	20.8	32.6	106.4	6.6	30.2	54.2	11.3	4.1	99.6	51.6	762.9	29.3	52.6	90.6	79.0
C15orf61	LOC145853	ENSG00000189227	"Chromosome 15 open reading frame 61"	A6NNL5	15	67521131-67530146	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 23.7"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 222.6;Spermatocytes: 258.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062820			Approved	Nucleoli,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Vesicles"	Cytosol	"HPA062820: AB_2684874"	"unprognostic (1.35e-1)"	"unprognostic (9.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.95e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.45e-2)"	"prognostic favorable (5.31e-5)"	"unprognostic (2.42e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	4.7	3.8	2.3	1.5	6.2	5.3	3.6	7.1	4.2	3.1	0.0	2.3	2.8	2.3	1.9	2.0	2.9	1.5	5.7	3.8	1.6	3.0	2.5	2.3	1.3	1.0	2.4	2.7	4.2	4.4	5.1	2.0	1.0	2.5	2.2	10.8	2.6	2.1	23.7	4.1	1.8	1.4	0.7	1.7	2.4	7.7	2.1	1.4	2.8	8.3	1.0	2.2	2.4	2.3	4.2	4.4	1.1	4.9	5.0	7.2	3.1	1.8	3.2	3.3	2.6	3.4	2.9	3.5	3.8	2.0	3.9	4.9	4.4	1.2	2.7	2.1	10.4	3.7	3.3	4.6	3.2	4.6	3.0	7.5	3.4	1.1	4.0	2.4	1.6	10.6	4.3	7.6	1.0	2.4	3.8	7.6	1.8	3.3	5.6	5.1	2.5	13.0	2.3	2.9	6.4	4.8	3.2	3.0	6.1	2.1	2.7	7.1	1.6	4.4	6.8	5.5	4.7	7.1	11.2	8.5	1.9	9.0	2.2	7.9	4.3	7.8	4.5	3.7	5.2	5.3	5.9	4.5	4.8	3.6	6.2	5.0	0.5	3.8	3.2	4.9	4.0	3.5	2.3	6.2	7.1	4.2	3.8	1.6	1.0	2.4	1.0	0.7	2.1	2.3	28.0	22.4	13.5	4.9	23.1	67.2	32.6	32.3	120.7	75.5	55.7	82.3	74.5	18.6	14.3	16.5	37.5	42.6	23.8	38.6	80.3	25.1	222.6	17.5	24.2	26.8	27.1	11.8	14.8	29.8	31.9	56.8	15.8	17.1	34.8	15.2	22.9	44.7	30.5	13.5	15.7	47.5	48.8	24.8	25.6	42.6	41.0	19.9	37.4	3.7	15.6	97.1	23.7	5.0	8.5	27.6	48.4	25.6	37.4	63.3	49.0	77.1	8.4	93.9	32.9	38.2	38.7	258.9	52.1	62.7	60.9	20.5	34.4	28.9	39.2	20.0
C1QTNF9	"AQL1, C1QTNF9A, CTRP9, MGC48915"	ENSG00000240654	"C1q and TNF related 9"	P0C862	13	24307166-24322535	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 8.4"	"Group enriched"	"Detected in some"	10	"Adipocytes: 34.9;Endothelial cells: 12.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056632	Uncertain				"Secreted to blood"	NA	NA	210000000			"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA056632: AB_2683197"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.14e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	3.1	0.2	0.3	0.1	0.2	0.2	1.5	0.4	0.3	0.3	0.0	1.6	0.6	0.3	0.4	0.4	0.3	0.8	3.8	1.9	0.5	0.3	0.5	0.2	0.2	0.1	0.1	0.1	0.6	0.1	0.1	1.3	0.2	0.6	0.3	0.4	0.4	0.1	8.4	2.1	0.6	0.6	0.0	0.3	0.5	0.9	0.2	0.2	0.2	3.3	0.1	0.8	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.3	1.9	0.5	0.1	0.1	0.2	0.0	0.2	0.2	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.3	2.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.1	2.0	0.5	0.1	12.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.9	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.1
C5orf22	FLJ11193	ENSG00000082213	"Chromosome 5 open reading frame 22"	Q49AR2	5	31532287-31555053	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 28.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 28.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043062	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA043062: AB_10795766"	"unprognostic (2.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.65e-1)"	"unprognostic (7.30e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	4.3	3.7	2.0	5.6	2.9	5.8	6.5	2.4	3.0	6.0	1.6	6.7	4.6	6.0	3.4	6.5	5.9	5.6	10.2	2.4	3.2	7.6	7.0	6.6	7.3	2.3	3.2	4.1	11.0	8.2	1.4	5.7	2.9	5.9	7.6	4.8	5.4	5.3	13.7	3.9	5.9	8.2	2.4	5.1	5.2	3.6	2.5	7.2	6.6	15.1	8.7	7.0	2.8	3.0	10.0	7.2	18.4	25.3	13.0	10.7	20.9	16.2	12.2	18.1	13.4	8.7	10.7	8.2	23.4	14.7	15.7	7.3	22.2	13.4	19.2	11.8	11.9	15.7	23.9	12.6	20.9	24.3	51.8	14.6	16.6	12.2	18.9	7.4	15.4	11.5	21.2	12.9	19.6	10.3	13.1	6.1	11.0	10.1	10.7	12.2	30.7	11.7	12.7	15.5	12.3	17.1	45.1	19.9	32.9	11.6	15.9	16.4	13.0	13.6	15.5	16.7	16.4	8.7	18.7	15.0	7.9	42.5	20.7	28.0	2.5	2.4	2.6	2.9	2.8	2.9	3.4	2.8	2.4	2.4	3.2	3.4	0.9	3.8	5.2	1.4	2.1	1.5	2.0	2.9	2.4	3.0	2.4	3.2	2.3	3.2	2.9	2.4	2.5	3.0	6.0	3.2	5.3	10.1	9.6	4.5	3.3	4.0	10.8	4.1	5.6	2.8	23.5	4.3	4.9	12.9	0.0	5.3	9.2	8.8	1.9	4.3	2.9	6.9	7.3	6.2	6.7	7.2	16.5	6.0	6.2	6.4	10.2	7.6	7.6	5.5	6.1	10.2	6.4	6.7	17.7	9.2	12.2	10.7	2.5	1.7	4.7	7.7	8.8	8.4	10.7	4.8	2.1	15.1	15.5	6.8	5.7	3.4	12.8	5.1	5.9	7.9	7.9	4.9	6.6	3.9	5.6	6.1	6.5	10.3	4.0	5.3	9.5	6.3	6.9	4.3
CAB39	"CGI-66, MO25"	ENSG00000135932	"Calcium binding protein 39"	Q9Y376	2	230712842-230821075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 188.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037112, HPA076632"	Approved		Approved	Nucleoli,Cytosol		NA	NA		100000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli	Cytosol	"CAB037112: AB_1078367, HPA076632: "	"unprognostic (4.36e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (1.04e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.92e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.36e-1)"	43.7	31.0	30.1	55.2	32.9	50.9	29.6	31.5	40.6	26.5	29.3	53.7	48.0	30.7	35.0	55.8	30.0	41.3	55.6	34.3	33.9	54.1	38.6	40.0	58.0	36.5	34.5	29.2	33.1	42.5	17.1	35.5	36.4	39.9	56.0	45.6	34.4	31.2	188.5	34.3	51.2	40.4	34.0	38.0	46.2	41.3	33.6	45.1	37.3	127.8	59.1	49.4	30.5	39.5	131.6	30.0	39.8	34.0	48.2	59.8	45.3	73.7	91.8	45.4	47.2	36.6	140.0	33.8	56.5	64.5	76.5	59.1	44.8	138.5	91.9	142.1	35.1	90.5	36.9	39.5	40.9	126.6	100.8	42.5	79.1	58.5	128.4	51.8	57.1	46.1	153.9	30.3	43.8	45.6	59.1	77.9	39.8	53.4	52.0	67.8	59.3	33.5	84.6	104.9	43.2	26.4	55.2	68.2	59.9	44.7	16.9	72.4	73.1	63.9	24.3	68.2	61.0	39.0	31.8	53.8	45.4	72.4	53.4	4.0	3.6	6.0	4.7	4.4	4.8	3.0	5.8	6.1	3.0	2.4	4.7	6.5	10.3	9.3	4.3	2.2	6.2	2.4	30.1	32.9	31.5	40.6	34.3	33.9	36.5	34.5	36.4	34.0	33.6	39.5	41.6	64.1	37.5	42.1	29.6	97.8	44.2	23.0	23.3	14.4	28.3	18.9	69.1	17.2	30.5	51.5	33.3	20.8	32.3	162.5	29.4	26.0	12.0	41.4	25.2	29.6	20.4	32.0	85.1	32.7	18.7	24.1	28.5	39.5	20.3	16.6	28.2	29.3	56.8	28.6	69.3	48.5	24.4	81.2	72.4	13.5	17.4	66.2	30.2	93.7	49.6	39.6	29.9	58.8	64.3	72.3	62.4	32.0	37.0	84.4	54.6	39.8	55.6	40.5	13.1	27.5	27.3	30.8	29.5	31.2	85.1	23.1	52.0	18.9	34.8	88.6
CACNA1S	"CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5"	ENSG00000081248	"Calcium voltage-gated channel subunit alpha1 S"	Q13698	1	201039512-201112451	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	86	"skeletal muscle: 254.9;tongue: 193.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Cone photoreceptor cells: 6.2;Late spermatids: 5.9;Skeletal myocytes: 6.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"BEWO: 1.1;HSkMC: 1.8"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.8"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 2.6"	"CAB009507, HPA048892, HPA056815"	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"			"CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242"	"unprognostic (2.14e-2)"		"unprognostic (1.38e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.52e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.84e-1)"		"unprognostic (2.23e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-1)"	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.9	1.5	0.0	254.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.0	193.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.6	0.2	0.8	0.2	0.1	1.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	6.3	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNB1	CACNLB1	ENSG00000067191	"Calcium voltage-gated channel auxiliary subunit beta 1"	Q02641	17	39173453-39197703	"FDA approved drug targets, Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 328.8;tongue: 216.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 20.9;Excitatory neurons: 14.3;Skeletal myocytes: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023343	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"			"HPA023343: AB_1845866"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (3.99e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.94e-11)"	"unprognostic (7.62e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.44e-3)"	5.7	3.6	17.8	2.6	23.7	1.4	5.6	0.0	31.7	12.2	0.0	7.6	1.5	6.3	5.4	6.8	6.9	2.1	7.5	23.4	10.9	3.2	0.9	9.3	2.5	4.4	5.9	6.7	2.6	1.6	7.7	1.7	13.0	8.1	2.5	5.5	13.5	5.4	328.8	12.1	4.1	2.9	1.0	4.7	3.7	7.6	5.0	4.4	6.8	216.0	1.8	6.5	6.5	20.4	6.1	2.7	3.3	7.6	3.6	4.4	0.1	3.6	4.4	3.3	4.1	2.0	6.0	10.4	3.6	5.4	4.7	5.6	3.2	5.9	2.4	5.0	3.7	1.5	7.4	0.8	7.4	0.2	0.9	4.9	1.9	6.9	7.8	4.3	2.4	6.4	0.9	8.9	3.5	1.7	7.6	2.8	2.4	0.9	1.9	5.1	10.9	4.6	1.3	1.9	8.3	5.0	2.1	11.2	3.5	1.2	7.9	4.1	3.4	5.9	6.8	4.4	3.7	4.1	1.5	1.7	4.8	0.0	2.4	0.0	0.4	0.0	0.6	0.1	0.9	0.0	0.6	0.8	0.1	0.0	0.2	0.3	0.0	0.6	0.1	1.0	0.1	0.2	17.8	23.7	0.0	31.7	23.4	10.9	4.4	5.9	13.0	1.0	5.0	20.4	1.4	3.2	3.2	20.9	0.8	2.9	0.7	2.3	2.8	3.1	1.5	1.1	1.7	0.0	2.2	0.0	0.0	0.1	4.0	7.1	0.0	0.6	4.2	1.1	3.3	1.5	0.0	0.4	14.3	0.9	0.1	4.9	2.6	1.7	0.0	2.1	0.4	0.1	1.0	0.0	8.3	1.4	4.1	0.8	5.1	2.4	1.8	1.6	5.4	1.0	0.6	7.2	1.0	2.5	2.1	1.5	1.0	1.2	2.3	2.4	0.0	0.0	0.8	1.4	0.0	13.4	7.0	2.9	0.8	1.1	3.0	0.1	4.6	1.6	1.0	1.1
CALML6	CAGLP	ENSG00000169885	"Calmodulin like 6"	Q8TD86	1	1915108-1917296	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	19	"skeletal muscle: 154.6;tongue: 109.9"	"Cell type enriched"	"Detected in some"	22	"Skeletal myocytes: 22.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;BEWO: 1.3;CAPAN-2: 1.2;hTCEpi: 1.4"															NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (3.85e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.59e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.33e-3)"	"unprognostic (9.72e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.76e-2)"	"unprognostic (5.21e-10)"	"unprognostic (5.06e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.48e-2)"	0.4	0.3	1.2	0.2	1.4	0.2	0.6	1.3	2.9	0.7	1.2	0.3	0.1	0.3	0.8	7.0	0.3	0.0	0.2	1.3	1.2	0.8	2.0	0.3	0.2	1.2	1.2	0.3	1.6	0.2	0.7	0.1	1.2	1.4	0.3	0.2	2.9	0.4	154.6	1.7	0.3	0.2	1.2	0.5	0.5	1.3	1.3	0.2	0.5	109.9	0.4	0.3	1.0	1.3	0.0	0.0	0.1	1.6	0.7	0.3	1.3	0.3	0.0	0.1	0.1	0.0	1.2	0.4	0.1	0.5	0.1	0.7	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.3	0.3	1.4	0.1	0.1	0.1	0.1	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.4	0.1	0.8	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	1.3	2.9	1.3	1.2	1.2	1.2	1.2	1.2	1.3	1.3	0.0	0.0	0.0	0.3	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	22.8	1.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393505-17557790	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 577.1;tongue: 313.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.5;Excitatory neurons: 158.1;Inhibitory neurons: 137.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 26.1;basal ganglia: 40.9;cerebral cortex: 87.2;hippocampal formation: 50.2;white matter: 32.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 101.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	17.8	11.6	26.1	7.6	40.9	0.0	10.7	0.9	87.2	15.4	2.9	32.6	4.1	28.5	17.8	21.7	16.8	11.4	113.6	50.2	11.1	8.7	4.5	4.7	1.7	3.2	3.8	4.5	4.2	7.5	5.1	8.8	2.7	25.1	9.6	9.1	7.7	30.7	577.1	2.6	8.9	42.7	0.0	3.1	9.8	1.5	9.1	3.1	5.5	313.0	2.3	14.5	6.4	32.3	15.5	24.6	44.4	55.1	0.3	0.1	10.4	52.3	42.7	46.6	43.0	8.1	6.9	0.0	48.9	62.1	60.5	8.2	21.3	20.9	66.8	0.1	7.9	0.0	15.4	26.5	4.3	0.0	0.0	3.5	9.9	23.1	10.3	72.3	2.2	0.0	0.0	0.1	101.6	25.2	0.0	0.0	17.0	0.8	15.6	5.2	59.1	1.1	23.6	6.4	6.1	10.9	19.0	59.2	31.3	82.8	65.0	11.2	0.2	36.6	31.6	1.0	47.6	0.0	0.0	0.2	11.7	0.1	48.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	40.9	0.9	87.2	50.2	11.1	3.2	3.8	2.7	0.0	9.1	32.3	2.0	3.2	1.5	9.8	0.0	1.9	4.3	6.2	5.7	16.4	10.2	8.4	126.5	4.3	5.4	1.8	4.2	16.5	0.0	1.9	3.9	2.7	0.1	13.9	13.7	2.7	6.0	0.0	158.1	0.7	12.2	7.9	0.0	5.8	0.0	22.8	3.9	2.4	2.2	8.4	137.2	1.3	2.0	0.0	2.2	0.0	0.6	0.3	0.0	10.3	0.0	6.3	0.0	16.6	7.2	3.7	1.9	4.9	0.0	1.9	0.0	16.7	33.9	2.2	32.9	25.5	43.4	0.1	3.2	2.1	0.9	37.5	0.3	0.3	1.6	0.6
CAPN7	PalBH	ENSG00000131375	"Calpain 7"	Q9Y6W3	3	15206152-15252916	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004745, HPA046617"	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Centrosome	"HPA004745: , HPA046617: AB_2679721"	"unprognostic (2.70e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (4.85e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.22e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.05e-2)"	13.9	11.9	4.6	11.6	5.9	13.2	16.6	12.5	5.4	16.9	9.3	12.1	12.9	16.1	14.9	11.4	14.4	11.1	11.6	4.1	8.1	15.2	19.1	12.1	14.3	5.9	5.7	19.8	15.3	20.1	9.2	12.9	5.5	14.1	12.2	28.5	13.9	12.7	25.3	11.6	13.6	13.8	6.0	11.4	14.0	12.1	6.8	16.9	23.5	16.5	15.7	10.2	9.8	9.7	14.3	18.5	15.1	9.5	26.0	20.1	51.4	18.1	20.8	22.1	16.7	13.3	10.0	24.6	12.3	20.7	13.6	9.7	22.5	23.3	19.0	23.7	17.5	30.8	24.8	17.7	19.3	25.1	15.0	13.9	33.2	28.7	14.1	20.9	15.9	23.3	30.3	25.1	21.6	20.8	17.9	10.5	14.5	20.7	17.7	10.2	25.1	17.1	16.4	25.8	12.2	15.8	29.5	15.7	20.8	19.2	27.9	25.8	14.4	19.8	14.9	25.9	21.4	17.2	37.1	12.4	18.1	18.0	17.5	4.6	3.0	5.1	3.3	2.5	5.3	3.5	3.6	2.8	2.9	3.1	4.9	4.6	1.8	3.6	4.4	2.4	3.0	3.0	4.6	5.9	12.5	5.4	4.1	8.1	5.9	5.7	5.5	6.0	6.8	9.7	15.8	12.8	23.6	44.1	35.0	21.4	13.5	10.6	47.3	42.7	20.3	16.0	33.2	8.6	20.6	1.8	56.3	21.2	21.7	11.2	9.8	12.6	15.5	32.2	31.5	19.0	20.9	14.9	60.2	16.9	12.6	27.6	30.1	29.9	15.8	28.9	14.6	20.8	12.2	55.5	65.8	11.3	4.1	11.9	23.0	14.8	24.8	20.9	21.4	49.6	18.4	31.2	10.3	73.9	86.0	13.0	6.9	26.4	52.8	20.0	16.7	15.2	34.9	98.1	39.5	31.5	24.8	26.8	17.8	29.7	23.2	26.1	34.2	21.1	11.8	14.3
CAPZB		ENSG00000077549	"Capping actin protein of muscle Z-line subunit beta"	P47756	1	19338775-19485539	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1188.8;Late spermatids: 3669.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031531	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		6600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Vesicles	"HPA031531: AB_10603556"	"unprognostic (7.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (4.55e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.78e-1)"	210.2	193.0	126.1	196.7	126.9	154.3	189.1	128.8	133.4	233.9	129.0	294.5	149.1	254.5	145.8	265.1	199.9	144.2	207.5	139.9	129.8	161.3	127.7	217.9	223.8	133.7	128.6	205.1	94.2	128.6	121.5	178.7	132.5	200.9	214.2	123.8	152.5	177.9	301.8	195.1	220.6	241.4	126.3	215.9	192.6	216.2	135.8	237.1	155.2	214.2	271.8	230.3	222.2	143.8	263.9	146.4	260.0	179.3	355.6	467.0	187.9	435.9	430.0	364.0	377.5	189.6	338.1	179.7	186.4	533.5	218.7	212.0	224.0	297.9	424.3	280.0	160.5	340.1	170.6	298.3	355.0	236.5	533.6	424.0	243.4	314.9	292.6	300.5	338.6	204.5	132.1	229.7	393.9	185.1	270.5	307.0	200.5	343.8	155.3	223.4	184.6	225.2	507.6	133.0	158.0	123.4	255.2	200.6	299.3	229.5	222.2	199.6	351.5	237.9	207.0	409.4	208.7	156.0	188.8	217.4	314.1	306.8	261.5	456.1	358.2	1077.5	304.0	542.3	265.0	266.1	318.5	329.4	362.3	203.7	263.5	293.7	576.3	196.7	703.0	199.1	404.2	597.6	126.1	126.9	128.8	133.4	139.9	129.8	133.7	128.6	132.5	126.3	135.8	143.8	197.7	99.3	68.9	52.9	160.3	156.3	282.8	263.0	103.6	93.9	106.9	117.7	87.6	112.9	143.5	101.2	41.7	338.0	247.5	301.7	297.4	322.1	1188.8	86.7	122.2	182.4	141.2	89.4	49.8	256.5	396.4	178.9	101.9	96.8	147.5	164.6	156.0	98.7	800.9	77.4	67.5	278.7	215.7	302.6	276.7	3669.8	232.7	311.2	144.1	124.6	561.5	151.1	338.8	42.7	64.9	349.6	295.2	302.4	103.4	206.8	235.6	251.2	122.6	93.2	243.3	97.8	262.6	119.0	81.5	150.3	182.7	342.2	268.2	197.9	193.8	280.5
CASZ1	"castor, cst, FLJ20321, SRG, ZNF693"	ENSG00000130940	"Castor zinc finger 1"	Q86V15	1	10636604-10796650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 49.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 608.8;Horizontal cells: 138.0;Rod photoreceptor cells: 477.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 12.4;HDLM-2: 13.4;SCLC-21H: 19.8;SK-BR-3: 18.9"					"Low region specificity"	"Detected in some"			"HPA028222, HPA029927"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA028222: AB_10600106, HPA029927: AB_10601564"	"unprognostic (1.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.49e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.55e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.03e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.56e-1)"	2.1	2.0	0.6	2.2	0.8	4.6	7.0	0.1	1.1	5.9	2.4	20.6	12.0	7.8	0.8	15.3	5.6	2.7	20.1	0.2	1.2	7.4	2.7	11.3	1.3	1.0	0.7	0.9	6.0	0.2	2.1	1.7	0.8	18.2	3.3	35.1	19.9	5.8	34.4	49.0	11.6	3.3	2.3	2.2	17.3	1.7	0.9	1.3	3.4	5.8	1.9	10.7	11.6	0.1	12.4	1.0	2.2	2.2	0.0	0.0	0.5	0.4	0.1	0.4	0.4	2.6	2.8	0.5	2.5	0.5	1.0	10.5	2.3	2.4	0.2	13.4	4.1	0.8	2.0	2.8	0.3	1.4	3.8	0.1	8.7	0.1	0.8	0.0	0.4	1.9	0.0	0.0	0.1	6.6	0.7	8.9	0.2	6.4	0.6	1.0	1.5	0.1	2.0	5.0	19.8	1.8	3.2	18.9	0.3	0.8	10.1	1.3	0.1	0.0	1.6	1.0	0.2	0.0	0.0	1.3	0.1	3.8	0.2	0.6	0.0	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.4	0.6	0.8	0.0	0.1	0.6	0.8	0.1	1.1	0.2	1.2	1.0	0.7	0.8	2.3	0.9	0.1	12.9	28.9	21.7	1.6	6.1	33.0	20.1	21.2	30.7	12.7	57.9	30.4	25.2	17.2	17.8	14.7	608.8	0.7	15.3	60.4	3.9	14.1	0.6	41.8	5.6	14.4	41.3	1.3	1.6	8.9	1.2	2.3	57.6	66.7	4.5	4.5	5.0	5.1	1.1	138.0	0.9	39.1	16.2	0.3	5.1	1.6	0.0	1.8	1.8	1.9	6.7	28.4	9.2	0.5	0.3	18.1	40.8	6.8	6.1	33.4	46.3	1.1	41.2	477.7	0.0	6.8	5.1	2.5	3.5	31.0	61.2	0.7	7.6	1.5	27.1	27.6
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733802-8841808	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 182.7;tongue: 72.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 22.9;Early spermatids: 4.2;Sertoli cells: 6.6;Skeletal myocytes: 11.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	5.7	0.1	0.1	27.4	0.1	0.1	0.0	0.0	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	2.5	0.2	182.7	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.1	72.8	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	11.0	2.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0
CAVIN4	"cavin-4, MURC"	ENSG00000170681	"Caveolae associated protein 4"	Q5BKX8	9	100578079-100588389	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 276.1;tongue: 92.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.9;Granulosa cells: 1.8;Pancreatic endocrine cells: 1.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.9;SCLC-21H: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020973, HPA020987, HPA021021"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082"	"unprognostic (9.54e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.14e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.74e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.55e-3)"	0.2	0.1	1.6	0.2	2.9	0.1	0.1	2.0	5.6	0.4	0.4	0.4	0.0	0.5	0.1	4.3	0.1	0.3	45.9	1.7	2.5	0.2	0.2	0.4	0.1	2.7	2.7	0.2	0.1	0.0	0.2	0.3	2.7	4.5	0.1	0.3	2.4	0.1	276.1	0.2	0.1	0.3	1.8	0.1	0.3	3.7	2.7	0.4	0.5	92.4	0.1	0.3	0.2	3.5	0.5	0.3	6.1	2.2	1.4	2.0	4.3	1.1	0.9	0.8	1.0	0.0	0.4	0.2	0.3	0.6	2.1	0.3	3.1	0.1	1.7	1.4	2.0	0.1	1.0	0.0	0.4	0.2	0.4	5.0	0.3	0.8	0.5	1.5	1.1	1.5	0.2	0.2	3.9	0.1	1.8	0.3	8.9	1.0	0.7	2.6	5.8	0.0	0.8	0.3	13.2	3.4	0.2	0.2	1.1	4.1	0.1	0.2	1.1	1.5	1.2	1.0	1.0	0.3	1.1	0.6	1.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.9	2.0	5.6	1.7	2.5	2.7	2.7	2.7	1.8	2.7	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.7	0.0	1.2	1.8	0.3	0.0	0.0	0.0	0.5	0.4	0.5	0.0	1.9	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0
CCDC43	FLJ31795	ENSG00000180329	"Coiled-coil domain containing 43"	Q96MW1	17	44673069-44689779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023078, HPA023391"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA023078: , HPA023391: AB_1846146"	"unprognostic (6.05e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (3.42e-5)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.11e-1)"	9.6	10.2	9.5	11.4	10.3	20.8	12.5	11.5	14.3	9.3	8.1	12.1	11.7	10.0	10.9	12.0	9.3	7.5	20.4	10.6	10.3	14.2	9.5	9.7	13.5	9.5	9.0	8.1	9.6	15.4	4.8	14.0	10.2	12.0	14.9	18.5	8.9	8.9	73.5	11.3	9.7	10.8	9.8	9.8	11.2	9.5	10.4	13.8	13.5	42.7	14.6	11.8	8.1	11.5	24.9	29.3	27.2	24.1	18.2	26.7	49.8	37.1	21.8	35.7	34.9	39.7	26.0	43.1	28.0	30.4	25.5	19.2	45.3	42.9	51.5	53.1	52.5	38.8	48.8	59.0	32.5	54.8	28.0	24.1	42.7	37.2	50.2	24.4	35.1	34.8	41.6	29.3	36.6	31.0	53.7	38.8	28.2	23.5	37.1	34.5	68.2	37.6	36.7	16.0	27.3	26.9	27.2	21.6	39.5	40.7	55.2	36.6	30.6	43.9	32.5	26.6	50.0	29.5	40.1	49.4	32.1	31.4	32.2	11.6	15.7	11.0	11.9	18.4	11.0	9.1	11.3	13.7	17.5	11.3	11.0	12.0	3.2	16.4	12.5	12.4	15.1	10.2	9.5	10.3	11.5	14.3	10.6	10.3	9.5	9.0	10.2	9.8	10.4	11.5	24.4	12.8	21.0	6.8	19.1	13.3	10.8	20.0	13.1	24.4	15.2	15.7	41.1	17.2	21.5	9.2	10.4	41.1	13.4	10.7	39.2	21.6	0.9	23.4	27.1	23.9	18.0	15.4	10.5	24.5	46.7	17.1	13.7	24.0	32.4	19.9	20.0	15.5	30.6	21.9	8.2	17.1	8.2	18.8	16.0	3.5	14.0	19.2	21.4	1.0	24.6	19.6	9.2	6.6	6.5	21.0	12.4	12.8	26.9	12.9	15.0	36.8	19.8	25.4	6.6	23.4	17.5	3.6	12.4	24.8	11.2	25.3	16.7	22.6	22.6	8.7
CCDC69	"DKFZP434C171, FLJ13705"	ENSG00000198624	"Coiled-coil domain containing 69"	A6NI79	5	151181052-151224093	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 351.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 124.5;dendritic cells: 106.9;Granulosa cells: 138.2;NK-cells: 197.8;Plasma cells: 133.6;Theca cells: 132.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 129.2;Daudi: 199.9;U-266/70: 120.5;U-698: 119.1"	"Region enhanced"	"Detected in some"		"cerebellum: 4.8"	"Low region specificity"	"Detected in all"			"HPA043648, HPA052896"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Actin filaments"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"	"Golgi apparatus, Actin filaments"	"HPA043648: AB_10795877, HPA052896: AB_2681983"	"prognostic favorable (3.21e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.29e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.01e-1)"	108.9	89.6	6.7	45.8	8.4	46.3	60.5	12.2	7.9	15.2	13.4	138.5	19.6	32.9	13.3	54.1	37.1	19.3	96.9	5.9	8.9	10.7	24.0	39.0	70.4	13.3	13.8	27.1	47.5	32.1	8.5	14.8	13.6	23.0	20.5	1.8	14.4	29.4	351.9	13.3	44.7	45.6	11.3	55.4	37.0	13.2	9.2	37.8	11.6	163.8	66.8	87.7	21.9	7.2	8.0	1.6	0.4	6.4	129.2	13.1	4.2	1.5	13.1	2.6	2.4	2.1	1.1	199.9	6.3	0.5	3.3	1.0	3.0	2.8	0.9	0.1	2.7	27.0	0.0	17.5	21.1	9.9	34.4	33.0	0.2	1.0	0.0	2.5	13.1	0.0	23.7	44.0	0.1	0.6	43.8	23.3	7.5	0.1	15.2	36.0	1.0	12.1	0.5	5.9	0.2	0.8	2.4	3.2	1.7	3.2	2.0	24.0	32.0	1.0	6.1	0.6	1.5	120.5	60.1	119.1	1.4	22.2	0.0	30.9	12.4	13.5	11.3	10.9	10.3	5.4	8.8	10.8	10.0	10.4	6.1	6.6	9.6	14.3	10.3	19.3	8.5	11.5	6.7	8.4	12.2	7.9	5.9	8.9	13.3	13.8	13.6	11.3	9.2	7.2	51.0	12.8	78.4	0.7	68.8	2.5	3.0	3.5	1.2	0.4	4.8	2.4	124.5	1.5	13.5	1.8	0.0	7.3	106.9	0.2	0.0	2.9	0.5	26.8	2.7	58.9	1.8	32.2	1.8	20.0	9.6	18.4	7.1	1.3	34.8	138.2	28.2	39.7	7.3	6.7	2.7	0.0	4.1	64.0	12.2	2.4	5.6	46.5	10.6	11.2	73.5	4.9	197.8	1.0	0.6	8.8	0.1	7.9	133.6	3.6	4.5	3.2	51.3	1.4	13.1	4.7	14.8	1.2	1.0	0.7	1.3	35.4	65.7	132.1	0.9	23.5
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736479	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1445.2;Prostatic glandular cells: 1678.0;Urothelial cells: 1531.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 3747.5;U-2197: 3049.9"									"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		58000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.66e-2)"	"prognostic favorable (1.39e-10)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.09e-1)"	517.4	248.3	284.5	209.6	310.8	198.8	555.9	329.0	365.1	305.5	542.2	255.1	120.7	290.7	971.7	478.9	368.1	475.3	608.3	288.2	359.7	577.4	339.8	553.5	148.8	327.9	340.2	228.5	353.6	706.1	250.3	485.6	340.9	256.8	271.4	130.7	693.6	443.2	529.3	282.8	167.9	380.0	330.5	131.8	422.7	127.7	337.0	167.7	308.1	915.0	288.6	550.5	325.5	315.6	297.2	278.4	77.6	212.0	1697.1	1314.9	46.8	1765.7	1778.5	408.9	451.9	129.7	822.1	23.9	291.5	1802.5	475.5	314.0	141.0	1589.9	561.1	475.5	218.2	31.3	846.7	193.1	483.2	183.4	94.8	631.8	387.2	343.3	1550.6	1104.9	2475.5	109.3	207.9	585.9	2575.4	282.7	79.9	70.3	43.5	541.8	1421.8	30.1	232.1	227.8	1304.4	510.0	54.3	79.5	576.2	243.7	298.2	218.0	187.5	18.1	3747.5	838.6	235.5	3049.9	595.9	273.8	558.8	30.4	734.2	1.3	1556.9	164.9	22.3	209.6	50.9	7.9	64.8	63.9	104.9	56.6	95.4	59.6	68.2	41.4	134.3	92.5	4.8	49.9	298.2	53.5	284.5	310.8	329.0	365.1	288.2	359.7	327.9	340.2	340.9	330.5	337.0	315.6	728.0	272.4	247.2	32.3	39.1	286.0	1103.2	951.4	82.0	51.3	434.9	270.0	315.5	444.7	569.7	242.8	33.3	553.5	29.2	344.6	164.4	1445.2	129.4	94.3	91.6	792.6	166.6	206.0	25.1	618.3	407.2	303.5	109.6	115.6	139.4	88.2	585.0	185.7	486.7	47.1	29.9	112.8	722.2	139.4	374.2	61.6	237.3	88.2	1270.0	54.4	161.7	198.3	26.8	32.6	22.2	1195.7	392.2	204.7	149.7	1678.0	41.7	208.2	1042.5	56.2	276.1	159.1	410.7	130.6	31.2	83.7	284.4	836.6	52.4	139.5	104.9	1531.0
CDH13	CDHH	ENSG00000140945	"Cadherin 13"	P55290	16	82626965-83800640	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 57.1;skeletal muscle: 68.6;tongue: 57.7"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 328.8;Inhibitory neurons: 867.0;Oligodendrocyte precursor cells: 335.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.2;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 222.2;U-138 MG: 279.2;U-87 MG: 244.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001380, CAB025863"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		240000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB025863: , HPA001380: AB_1078371"	"unprognostic (2.50e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.06e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (5.16e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	20.3	2.8	18.7	3.8	21.5	0.6	10.0	0.0	14.3	42.5	0.0	5.0	1.5	47.2	3.3	9.5	7.6	5.0	57.1	10.5	3.3	5.0	1.8	16.1	1.4	1.5	6.5	3.1	0.6	2.4	0.5	6.0	0.6	3.5	6.2	1.5	4.9	7.2	68.6	21.1	2.3	29.9	6.3	2.1	1.7	1.8	22.9	1.8	5.8	57.7	1.9	7.1	19.4	3.2	10.2	0.0	3.6	0.5	63.2	60.6	0.1	47.1	51.9	53.6	23.1	0.1	0.4	0.1	8.5	138.5	26.0	89.1	1.0	70.7	79.8	0.0	0.2	0.1	31.4	0.1	36.4	0.0	0.4	7.9	59.9	107.8	130.4	83.9	26.7	0.0	0.2	0.5	222.2	0.5	0.1	0.2	10.6	0.0	19.4	0.0	57.7	0.0	46.2	0.4	0.1	0.1	84.4	0.3	0.1	103.5	0.8	0.1	43.1	279.2	22.7	1.6	43.0	0.2	0.1	0.2	244.0	0.2	70.1	2.2	0.5	1.4	0.0	2.1	0.0	0.5	0.0	0.0	0.5	0.5	0.0	0.0	1.1	0.0	4.3	0.3	0.0	0.2	18.7	21.5	0.0	14.3	10.5	3.3	1.5	6.5	0.6	6.3	22.9	3.2	125.4	0.0	0.5	11.1	0.3	70.7	28.7	32.3	25.0	3.0	1.0	5.8	86.9	0.0	2.6	3.7	0.0	0.1	0.9	2.1	7.9	0.4	44.5	1.0	27.1	49.2	1.8	0.0	328.8	0.0	0.2	9.7	0.0	0.7	0.0	0.0	29.6	0.3	0.6	5.0	867.0	1.6	0.0	1.9	13.3	43.3	0.3	1.4	8.8	17.8	0.0	0.4	0.0	335.8	65.0	0.1	1.4	0.0	0.0	36.7	0.0	1.3	0.8	0.4	0.0	51.0	22.7	2.9	0.6	3.3	18.8	0.1	1.2	0.7	0.1	6.4
CDK5RAP1	"C20orf34, C42, CGI-05, HSPC167"	ENSG00000101391	"CDK5 regulatory subunit associated protein 1"	Q96SZ6	20	33358839-33401561	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 128.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 116.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066301			Approved	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	Mitochondria	"HPA066301: AB_2685653"	"unprognostic (2.86e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.49e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.18e-2)"	"unprognostic (5.10e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (3.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.06e-1)"	9.1	8.4	4.9	10.7	5.7	18.6	10.5	4.9	5.3	8.4	6.3	9.0	8.9	9.8	11.5	9.3	9.2	6.2	12.0	5.7	4.3	9.0	11.1	9.0	12.7	4.5	4.4	8.6	7.6	11.2	7.2	10.3	4.1	8.4	12.2	15.9	10.6	8.7	20.9	12.6	9.5	10.8	3.9	10.3	9.7	9.3	4.6	11.3	11.9	22.8	15.2	8.7	7.9	4.9	27.0	27.6	18.6	17.1	17.4	13.4	40.7	15.8	22.5	45.0	46.9	116.5	23.9	47.3	21.0	17.2	29.0	39.1	31.8	45.1	34.8	8.9	17.3	57.1	30.8	45.1	20.3	36.6	17.4	17.5	18.9	30.2	35.9	11.4	24.9	13.6	36.7	19.3	20.0	26.6	37.8	27.5	14.1	30.2	40.1	27.8	42.4	36.1	24.5	23.6	25.2	14.3	50.5	24.4	33.0	20.9	34.7	17.4	18.4	33.3	27.3	23.1	27.4	16.6	20.1	34.8	19.8	39.3	15.9	4.5	17.3	11.8	18.5	22.3	22.2	21.4	18.3	18.0	19.1	14.1	16.2	14.0	0.9	21.6	18.4	13.4	17.3	15.1	4.9	5.7	4.9	5.3	5.7	4.3	4.5	4.4	4.1	3.9	4.6	4.9	13.2	16.0	20.0	26.8	18.6	12.1	10.3	21.1	10.8	25.6	9.3	8.9	15.7	11.5	18.6	7.3	27.1	31.4	18.2	7.4	13.7	17.6	2.9	10.1	10.3	11.4	12.6	12.2	36.7	18.3	18.5	10.4	13.3	14.6	29.8	15.6	6.1	15.6	17.5	11.8	25.4	8.6	128.1	10.1	12.6	2.8	13.1	13.5	10.6	10.3	15.2	16.5	19.6	16.1	26.6	13.0	9.0	10.5	19.3	8.3	13.8	15.3	20.9	39.9	19.7	14.8	15.3	32.6	23.6	8.5	10.4	16.0	22.3	16.1	12.6	8.9
CDNF	ARMETL1	ENSG00000185267	"Cerebral dopamine neurotrophic factor"	Q49AH0	10	14819245-14838575	"Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.9;tongue: 20.3"	"Group enriched"	"Detected in many"	9	"Early spermatids: 99.9;Late spermatids: 274.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 8.4;U-266/70: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044587	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA044587: AB_10795881"	"unprognostic (2.80e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.62e-1)"	2.5	2.4	0.8	0.5	1.1	0.4	3.6	1.2	1.2	1.7	1.3	1.2	1.8	2.0	3.8	1.5	3.9	1.5	2.2	0.9	1.3	3.4	8.6	1.1	1.5	1.2	1.3	2.8	5.4	2.9	2.0	0.5	1.4	2.9	1.1	1.7	3.8	1.8	25.9	5.0	1.1	0.7	1.3	1.0	2.5	10.1	1.0	1.2	4.1	20.3	1.5	1.2	1.3	1.7	0.4	0.4	1.0	0.4	2.2	1.9	0.1	0.8	1.7	0.7	0.5	0.6	0.9	3.3	0.7	0.5	0.0	0.3	0.1	0.0	0.7	0.3	1.0	0.5	0.5	0.2	1.4	0.2	0.0	1.7	1.2	0.3	1.3	1.1	0.7	1.5	1.0	2.1	1.0	0.9	0.4	0.3	0.6	0.6	0.2	0.6	0.4	8.4	0.4	0.1	0.8	1.3	0.2	0.5	1.4	0.5	1.2	0.3	0.5	0.1	0.3	1.4	0.1	4.5	1.2	0.5	0.6	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.3	0.3	0.5	0.3	0.3	1.2	0.8	0.0	0.9	0.1	0.4	1.6	0.2	0.8	1.1	1.2	1.2	0.9	1.3	1.2	1.3	1.4	1.3	1.0	1.7	0.5	0.0	2.2	2.0	2.3	2.0	1.4	0.7	4.0	1.0	2.3	2.2	2.0	2.8	2.3	0.0	2.1	0.9	0.6	0.1	3.9	1.0	99.9	4.2	0.8	0.9	0.0	0.4	1.0	3.6	1.6	2.1	5.1	0.6	0.0	0.7	0.4	5.8	0.4	0.0	1.4	0.5	2.0	1.2	0.6	274.2	1.2	0.4	0.0	1.0	0.2	3.1	3.1	1.5	3.3	0.6	0.5	1.2	4.8	0.9	1.4	5.2	5.8	1.0	0.0	3.2	1.8	18.9	7.5	1.6	0.1	1.4	1.2	0.5	0.7	1.2
CEBPG	"GPE1BP, IG/EBP-1"	ENSG00000153879	"CCAAT enhancer binding protein gamma"	P53567	19	33373685-33382686	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012024	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA012024: AB_1846503"	"unprognostic (5.56e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.12e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.01e-2)"	19.1	8.8	16.0	14.2	16.9	15.4	15.1	17.6	23.8	11.0	12.4	30.2	34.1	12.0	9.1	20.1	11.9	11.4	14.8	15.6	19.3	12.9	34.6	16.0	12.4	17.0	17.6	5.3	28.3	15.1	11.0	16.8	17.6	12.0	28.8	17.3	13.5	9.4	47.4	27.7	35.3	14.6	18.7	9.7	18.8	12.5	19.0	14.1	25.7	44.2	13.8	16.3	14.2	18.4	33.4	29.7	30.9	31.0	14.8	21.6	41.8	24.8	22.1	21.9	26.4	35.3	14.4	54.0	19.1	11.8	26.2	16.6	54.8	25.0	37.5	91.7	23.3	29.1	15.6	34.5	49.3	49.1	31.0	28.6	121.0	27.7	86.7	11.1	27.7	45.1	39.3	49.7	17.9	20.4	33.0	25.7	17.5	94.2	18.2	35.1	21.0	22.5	12.4	19.9	61.1	37.2	25.8	26.7	61.3	22.6	22.7	96.8	26.7	22.2	26.3	23.8	39.6	28.4	27.0	32.4	23.4	53.2	31.4	7.5	9.7	4.4	3.6	11.8	4.3	4.6	4.9	5.6	10.3	3.7	5.2	5.0	0.8	3.0	19.1	3.2	6.0	5.6	16.0	16.9	17.6	23.8	15.6	19.3	17.0	17.6	17.6	18.7	19.0	18.4	61.3	19.2	13.2	2.6	30.5	124.3	95.8	51.5	67.7	11.3	32.8	31.9	15.1	48.6	29.6	14.7	8.4	42.6	27.6	160.5	19.6	37.0	90.3	43.2	14.9	50.4	35.3	22.3	11.7	54.1	71.5	26.1	34.1	26.6	26.0	9.5	31.4	66.2	45.6	3.3	8.3	81.8	34.6	35.4	65.1	74.5	6.8	34.4	28.4	10.3	63.9	27.7	28.8	6.0	3.9	75.8	107.7	9.1	30.5	70.2	115.7	30.4	49.4	12.9	6.6	24.7	31.5	76.4	45.2	57.8	155.7	74.8	29.4	5.1	67.8	120.4
CHCHD3	"FLJ20420, Mic19, MICOS19, MINOS3, PPP1R22"	ENSG00000106554	"Coiled-coil-helix-coiled-coil-helix domain containing 3"	Q9NX63	7	132784870-133082090	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 125.6;skeletal muscle: 351.7;tongue: 243.0"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 210.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042935	Enhanced		Supported	Mitochondria		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA042935: AB_10794538"	"unprognostic (1.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.03e-2)"	40.4	33.3	18.0	29.0	19.4	51.5	32.8	21.7	25.4	25.5	22.2	45.5	56.7	28.0	19.2	28.3	25.5	22.5	125.6	20.1	19.3	54.8	32.1	26.4	30.3	19.6	19.0	27.2	26.6	59.7	17.2	30.2	19.2	25.4	49.7	40.3	24.3	28.6	351.7	20.8	42.2	37.1	17.7	21.9	31.6	16.8	18.2	42.5	35.6	243.0	29.8	31.8	23.0	21.5	102.0	103.8	99.7	138.9	70.6	64.9	60.2	97.0	90.3	106.7	117.4	121.0	108.9	83.1	37.6	61.1	237.1	69.1	117.0	82.7	148.7	113.4	111.8	85.9	101.9	70.7	139.3	194.7	62.1	59.0	55.8	146.9	151.7	53.2	75.9	107.6	186.1	74.2	100.1	134.3	284.0	169.9	165.1	160.3	117.2	140.6	146.2	119.8	103.9	83.1	127.4	158.8	80.5	62.4	186.7	67.6	52.5	116.2	63.5	101.8	44.3	162.0	176.7	71.3	100.4	206.6	161.1	163.9	146.6	42.3	43.7	33.2	30.5	62.8	28.9	38.5	27.6	29.6	57.9	23.2	23.9	26.9	6.4	45.2	52.1	49.5	41.9	34.0	18.0	19.4	21.7	25.4	20.1	19.3	19.6	19.0	19.2	17.7	18.2	21.5	32.0	25.6	26.2	103.8	36.5	34.9	28.7	56.9	31.9	26.5	29.0	25.7	138.8	38.6	36.2	14.7	22.9	69.7	29.0	40.4	125.2	61.5	99.6	27.8	33.6	34.3	35.9	64.3	201.3	60.7	79.5	38.9	32.6	22.4	34.2	34.6	17.2	20.7	78.4	15.2	210.5	48.9	30.5	27.3	44.4	103.4	31.4	38.3	37.4	100.2	49.7	34.2	37.0	161.4	143.5	50.1	31.0	35.3	46.5	44.4	50.7	88.8	29.6	27.0	32.9	43.4	53.5	20.9	29.2	37.0	40.3	68.4	34.0	55.8	73.1	42.6
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 102.7;skeletal muscle: 289.7;tongue: 98.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 5.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	18.9	1.5	3.2	4.3	4.4	0.2	6.5	1.5	2.9	19.0	0.5	28.6	20.9	2.1	0.9	2.9	4.5	3.0	102.7	2.1	5.0	54.7	0.3	70.8	1.7	2.1	3.8	0.5	1.1	1.7	3.0	16.5	2.2	2.6	25.8	16.9	2.7	1.4	289.7	1.2	36.6	2.3	1.8	44.5	1.6	1.4	5.5	1.0	7.3	98.3	1.9	2.0	2.6	1.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.5	0.0	9.2	0.0	0.0	0.3	0.0	0.1	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.4	1.6	0.0	11.9	0.3	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.1	0.1	2.0	1.3	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.5	3.2	4.4	1.5	2.9	2.1	5.0	2.1	3.8	2.2	1.8	5.5	1.9	59.6	509.6	30.0	4.6	1.4	0.1	0.1	0.0	1.2	0.3	0.5	0.4	285.7	5.7	26.9	14.7	0.0	0.2	0.7	164.2	0.0	1.7	52.9	4.6	0.5	29.8	13.1	0.4	8.6	0.2	0.1	7.9	0.5	5.7	1.3	0.0	0.7	0.0	0.0	0.0	5.4	23.5	0.0	0.0	0.0	93.8	0.9	0.7	0.0	34.7	0.6	53.8	0.0	0.5	2.9	2.9	51.1	0.7	3.4	3.2	126.0	2.9	11.4	1.8	0.0	6.1	4.3	1.0	0.1	0.1	0.1	2.2	5.8	0.1	13.5	4.3
CMYA5	"C5orf10, DKFZp451G223, SPRYD2, TRIM76"	ENSG00000164309	"Cardiomyopathy associated 5"	Q8N3K9	5	79689836-79800240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 623.5;tongue: 799.5"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 3425.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.3;RT4: 1.5;THP-1: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA074081, HPA077831"	Enhanced		Approved	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles, Cytosol"	"Vesicles, Plasma membrane"	"HPA074081: , HPA077831: "	"unprognostic (5.53e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.01e-4)"	"unprognostic (7.00e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.69e-2)"	"unprognostic (9.74e-2)"	0.9	0.1	1.4	0.2	1.4	0.0	3.9	1.2	2.1	1.7	3.1	1.3	0.1	5.9	4.6	6.6	2.1	0.9	155.8	0.6	0.6	2.5	1.2	0.5	0.0	1.6	2.0	14.6	0.3	3.6	2.0	1.1	1.1	6.1	0.2	1.7	6.1	2.1	623.5	2.2	0.4	4.6	1.1	0.0	0.6	0.5	1.7	0.9	2.3	799.5	0.1	2.1	1.2	0.8	0.0	0.0	0.0	0.1	0.5	0.4	0.6	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	5.4	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.4	1.2	2.1	0.6	0.6	1.6	2.0	1.1	1.1	1.7	0.8	2.7	9.6	2.8	69.5	0.4	1.3	17.9	2.9	4.6	2.0	24.4	46.6	3425.2	5.7	12.2	25.8	0.0	21.4	1.3	0.4	17.6	0.7	0.3	29.3	7.2	19.7	1.8	0.0	32.9	0.4	2.9	113.7	3.6	55.2	1.3	2.5	0.4	2.3	2.1	217.0	10.7	0.2	8.2	0.6	1.6	2.3	14.9	1.4	0.0	6.5	0.1	8.8	2.1	156.3	2.9	0.6	0.2	13.5	0.6	4.8	0.0	15.4	6.2	3.0	0.0	165.6	23.1	2.5	2.0	2.2	5.4	32.8	1.2	1.7	0.2	18.1
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129167827-129183922	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Approved	Nucleoplasm,Cytosol		NA	NA		160000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA063097: AB_2684939"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	292.7	308.2	175.2	181.1	184.0	254.1	274.6	198.6	211.3	295.9	175.7	314.1	198.5	285.8	197.6	264.6	275.7	195.1	487.2	170.6	184.3	231.6	433.7	258.3	251.0	182.7	175.1	385.8	307.4	277.9	169.5	214.3	187.1	256.6	219.0	231.8	250.8	282.4	1207.6	288.0	199.2	234.9	195.6	200.7	262.1	131.2	181.9	254.2	261.8	797.9	250.7	317.5	269.2	211.7	452.7	266.4	369.9	294.6	355.2	303.9	294.9	344.2	535.7	362.2	412.4	389.2	305.7	589.8	292.2	318.1	269.6	328.3	484.3	396.4	484.6	404.5	357.9	569.2	251.7	420.2	355.7	622.4	314.5	295.5	449.2	254.8	897.8	247.6	324.1	328.1	437.6	391.9	384.0	538.9	578.6	454.1	452.7	399.7	439.1	502.4	343.4	707.7	379.1	425.4	501.2	402.8	271.5	263.0	766.3	214.4	305.6	421.3	347.9	268.4	266.2	374.1	353.7	367.3	365.4	932.3	277.3	419.2	362.4	1077.7	810.5	930.9	551.8	596.8	699.0	691.0	658.8	595.3	552.8	603.8	700.3	610.5	1102.3	601.1	485.5	320.4	704.3	2029.8	175.2	184.0	198.6	211.3	170.6	184.3	182.7	175.1	187.1	195.6	181.9	211.7	253.7	259.6	263.9	27.1	292.8	524.7	417.0	262.9	259.6	153.7	177.5	272.5	608.0	141.5	235.1	79.1	33.3	252.3	188.1	143.9	373.7	226.9	36.0	141.4	195.1	267.5	171.3	246.5	28.2	290.7	396.6	309.4	142.8	172.8	314.5	173.0	167.0	138.5	246.5	92.5	33.7	178.6	140.4	194.4	463.0	42.9	316.0	232.4	318.4	35.6	392.7	350.3	236.9	32.6	42.8	230.1	158.0	319.7	311.7	405.1	196.5	237.4	164.8	153.8	263.0	343.6	571.0	305.2	271.5	286.5	586.7	291.7	304.2	277.7	213.6	376.2
CNNM4	"ACDP4, KIAA1592"	ENSG00000158158	"Cyclin and CBS domain divalent metal cation transport mediator 4"	Q6P4Q7	2	96760902-96811874	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Biomineralization, Ion transport, Sensory transduction, Transport, Vision"		"Amelogenesis imperfecta, Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 38.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Distal enterocytes: 103.4;Rod photoreceptor cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017732	Enhanced		Uncertain	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"	"Plasma membrane"	"HPA017732: AB_1847395"	"unprognostic (1.98e-3)"	"unprognostic (8.95e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (3.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.72e-1)"	"unprognostic (8.14e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	2.8	3.6	5.0	6.1	6.8	4.9	7.0	11.2	5.4	5.8	2.8	32.4	6.2	4.0	4.7	7.1	10.4	4.4	12.5	4.9	4.4	6.8	4.4	8.0	4.6	4.1	4.5	5.1	7.4	6.3	9.1	5.8	4.2	5.7	34.3	38.8	6.8	5.1	24.8	7.2	11.3	4.7	3.5	5.3	12.8	7.9	4.5	3.5	9.5	13.1	4.9	5.5	6.4	5.7	11.1	7.2	5.7	10.5	5.8	3.9	15.6	4.8	6.8	6.9	9.3	13.2	11.8	8.1	13.5	5.0	9.5	14.1	14.9	8.1	6.3	16.3	11.7	6.4	4.8	7.2	8.1	3.1	6.2	3.8	10.0	11.0	6.6	4.6	3.8	8.0	3.3	22.3	3.6	15.7	6.6	4.5	7.5	20.5	9.8	9.7	2.6	9.3	6.9	8.6	26.7	8.0	9.1	45.7	6.8	15.9	22.3	5.3	3.4	4.0	8.9	8.8	5.4	7.7	6.6	4.0	5.9	6.1	7.2	1.2	0.4	0.1	0.8	0.4	0.2	0.9	0.4	0.4	0.6	0.5	0.2	0.5	0.2	0.2	0.7	0.4	0.2	0.3	5.0	6.8	11.2	5.4	4.9	4.4	4.1	4.5	4.2	3.5	4.5	5.7	4.5	38.5	7.7	12.4	6.4	5.7	4.9	4.0	4.6	43.1	14.7	11.2	14.1	4.3	11.6	7.3	112.6	5.4	6.1	103.4	0.0	3.2	4.9	14.3	4.4	4.0	10.1	0.8	9.8	4.2	1.7	3.2	12.2	16.1	1.3	5.9	2.2	3.3	3.3	33.7	8.3	26.4	6.1	5.4	4.8	1.6	0.9	5.9	0.0	8.4	2.3	8.3	2.1	11.1	14.6	5.2	21.3	1.2	4.5	4.1	22.3	1.2	10.6	51.5	0.0	4.6	4.3	4.6	2.5	7.3	4.1	6.7	5.4	6.7	26.5	6.1
COPZ2	MGC23008	ENSG00000005243	"COPI coat complex subunit zeta 2"	Q9P299	17	48026167-48038030	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 49.8;Endometrial stromal cells: 63.8;Fibroblasts: 77.7;Leydig cells: 50.4;Smooth muscle cells: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 167.4;ASC TERT1: 185.6;BJ: 127.1;BJ hTERT+: 133.1;fHDF/TERT166: 271.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055999	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA055999: AB_2683003"	"unprognostic (2.66e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (3.45e-9)"	"unprognostic (7.42e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (2.89e-6)"	"prognostic unfavorable (4.66e-4)"	71.7	28.6	11.8	11.7	12.6	1.0	46.4	13.0	19.1	41.8	22.8	57.0	6.2	38.3	21.4	15.9	32.6	22.9	57.1	12.4	16.4	19.2	33.2	22.1	5.8	15.3	12.5	13.6	19.7	24.3	14.8	22.5	15.1	34.2	14.7	5.1	23.4	36.8	90.8	35.3	18.2	45.6	14.0	11.7	27.1	11.6	13.1	4.9	32.1	48.6	6.9	37.3	33.1	15.7	38.7	7.5	4.1	0.0	167.4	185.6	0.0	127.1	133.1	35.0	38.6	0.0	4.4	0.0	28.3	271.6	0.0	39.5	0.0	0.5	34.9	1.7	0.1	13.6	21.3	0.1	68.4	0.0	0.8	111.7	16.0	26.2	3.5	41.1	5.3	0.3	0.1	0.8	86.9	18.1	0.4	0.0	0.2	2.6	2.5	0.0	0.0	6.1	2.4	0.0	0.2	5.7	24.6	0.0	28.3	1.0	6.0	4.2	34.4	91.5	14.5	72.9	0.5	91.6	11.1	1.3	99.3	0.0	13.1	0.0	0.5	0.0	0.3	0.4	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.1	11.8	12.6	13.0	19.1	12.4	16.4	15.3	12.5	15.1	14.0	13.1	15.7	31.6	9.6	2.2	8.1	2.6	49.8	16.7	9.4	9.1	1.2	7.3	30.1	37.1	0.0	1.4	7.3	0.0	1.0	7.5	0.4	11.7	1.0	7.0	2.1	63.8	15.6	0.0	0.0	1.4	5.1	1.2	77.7	0.0	1.5	1.3	2.7	16.4	39.0	6.9	0.0	1.7	2.3	2.0	4.4	28.4	21.1	50.4	3.4	28.4	7.5	0.8	34.8	4.1	2.5	7.6	2.5	0.0	41.8	3.5	6.0	0.1	19.1	0.6	1.3	6.6	21.6	49.2	14.1	3.7	3.1	26.0	2.3	3.7	8.5	0.4	11.7
COQ10A	FLJ32452	ENSG00000135469	"Coenzyme Q10A"	Q96MF6	12	56266890-56270966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"heart muscle: 166.3;skeletal muscle: 280.7;tongue: 387.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 120.5;Distal tubular cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068931			Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 24: NB-4 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"HPA068931: AB_2686061"	"unprognostic (4.55e-2)"	"unprognostic (4.88e-3)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (8.99e-3)"	"unprognostic (2.77e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.86e-3)"	"unprognostic (6.09e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (5.03e-2)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.07e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.15e-1)"	7.0	33.3	16.3	3.5	16.9	4.6	7.2	17.7	19.7	9.1	21.1	9.5	3.2	10.0	16.2	9.0	10.8	6.3	166.3	16.2	17.6	17.1	37.0	6.7	7.8	16.5	18.3	10.2	18.0	15.7	25.4	2.7	17.2	11.9	5.0	26.0	12.6	9.8	280.7	5.0	9.7	7.2	16.4	12.2	8.8	6.8	18.6	7.9	10.3	387.5	8.9	8.5	6.8	15.8	3.7	15.2	14.4	9.4	8.1	8.0	6.0	5.2	12.5	18.3	18.2	11.9	5.6	21.5	11.3	13.3	5.1	3.5	16.8	3.0	10.9	3.2	17.0	10.2	14.1	12.4	11.0	8.1	5.9	8.4	4.9	13.6	5.3	11.4	9.8	14.9	6.8	8.8	17.1	5.1	11.7	29.1	12.0	2.7	8.7	24.2	15.6	14.5	10.1	2.2	20.5	22.0	18.1	3.8	5.8	10.6	5.8	8.9	6.9	3.4	10.0	9.5	5.3	18.1	20.4	10.8	10.2	7.6	2.6	14.1	1.1	1.1	7.4	1.0	7.4	12.7	7.0	7.8	1.7	6.8	8.3	8.1	0.4	5.8	0.9	6.9	5.1	3.9	16.3	16.9	17.7	19.7	16.2	17.6	16.5	18.3	17.2	16.4	18.6	15.8	8.1	3.2	7.2	12.4	20.8	13.4	13.0	2.3	15.4	17.9	8.4	12.7	120.5	7.2	3.2	11.0	16.7	5.8	32.0	2.0	52.8	2.8	0.2	13.7	6.3	9.6	16.2	4.2	3.9	4.6	6.8	10.9	6.6	5.1	4.5	8.2	3.6	15.2	5.2	32.0	6.2	3.4	4.1	2.5	12.1	1.7	8.4	4.5	12.4	3.7	2.5	26.5	13.4	4.5	2.3	2.7	2.5	17.0	18.6	4.4	3.1	18.1	11.0	32.3	39.5	22.1	14.0	4.0	22.2	4.9	10.5	3.0	19.5	10.4	4.4	5.9
COQ2	"CL640, FLJ26072"	ENSG00000173085	"Coenzyme Q2, polyprenyltransferase"	Q96H96	4	83261536-83284914	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Disease variant, Neurodegeneration, Parkinsonism, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 37.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 50.7;Kupffer cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056599, HPA068727"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056599: AB_2683184, HPA068727: AB_2686022"	"unprognostic (8.26e-2)"	"unprognostic (7.40e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.46e-1)"	6.0	17.0	2.8	8.0	3.2	11.8	5.8	3.5	3.3	7.9	3.6	14.2	9.5	6.3	7.5	10.4	4.4	4.3	15.0	3.0	3.5	5.6	13.6	7.9	6.4	3.6	3.5	6.5	6.5	6.0	4.0	8.4	3.8	6.6	14.2	4.0	7.8	5.0	29.1	10.8	9.1	6.9	4.1	10.1	5.5	3.5	3.9	3.6	5.7	37.5	7.1	7.9	6.5	4.9	26.1	14.7	14.1	27.4	10.5	11.9	9.7	16.1	27.0	29.7	34.4	10.5	38.7	17.2	11.7	28.4	24.6	18.6	23.9	26.0	38.7	17.2	14.8	15.3	22.3	15.4	11.7	31.3	73.5	15.9	16.3	14.2	24.8	8.9	30.7	9.7	10.0	21.4	29.3	27.4	8.6	21.7	10.9	30.6	19.9	14.1	11.4	22.1	45.4	13.8	10.3	6.3	19.0	24.5	9.2	6.7	15.4	18.8	21.0	14.6	14.6	11.1	23.4	5.7	5.2	10.2	29.5	36.8	20.2	2.1	28.8	4.0	2.7	26.8	1.9	6.2	3.0	2.5	21.1	6.9	2.1	3.2	9.8	6.7	33.5	11.2	4.1	13.6	2.8	3.2	3.5	3.3	3.0	3.5	3.6	3.5	3.8	4.1	3.9	4.9	5.4	0.0	4.2	15.7	11.5	6.6	12.4	9.8	4.6	5.9	6.3	5.6	19.5	2.8	10.7	9.2	0.0	25.4	7.1	14.0	31.3	6.7	0.8	7.6	19.5	6.1	4.8	14.1	12.8	10.8	30.0	9.0	6.6	9.2	0.0	17.2	9.3	15.0	50.7	1.7	20.1	15.3	8.2	53.2	7.9	0.8	3.7	25.2	7.2	33.7	21.8	12.6	6.2	25.6	15.6	5.4	15.4	4.9	4.3	12.6	11.0	9.9	6.2	4.8	0.0	7.3	9.7	18.1	19.7	16.7	12.6	12.4	9.6	35.5	26.7	12.9
CORO6	FLJ14871	ENSG00000167549	"Coronin 6"	Q6QEF8	17	29614756-29622907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 600.0;tongue: 252.6"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 38.1;Excitatory neurons: 64.1;Extravillous trophoblasts: 32.7;Horizontal cells: 30.3;Inhibitory neurons: 73.8;Skeletal myocytes: 25.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"REH: 16.5;RH-30: 17.8;SH-SY5Y: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021556			Approved	"Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	"Golgi apparatus"		"HPA021556: "	"unprognostic (7.12e-3)"	"unprognostic (2.68e-2)"	"unprognostic (2.60e-4)"	"unprognostic (9.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.00e-4)"	"unprognostic (6.70e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.61e-7)"	"unprognostic (8.48e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.13e-2)"	11.2	3.2	7.6	1.2	7.8	0.5	10.3	1.1	23.0	6.8	0.0	23.2	1.3	14.4	1.9	15.3	15.8	4.1	70.6	5.9	5.3	1.9	0.7	9.7	0.7	11.9	2.5	4.7	1.5	16.0	4.3	27.9	10.8	14.6	2.2	2.0	16.0	4.4	600.0	6.2	11.7	11.9	2.2	1.4	8.9	1.9	6.4	1.8	99.4	252.6	0.8	21.7	8.5	12.6	10.2	4.4	3.8	0.0	5.9	3.2	6.0	3.3	1.2	2.1	0.8	0.3	0.0	0.1	0.8	5.3	0.3	10.5	2.9	0.6	1.0	0.2	4.9	0.0	9.8	1.3	9.4	0.0	0.6	11.5	0.9	1.1	0.0	5.4	2.2	0.0	0.7	0.2	7.1	0.0	6.8	0.3	1.2	0.0	0.2	16.5	17.8	0.4	0.5	0.0	0.1	21.9	0.9	3.0	0.0	2.8	0.0	1.4	0.6	1.4	0.0	1.7	1.4	8.3	4.7	1.2	3.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	7.8	1.1	23.0	5.9	5.3	11.9	2.5	10.8	2.2	6.4	12.6	1.1	0.0	0.0	4.6	0.4	1.5	2.5	0.6	1.8	3.5	0.8	1.9	38.1	0.0	0.6	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.2	0.1	2.4	1.8	0.0	0.0	64.1	0.0	32.7	7.7	0.5	0.2	0.0	1.0	2.2	0.1	1.3	30.3	73.8	0.0	2.0	1.2	0.8	0.6	7.2	0.7	0.0	7.5	0.0	0.2	2.1	5.0	6.6	0.0	0.0	4.1	0.7	1.0	0.0	0.3	0.2	1.5	6.6	25.6	6.0	2.4	3.9	0.2	0.4	2.5	1.3	1.1	0.0	0.2
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428360	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	46	"heart muscle: 3905.3;skeletal muscle: 6742.0;tongue: 2096.1"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 4861.8"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	150	"NK-cell: 15.0"	"Lineage enriched"	"Detected in single"	150	"NK-cells: 15.0"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			1.9	0.9	1.8	0.1	1.3	0.0	2.9	2.3	2.3	0.4	0.2	1.4	1.1	1.0	0.0	74.8	0.9	0.0	3905.3	0.9	2.1	4.5	15.9	3.3	0.4	1.6	2.6	1.2	3.0	2.9	11.9	0.1	7.3	38.9	0.0	1.0	92.1	0.1	6742.0	3.5	1.2	0.0	0.8	0.5	1.3	1.3	2.6	0.5	2.0	2096.1	0.1	0.3	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	1.8	1.3	2.3	2.3	0.9	2.1	1.6	2.6	7.3	0.8	2.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.4	4861.8	2.8	0.0	3.7	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.1	48.8	0.0	0.0	0.0	0.4	0.0	96.2	0.0	0.1	0.0	0.2	0.4	75.7	2.9	3.3	0.0	0.1	0.0	1.6	0.0	0.8	0.3	1.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.1	1.3	24.9	0.0	4.2	19.7	258.0	53.7	0.2	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0
COX7A1	"COX7A, COX7AH"	ENSG00000161281	"Cytochrome c oxidase subunit 7A1"	P24310	19	36150922-36152449	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	18	"heart muscle: 2260.5;skeletal muscle: 6947.0;tongue: 4960.0"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 21879.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 162.5;ASC TERT1: 122.3;BJ: 84.7;BJ hTERT+: 102.7;fHDF/TERT166: 178.6;HHSteC: 91.4;HSkMC: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (5.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.27e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.54e-2)"	269.2	91.5	197.5	20.4	198.8	2.1	105.9	195.3	256.5	70.6	197.2	122.8	14.9	54.6	39.3	82.3	57.8	31.9	2260.5	210.0	214.7	86.9	11.9	63.3	12.0	197.7	188.7	46.0	40.6	147.8	105.6	27.4	199.5	86.6	23.7	49.7	88.0	119.1	6947.0	33.8	36.7	85.1	192.1	34.4	46.7	9.7	200.0	85.8	54.8	4960.0	7.3	88.5	50.1	217.9	0.5	5.9	0.6	0.1	162.5	122.3	0.0	84.7	102.7	3.4	0.0	0.0	1.8	1.4	13.0	178.6	0.0	0.7	0.0	0.0	0.8	0.2	1.8	0.4	2.1	0.3	91.4	0.0	0.8	109.0	0.0	0.0	0.0	0.0	11.3	0.0	0.6	0.7	0.0	0.8	0.0	0.7	1.0	0.6	1.2	0.2	0.0	0.4	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.2	0.6	0.1	20.7	0.0	1.3	0.5	0.4	0.8	1.9	0.7	0.2	0.8	1.2	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	197.5	198.8	195.3	256.5	210.0	214.7	197.7	188.7	199.5	192.1	200.0	217.9	309.7	0.0	5.1	2.3	2.2	26.4	1.0	28.2	2.8	80.6	25.0	89.4	21879.1	18.6	11.0	22.0	45.9	1.0	1.5	0.0	817.8	13.7	17.0	6.0	124.6	360.4	0.0	5.3	5.9	14.1	0.7	602.1	0.5	3.7	45.0	5.5	259.5	7.3	24.0	67.3	4.3	0.0	26.4	10.7	30.5	90.8	224.6	5.2	284.6	3.7	0.0	31.5	0.0	2.0	2.3	6.2	0.0	281.3	1.5	3.5	0.0	183.1	10.7	84.7	184.1	328.4	463.4	2.0	3.8	4.3	19.0	1.9	4.8	17.3	0.1	0.8
CSDE1	"D1S155E, UNR"	ENSG00000009307	"Cold shock domain containing E1"	O75534	1	114716913-114758676	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1408.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 2403.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018846, HPA052221"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		100000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA018846: AB_1847266, HPA052221: AB_2681767"	"unprognostic (2.84e-1)"	"unprognostic (9.18e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.30e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.54e-2)"	412.5	166.8	149.0	170.9	168.8	276.4	241.9	160.5	170.8	193.8	163.5	300.1	187.3	226.7	196.2	247.2	162.9	172.0	414.8	137.6	169.8	228.2	233.6	182.8	172.4	166.4	169.5	258.8	216.2	273.8	85.8	182.4	172.6	229.8	199.6	177.6	230.0	245.6	1408.6	201.6	196.1	236.4	172.2	176.5	201.7	257.4	164.7	218.8	262.6	1039.4	208.2	238.4	137.0	187.3	658.8	226.6	395.5	396.1	440.7	561.4	550.1	566.7	420.5	373.0	301.1	334.0	193.7	514.9	465.6	543.1	217.0	272.3	442.4	439.6	539.2	632.1	302.8	506.1	390.3	299.9	388.2	380.7	288.7	414.7	468.2	447.0	583.2	502.2	433.5	426.5	523.3	327.3	458.9	2403.4	513.8	242.0	755.0	274.0	302.5	378.4	1221.9	244.0	295.4	508.4	485.6	320.7	553.9	455.8	433.3	411.9	234.5	599.4	526.9	437.8	597.3	579.6	629.1	495.7	587.9	567.7	564.9	422.2	1365.1	217.2	241.4	230.8	146.4	233.1	199.7	161.6	186.5	180.7	226.8	130.4	219.3	189.1	155.2	191.0	270.8	87.2	222.2	389.4	149.0	168.8	160.5	170.8	137.6	169.8	166.4	169.5	172.6	172.2	164.7	187.3	193.2	198.7	194.2	41.8	198.3	216.2	219.7	149.0	235.6	134.0	218.2	161.5	572.0	160.2	181.1	128.8	58.4	172.4	155.2	160.8	226.9	198.2	405.5	130.4	178.8	191.3	219.9	232.8	70.8	202.9	208.2	181.7	143.2	174.3	219.1	234.7	156.4	189.1	156.8	99.3	73.7	220.3	120.1	277.9	202.0	639.7	161.8	216.8	220.5	55.3	241.8	195.5	117.4	54.3	86.5	213.8	150.6	225.7	283.6	269.0	240.1	235.5	143.2	121.3	164.3	232.4	274.2	263.3	189.8	247.2	234.0	272.9	193.3	208.2	210.5	283.8
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 385.5;tongue: 204.2"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	38.7	15.5	19.3	14.6	21.9	23.6	27.3	20.8	25.9	17.3	17.3	19.4	11.1	14.7	11.0	16.0	17.1	12.1	41.7	18.7	20.7	13.5	30.2	15.1	22.3	21.0	20.6	12.6	14.2	8.6	7.8	11.3	21.3	16.1	15.9	28.3	16.9	11.2	385.5	18.6	20.9	14.4	20.1	28.6	18.6	43.4	20.3	23.9	13.2	204.2	19.7	43.8	16.7	25.0	27.4	57.7	19.9	60.7	71.8	32.8	10.8	22.0	28.0	21.6	24.2	26.7	20.5	98.9	19.1	37.5	10.6	22.9	40.8	36.6	23.9	29.5	39.0	32.9	26.1	42.7	33.2	61.5	15.5	34.0	22.3	34.5	71.1	26.8	37.8	56.2	29.6	21.4	16.4	19.4	55.7	63.2	20.0	27.7	21.4	37.5	23.3	38.3	22.8	11.2	6.5	14.8	10.1	15.9	28.9	27.1	25.3	34.7	21.2	9.0	12.2	9.9	29.5	34.7	48.5	69.6	29.4	130.0	8.2	70.6	42.6	111.7	56.9	35.2	60.0	73.4	53.9	54.9	47.1	66.5	74.4	57.2	68.6	63.1	46.0	54.2	57.0	45.3	19.3	21.9	20.8	25.9	18.7	20.7	21.0	20.6	21.3	20.1	20.3	25.0	26.3	9.6	12.5	15.3	32.8	12.1	14.7	23.1	5.7	18.7	12.6	15.2	40.6	14.3	14.9	5.5	8.4	18.6	23.2	4.6	21.5	16.9	12.6	11.4	12.0	19.8	12.1	28.2	8.5	17.4	13.5	32.8	10.7	8.3	30.4	14.4	27.5	23.4	20.9	11.8	9.0	7.4	12.2	17.0	11.7	10.8	13.1	16.6	30.2	7.5	28.0	25.9	21.6	8.0	26.9	10.5	7.4	16.1	27.2	16.1	19.2	34.8	21.5	33.0	19.7	27.1	15.5	163.3	36.7	14.3	10.9	13.5	25.6	36.3	9.6	11.6
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961873-202967275	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 605.2"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 187.2;Extravillous trophoblasts: 196.5;Syncytiotrophoblasts: 293.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 187.3;hTCEpi: 188.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	38.6	57.3	37.4	23.0	38.8	19.7	43.7	41.1	40.5	49.7	57.3	35.7	19.3	41.2	131.4	61.6	68.2	27.2	154.8	38.3	48.0	64.5	50.2	44.0	25.2	45.4	49.4	41.7	45.1	82.9	46.1	66.6	55.7	41.1	21.2	34.3	56.9	40.0	605.2	123.8	25.7	37.5	39.9	39.1	92.8	50.7	41.4	40.1	40.5	308.0	38.8	52.7	45.8	43.6	34.8	21.3	18.3	37.7	166.0	37.9	178.5	68.3	63.4	43.2	38.4	17.5	39.9	21.5	56.5	68.1	24.0	187.3	14.9	58.0	28.2	31.2	37.8	12.4	24.0	20.4	59.7	10.5	29.6	61.2	188.3	47.5	25.8	36.4	28.9	25.8	37.0	37.6	157.8	40.4	13.6	9.5	12.1	31.0	40.1	21.9	87.6	45.7	41.1	40.8	15.7	19.1	38.0	124.0	57.4	39.4	57.7	23.4	28.5	49.0	20.8	18.7	38.3	34.9	44.5	10.0	53.6	16.2	37.1	24.4	56.7	46.6	27.4	42.6	36.3	23.4	30.9	28.9	37.6	35.0	41.9	29.6	46.0	32.2	29.4	25.9	34.2	52.6	37.4	38.8	41.1	40.5	38.3	48.0	45.4	49.4	55.7	39.9	41.4	43.6	33.0	22.4	29.8	10.1	15.5	187.2	38.5	89.5	42.1	21.0	46.1	41.9	119.3	37.1	60.5	29.5	29.2	171.1	15.8	10.6	7.9	38.3	5.0	58.7	17.3	30.0	19.2	30.7	8.9	48.3	196.5	28.9	31.6	34.9	28.5	13.6	32.9	44.6	63.5	10.1	11.3	10.8	105.8	45.4	29.7	8.6	29.8	39.5	64.0	8.4	20.9	65.9	11.3	11.6	8.1	72.8	11.3	31.2	12.5	25.8	16.0	38.9	75.9	35.0	13.1	49.1	30.0	23.0	4.3	40.6	157.4	293.5	19.5	27.9	14.7	48.2
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 207.9;Skeletal myocytes: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 280.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353, HPA070563"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"CAB001960: , CAB016353: AB_627292, HPA070563: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	25.2	22.0	31.5	17.9	32.6	5.4	26.6	30.7	30.7	26.2	25.5	38.8	24.0	32.1	16.2	28.3	31.8	26.4	68.9	30.1	28.9	28.1	43.0	31.8	9.4	33.3	31.4	24.6	51.4	44.3	18.6	77.0	28.6	29.5	30.6	9.8	31.8	37.9	93.8	28.5	24.0	45.9	30.2	12.6	32.0	26.9	34.1	10.5	25.5	95.7	14.3	27.8	22.0	31.2	92.3	92.4	61.9	152.3	80.3	38.8	280.9	63.9	93.7	108.0	69.0	74.2	96.0	13.0	62.2	103.2	87.6	168.4	55.6	81.2	67.2	12.7	18.6	9.6	84.3	87.2	35.5	11.2	17.4	33.3	72.5	100.3	33.3	96.7	97.1	15.3	14.5	9.8	31.2	75.5	10.1	8.1	66.4	110.0	31.2	5.5	60.5	22.3	82.5	126.4	21.8	45.2	74.8	206.0	105.5	170.3	171.6	22.8	51.8	39.1	63.9	76.0	91.4	11.0	24.2	8.1	50.4	12.6	245.9	2.3	1.2	0.7	1.1	1.3	1.2	1.2	0.9	0.9	0.7	1.0	1.0	1.0	2.2	1.1	2.5	1.3	0.7	1.4	31.5	32.6	30.7	30.7	30.1	28.9	33.3	31.4	28.6	30.2	34.1	31.2	19.0	54.5	18.4	32.0	4.0	14.3	8.0	31.7	17.1	7.4	36.1	46.4	56.6	30.0	20.6	35.0	4.2	116.4	5.8	37.3	1.9	32.4	30.0	30.2	17.3	20.9	33.0	14.3	15.6	79.6	118.4	26.1	37.8	37.9	7.0	207.9	16.8	59.9	21.2	3.3	16.5	29.7	14.2	8.6	7.0	20.0	21.5	6.3	33.8	9.4	5.6	27.1	5.2	19.6	10.7	57.2	21.4	36.9	5.1	14.4	18.9	7.6	23.2	8.7	46.0	326.1	36.2	7.1	19.9	19.0	17.0	95.9	5.9	10.0	29.2	10.2
DCAF6	"IQWD1, PC326"	ENSG00000143164	"DDB1 and CUL4 associated factor 6"	Q58WW2	1	167935783-168075843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 641.3;tongue: 470.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 438.6;Excitatory neurons: 243.8;Late spermatids: 700.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054305			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Focal adhesion sites"		"HPA054305: AB_2682444"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	29.1	45.9	12.8	16.2	17.5	24.6	29.3	9.3	22.4	32.9	22.1	36.8	21.7	24.7	19.5	29.7	25.6	27.5	129.9	20.5	7.0	28.6	95.1	25.4	17.7	5.6	8.8	25.3	20.9	34.5	19.9	27.3	5.8	35.4	29.3	21.3	28.8	25.3	641.3	21.9	21.5	33.8	5.7	18.5	28.2	82.6	12.3	24.4	23.5	470.8	21.4	28.1	20.1	14.0	64.8	30.0	16.4	27.0	52.7	74.3	57.4	64.9	95.3	44.5	65.7	50.4	53.1	52.8	36.9	83.3	21.4	47.4	25.8	47.9	62.4	30.2	27.6	56.5	42.8	36.4	42.4	25.7	26.1	53.2	47.4	42.3	35.0	67.4	49.1	16.9	64.8	42.9	66.3	14.8	28.9	23.3	10.6	36.0	33.1	21.9	34.0	41.7	110.6	30.9	24.2	19.2	51.8	47.0	36.6	33.9	80.8	31.3	70.3	44.6	27.5	44.0	27.3	45.4	39.3	41.3	59.9	21.6	18.6	5.4	5.5	10.4	4.9	7.5	5.2	4.8	3.9	4.3	6.0	3.3	3.5	4.6	5.7	3.7	12.0	3.6	4.8	4.0	12.8	17.5	9.3	22.4	20.5	7.0	5.6	8.8	5.8	5.7	12.3	14.0	22.9	57.7	43.3	81.3	22.5	57.9	30.5	32.1	33.0	14.7	26.7	19.3	216.3	48.6	43.4	25.8	22.9	75.7	19.7	28.1	17.6	33.0	438.6	39.3	24.1	25.3	21.1	111.9	243.8	19.3	32.4	42.7	39.3	35.5	19.6	73.0	23.6	95.4	19.6	5.0	90.0	27.9	26.4	44.0	38.3	700.1	57.5	23.6	37.4	70.3	113.0	15.9	18.6	108.6	71.0	21.2	26.7	48.5	31.1	35.6	35.7	34.9	52.3	18.4	32.9	29.1	30.6	108.3	64.1	34.6	39.8	81.3	22.2	81.5	33.0	29.0
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262549	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	63.3	62.6	35.3	47.0	43.3	54.6	60.6	47.7	52.8	55.8	47.1	72.0	56.6	60.4	76.2	50.2	58.9	53.5	85.1	33.7	41.8	55.8	103.4	50.9	60.5	39.2	37.3	62.2	80.2	85.7	66.3	45.1	37.0	53.6	40.6	106.7	60.6	53.2	219.7	67.2	61.8	44.0	32.6	65.6	67.3	40.7	41.1	67.5	77.9	118.3	51.1	61.1	49.8	53.0	54.2	62.5	72.0	64.8	86.3	65.5	63.7	62.7	81.8	49.5	42.2	69.8	89.6	56.3	112.1	67.2	34.6	64.8	34.6	57.4	31.0	134.9	69.0	63.4	99.7	54.1	69.3	52.9	80.3	74.6	58.9	44.2	60.8	55.3	73.5	73.1	60.6	98.4	46.0	50.0	71.7	54.5	52.7	70.1	62.6	69.2	41.8	115.5	57.7	87.6	49.0	47.3	101.8	113.1	68.2	68.9	104.9	82.0	95.1	60.7	31.5	38.6	58.7	169.8	124.9	94.3	68.7	49.6	51.2	32.9	21.5	22.0	31.5	19.7	29.6	28.5	27.0	29.2	17.5	30.4	29.4	27.0	24.9	30.4	28.4	22.0	30.4	19.2	35.3	43.3	47.7	52.8	33.7	41.8	39.2	37.3	37.0	32.6	41.1	53.0	21.4	57.7	54.9	57.5	35.4	18.4	16.3	17.3	38.7	44.6	27.5	21.8	54.2	30.0	30.5	25.8	64.6	30.9	26.4	20.4	62.6	23.9	3.6	26.6	18.9	26.4	25.1	48.4	53.7	21.6	21.0	28.9	35.2	21.4	34.1	21.2	21.4	77.6	23.8	40.4	49.5	19.2	20.3	29.8	18.9	4.3	28.0	24.2	14.2	39.4	27.6	38.1	18.6	58.8	93.1	19.2	13.6	32.7	45.3	16.3	29.0	38.1	40.5	60.5	13.1	29.5	26.6	28.0	20.4	35.1	24.2	44.3	36.5	25.6	18.8	12.5
DCUN1D3	"DKFZp686O0290, FLJ41725, MGC48972, SCCRO3"	ENSG00000188215	"Defective in cullin neddylation 1 domain containing 3"	Q8IWE4	16	20854925-20900358	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 58.6;Late spermatids: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 52.2;ASC TERT1: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041983, HPA043511"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA041983: , HPA043511: AB_2678521"	"unprognostic (9.34e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.42e-1)"	20.6	9.5	3.9	6.3	4.3	2.8	9.3	5.5	4.6	8.3	4.1	6.2	3.3	6.2	2.5	8.3	6.9	9.7	7.1	3.4	4.8	5.2	11.9	9.9	2.6	4.0	4.0	5.0	6.8	4.4	4.7	7.9	4.0	5.4	3.9	12.6	3.7	4.1	28.5	7.1	4.0	8.6	3.7	4.4	5.9	8.3	4.8	3.2	4.4	4.0	2.6	8.3	9.4	7.2	4.8	8.6	4.2	8.7	52.2	38.9	5.4	16.1	13.6	7.9	10.5	10.7	8.5	3.0	12.6	15.8	4.7	6.1	4.8	6.7	10.6	4.0	2.9	2.5	7.1	15.8	13.6	3.7	23.9	25.9	9.0	15.2	8.5	8.4	22.2	2.9	2.9	7.4	16.4	6.6	3.4	5.5	9.9	4.1	2.7	6.1	4.5	2.6	7.0	5.0	3.6	4.8	6.2	6.2	3.6	4.7	4.2	1.8	10.9	16.5	5.4	6.9	4.4	6.9	4.3	2.0	17.1	4.1	8.3	1.3	0.3	0.2	0.4	0.6	0.3	0.2	0.2	0.6	0.4	0.3	0.3	0.6	0.3	0.6	0.5	0.2	0.2	0.2	3.9	4.3	5.5	4.6	3.4	4.8	4.0	4.0	4.0	3.7	4.8	7.2	25.6	12.8	19.3	4.6	2.9	31.4	11.7	7.5	19.4	12.4	19.0	10.8	5.2	2.8	7.2	9.2	35.5	3.6	8.2	6.3	0.0	3.8	58.6	14.5	16.2	18.4	20.3	1.3	10.6	5.2	2.0	16.5	5.6	34.3	0.0	4.2	9.7	16.3	2.3	13.5	9.7	4.3	6.1	5.0	20.6	48.5	10.8	15.8	12.4	1.9	1.8	5.2	1.0	10.6	10.8	4.9	1.2	9.8	3.3	6.1	3.0	5.2	4.3	24.8	6.6	20.1	19.6	6.4	3.7	10.7	22.6	5.1	5.9	4.1	4.7	18.3
DDX19A	"DDX19L, FLJ11126"	ENSG00000168872	"DEAD-box helicase 19A"	Q9NUU7	16	70346861-70373383	"Enzymes, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045252, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA045252: AB_10961128, HPA066668: "	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.38e-4)"	"prognostic unfavorable (8.05e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.68e-3)"	20.1	19.1	11.3	14.2	12.0	12.6	17.6	12.5	12.6	16.3	12.6	21.4	10.3	20.8	14.1	19.8	17.2	16.0	22.9	11.1	12.4	17.5	21.8	15.6	19.1	12.2	12.2	21.7	17.3	24.8	11.9	23.6	12.6	15.4	15.0	12.6	14.5	20.8	58.4	16.4	14.0	26.9	12.1	15.2	16.9	7.4	12.7	21.0	20.3	38.5	20.5	22.3	14.5	12.5	36.5	39.9	42.4	43.8	60.8	41.7	39.6	45.8	46.7	70.0	54.1	60.9	27.5	60.4	41.8	49.2	34.1	41.6	75.3	45.2	60.4	20.0	41.1	31.7	32.0	75.5	55.0	56.9	26.3	51.0	31.7	65.3	49.8	35.1	46.3	43.5	77.6	15.6	42.6	53.0	62.2	47.8	68.6	43.6	24.6	79.2	27.9	84.8	42.3	23.0	35.1	45.8	115.3	25.4	35.6	43.8	47.4	35.5	31.0	49.0	39.2	31.4	43.9	44.6	70.5	132.7	32.8	50.8	50.5	9.3	8.6	4.7	7.3	8.0	6.7	5.3	6.4	7.2	10.5	5.8	7.0	7.4	0.8	7.1	7.6	5.9	6.0	7.0	11.3	12.0	12.5	12.6	11.1	12.4	12.2	12.2	12.6	12.1	12.7	12.5	14.8	16.0	20.7	15.3	19.1	9.9	21.2	8.6	14.8	35.0	10.4	11.0	18.0	22.8	17.5	11.0	33.3	23.0	12.7	8.2	9.8	14.7	3.2	14.7	18.6	15.6	14.4	21.0	23.4	13.8	16.3	16.0	7.1	15.2	17.7	18.0	12.5	19.5	14.0	23.5	25.7	10.1	2.0	14.2	9.5	2.0	26.1	11.2	10.6	2.8	19.2	15.6	27.8	8.5	10.9	14.0	9.5	12.4	19.8	23.0	8.7	13.3	12.8	32.3	26.3	14.7	15.1	14.7	15.7	16.3	10.2	17.2	16.3	18.0	13.6	16.0
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050918	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.2;tongue: 122.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 86.1;Glandular and luminal cells: 66.1;Oligodendrocytes: 123.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"myeloid DC: 20.3"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 20.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 105.1;RPMI-8226: 193.2;RPTEC TERT1: 149.3;U-698: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	Mitochondria	"Nucleoplasm, Nuclear bodies"	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	14.4	52.8	12.0	3.0	16.7	2.0	20.7	12.6	11.9	39.2	3.8	23.3	16.9	16.5	11.1	15.2	27.1	10.8	5.1	9.7	23.2	40.0	16.3	5.3	10.1	15.8	12.5	24.7	11.9	16.9	11.4	4.9	15.3	12.1	9.9	2.0	106.3	15.6	158.2	6.6	14.5	15.5	14.8	9.5	40.0	2.9	16.3	5.1	98.0	122.3	2.9	5.6	7.0	24.2	0.1	3.5	0.3	1.1	21.0	6.2	0.3	0.1	0.3	0.6	0.5	2.4	0.4	105.1	2.3	1.2	0.3	0.3	5.4	0.2	0.4	2.3	2.7	14.2	0.9	0.6	12.8	3.0	23.7	5.5	9.5	0.8	0.6	0.1	0.0	1.8	0.1	16.9	0.3	7.1	0.1	2.5	1.3	45.5	3.7	0.4	4.9	193.2	149.3	4.1	3.2	0.7	1.7	11.0	3.2	2.8	9.6	0.5	0.0	0.4	0.9	21.4	0.5	45.4	11.4	55.2	6.5	3.9	0.6	0.0	0.9	0.0	0.2	1.7	0.8	0.1	0.4	0.7	20.3	0.1	0.8	0.6	0.3	0.4	0.2	1.0	0.4	1.0	12.0	16.7	12.6	11.9	9.7	23.2	15.8	12.5	15.3	14.8	16.3	24.2	23.1	6.4	9.3	4.9	2.9	5.2	15.4	3.8	27.3	2.1	16.5	10.4	2.4	15.7	8.4	25.8	0.0	0.6	0.8	2.7	86.1	5.7	2.2	19.0	9.7	7.5	16.7	12.4	14.5	11.8	4.1	10.0	29.6	66.1	12.0	5.4	2.5	12.7	3.3	0.0	31.0	7.7	0.0	16.0	39.5	2.2	11.8	14.9	14.2	46.9	1.5	1.2	2.1	9.5	123.9	1.1	36.5	3.4	6.4	7.1	21.0	33.6	1.1	0.7	0.0	8.1	5.7	3.6	3.8	16.5	5.5	0.4	1.3	6.0	16.5	21.9
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13020.7;intestine: 8627.2;skeletal muscle: 16532.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2531.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1;stomach cancer: 400.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"midbrain: 29.5"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1600000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	235.3	57.1	2.1	436.2	4.9	1.1	51.2	2.1	9.6	504.3	5.0	8627.2	291.3	3015.2	86.0	1481.2	1085.0	452.1	13020.7	2.4	2.5	37.6	15.5	173.9	7.2	3.4	2.5	171.8	14.6	0.5	8.4	52.7	2.4	2218.8	245.6	0.0	255.3	2253.1	16532.0	152.4	1343.5	2557.5	2.1	25.2	1965.6	16.1	2.6	3.2	66.2	5753.8	1.2	4761.8	669.4	2.4	0.0	0.0	0.1	0.0	0.0	2.2	5.3	0.2	0.0	0.1	0.1	0.5	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	17.0	0.1	1.3	70.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	145.3	0.0	0.0	39.5	0.5	0.0	0.0	0.0	333.1	2.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	9.2	0.0	5.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.1	4.9	2.1	9.6	2.4	2.5	3.4	2.5	2.4	2.1	2.6	2.4	0.4	0.0	0.0	0.0	0.0	4.1	2.7	0.0	0.0	0.0	0.1	0.0	2531.9	1.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	90.6	0.5	6.7	22.7	0.0	0.0	0.1	0.0	5.2	104.6	0.0	0.1	0.0	0.0	1.8	0.0	5.6	0.0	0.0	0.9	0.0	0.0	10.7	71.6	28.9	2.8	12.4	0.0	0.6	0.0	0.0	0.5	0.0	0.5	0.0	50.4	0.0	8.7	0.0	0.1	0.0	0.0	46.0	497.8	210.5	5.0	5.1	0.1	9.8	8.5	2.4	0.0	0.2	2.9
DHRS7C	SDR32C2	ENSG00000184544	"Dehydrogenase/reductase 7C"	A6NNS2	17	9771434-9791592	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	66	"heart muscle: 125.0;skeletal muscle: 308.1;tongue: 367.4"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 87.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"								"unprognostic (6.83e-2)"													0.1	0.1	0.4	0.0	0.5	0.0	0.1	0.3	1.1	0.0	0.3	0.4	0.2	0.0	0.0	4.0	0.0	0.0	125.0	0.5	0.3	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.1	0.0	0.2	0.0	0.3	0.5	1.1	0.0	2.9	0.0	308.1	0.0	0.2	0.0	0.4	0.0	0.0	0.6	0.3	0.0	0.0	367.4	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.3	1.1	0.5	0.3	0.3	0.3	0.3	0.4	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DNAJB5	Hsc40	ENSG00000137094	"DnaJ heat shock protein family (Hsp40) member B5"	O75953	9	34989641-34998900	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.5;tongue: 218.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.9;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"myeloid DC: 5.5;neutrophil: 5.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.5;granulocytes: 5.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023818, HPA050794"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA023818: AB_1847793, HPA050794: AB_2681241"	"unprognostic (1.41e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.53e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-3)"	14.7	12.5	18.5	11.0	18.7	1.5	8.7	23.0	27.7	14.0	14.8	63.0	7.7	56.0	11.8	32.5	29.6	12.7	64.8	24.0	20.1	8.5	4.4	12.3	4.6	20.3	21.0	8.6	6.1	4.0	25.3	2.4	19.4	27.5	12.2	10.1	6.3	52.1	164.5	5.1	17.9	64.3	18.1	12.2	26.8	16.0	19.3	5.8	10.9	218.5	5.0	33.7	11.5	18.8	4.7	3.8	23.7	12.7	13.6	10.4	2.6	20.1	14.5	30.3	26.8	2.8	1.0	4.5	4.9	22.2	31.7	0.6	9.1	15.8	25.5	6.4	2.9	1.6	5.6	1.3	15.6	0.5	14.2	15.2	1.1	18.0	8.9	13.4	19.6	8.3	0.4	9.3	24.7	3.3	7.8	6.7	11.2	2.1	8.1	6.0	24.4	2.5	4.4	0.4	10.1	16.4	10.8	0.6	2.4	20.2	3.8	1.4	8.8	14.4	31.4	7.6	6.3	3.4	2.5	3.3	16.6	1.8	15.9	0.0	1.0	0.0	0.2	0.3	0.9	0.4	0.2	0.0	5.5	0.2	0.3	0.7	5.2	0.4	0.1	0.1	1.0	0.5	18.5	18.7	23.0	27.7	24.0	20.1	20.3	21.0	19.4	18.1	19.3	18.8	1.9	6.4	1.5	8.5	0.9	2.0	2.3	4.7	1.8	6.0	1.7	1.4	42.9	1.5	1.8	0.0	6.2	0.1	0.5	0.5	0.0	2.8	8.0	1.7	4.8	4.5	0.0	0.0	4.9	3.4	0.7	6.7	2.0	2.2	0.0	1.7	3.6	1.2	4.7	1.7	3.3	0.3	2.0	1.9	11.1	6.7	1.5	3.6	5.4	1.9	1.2	12.0	2.1	6.6	3.2	4.3	0.0	7.9	0.7	1.5	1.6	4.4	1.0	2.7	6.6	14.7	16.8	6.3	1.3	1.8	3.0	0.8	1.4	1.5	0.3	0.7
DNAJC24	"DPH4, JJJ3, ZCSL3"	ENSG00000170946	"DnaJ heat shock protein family (Hsp40) member C24"	Q6P3W2	11	31369840-31432835	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 204.8;Late spermatids: 223.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020025, HPA025237"	Approved		Approved	Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA020025: AB_1847801, HPA025237: AB_1847802"	"unprognostic (2.07e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.67e-1)"	7.2	6.3	6.7	5.4	6.7	1.9	6.8	8.5	8.9	4.8	5.8	4.8	4.4	5.9	6.4	5.3	3.1	4.9	11.8	7.0	7.4	6.4	6.0	4.3	6.8	6.7	7.0	4.6	7.3	4.7	4.6	5.0	6.7	5.7	4.4	8.3	5.8	5.9	17.0	8.8	4.5	6.3	6.5	5.8	5.0	4.4	6.9	5.2	6.6	11.3	5.7	5.6	3.4	7.1	4.8	6.4	11.2	8.2	8.7	10.9	4.9	12.7	8.0	7.0	7.3	5.2	4.5	6.3	6.7	8.6	10.4	6.2	6.4	8.2	12.2	14.8	11.9	6.9	10.2	5.3	11.1	14.0	10.9	10.3	10.4	4.3	13.8	10.2	9.5	10.7	13.3	10.9	14.0	5.0	10.8	9.4	5.7	7.0	6.7	6.7	18.8	6.5	10.3	4.5	4.9	6.9	11.0	7.5	11.0	6.3	10.5	9.1	10.0	13.1	8.9	16.3	15.8	13.3	11.3	7.6	19.3	6.6	14.9	4.5	1.0	0.9	2.2	1.8	3.1	1.5	2.2	1.9	0.8	1.6	2.8	2.9	0.7	1.3	1.1	1.6	1.5	1.3	6.7	6.7	8.5	8.9	7.0	7.4	6.7	7.0	6.7	6.5	6.9	7.1	7.5	3.2	7.4	14.0	14.4	12.1	7.0	9.2	6.8	11.9	9.1	7.2	20.3	1.5	9.3	3.7	10.4	8.6	15.5	5.6	3.9	9.1	204.8	6.4	11.0	7.7	7.2	5.2	40.7	9.1	9.4	10.4	7.1	6.3	5.1	5.3	9.3	10.5	8.2	23.5	28.9	5.1	4.1	6.9	10.3	223.9	9.0	8.5	12.4	25.3	7.1	26.2	9.2	41.2	29.9	11.7	6.2	9.4	18.5	7.2	5.2	11.4	4.4	14.6	0.0	9.6	8.3	28.2	18.2	9.5	8.2	6.3	13.5	7.1	5.9	9.1
DNASE1L1	"DNAS1L1, DNASEX, DNL1L, XIB"	ENSG00000013563	"Deoxyribonuclease 1 like 1"	P49184	X	154401236-154412112	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 147.0"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072635	Approved				"Intracellular and membrane"	NA	NA		96000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"HPA072635: AB_2686542"	"unprognostic (5.27e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.57e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.82e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.98e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (7.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.75e-2)"	18.7	26.6	12.6	13.0	12.1	24.1	17.8	11.7	14.1	15.8	26.6	15.2	15.2	15.8	22.5	21.6	14.0	13.0	43.2	13.5	14.3	20.9	18.8	22.0	16.4	12.2	13.4	13.7	12.8	22.7	20.1	16.1	12.6	15.1	12.3	3.9	22.0	11.3	147.0	11.3	19.3	11.3	13.0	28.5	18.1	7.7	13.6	8.9	24.1	94.8	13.2	13.5	16.9	11.9	19.7	19.6	6.3	12.2	56.6	74.5	7.7	54.5	85.3	17.6	34.6	5.7	28.0	32.9	68.2	103.0	67.4	9.6	7.6	31.0	12.8	9.9	13.0	4.8	20.6	7.1	38.8	8.6	33.4	55.6	35.7	39.6	40.0	47.9	76.4	5.3	6.5	34.0	61.1	33.0	3.6	4.2	5.0	35.5	22.1	7.3	28.5	52.9	31.0	9.7	20.2	12.0	17.1	29.9	22.5	13.9	11.9	7.8	112.9	17.7	20.3	25.6	10.9	64.2	15.4	34.4	26.6	14.4	22.4	13.0	12.0	17.1	3.5	21.6	4.0	6.2	3.3	3.1	14.5	4.1	2.4	2.2	7.0	4.6	20.9	8.3	4.9	6.4	12.6	12.1	11.7	14.1	13.5	14.3	12.2	13.4	12.6	13.0	13.6	11.9	20.1	6.4	6.5	3.3	8.0	1.3	7.1	11.1	9.6	1.8	5.1	3.8	2.0	5.7	5.4	5.5	0.0	5.3	6.7	15.5	9.8	6.1	0.1	5.8	5.7	17.7	6.1	6.5	3.2	10.2	23.3	5.2	11.7	7.5	13.3	4.9	23.2	8.6	29.1	0.0	2.2	10.4	6.1	36.6	11.7	1.2	3.4	25.4	16.0	4.7	22.9	12.8	7.2	0.0	0.5	13.5	18.1	2.6	6.8	5.9	27.0	9.6	7.0	1.4	0.0	16.7	3.3	0.4	0.4	10.4	1.7	8.9	6.0	3.2	10.9	10.9
DNPEP	"ASPEP, DAP"	ENSG00000123992	"Aspartyl aminopeptidase"	Q9ULA0	2	219372043-219400022	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 364.4;Late spermatids: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036398, HPA044860"	Enhanced		Supported	Cytosol		NA	NA		2700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA036398: AB_10970915, HPA044860: AB_10961275"	"unprognostic (3.71e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-3)"	25.8	18.9	15.4	25.0	15.8	18.0	23.6	14.8	18.6	24.9	14.7	34.5	56.5	22.4	21.5	25.1	25.1	22.6	39.9	16.2	16.9	22.1	32.0	27.6	23.4	15.8	15.0	30.2	27.2	25.8	13.0	37.1	15.2	22.6	30.8	9.5	26.2	24.4	64.5	31.7	56.2	19.9	16.0	24.7	25.4	58.5	17.4	17.5	15.2	46.4	16.2	29.6	21.6	14.7	47.5	25.8	15.4	45.7	39.7	32.2	122.0	23.0	46.5	59.3	62.5	72.6	61.2	27.2	48.7	49.5	76.0	45.0	18.6	53.6	21.3	56.4	12.5	46.6	25.0	79.8	107.2	38.9	32.2	54.4	55.4	61.8	50.2	37.9	41.2	38.6	53.8	45.3	31.0	103.7	60.8	44.5	25.5	67.7	15.1	77.2	35.7	36.5	33.0	74.0	19.1	26.0	27.1	86.5	34.5	26.9	25.8	43.3	23.5	55.4	46.1	31.4	33.7	49.6	31.8	21.3	80.0	37.7	24.1	8.7	17.2	7.3	16.1	19.7	18.8	13.2	13.2	18.3	20.8	16.2	14.0	18.7	1.6	21.2	17.0	7.2	16.6	14.8	15.4	15.8	14.8	18.6	16.2	16.9	15.8	15.0	15.2	16.0	17.4	14.7	43.1	12.8	18.2	8.8	35.6	38.6	74.1	55.1	52.9	19.3	41.2	36.7	33.6	55.8	27.2	25.8	33.3	90.4	26.7	70.4	49.0	62.9	364.4	16.5	36.5	41.8	48.0	19.8	3.1	66.3	96.9	43.4	29.0	19.6	24.1	39.1	30.4	47.9	51.0	10.1	5.2	110.3	38.7	31.5	26.8	462.0	52.5	26.2	32.0	4.7	53.0	29.8	45.3	3.0	3.3	52.3	75.6	41.0	38.3	113.1	202.6	79.6	16.3	37.6	26.3	31.9	120.0	20.1	20.1	43.4	44.8	66.4	34.1	36.9	70.9	74.6
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791954-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 124.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 43.3;granulocytes: 124.8;monocytes: 50.9"	"Cell line enhanced"	"Detected in all"		"PC-3: 280.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	19.9	19.4	22.8	24.7	23.2	44.1	20.0	23.3	26.1	21.0	23.9	33.2	17.5	27.2	25.0	19.5	24.7	21.7	27.3	23.1	24.2	19.2	19.3	22.3	23.7	23.2	24.3	20.6	15.8	26.1	20.8	23.1	23.4	22.0	38.7	21.7	19.4	22.8	62.0	28.2	21.0	24.4	23.4	25.3	24.6	30.4	23.8	30.1	19.6	31.0	28.0	34.0	19.3	24.4	79.8	41.6	42.1	40.2	31.7	34.1	43.7	29.2	47.1	92.7	83.4	134.8	126.1	32.8	93.2	42.9	147.1	58.4	37.3	62.8	61.1	18.0	47.2	36.0	45.2	87.2	64.4	70.0	56.7	34.4	58.0	60.8	58.2	42.4	55.1	46.9	33.9	32.6	56.0	107.5	57.9	108.2	28.7	44.8	280.7	46.0	52.3	34.4	47.4	37.9	39.5	35.6	59.7	48.2	65.2	32.7	47.6	111.4	32.6	55.4	41.1	54.0	71.0	35.5	24.8	41.0	120.5	44.8	48.1	16.7	50.9	71.0	4.1	22.0	4.2	12.0	5.5	7.0	43.3	11.1	10.1	4.7	124.8	3.3	13.6	16.6	9.3	13.5	22.8	23.2	23.3	26.1	23.1	24.2	23.2	24.3	23.4	23.4	23.8	24.4	21.2	16.0	22.9	10.1	22.0	25.5	44.8	43.1	22.2	19.8	20.3	23.0	19.9	21.5	37.1	25.8	4.2	60.7	14.3	37.2	50.9	57.6	37.9	35.1	19.4	22.6	22.2	9.7	11.2	75.4	43.0	25.7	26.5	20.6	6.3	26.4	25.0	16.6	70.8	20.2	9.5	92.7	59.0	26.3	34.7	15.7	28.3	32.4	16.0	11.2	68.3	53.1	15.5	7.5	10.6	105.0	50.5	27.1	21.9	38.2	33.3	44.2	48.0	29.7	0.0	20.8	26.5	92.9	35.4	19.4	27.6	57.7	16.3	32.9	34.8	60.7
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 133.1;Horizontal cells: 80.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: AB_2683271"	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	9.9	4.6	2.9	14.2	3.3	14.9	6.3	2.3	6.1	7.8	3.2	25.7	20.4	13.1	6.2	10.7	10.0	14.3	24.4	8.6	2.3	4.7	4.2	9.1	21.6	3.4	2.3	8.7	8.6	4.9	3.0	14.1	2.7	6.5	21.9	14.8	5.4	8.8	39.4	7.5	28.0	13.0	3.1	14.7	20.6	5.0	2.7	24.1	6.9	10.4	14.2	11.9	7.6	3.5	24.5	13.4	19.8	14.4	9.7	13.2	15.8	24.2	15.7	11.6	6.6	17.9	13.2	45.3	29.2	35.3	7.1	27.8	16.0	9.6	12.4	19.6	20.9	7.3	9.5	6.9	3.8	16.8	15.2	11.0	13.3	31.4	24.8	19.6	6.6	18.9	9.2	22.9	15.1	13.9	14.4	8.2	17.2	15.8	21.5	37.9	19.7	20.0	13.6	30.2	26.0	30.7	10.1	13.4	13.9	13.3	9.2	13.9	10.0	18.4	17.3	12.8	19.4	10.9	1.9	24.9	17.6	11.1	19.4	2.0	0.3	4.0	3.2	0.7	2.3	1.8	2.3	4.2	1.2	2.0	1.9	3.7	0.4	4.7	0.9	0.5	2.0	1.1	2.9	3.3	2.3	6.1	8.6	2.3	3.4	2.3	2.7	3.1	2.7	3.5	13.0	9.6	10.2	3.9	14.4	11.3	11.9	6.7	8.6	18.0	7.4	8.1	44.5	20.0	11.2	1.8	22.9	3.5	28.6	133.1	0.0	19.0	0.6	28.0	35.9	12.1	24.6	4.8	11.0	18.2	7.9	18.9	25.0	15.6	5.7	13.3	6.4	6.1	17.0	80.8	11.4	62.0	4.1	15.7	22.5	2.0	11.5	15.5	8.8	13.1	12.0	16.7	42.2	6.0	9.1	17.7	61.3	13.2	9.0	16.1	62.9	11.3	30.3	23.3	13.1	53.5	33.6	2.7	10.1	15.6	16.2	4.5	31.0	17.9	32.3	34.4
EGFLAM	"AGRINL, AGRNL, FLJ39155, PIKA"	ENSG00000164318	"EGF like, fibronectin type III and laminin G domains"	Q63HQ2	5	38258409-38465480	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 121.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 120.9;Early spermatids: 50.7;Late spermatids: 49.1;Leydig cells: 155.4;Sertoli cells: 85.5;Smooth muscle cells: 70.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 10.2;HBEC3-KT: 12.6;hTERT-HME1: 16.4;HUVEC TERT2: 16.1;LHCN-M2: 37.0;U-2 OS: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066577	Approved				"Secreted - unknown location"	NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA066577: "	"unprognostic (2.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (7.02e-6)"	"unprognostic (2.60e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.04e-2)"	41.7	19.8	2.0	2.8	2.5	0.2	47.1	1.9	2.3	15.6	3.5	6.1	1.9	5.6	6.8	4.0	8.2	4.9	26.2	1.5	2.4	6.9	4.7	2.9	14.2	3.2	4.2	23.7	3.1	4.0	5.8	51.6	3.6	14.2	3.2	66.7	6.9	20.6	72.0	5.9	4.7	6.7	1.6	9.8	3.4	15.0	3.6	20.4	9.0	121.2	9.1	7.7	13.0	2.5	3.2	0.0	6.5	0.2	0.8	0.2	0.0	2.9	0.0	0.5	0.1	0.0	0.0	0.1	10.2	0.1	0.1	0.0	0.0	12.6	0.0	0.0	1.6	0.0	6.1	0.0	2.8	0.0	0.1	5.4	0.0	0.1	16.4	0.0	16.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	3.9	0.0	3.7	0.1	1.3	0.0	0.2	0.0	0.1	15.6	0.6	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.5	1.9	2.3	1.5	2.4	3.2	4.2	3.6	1.6	3.6	2.5	11.4	0.0	0.0	0.3	0.0	2.7	0.3	0.0	0.0	1.3	2.4	9.8	2.6	0.0	0.0	0.0	120.9	0.3	0.4	0.0	3.9	0.5	50.7	0.2	3.2	5.4	0.0	0.0	0.6	1.0	0.5	17.8	0.0	0.3	0.0	1.6	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	4.2	49.1	155.4	0.6	5.4	1.9	0.0	3.4	0.0	1.0	0.1	1.3	0.0	30.9	0.0	0.2	0.0	6.5	0.0	33.1	85.5	22.0	70.9	9.8	3.3	0.3	2.0	0.5	0.4	23.5	0.0	0.3
EIF2B3	"EIF-2B, EIF2Bgamma"	ENSG00000070785	"Eukaryotic translation initiation factor 2B subunit gamma"	Q9NR50	1	44850522-44986722	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024213, HPA024218, HPA024219"	Supported		Supported	Vesicles,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069"	"unprognostic (2.12e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.80e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.73e-2)"	23.6	27.2	11.4	11.6	10.9	10.9	21.9	13.2	15.6	18.7	10.1	17.5	8.6	17.0	12.5	17.4	16.3	9.6	40.6	11.2	11.6	15.4	24.7	13.5	14.3	11.9	12.1	18.2	16.9	30.0	15.8	9.7	12.8	15.0	13.4	19.0	25.1	13.7	77.0	17.6	10.7	19.4	11.0	14.9	14.2	19.3	11.2	13.3	12.5	48.0	14.5	17.7	17.1	14.0	35.4	26.9	30.9	25.5	36.3	43.1	36.2	56.1	42.2	56.5	52.9	39.0	20.7	90.6	39.9	43.2	45.0	20.6	65.3	48.6	69.5	32.5	58.1	44.3	29.3	38.4	46.2	71.2	24.3	29.3	25.8	61.0	69.9	26.5	52.8	30.1	106.1	31.6	62.3	23.1	69.7	30.2	42.0	38.8	52.7	54.7	51.3	65.7	28.7	15.7	53.2	20.5	55.1	63.8	37.4	40.7	24.7	32.8	28.3	35.9	42.9	53.4	73.7	31.6	37.9	68.9	27.9	59.5	43.1	1.6	23.4	3.9	18.6	37.2	22.8	14.8	18.3	21.1	37.0	18.9	22.9	23.6	2.1	25.5	33.1	25.3	17.6	21.4	11.4	10.9	13.2	15.6	11.2	11.6	11.9	12.1	12.8	11.0	11.2	14.0	13.9	6.4	22.0	24.8	15.8	13.8	19.0	33.0	10.8	15.1	15.8	16.8	79.2	15.7	24.9	5.5	20.9	25.1	12.1	4.5	29.4	18.9	26.1	17.0	23.0	14.4	3.6	15.3	39.9	15.8	22.6	22.6	13.7	11.5	25.9	21.1	3.9	22.6	24.8	21.9	44.5	7.0	20.3	10.7	11.2	11.3	26.4	15.4	17.8	26.2	30.1	21.7	10.3	29.1	35.7	13.7	6.9	25.2	22.6	17.1	5.7	23.1	34.2	21.8	26.3	19.7	45.4	45.5	23.6	17.1	14.9	14.9	13.5	40.4	9.4	13.9
EML1	"ELP79, EMAP, EMAPL, HuEMAP"	ENSG00000066629	"EMAP like 1"	O00423	14	99737693-99942060	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 158.4;Excitatory neurons: 57.5;Late spermatids: 61.3;Microglial cells: 69.3;Oligodendrocytes: 61.8;Rod photoreceptor cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 67.3;HDLM-2: 89.5;U-2197: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033137, HPA049105"	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB033137: AB_2098052, HPA049105: AB_2680633"	"unprognostic (9.86e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.09e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.89e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.81e-3)"	"unprognostic (7.03e-3)"	15.5	6.4	8.6	9.1	25.5	0.3	9.7	7.3	12.7	13.2	15.0	35.5	6.8	16.1	10.8	24.1	15.1	18.6	17.2	8.6	7.9	8.6	5.5	13.2	3.3	9.2	9.0	3.8	8.7	28.3	9.2	27.2	10.7	9.6	14.9	50.1	5.0	16.9	47.5	9.4	10.1	31.0	9.4	3.9	14.9	8.0	8.9	1.3	14.8	34.4	4.4	17.1	10.3	22.8	0.0	44.9	36.8	12.9	20.1	39.5	0.3	35.9	67.3	25.2	8.4	5.1	0.9	0.0	22.2	22.6	30.3	0.2	26.7	3.1	11.5	89.5	13.6	0.0	7.9	0.8	4.8	0.1	0.9	11.6	4.9	31.0	11.7	16.0	44.5	0.7	0.1	0.0	10.4	21.3	0.1	0.1	14.5	0.1	17.2	5.4	13.5	0.2	56.2	0.6	14.1	20.9	11.8	1.8	0.0	24.1	13.7	1.2	42.3	22.8	4.1	104.3	14.9	0.5	0.0	0.3	57.3	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	25.5	7.3	12.7	8.6	7.9	9.2	9.0	10.7	9.4	8.9	22.8	22.8	16.0	7.0	17.3	0.3	2.8	1.2	0.4	1.2	9.2	1.0	1.3	15.0	1.5	4.5	3.7	158.4	2.7	0.1	0.1	0.0	4.6	29.1	15.9	14.2	30.1	0.0	0.0	57.5	4.9	0.6	20.6	4.1	4.7	0.0	1.6	40.0	1.3	1.3	1.7	29.9	0.6	0.0	2.5	4.7	61.3	7.2	1.9	7.2	69.3	0.6	8.8	1.0	17.6	61.8	0.8	0.0	6.0	1.2	1.4	0.0	2.5	11.8	113.6	0.0	20.8	8.7	4.8	11.3	0.4	4.0	2.9	0.7	1.2	0.0	0.7
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	26	"skeletal muscle: 14758.3;tongue: 10771.0"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 582.2;Skeletal myocytes: 248.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 263.8;HeLa: 120.0;HMC-1: 115.1;RH-30: 170.2;RPMI-8226: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		Yes	No		86000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.8	5.5	3.8	15.6	3.9	20.4	8.0	7.1	4.3	6.6	5.0	8.0	20.1	7.2	7.1	173.8	7.4	2.6	499.8	3.5	3.7	10.3	108.0	8.6	13.0	4.3	5.0	6.0	5.5	4.0	7.9	6.3	4.6	47.3	3.0	5.0	116.8	3.1	14758.3	8.3	15.6	2.8	4.1	16.9	10.1	9.3	4.3	5.8	10.3	10771.0	4.9	5.6	5.0	4.9	12.0	25.5	11.3	10.7	9.1	2.2	27.6	21.0	2.7	1.5	1.3	12.8	8.1	21.9	25.8	1.9	3.5	15.4	3.8	1.9	1.0	263.8	24.3	21.9	120.0	18.9	3.7	6.8	115.1	14.4	3.8	2.1	4.1	9.8	1.4	24.8	10.2	39.0	4.9	6.6	7.9	26.5	14.8	3.3	10.6	34.6	170.2	96.9	3.1	7.9	7.1	27.1	13.6	11.4	14.7	7.6	10.2	7.0	6.5	12.1	21.3	5.4	16.0	27.6	16.8	18.2	6.7	20.8	12.2	31.4	28.5	50.4	36.8	41.5	24.8	24.5	30.8	34.4	37.6	20.1	20.0	32.2	34.4	34.9	47.6	29.9	43.2	83.6	3.8	3.9	7.1	4.3	3.5	3.7	4.3	5.0	4.6	4.1	4.3	4.9	1.2	0.0	1.8	2.3	2.7	2.0	1.2	2.1	4.0	6.6	3.0	3.0	582.2	0.0	2.2	5.5	4.2	5.4	3.2	2.9	0.0	1.5	1.8	0.9	1.6	7.3	0.0	3.8	0.2	0.8	3.8	17.3	4.6	2.2	8.2	2.4	2.2	56.2	4.5	3.3	0.2	2.2	2.0	3.5	6.7	3.7	0.3	4.3	1.8	0.0	78.3	1.9	4.1	1.0	0.5	1.8	1.9	0.4	2.3	1.2	6.6	9.5	0.3	2.5	6.6	248.4	55.8	7.9	7.5	2.1	1.8	3.3	4.5	1.1	2.6	0.8
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 238.6;Excitatory neurons: 334.2;Inhibitory neurons: 306.8;Microglial cells: 341.0;Oligodendrocyte precursor cells: 395.6;Oligodendrocytes: 345.9;Rod photoreceptor cells: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA		10000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: AB_2673886"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favorable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	20.7	21.1	18.7	13.8	20.2	13.8	21.4	19.3	20.3	22.6	24.3	19.7	13.1	21.5	13.6	24.4	27.3	17.8	15.3	20.9	19.4	17.7	17.8	17.7	16.4	18.4	20.3	30.6	27.3	27.3	16.9	19.6	19.9	18.3	21.5	53.1	16.3	20.5	68.4	25.4	13.5	23.9	18.8	21.0	17.3	18.7	19.1	28.1	26.4	38.5	20.3	21.1	18.6	20.8	40.1	32.2	43.3	43.3	49.7	51.6	15.0	28.6	47.2	25.4	33.2	18.8	54.7	29.8	20.1	54.1	36.9	24.7	23.7	38.8	41.8	45.6	28.2	24.0	31.5	19.9	54.7	32.0	25.1	50.4	47.6	36.3	66.5	55.7	43.5	38.6	35.1	28.8	47.7	26.1	58.5	35.2	32.8	47.5	29.8	25.7	38.7	54.2	40.7	35.2	33.9	53.2	43.0	39.1	46.3	48.9	25.8	29.3	47.9	28.1	14.6	30.0	31.5	45.0	29.4	28.1	82.9	36.4	43.8	10.3	12.0	7.2	11.2	12.9	10.0	8.3	11.6	11.9	16.3	8.1	9.4	9.6	4.0	19.6	11.4	7.2	12.9	11.2	18.7	20.2	19.3	20.3	20.9	19.4	18.4	20.3	19.9	18.8	19.1	20.8	22.9	22.4	22.3	238.6	27.3	18.9	16.3	16.6	25.6	39.9	16.8	15.4	30.9	11.5	18.0	14.7	93.8	17.5	26.7	21.5	3.9	15.0	29.6	27.0	21.2	23.0	17.4	18.7	334.2	18.2	16.6	21.2	34.1	21.0	8.2	32.4	23.2	15.9	18.1	50.5	306.8	21.0	26.4	27.3	14.5	27.6	17.4	20.4	14.2	341.0	23.9	20.4	23.7	395.6	345.9	15.4	17.4	18.8	27.7	13.2	16.3	16.9	29.8	231.5	13.1	26.0	15.3	20.5	13.1	28.2	17.0	11.2	26.2	26.4	21.9	20.1
FAM126A	"DRCTNNB1A, HCC, HYCC1, hyccin"	ENSG00000122591	"Family with sequence similarity 126 member A"	Q9BYI3	7	22889371-23014130	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cataract, Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 133.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042873	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA042873: AB_2678207"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-4)"	"unprognostic (1.35e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (6.04e-7)"	"prognostic unfavorable (5.99e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (9.03e-4)"	14.9	4.7	5.0	8.5	6.9	4.2	12.2	4.4	6.5	9.7	7.9	9.7	9.4	8.7	1.4	12.2	6.7	11.4	10.5	12.1	4.5	4.7	8.5	13.7	11.5	5.0	5.9	6.6	6.2	2.3	5.0	14.8	5.4	5.9	4.4	4.9	6.8	4.8	25.0	4.9	6.9	11.5	4.5	11.8	4.6	12.0	6.3	4.2	6.6	15.3	9.2	9.4	11.2	7.8	22.4	12.4	63.6	22.3	61.3	100.9	10.6	103.0	101.8	41.6	63.9	19.8	10.6	13.3	15.9	82.6	87.2	7.7	44.3	14.7	72.6	6.6	22.4	14.7	18.1	13.0	48.0	19.3	15.7	41.1	9.2	85.0	61.3	83.4	42.5	7.5	30.4	58.6	77.5	7.9	10.8	24.2	63.0	0.1	22.9	15.7	63.5	9.5	13.1	11.2	10.4	0.1	38.1	0.4	19.2	52.5	8.2	20.4	51.0	150.0	18.3	71.8	37.4	67.2	30.6	60.9	91.1	12.5	112.6	4.7	2.9	13.7	1.4	7.8	1.3	6.4	2.6	1.3	3.9	7.4	0.9	1.5	0.3	2.1	9.8	1.6	4.0	2.5	5.0	6.9	4.4	6.5	12.1	4.5	5.0	5.9	5.4	4.5	6.3	7.8	27.8	3.2	15.1	19.6	29.1	25.5	5.1	8.3	15.9	60.3	5.4	32.4	21.9	2.8	4.2	3.7	2.1	11.8	28.8	0.5	0.0	6.8	49.0	12.5	22.4	31.4	7.7	19.8	13.6	4.8	15.5	42.9	2.6	11.3	8.2	8.6	26.0	17.7	15.2	16.8	13.6	3.0	2.0	25.1	55.2	22.4	20.2	31.5	35.6	47.8	24.0	6.8	11.3	23.6	133.2	3.6	1.4	19.5	26.4	4.7	8.3	5.7	2.4	4.6	19.7	24.0	31.7	72.2	11.1	35.0	24.0	6.0	20.6	12.2	4.7	6.5
FAM160A1	FLJ43373	ENSG00000164142	"Family with sequence similarity 160 member A1"	Q05DH4	4	151409176-151670503	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 32.3;skeletal muscle: 34.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 11.9;Excitatory neurons: 15.8;Oligodendrocyte precursor cells: 19.1;Suprabasal keratinocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	11	"cerebellum: 13.8"	"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 2.5"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A-431: 8.6;HeLa: 10.0;hTERT-HME1: 9.2;SiHa: 8.9;SK-BR-3: 7.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA046348	Enhanced		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA046348: AB_10966145"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-1)"	0.6	1.3	0.8	0.3	0.7	1.8	4.4	13.8	1.2	3.2	32.3	3.3	1.9	1.6	4.0	7.8	2.7	0.9	3.4	1.2	0.0	3.4	0.7	1.9	0.2	0.6	0.6	2.4	10.2	8.3	1.3	0.5	0.8	2.2	3.4	6.7	4.7	1.5	34.5	13.4	2.0	1.1	0.3	0.5	2.5	3.4	0.4	1.5	6.8	16.5	2.3	2.2	3.4	0.2	8.6	0.7	0.0	0.2	0.0	0.1	2.9	0.3	1.4	0.8	0.2	3.6	3.0	0.0	0.8	0.3	2.6	7.4	2.1	6.1	0.9	0.0	3.3	0.0	10.0	0.9	0.0	0.0	0.2	0.2	7.0	0.0	9.2	2.4	0.2	0.7	0.0	0.0	0.5	1.2	0.0	0.0	2.8	2.8	0.8	0.0	2.0	0.2	5.1	5.5	1.2	0.4	8.9	7.8	0.2	2.2	3.3	0.0	0.0	0.4	3.7	0.2	1.4	0.0	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.8	0.7	13.8	1.2	1.2	0.0	0.6	0.6	0.8	0.3	0.4	0.2	0.1	3.2	2.0	1.3	0.0	11.9	6.6	2.9	10.8	0.1	2.7	1.9	1.8	0.0	5.2	0.0	0.0	0.3	0.5	5.9	0.0	1.6	3.3	5.9	0.6	0.4	0.0	0.0	15.8	1.8	0.6	0.6	6.1	10.8	1.3	0.3	0.0	0.5	0.3	8.4	2.4	2.3	0.0	0.0	2.1	1.5	0.0	0.6	0.0	1.0	0.0	2.5	0.0	19.1	1.3	1.9	0.3	0.0	1.4	7.9	2.2	0.7	1.3	4.7	0.0	1.0	0.4	6.1	5.8	11.6	14.5	1.6	0.2	0.3	1.8	8.6
FAM240C		ENSG00000216921	"Family with sequence similarity 240 member C"	A0A1B0GVR7	2	241893988-241902551	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"tongue: 225.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.5;REH: 2.4;SCLC-21H: 1.6"									HPA073342			Approved	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"		Nucleoplasm		"HPA073342: "	"unprognostic (9.31e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.75e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.29e-1)"	3.5	0.7	5.9	0.1	6.9	0.3	3.9	6.4	8.2	1.4	5.6	0.2	0.2	1.9	0.0	4.0	1.7	0.1	1.3	5.4	5.9	0.1	0.2	0.1	0.4	6.2	6.4	1.6	36.8	0.5	0.4	0.2	6.4	3.5	0.0	0.6	5.4	3.9	10.2	3.1	0.2	0.1	5.6	0.3	0.4	1.3	6.3	3.4	6.9	225.1	0.2	0.4	1.0	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.2	0.0	0.7	0.5	0.0	0.2	0.0	0.0	2.4	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.9	6.4	8.2	5.4	5.9	6.2	6.4	6.4	5.6	6.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FAM76A	MGC34648	ENSG00000009780	"Family with sequence similarity 76 member A"	Q8TAV0	1	27725961-27763116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.5;Late spermatids: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044762, HPA077897"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA044762: AB_10795886, HPA077897: AB_2686867"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.22e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.32e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-2)"	21.0	5.8	5.9	8.5	6.5	13.7	11.7	8.3	8.9	9.3	10.1	10.1	8.7	12.9	10.0	11.7	9.7	10.8	10.1	5.5	7.4	11.6	12.0	10.5	10.7	6.9	5.7	9.6	11.3	13.7	7.8	11.1	6.5	10.0	13.4	15.4	7.9	10.4	40.4	12.0	8.8	10.3	4.5	11.0	11.7	18.6	6.9	8.0	15.9	12.8	10.9	7.1	8.0	12.3	10.0	7.8	8.8	9.1	10.9	9.4	15.9	9.1	9.5	13.1	12.9	9.1	13.0	18.1	5.9	10.2	12.5	12.8	11.2	10.1	10.2	9.4	8.2	5.6	11.7	10.7	8.7	8.9	8.4	9.7	10.8	14.6	14.5	6.7	6.7	9.5	10.9	16.5	9.6	9.5	21.4	8.3	13.9	9.6	7.8	12.8	10.4	10.3	10.6	14.1	12.7	5.7	10.5	11.1	11.3	10.7	7.8	3.5	7.3	15.5	6.7	18.1	6.4	14.9	17.7	14.6	9.7	11.5	6.7	9.8	8.8	11.0	10.4	9.4	11.3	9.2	10.8	10.2	8.1	9.7	10.1	11.2	6.1	9.4	10.1	11.3	8.9	5.3	5.9	6.5	8.3	8.9	5.5	7.4	6.9	5.7	6.5	4.5	6.9	12.3	20.0	28.9	17.0	9.4	20.3	19.1	9.4	8.1	23.3	28.5	14.8	12.1	15.9	14.3	8.8	23.9	27.1	31.3	26.7	12.1	21.5	11.7	131.5	19.6	19.6	14.8	4.2	13.5	15.9	9.7	11.5	26.0	17.3	13.9	11.4	8.5	22.1	18.4	11.8	28.6	15.2	10.4	6.1	15.8	25.2	110.7	16.8	15.2	39.2	13.1	11.4	19.1	16.5	5.0	11.6	9.6	9.1	37.2	10.9	5.4	10.3	20.1	25.3	39.6	19.7	25.4	27.6	35.3	55.4	17.3	27.0	45.4	18.9	11.0	9.2	5.3
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593824	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 753.6;tongue: 385.3"	"Group enriched"	"Detected in some"	7	"Gastric mucus-secreting cells: 11.2;Skeletal myocytes: 8.7;Spermatogonia: 8.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.9;CACO-2: 2.1;HMC-1: 2.2;MCF7: 3.0;OE19: 2.9;PC-3: 2.0;SiHa: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012513, HPA077371"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		960000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA012513: AB_1848446, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	0.1	0.9	0.1	0.1	0.0	0.0	0.2	1.2	0.1	0.0	69.2	0.3	5.3	0.0	0.0	8.1	0.0	0.1	0.2	6.1	0.0	0.2	0.2	0.4	0.4	0.7	0.3	0.0	4.3	49.7	0.0	0.1	0.1	1.2	0.0	0.0	4.2	3.3	753.6	0.2	0.9	0.0	0.9	0.0	36.1	1.4	1.4	0.2	0.3	385.3	0.9	0.3	0.0	0.0	0.3	1.3	0.0	1.4	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	1.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	2.9	2.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	2.8	0.6	0.0	0.1	0.2	0.1	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.6	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	6.1	0.0	0.7	0.3	0.1	0.9	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	11.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.2	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FBXO30	"Fbx30, MGC21674"	ENSG00000118496	"F-box protein 30"	Q8TB52	6	145793502-145814795	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 9.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012583	Approved		Approved	Microtubules		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 40: Granulosa cells - Unknown function"	Microtubules		"HPA012583: AB_2668686"	"unprognostic (8.69e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.47e-3)"	"unprognostic (8.36e-2)"	"unprognostic (7.61e-7)"	"unprognostic (5.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.18e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.78e-1)"	4.5	4.0	3.8	4.2	5.0	7.2	4.0	4.6	3.9	4.1	2.7	9.7	4.1	6.7	3.1	9.6	3.2	5.6	7.2	3.1	6.0	4.1	3.4	3.2	4.3	4.5	5.5	5.9	3.8	4.0	1.6	4.8	4.7	6.0	4.7	5.3	4.4	6.8	11.5	2.6	3.5	8.0	4.2	3.7	3.7	6.5	5.1	2.9	8.0	9.1	4.1	5.7	2.9	5.3	3.7	6.9	9.7	13.2	9.9	8.8	9.9	10.3	9.6	6.9	6.8	8.7	3.3	17.0	7.8	11.8	12.6	5.7	8.4	7.5	10.4	10.0	5.8	10.8	9.1	8.8	17.8	14.1	10.8	14.6	8.3	8.6	11.4	9.0	10.1	4.1	12.6	11.9	13.6	2.9	6.4	7.5	11.2	2.4	5.1	8.2	21.7	5.9	7.2	3.8	4.3	6.9	12.6	6.5	6.1	9.6	3.0	13.8	13.4	7.1	6.0	9.1	10.4	8.8	7.2	6.8	11.4	6.0	7.7	9.3	1.3	1.6	0.4	1.1	0.3	0.6	0.4	0.8	1.6	1.3	0.6	0.6	1.2	0.5	0.9	0.5	0.3	0.6	3.8	5.0	4.6	3.9	3.1	6.0	4.5	5.5	4.7	4.2	5.1	5.3	11.1	3.2	5.9	7.2	5.4	14.3	5.3	4.2	12.5	8.8	10.5	8.3	22.9	10.0	4.7	3.7	4.2	5.8	5.7	4.9	11.7	4.7	10.9	4.1	13.7	13.8	6.0	36.7	5.3	3.2	3.4	15.4	7.1	6.2	12.0	37.1	11.4	9.7	7.5	26.9	6.4	5.0	2.0	11.9	20.8	4.4	11.1	10.2	7.2	7.5	7.5	12.0	0.0	5.0	7.6	5.1	3.2	10.1	11.1	7.1	4.3	8.2	2.8	8.7	0.0	26.5	18.4	19.7	10.5	12.4	17.3	5.6	6.2	7.2	5.0	5.0
FBXO40	"Fbx40, KIAA1195"	ENSG00000163833	"F-box protein 40"	Q9UH90	3	121593379-121630295	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	97	"heart muscle: 90.4;skeletal muscle: 162.2;tongue: 100.3"	"Cell type enriched"	"Detected in some"	33	"Cardiomyocytes: 416.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 1.7"	"Low region specificity"	"Detected in many"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.67e-2)"	"unprognostic (1.23e-4)"			"unprognostic (9.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-1)"		"unprognostic (4.30e-2)"	0.2	0.1	0.3	0.0	0.7	0.6	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.0	90.4	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.1	0.8	0.0	162.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	100.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.3	0.7	0.0	0.7	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	416.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.8	0.0	0.0	2.8	0.0	0.1	9.6	0.0	0.2	0.0	12.4	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0
FGF6		ENSG00000111241	"Fibroblast growth factor 6"	P10767	12	4428155-4445614	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"skeletal muscle: 16.0;tongue: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.4;REH: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"																			"unprognostic (4.29e-2)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	2.4	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 11467.1;tongue: 9770.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1145.1;Early spermatids: 373.8;Late spermatids: 1206.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 88.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 36.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 36.1;T-cells: 18.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 303.7;fHDF/TERT166: 258.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavorable (2.11e-4)"	938.4	65.8	120.8	75.5	117.2	11.7	441.8	95.9	126.3	315.5	85.8	672.0	83.2	464.6	107.7	538.1	281.6	127.6	1462.3	130.8	144.9	45.2	43.1	285.6	41.7	103.9	125.4	102.8	39.4	196.5	92.9	106.6	115.9	408.8	161.4	76.2	161.3	541.1	11467.1	101.3	235.5	486.5	114.8	43.0	368.4	60.2	130.1	25.1	310.1	9770.8	32.1	469.6	253.1	102.9	0.4	44.3	60.7	57.8	127.2	52.3	1.5	183.7	303.7	34.8	81.3	0.3	12.7	0.7	55.8	258.8	95.0	0.5	119.2	148.0	28.2	0.4	136.7	0.7	34.4	0.0	121.6	0.3	26.8	96.6	24.4	41.2	128.7	14.1	36.6	34.5	0.1	26.0	81.9	2.5	26.1	1.6	19.1	0.2	52.2	69.8	2.6	38.2	1.1	0.1	43.5	63.8	6.6	0.2	12.4	24.1	0.3	2.4	102.5	150.2	71.0	5.9	44.7	6.8	16.0	1.1	11.9	1.4	18.2	0.1	0.7	0.0	5.2	0.1	13.8	5.8	18.2	7.2	3.1	3.6	12.0	4.0	1.2	36.1	0.0	19.4	2.2	11.1	120.8	117.2	95.9	126.3	130.8	144.9	103.9	125.4	115.9	114.8	130.1	102.9	203.0	48.1	11.7	32.0	8.1	56.5	26.9	15.1	14.2	36.2	1.4	8.3	1145.1	0.0	4.9	11.0	8.4	0.6	8.6	0.5	1.9	3.0	373.8	4.3	32.3	61.1	13.8	17.9	70.2	0.2	1.1	236.0	2.0	2.0	15.8	41.0	113.6	6.1	4.3	99.3	55.6	0.8	0.0	5.1	47.0	1206.9	123.9	35.6	32.0	16.9	7.4	209.6	2.1	35.2	8.2	0.6	7.6	152.4	15.5	20.1	0.6	11.6	4.8	19.4	105.2	248.1	235.7	7.4	88.6	2.7	44.8	2.7	15.5	9.6	2.0	2.6
FILIP1L	"DOC-1, GIP130"	ENSG00000168386	"Filamin A interacting protein 1 like"	Q4L180	3	99830141-100114513	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 210.1;Early spermatids: 376.7;Sertoli cells: 256.4;Skeletal myocytes: 184.2;Smooth muscle cells: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.1;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 84.2;HDLM-2: 79.9;TIME: 145.8"	"Region enriched"	"Detected in many"	7	"olfactory bulb: 18.0"	"Low region specificity"	"Detected in all"			HPA043133	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA043133: AB_10793991"	"unprognostic (9.14e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (2.46e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.82e-3)"	77.1	21.7	4.9	52.4	6.3	0.8	32.6	4.8	6.6	63.8	4.0	57.7	28.4	117.6	23.8	56.0	31.2	90.9	54.8	6.2	4.4	24.0	28.1	30.7	30.1	9.6	4.2	76.4	35.5	17.5	3.9	43.9	9.7	67.9	29.8	4.7	9.3	54.3	140.4	16.8	41.2	151.7	3.7	42.9	46.7	22.0	3.6	11.9	20.1	161.5	22.3	101.5	21.9	4.0	59.0	0.0	22.3	0.1	35.8	30.2	2.0	29.4	58.8	50.2	56.5	17.8	0.2	0.2	5.0	84.2	13.2	7.1	0.0	14.4	59.0	79.9	0.6	4.8	0.2	23.3	17.8	1.4	0.0	24.2	5.1	5.6	0.0	32.0	22.8	0.0	3.8	0.5	7.7	0.1	5.2	1.2	1.3	3.1	0.0	0.1	26.1	0.7	33.5	1.0	2.0	3.7	0.4	0.4	0.1	11.7	0.0	10.5	145.8	8.8	0.2	1.9	15.5	4.2	0.2	0.3	6.5	0.4	0.0	0.2	0.4	0.0	0.1	1.0	0.0	0.6	0.1	0.1	2.1	0.6	0.0	0.1	0.2	0.4	2.9	0.4	0.1	0.3	4.9	6.3	4.8	6.6	6.2	4.4	9.6	4.2	9.7	3.7	3.6	4.0	92.9	16.0	23.1	9.4	4.1	27.8	56.7	7.9	2.2	11.8	12.3	6.5	145.7	35.8	2.3	5.5	8.4	1.1	1.8	2.1	1.9	210.1	376.7	2.3	60.5	77.2	3.0	0.0	42.0	109.3	0.7	145.2	21.9	2.4	34.8	16.3	41.0	0.7	3.2	106.0	25.8	5.7	6.1	36.3	98.9	180.2	83.0	86.1	17.8	25.3	17.7	0.9	0.0	22.1	21.6	43.7	0.2	104.2	3.0	5.1	5.4	2.6	1.9	6.0	256.4	184.2	351.9	40.1	2.5	1.5	22.7	3.1	8.8	41.8	3.2	3.5
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FKBP prolyl isomerase 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 892.7;tongue: 925.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 759.3;ASC TERT1: 468.5;HHSteC: 593.0;HSkMC: 718.3;hTCEpi: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	400.1	92.3	18.2	70.1	26.8	26.6	160.4	19.7	32.1	86.4	20.2	110.9	11.3	97.5	63.0	130.6	104.6	78.9	93.7	16.8	20.7	108.8	144.5	92.7	166.7	22.7	23.8	122.1	200.4	227.0	52.9	28.5	23.5	85.0	37.1	25.6	61.0	49.8	892.7	114.0	135.7	81.8	17.0	105.6	129.0	41.4	22.1	229.4	97.2	925.1	80.3	108.9	109.1	26.2	40.0	17.1	73.1	109.7	759.3	468.5	1.2	21.2	1.0	13.6	31.0	29.7	6.9	195.3	19.5	4.1	11.8	0.6	44.1	93.2	32.0	77.7	41.6	84.0	14.1	41.7	593.0	53.3	8.3	718.3	368.6	23.7	220.5	14.8	80.1	38.8	91.3	77.1	144.3	25.3	222.5	99.6	18.9	8.7	12.3	97.7	19.1	95.4	60.2	23.7	27.7	16.8	17.3	19.8	4.2	15.9	108.4	62.2	178.7	19.3	17.3	2.8	29.7	34.9	42.9	243.5	6.6	102.3	7.6	57.6	105.0	70.0	64.4	92.3	78.0	9.7	90.6	68.5	107.5	12.5	133.4	96.7	85.1	45.2	46.8	32.0	37.2	158.5	18.2	26.8	19.7	32.1	16.8	20.7	22.7	23.8	23.5	17.0	22.1	26.2	180.2	12.8	11.3	23.2	42.9	17.6	59.2	20.1	37.0	1.9	32.0	20.8	131.8	74.4	14.2	5.5	0.0	1.2	102.0	14.3	23.5	0.6	9.8	55.7	76.1	57.9	20.9	102.2	25.9	7.9	0.8	97.5	18.8	79.2	38.5	54.7	117.1	225.6	35.1	0.0	2.8	35.5	34.6	384.2	44.8	22.0	160.9	192.2	7.2	66.5	110.3	4.6	44.3	16.6	26.3	2.9	19.3	218.6	66.4	49.9	157.0	27.4	18.2	22.6	144.7	188.1	106.8	14.9	19.1	37.5	21.3	0.4	128.7	2.8	39.5	22.2
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830406-128859274	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 635.2;skeletal muscle: 1384.8;tongue: 442.6"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 393.6;fHDF/TERT166: 180.2;hTEC/SVTERT24-B: 190.6;U-2 OS: 163.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	13.1	3.4	5.8	25.9	11.5	0.0	5.9	11.5	9.9	16.9	3.0	215.4	9.4	96.6	4.6	40.3	35.4	13.8	635.2	5.9	16.7	2.8	1.1	12.5	0.6	52.1	11.1	9.4	2.1	3.2	1.6	2.4	29.9	71.1	9.8	0.5	16.5	100.7	1384.8	8.9	40.3	114.4	51.7	0.7	65.6	2.2	19.1	0.3	4.3	442.6	0.2	162.7	21.3	49.8	0.1	0.8	4.2	0.1	34.4	41.2	4.1	393.6	73.6	109.2	52.3	124.0	1.0	0.1	64.7	180.2	44.9	0.1	23.7	0.9	64.4	0.2	13.1	0.1	20.2	0.1	43.2	0.0	0.2	78.0	0.1	190.6	0.1	44.2	69.0	0.3	49.0	0.2	75.8	0.0	0.0	1.5	64.5	0.1	22.6	0.1	127.5	1.0	0.1	0.0	2.1	7.0	0.7	0.1	0.3	88.0	0.4	1.6	144.6	38.2	163.5	10.1	0.2	0.1	0.0	0.3	129.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	11.5	11.5	9.9	5.9	16.7	52.1	11.1	29.9	51.7	19.1	49.8	3.6	3.2	0.5	0.7	0.0	3.7	0.3	0.1	1.2	0.6	0.3	1.3	1892.3	0.0	1.9	1.8	0.0	0.4	0.2	0.5	0.0	0.7	0.4	1.8	5.0	31.4	0.0	0.0	0.2	0.2	3.0	31.6	0.0	2.9	0.0	0.6	1.8	0.0	0.9	0.0	1.1	0.3	0.0	0.0	6.9	0.9	5.3	0.5	5.4	0.0	0.0	0.1	0.0	0.0	5.8	2.6	0.1	10.5	1.2	2.7	0.0	1.1	0.0	0.2	0.0	71.8	38.1	0.3	1.0	0.2	4.5	1.9	1.0	0.1	0.2	1.0
FNDC5	FRCP2	ENSG00000160097	"Fibronectin type III domain containing 5"	Q8NAU1	1	32862268-32872482	"Predicted membrane proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 323.1;tongue: 478.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 71.3;Cardiomyocytes: 64.9;Early spermatids: 28.1;Granulosa cells: 38.6;Muller glia cells: 44.1"	"Group enriched"	"Detected in many"	7	"glioma: 4.2;liver cancer: 10.0;testis cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RH-30: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051290	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"HPA051290: AB_2681422"	"unprognostic (4.36e-2)"	"unprognostic (9.08e-3)"	"unprognostic (7.62e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.07e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.33e-2)"	1.3	12.8	10.5	0.1	5.8	0.2	0.8	21.6	10.0	1.4	47.6	1.3	0.8	3.3	2.4	11.6	4.1	1.8	42.2	6.7	16.8	0.7	18.4	1.1	0.2	10.5	14.7	4.6	0.5	10.4	5.2	0.5	7.6	3.6	0.5	8.0	25.5	1.0	323.1	0.4	1.3	2.0	5.3	0.2	5.2	2.7	29.6	0.6	1.2	478.4	0.1	1.2	0.8	3.3	0.0	0.1	1.1	0.4	0.0	1.2	0.2	0.5	0.1	0.7	0.1	0.9	0.3	0.2	0.8	0.4	0.2	0.1	4.7	0.1	0.1	0.1	0.3	0.1	0.4	0.2	0.0	0.2	0.0	1.8	0.0	0.3	0.0	0.6	0.0	0.2	0.9	0.1	0.8	0.1	0.1	0.1	1.4	0.0	0.1	0.6	48.2	0.3	0.0	0.1	6.9	1.1	0.5	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.8	2.2	0.4	0.2	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	5.8	21.6	10.0	6.7	16.8	10.5	14.7	7.6	5.3	29.6	3.3	1.1	0.0	0.0	7.5	0.0	0.1	0.2	0.0	0.0	71.3	0.6	0.5	64.9	0.0	0.0	1.8	4.2	0.0	0.0	0.0	1.9	0.0	28.1	0.3	4.6	1.4	0.0	0.0	10.3	0.0	0.0	14.5	0.0	0.5	0.0	38.6	0.7	2.0	0.9	0.0	15.8	0.1	0.0	0.0	0.5	5.9	5.3	0.8	0.0	5.6	0.0	44.1	0.0	3.0	0.7	0.1	0.0	5.7	0.0	0.2	0.1	0.2	0.0	7.4	0.0	12.9	1.7	0.5	1.0	0.0	0.0	0.3	0.2	0.5	0.5	0.1
FSD2	"RP11-127F21, SPRYD1"	ENSG00000186628	"Fibronectin type III and SPRY domain containing 2"	A1L4K1	15	82755362-82806070	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"heart muscle: 52.3;skeletal muscle: 154.3;tongue: 44.3"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 81.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 3.6;U-266/70: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046263			Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA046263: AB_2679604"	"unprognostic (2.80e-1)"	"unprognostic (3.54e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.59e-2)"	0.2	0.7	0.2	0.9	0.2	0.8	0.1	0.7	0.4	0.0	0.0	0.1	0.9	0.4	0.6	1.9	0.3	0.3	52.3	0.3	0.5	0.3	0.1	0.2	1.1	0.1	0.1	0.6	0.6	0.7	0.1	0.3	0.2	1.2	0.0	2.4	0.8	0.0	154.3	1.5	0.8	0.1	0.0	0.6	0.6	0.7	0.3	0.0	0.9	44.3	0.1	0.1	0.0	0.6	0.7	0.7	1.1	1.3	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.6	1.2	2.3	0.5	0.0	0.6	2.8	0.0	0.0	0.2	0.4	3.1	1.3	3.6	1.0	0.0	0.7	0.5	0.0	0.0	0.0	0.1	0.7	0.0	1.0	1.2	2.0	0.0	0.7	0.4	1.4	1.0	0.5	0.6	0.8	0.8	0.6	0.1	1.3	1.1	0.9	0.5	0.5	0.9	0.5	0.9	1.0	0.5	1.6	0.8	0.6	1.0	4.7	2.1	0.8	1.0	2.8	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.7	0.4	0.3	0.5	0.1	0.1	0.2	0.0	0.3	0.6	0.4	0.0	2.2	1.3	0.2	0.4	1.0	0.2	0.0	2.1	0.5	0.3	81.6	1.5	0.8	0.0	6.2	0.1	0.3	0.1	0.0	0.0	4.8	1.7	0.3	1.2	1.2	0.0	3.9	0.4	0.1	3.0	0.0	1.6	1.3	0.6	0.0	0.0	0.3	11.8	3.6	0.0	2.0	0.3	2.1	6.1	0.3	0.2	0.0	1.0	0.1	0.7	0.0	4.0	3.3	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.5	4.5	0.0	4.5	0.6	0.6	0.3	0.0	0.6	0.3	0.4	0.2	0.1	0.3
FYCO1	"FLJ13335, ZFYVE7"	ENSG00000163820	"FYVE and coiled-coil domain autophagy adaptor 1"	Q9BQS8	3	45917899-45995824	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 263.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 89.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035526, HPA057966"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA035526: AB_10672867, HPA057966: AB_2683567"	"unprognostic (2.45e-1)"	"unprognostic (6.62e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.85e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.33e-11)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.99e-2)"	16.7	13.0	10.5	9.7	12.0	6.5	13.4	9.6	9.4	23.1	11.3	42.0	8.0	25.6	10.3	21.3	15.4	18.7	66.8	8.6	10.3	10.7	10.8	14.7	8.6	15.5	10.8	23.1	12.7	20.3	7.6	8.2	14.8	19.3	10.7	33.0	14.9	22.9	263.3	19.3	14.4	28.2	15.1	10.2	20.4	3.3	11.9	10.5	16.5	104.6	8.2	39.6	16.9	15.1	10.8	10.3	3.0	13.0	27.9	21.8	4.9	10.2	23.7	13.1	14.6	5.6	9.3	7.9	5.6	14.2	12.7	7.9	8.5	17.0	15.7	3.3	9.0	11.4	8.7	6.3	19.0	8.8	7.9	24.3	16.7	21.1	20.5	20.3	26.7	13.4	7.4	11.3	9.5	6.7	9.0	5.5	4.5	8.8	9.8	3.1	8.3	4.4	15.9	37.2	2.2	3.4	6.4	20.0	17.6	4.4	9.7	5.7	20.8	5.0	5.9	17.0	5.7	6.4	4.4	2.7	17.2	11.1	9.6	0.7	0.5	0.3	2.0	0.5	2.7	0.2	1.2	2.1	0.2	0.2	0.5	0.7	0.4	1.5	0.3	1.3	1.2	0.7	10.5	12.0	9.6	9.4	8.6	10.3	15.5	10.8	14.8	15.1	11.9	15.1	9.5	28.9	13.7	12.4	4.8	4.1	4.8	5.6	3.4	11.2	8.5	4.8	89.3	8.6	13.0	16.5	35.5	4.3	8.7	6.8	3.9	8.8	0.1	6.4	8.9	9.3	9.6	6.9	0.8	8.3	2.2	14.0	12.8	11.2	2.5	14.9	11.4	9.2	4.1	0.0	0.8	7.6	2.0	5.8	4.6	1.6	12.8	5.1	10.6	10.3	4.0	20.0	6.2	8.0	21.2	11.0	2.5	17.7	3.0	17.3	8.7	6.2	18.6	37.1	6.6	20.8	12.8	2.3	0.8	8.4	4.1	2.9	12.7	6.1	6.2	7.9
FYTTD1	"DKFZp761B1514, UIF"	ENSG00000122068	"Forty-two-three domain containing 1"	Q96QD9	3	197737179-197787596	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054474, HPA074880"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"HPA054474: , HPA074880: "	"unprognostic (3.61e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.33e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.69e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.04e-3)"	"unprognostic (8.74e-2)"	"unprognostic (8.49e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.15e-1)"	29.7	20.9	12.1	27.1	12.6	39.2	26.6	16.1	14.6	24.8	9.1	19.9	16.7	30.4	19.6	43.9	19.1	24.4	41.3	12.1	14.9	25.7	28.9	23.6	32.4	12.4	13.9	27.5	36.4	28.7	12.6	33.5	13.0	25.1	21.6	33.8	18.2	28.8	92.6	27.1	19.3	34.9	12.8	26.3	18.2	41.1	13.3	34.1	29.6	67.0	37.7	33.6	16.9	14.9	104.5	22.6	43.7	41.7	50.1	55.3	13.4	50.0	50.8	75.4	61.4	35.3	34.8	66.4	177.1	59.3	40.0	36.7	55.5	51.0	79.8	14.5	24.9	99.8	32.9	16.1	48.9	75.1	46.5	40.0	64.6	40.8	58.3	52.1	60.4	36.8	45.9	139.0	67.6	86.9	82.2	18.1	9.6	45.1	41.2	74.9	53.6	47.4	54.8	67.3	82.4	35.7	76.8	60.0	56.4	31.8	141.2	39.1	54.0	38.5	38.1	49.0	53.6	83.5	137.2	79.3	40.8	106.4	40.6	59.2	26.9	26.5	32.4	31.8	40.7	20.0	30.7	35.9	29.9	18.9	33.4	32.2	8.5	64.6	31.0	16.9	30.2	45.7	12.1	12.6	16.1	14.6	12.1	14.9	12.4	13.9	13.0	12.8	13.3	14.9	60.6	35.3	27.2	14.7	78.5	82.3	46.6	24.3	42.7	35.1	47.0	34.4	109.7	25.8	30.1	47.8	31.3	24.4	63.9	19.0	90.1	35.5	21.7	27.3	58.9	55.2	56.4	25.2	23.7	36.1	27.5	53.7	30.1	42.6	66.6	29.4	36.4	50.7	38.0	45.4	19.6	23.7	28.5	48.6	67.8	18.3	32.0	54.8	51.6	22.5	108.6	41.8	82.4	19.6	23.0	34.3	16.5	37.2	65.4	74.5	17.1	51.1	44.6	45.2	39.5	45.8	63.1	96.3	90.7	54.0	91.1	50.1	60.7	51.9	20.0	63.6
GOLGA4	"GCP2, GOLG, golgin-240, p230"	ENSG00000144674	"Golgin A4"	Q13439	3	37243177-37366751	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 683.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035102, HPA040675"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"	Nucleoplasm	"HPA035102: AB_10601472, HPA040675: "	"unprognostic (9.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.62e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.33e-1)"	38.6	36.3	18.3	19.5	26.7	21.2	28.8	26.6	22.3	27.6	58.3	28.1	38.8	20.0	23.5	37.3	21.1	19.3	63.7	17.6	20.8	34.5	60.8	25.7	17.0	27.2	24.6	23.4	48.0	33.5	40.6	36.1	27.5	29.6	28.1	56.8	38.4	20.7	118.8	48.2	36.9	19.5	21.8	24.1	38.2	44.3	22.3	17.6	47.2	102.3	19.6	25.0	28.9	29.9	62.6	42.3	21.4	27.1	55.2	47.2	54.4	78.3	65.2	30.2	36.3	36.5	33.9	21.4	19.9	67.1	34.7	35.9	34.4	55.5	62.3	27.4	25.2	28.9	37.9	58.5	55.2	30.9	20.3	25.4	51.8	47.7	92.1	48.8	44.4	15.8	35.9	32.6	49.1	26.8	23.7	13.4	23.4	31.7	39.9	5.4	64.8	22.8	37.4	64.4	13.7	18.1	48.6	51.8	61.4	40.8	76.3	22.4	54.0	30.7	35.6	60.0	56.7	39.8	30.1	18.3	54.4	26.6	36.8	30.7	6.6	15.5	16.2	7.6	14.0	9.9	10.3	11.9	5.5	11.6	10.7	8.1	8.9	15.7	15.2	11.8	7.6	4.3	18.3	26.7	26.6	22.3	17.6	20.8	27.2	24.6	27.5	21.8	22.3	29.9	85.4	237.2	312.9	142.0	98.2	158.3	134.0	70.2	128.1	171.9	97.0	84.1	683.5	84.4	147.4	46.0	358.6	112.7	126.4	154.3	29.4	117.5	240.7	131.6	141.8	102.2	89.6	127.1	154.5	120.2	117.8	128.0	140.2	242.7	62.0	112.9	63.1	147.5	92.0	188.4	168.6	166.2	65.1	73.1	73.9	46.7	119.9	80.3	69.4	107.7	91.9	145.8	132.8	133.7	223.2	136.4	109.1	113.6	150.2	169.7	181.2	64.5	82.4	361.0	85.5	161.8	95.7	435.6	227.2	98.5	175.7	249.6	97.2	125.7	139.3	189.2
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415489	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.3;Alveolar cells type 2: 29.2;Astrocytes: 54.5;Extravillous trophoblasts: 36.2;Granulosa cells: 30.6;Proximal tubular cells: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 209.7;HAP1: 121.8;NTERA-2: 110.3;RPTEC TERT1: 276.6;SuSa: 242.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		190000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	9.6	9.8	5.9	4.9	6.4	0.1	5.6	5.0	5.8	12.0	4.6	22.5	10.6	10.8	16.4	7.4	11.2	9.0	7.9	6.3	7.5	20.6	1.8	17.4	2.5	7.2	6.9	12.3	10.8	5.6	16.6	29.0	6.0	8.0	10.9	1.2	13.0	11.4	24.3	3.8	10.8	17.7	6.6	5.7	16.9	7.8	4.9	8.4	5.9	20.0	2.0	10.3	5.2	8.5	0.0	0.0	209.7	8.3	8.9	1.3	26.0	1.6	0.0	0.0	0.0	0.1	0.5	0.3	71.7	1.2	0.0	0.1	121.8	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.2	0.0	0.0	37.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	6.0	0.1	0.1	110.3	0.0	3.2	0.6	19.2	0.0	276.6	8.4	0.1	1.5	0.8	0.1	0.1	242.0	3.2	3.2	0.0	21.3	24.8	0.0	13.6	0.0	0.0	0.1	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.4	5.0	5.8	6.3	7.5	7.2	6.9	6.0	6.6	4.9	8.5	1.7	51.3	29.2	54.5	0.2	1.5	3.7	14.7	14.2	0.0	2.9	2.0	4.4	5.7	8.7	23.9	0.0	0.5	0.2	2.5	3.9	7.0	0.6	5.9	1.7	1.2	2.4	0.0	4.7	12.7	36.2	14.4	6.6	10.0	0.0	30.6	0.0	0.0	2.5	0.0	1.4	11.1	4.1	0.6	3.9	2.1	2.1	2.0	1.8	14.0	1.1	1.0	0.0	4.5	4.3	16.5	4.3	0.4	0.1	1.4	4.6	30.3	12.8	0.1	0.0	6.3	13.6	2.4	23.6	2.3	0.4	3.1	1.0	1.4	11.3	0.6
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103982-50111313	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 609.9;skeletal muscle: 577.1"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 99.1;Proximal enterocytes: 247.0;Proximal tubular cells: 298.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 134.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044620, HPA058621"	Enhanced					NA	NA		4700000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044620: AB_10796803, HPA058621: "	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	609.9	4.7	9.1	1.6	16.8	0.2	229.2	22.7	12.8	0.3	5.5	6.4	76.4	0.2	5.3	4.9	0.5	16.6	9.2	10.1	14.2	149.3	147.6	18.4	1.0	32.6	18.3	0.3	7.2	13.0	1.3	0.0	26.5	1.3	3.3	1.0	33.0	1.3	577.1	10.2	76.9	1.3	32.7	0.4	3.3	0.8	18.4	1.5	2.7	215.7	0.4	4.1	1.0	49.4	0.1	0.2	0.1	0.1	134.0	0.0	0.3	0.1	0.0	0.0	0.0	27.0	0.1	0.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.1	0.6	25.2	0.0	0.2	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.7	0.7	0.3	0.0	0.2	0.1	0.4	0.1	3.7	0.0	0.2	0.2	30.2	0.2	0.0	0.6	0.2	0.0	1.5	1.0	0.0	1.8	0.0	0.0	0.0	0.3	0.2	0.1	0.6	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	16.8	22.7	12.8	10.1	14.2	32.6	18.3	26.5	32.7	18.4	49.4	3.4	3.2	3.2	0.0	2.4	0.0	0.2	0.3	0.6	3.2	3.4	3.7	5.8	11.5	1.8	5.5	8.4	0.0	0.0	3.0	43.0	0.9	0.1	0.5	0.1	0.2	1.2	5.3	0.2	0.7	0.0	0.8	4.1	0.2	0.0	0.1	1.1	99.1	2.3	3.3	0.2	9.7	0.0	1.0	0.4	0.0	0.0	5.2	1.8	0.0	1.0	2.8	0.0	0.0	4.0	0.6	8.0	0.0	0.0	0.1	247.0	298.4	0.4	1.7	0.0	7.0	1.1	0.0	0.0	0.8	0.4	0.0	1.2	0.0	10.6	0.2
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815783-70839897	"Predicted intracellular proteins"	"mRNA processing, tRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 275.2"	"Cell type enhanced"	"Detected in all"		"monocytes: 301.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	38.0	61.2	38.4	36.9	37.7	23.7	37.7	42.5	47.1	36.3	58.9	54.6	43.1	32.5	34.0	42.0	43.0	35.2	80.7	41.0	44.5	55.8	54.4	35.5	47.4	40.3	42.3	38.4	62.0	48.8	21.5	43.8	41.6	39.9	62.7	25.4	83.9	35.3	275.2	32.0	41.3	40.0	40.7	34.6	50.8	32.8	40.9	76.0	45.7	155.0	53.7	50.3	25.8	46.1	116.9	78.1	90.0	94.5	93.5	108.1	128.3	138.2	87.3	102.3	83.5	80.5	117.1	167.6	102.9	143.7	53.0	43.4	161.3	108.6	135.9	91.3	52.8	88.4	75.2	112.4	115.1	130.8	48.7	91.9	102.2	103.6	71.6	123.0	106.9	91.9	102.6	94.7	144.2	124.9	217.4	92.0	96.3	127.1	80.9	88.2	139.8	71.6	126.1	144.0	93.4	84.0	65.3	183.6	234.3	104.7	79.8	63.3	98.4	95.1	99.7	79.4	88.7	78.1	66.2	106.4	78.6	83.6	94.5	12.7	17.4	7.7	10.1	12.3	12.2	7.4	14.6	15.5	28.1	6.1	14.4	12.6	2.0	20.0	15.2	27.2	13.3	8.4	38.4	37.7	42.5	47.1	41.0	44.5	40.3	42.3	41.6	40.7	40.9	46.1	27.8	32.1	36.6	19.6	38.0	50.0	53.7	32.9	48.3	18.2	37.7	28.3	135.5	40.0	30.4	27.6	25.0	106.2	57.4	52.9	74.3	70.3	7.6	53.8	40.4	33.0	69.0	41.2	35.1	61.3	141.3	41.2	65.2	44.5	17.2	60.2	35.0	50.9	63.2	28.6	30.5	73.5	36.7	66.3	53.7	6.7	34.8	45.4	62.2	24.4	301.5	23.8	41.2	21.6	28.0	60.1	46.7	39.1	58.7	65.9	47.1	74.1	27.6	19.6	19.7	38.4	46.2	35.0	61.8	69.7	50.4	77.2	45.1	99.0	89.3	67.0
GTF2IRD1	"BEN, Cream1, GTF3, MusTRD1, RBAP2, WBSCR11, WBSCR12"	ENSG00000006704	"GTF2I repeat domain containing 1"	Q9UHL9	7	74453790-74602605	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Inhibitory neurons: 42.1;Rod photoreceptor cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044254	Approved		Supported	Nucleoplasm,Cytosol		Yes	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA044254: AB_10964747"	"unprognostic (8.92e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.71e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-3)"	6.0	12.6	7.0	3.4	7.0	0.5	6.9	7.2	8.1	16.8	14.0	15.1	7.7	11.3	8.6	26.7	8.8	5.7	11.6	6.0	8.4	18.6	4.6	11.7	1.0	9.2	8.9	10.5	10.0	18.9	27.6	5.8	9.0	13.3	5.6	36.7	17.3	8.2	68.1	22.4	6.7	8.4	6.7	2.0	13.9	5.0	10.1	3.4	17.4	29.7	5.4	15.0	19.8	10.2	21.2	12.9	28.1	30.8	22.2	10.8	0.2	8.8	23.7	17.1	17.7	21.7	30.1	5.4	6.5	18.1	41.7	11.6	22.6	10.2	12.6	0.2	13.0	1.1	43.1	26.1	71.2	0.2	0.7	14.7	42.1	12.0	48.9	39.7	8.9	10.4	15.5	0.1	19.2	26.1	2.7	18.9	22.6	25.7	12.8	28.1	16.4	20.0	32.7	14.6	23.1	30.5	21.7	39.0	19.9	14.2	23.4	21.2	4.6	17.5	16.9	11.4	20.5	1.1	3.4	8.9	6.7	0.3	14.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	7.0	7.0	7.2	8.1	6.0	8.4	9.2	8.9	9.0	6.7	10.1	10.2	0.9	9.6	8.2	48.3	0.1	7.9	9.9	10.5	9.6	30.8	5.6	4.1	10.4	12.8	6.8	9.2	33.3	1.4	1.5	4.5	11.7	7.6	1.6	11.5	8.0	4.1	4.2	0.8	24.6	9.2	1.8	5.6	6.1	17.0	2.5	8.0	2.9	3.1	2.6	21.9	42.1	3.6	8.2	1.2	5.7	0.3	4.1	2.5	7.2	14.0	0.7	5.9	1.0	25.6	24.9	11.6	3.2	5.7	0.0	17.8	3.6	17.4	12.7	41.1	0.0	19.0	5.7	0.1	3.7	18.2	6.7	2.9	1.1	2.4	7.4	15.8
GUF1	FLJ13220	ENSG00000151806	"GUF1 homolog, GTPase"	Q8N442	4	44678420-44700928	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003934, HPA024222"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA003934: AB_1079034, HPA024222: AB_2671488"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.65e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.38e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.98e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (5.40e-2)"	5.2	4.1	2.5	3.9	3.2	6.3	5.2	4.3	3.6	3.5	0.6	5.7	4.6	4.8	3.8	5.2	4.1	2.7	6.1	3.3	2.5	6.9	7.1	3.1	4.7	1.6	1.9	4.9	3.7	4.3	2.4	3.7	1.9	4.9	5.9	6.7	4.0	3.5	15.8	5.0	6.3	3.5	2.4	4.8	7.9	5.9	2.2	4.4	5.3	17.0	4.6	3.9	3.8	4.4	11.9	6.0	10.9	13.9	4.4	9.0	24.0	16.1	8.2	16.2	12.4	10.5	8.3	25.8	12.3	7.7	14.9	9.2	18.7	18.2	18.2	8.7	12.2	30.7	5.3	7.2	14.3	33.4	12.7	9.2	8.1	12.1	10.5	7.6	11.8	15.0	31.7	4.9	13.2	5.9	19.1	7.0	7.0	8.5	13.8	13.5	22.5	11.0	4.8	4.6	14.8	11.1	10.1	4.2	11.2	8.4	6.8	9.6	11.7	11.0	12.7	14.8	19.1	17.9	17.4	18.3	11.9	19.7	9.6	0.5	2.2	2.3	2.0	2.9	2.6	2.1	2.1	1.8	2.1	1.7	1.9	2.0	0.0	2.3	1.9	2.3	3.6	1.9	2.5	3.2	4.3	3.6	3.3	2.5	1.6	1.9	1.9	2.4	2.2	4.4	7.2	6.4	9.5	9.8	11.6	4.0	9.6	6.0	5.2	10.5	9.8	7.5	22.8	7.2	9.1	7.3	2.1	13.1	10.1	11.5	13.7	10.3	2.0	12.0	14.3	8.1	11.4	14.9	20.3	10.2	17.6	9.7	18.3	8.8	1.3	16.6	7.9	13.9	12.1	11.8	19.5	12.4	4.1	11.7	5.4	2.9	5.6	9.0	7.2	9.4	9.2	9.2	14.4	18.6	19.0	16.4	6.6	7.2	13.9	9.8	11.3	12.2	16.7	10.3	0.0	6.8	10.0	12.3	14.6	14.9	7.1	13.4	9.5	18.9	13.3	10.6
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968130-48993310	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 118.5;skeletal muscle: 319.4;tongue: 201.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Microtubules, Cytosol"		"CAB007793: AB_562291, HPA041598: AB_2677571"	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	32.4	26.3	17.9	16.2	18.8	46.0	23.7	26.4	23.3	17.1	22.2	21.7	15.3	18.8	8.9	38.2	18.7	10.1	118.5	19.7	17.6	21.8	14.9	16.0	15.5	22.2	20.9	19.7	13.6	15.7	15.5	11.3	19.6	27.4	14.7	19.2	22.2	15.5	319.4	20.7	19.9	16.7	16.4	18.5	23.2	6.1	20.2	14.7	15.9	201.6	14.4	24.3	23.2	18.3	67.3	26.3	19.0	26.3	43.2	16.9	37.6	45.5	31.7	46.8	54.3	25.8	21.3	28.0	27.0	44.7	12.4	46.6	32.0	57.7	40.6	17.4	46.5	23.1	33.3	23.1	24.3	25.4	15.9	41.8	27.2	30.2	25.4	40.5	39.8	28.8	16.4	36.1	59.4	25.4	31.8	21.9	10.2	29.0	29.8	26.6	33.2	27.5	46.7	70.6	11.8	16.4	40.5	52.1	10.4	25.2	27.7	26.1	31.0	57.1	22.0	26.1	50.5	29.8	33.1	13.5	58.3	22.2	13.1	7.7	9.4	6.6	7.0	5.3	8.6	5.2	6.0	6.5	13.4	3.9	4.7	4.4	3.7	10.6	8.0	7.2	8.6	7.1	17.9	18.8	26.4	23.3	19.7	17.6	22.2	20.9	19.6	16.4	20.2	18.3	3.5	0.0	14.2	21.9	5.9	5.1	3.7	11.7	11.4	4.2	7.3	5.5	67.9	2.8	5.8	0.0	16.7	7.6	6.8	13.2	0.0	8.1	0.3	6.9	8.9	7.1	7.2	4.8	14.7	6.9	31.7	5.0	12.8	11.9	4.5	6.7	9.7	5.2	8.3	0.0	16.6	9.2	4.1	7.0	5.7	0.7	5.3	7.2	7.2	4.7	9.8	3.3	10.3	8.5	6.9	11.8	8.2	5.7	9.7	5.4	9.2	6.0	6.2	11.7	0.0	5.0	7.3	1.3	2.9	15.3	4.1	4.0	5.2	3.8	11.7	3.3
HCFC2	HCF-2	ENSG00000111727	"Host cell factor C2"	Q9Y5Z7	12	104064531-104106524	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 250.3;Spermatocytes: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006227	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA006227: AB_1079042"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.54e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (7.23e-2)"	6.3	6.7	3.8	3.6	5.2	2.7	5.1	4.4	5.4	7.4	2.0	9.2	5.2	7.9	5.0	6.2	5.3	5.7	5.1	3.7	4.2	5.7	7.3	4.7	4.6	4.9	5.0	7.8	6.0	6.7	4.1	6.4	4.8	7.2	4.3	8.0	4.5	9.4	9.7	4.4	5.0	7.2	4.7	5.1	5.2	9.5	4.6	5.2	6.9	11.2	3.7	5.9	6.0	6.6	2.0	2.3	2.3	2.0	12.7	12.5	1.7	9.1	4.1	6.8	3.9	1.1	0.9	2.1	3.1	7.1	2.5	2.2	2.9	1.6	7.3	3.5	2.8	2.1	2.3	1.0	8.5	1.7	3.3	7.8	4.3	4.2	3.5	9.8	5.3	3.1	2.5	4.2	12.3	1.8	3.1	4.0	0.5	1.3	4.7	2.5	7.6	1.3	3.1	1.4	3.3	2.5	4.4	3.2	3.5	1.5	5.0	1.9	8.0	10.7	1.4	5.6	3.1	5.3	1.7	1.8	5.1	2.3	4.4	0.4	0.6	0.9	0.8	1.1	0.9	0.5	0.7	0.9	0.7	0.5	0.8	0.9	0.1	0.8	1.8	0.4	0.9	0.5	3.8	5.2	4.4	5.4	3.7	4.2	4.9	5.0	4.8	4.7	4.6	6.6	19.3	12.8	14.1	18.9	10.0	8.0	6.6	5.4	8.6	19.6	6.1	5.0	12.5	1.5	9.6	5.5	20.9	5.0	8.8	7.4	9.8	6.2	250.3	7.9	18.5	14.4	8.4	7.4	31.8	3.3	5.0	16.0	6.6	6.5	17.1	9.8	15.7	11.5	7.4	23.5	33.9	4.7	8.2	11.4	5.7	59.4	21.8	8.6	7.2	16.9	9.3	13.7	7.2	30.7	45.6	3.1	6.0	27.8	12.2	2.7	7.7	8.6	10.4	22.2	13.1	18.7	17.4	130.9	16.4	8.5	7.2	10.8	11.3	17.9	3.8	3.3
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 218.4"	"Cell type enhanced"	"Detected in all"		"Urothelial cells: 302.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	43.0	48.6	27.8	23.1	33.6	54.0	37.6	58.6	33.7	43.5	34.0	38.3	25.1	37.0	30.7	74.6	33.8	26.7	47.2	27.2	30.9	37.0	74.3	32.9	28.7	30.2	30.1	38.5	34.7	56.5	34.4	35.5	32.5	30.7	31.2	66.9	42.6	31.0	218.4	50.8	33.6	30.8	28.0	30.4	43.7	42.7	31.3	26.3	51.3	133.6	37.3	39.8	51.5	36.6	95.1	54.6	49.2	30.4	144.0	77.2	44.7	54.8	54.1	47.4	39.7	41.0	47.8	72.1	57.8	97.3	34.0	62.6	63.2	47.7	69.6	44.5	24.9	75.6	44.3	163.9	66.9	81.8	52.7	66.3	64.4	52.2	80.9	63.6	87.5	42.2	54.4	32.1	72.8	72.4	31.8	31.7	36.0	76.6	47.5	53.6	58.0	30.4	71.3	93.2	36.2	40.8	79.8	54.5	49.0	56.3	58.7	49.5	93.4	56.6	42.9	41.9	49.0	34.3	52.9	79.0	28.0	37.3	49.7	9.1	5.7	8.3	4.5	4.8	5.2	4.8	5.2	4.1	6.4	6.3	4.2	4.3	3.0	6.3	3.8	5.3	5.6	2.4	27.8	33.6	58.6	33.7	27.2	30.9	30.2	30.1	32.5	28.0	31.3	36.6	63.4	48.1	80.8	84.5	60.7	86.7	93.5	61.2	48.3	98.9	40.8	28.6	108.1	25.8	94.8	71.7	98.0	70.2	72.1	40.9	11.7	44.2	3.6	101.6	83.0	60.0	48.7	41.2	89.9	36.1	42.9	59.9	96.8	118.1	32.9	81.6	46.4	84.7	29.0	65.6	101.1	33.0	63.1	43.9	34.5	8.7	69.0	54.0	33.8	90.9	65.1	40.9	78.2	100.0	127.9	52.6	33.9	74.4	71.1	106.3	37.1	22.4	148.4	194.5	46.0	77.4	78.9	50.6	100.0	83.7	114.9	140.0	61.4	97.0	44.5	302.9
HIF1AN	"DKFZp762F1811, FIH1, FLJ20615, FLJ22027"	ENSG00000166135	"Hypoxia inducible factor 1 subunit alpha inhibitor"	Q9NWT6	10	100529072-100559998	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.6;tongue: 40.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048742, HPA065302, CAB069903"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"CAB069903: AB_10000508, HPA048742: AB_2680507, HPA065302: AB_2685458"	"unprognostic (4.07e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-2)"	6.5	8.1	6.9	7.8	6.5	6.2	6.5	6.1	7.3	6.2	5.7	7.5	7.2	7.3	7.2	7.5	6.8	6.3	12.3	6.6	6.0	7.5	5.4	5.7	7.8	6.7	7.5	10.3	8.1	12.1	6.5	6.0	6.5	7.5	6.6	9.8	6.5	8.3	41.6	10.1	7.2	7.4	6.0	6.8	6.5	13.9	7.0	9.3	5.5	40.8	9.6	7.1	5.4	6.5	13.8	14.4	19.0	19.1	28.8	11.9	16.3	14.4	34.4	20.9	24.5	22.3	11.5	14.8	12.8	21.7	15.4	15.9	16.9	13.0	22.6	16.5	10.2	14.2	12.8	17.2	14.9	17.1	17.9	11.7	12.9	20.4	22.2	29.4	11.9	19.5	6.3	8.1	23.9	14.4	18.3	11.2	6.2	11.6	6.9	13.2	23.4	7.2	14.6	18.2	7.2	11.9	12.4	7.6	13.7	15.8	25.7	9.2	10.1	10.6	13.8	10.6	14.7	10.9	11.8	11.1	17.6	13.8	8.1	13.7	7.6	15.3	7.7	10.7	7.7	7.9	8.0	7.3	7.2	6.4	7.6	7.8	8.0	9.1	13.0	2.6	9.8	8.4	6.9	6.5	6.1	7.3	6.6	6.0	6.7	7.5	6.5	6.0	7.0	6.5	7.9	0.0	6.5	11.8	16.7	11.0	11.5	16.4	13.1	17.9	12.3	8.9	40.7	14.3	11.7	11.0	16.7	27.8	16.5	15.5	9.8	17.3	21.5	9.0	11.3	12.1	13.2	16.0	12.2	13.9	17.6	10.9	11.2	8.7	6.3	20.0	8.2	10.9	14.3	25.2	11.2	12.0	8.2	18.5	6.8	49.3	11.1	10.1	3.6	11.2	23.4	15.0	27.8	11.1	12.8	17.7	11.3	12.0	11.2	11.4	20.1	20.5	11.6	23.1	6.6	12.0	16.1	48.2	26.6	11.4	11.6	32.7	14.0	14.8	13.3	10.3
HOXA10	"HOX1, HOX1H"	ENSG00000253293	"Homeobox A10"	P31260	7	27170592-27180261	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 76.8;skeletal muscle: 76.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 174.0;Enteroendocrine cells: 68.1;Paneth cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 10.7;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.7;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 179.0;THP-1: 96.7;U-937: 100.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	190	"spinal cord: 18.9"	"CAB019384, HPA071918"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Nuclear bodies"	"CAB019384: , HPA071918: "	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-2)"	13.4	6.8	0.0	6.1	0.0	4.3	6.8	0.0	0.0	40.8	0.0	32.6	0.1	76.8	9.1	0.2	8.3	0.1	0.0	0.0	0.0	13.7	0.1	0.1	2.3	0.0	0.0	0.8	0.0	0.0	0.0	13.4	0.0	26.3	13.2	0.0	0.0	15.4	76.4	6.0	7.9	44.9	0.1	0.2	0.1	0.3	0.0	5.2	0.1	0.0	0.2	20.4	17.2	0.1	20.6	4.3	0.0	59.9	29.3	28.0	0.2	40.1	27.2	18.0	16.8	6.1	17.8	0.0	10.9	31.6	0.0	22.6	15.5	0.0	13.2	9.5	179.0	21.6	15.0	0.5	0.8	9.6	31.4	17.8	0.9	1.5	0.0	0.0	27.5	6.3	0.9	0.0	13.3	0.0	0.0	63.1	0.0	16.6	18.8	1.9	4.0	0.1	34.7	9.6	46.7	0.1	13.8	0.0	0.1	6.4	0.1	96.7	0.0	0.0	16.1	21.1	0.2	0.4	0.1	0.0	0.0	100.4	0.5	10.7	0.1	0.3	2.2	0.0	0.0	0.1	0.0	0.2	1.2	0.3	0.0	0.0	0.0	13.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.5	0.0	0.0	0.0	0.2	3.7	10.0	0.0	0.6	0.0	4.4	4.6	1.6	0.0	0.0	7.3	0.0	0.5	4.5	28.8	19.6	0.0	0.0	3.1	174.0	5.4	68.1	15.5	0.0	0.0	0.4	13.3	0.0	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	25.0	0.0	2.5	4.7	0.0	0.0	2.0	5.4	0.0	0.5	0.0	7.2	0.0	0.0	0.0	32.1	0.4	1.3	18.1	18.8	27.1	0.0	0.0	0.0	13.3	15.7	2.3	4.6	0.5	4.1	0.5	3.1	0.0	25.5	10.1
HSPB2	"Hs.78846, MKBP"	ENSG00000170276	"Heat shock protein family B (small) member 2"	Q16082	11	111912734-111914093	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 153.2;skeletal muscle: 251.3;tongue: 316.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 115.7;Fibroblasts: 39.1;Leydig cells: 43.5;Melanocytes: 37.4;Smooth muscle cells: 39.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.1;renal cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 48.4;ASC TERT1: 23.4;fHDF/TERT166: 59.7;HSkMC: 23.3;LHCN-M2: 35.2;U-138 MG: 31.5"									HPA079414	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA079414: "	"unprognostic (5.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.69e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.46e-2)"	39.8	5.3	26.7	4.3	28.9	0.0	21.5	37.4	32.5	30.2	24.4	21.1	3.4	25.0	5.7	15.4	22.2	18.5	153.2	25.8	26.7	13.3	2.3	17.3	5.4	29.0	27.3	14.0	1.4	1.4	3.8	12.2	27.2	13.1	4.0	1.8	7.1	13.0	251.3	14.7	9.1	19.1	27.2	7.3	9.6	2.3	28.9	1.4	9.6	316.8	2.0	16.1	19.0	26.2	0.0	0.0	0.0	7.0	48.4	23.4	0.2	5.6	0.0	0.0	0.3	0.0	0.0	0.0	0.5	59.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	23.3	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	35.2	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.2	31.5	3.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.7	28.9	37.4	32.5	25.8	26.7	29.0	27.3	27.2	27.2	28.9	26.2	8.5	0.0	0.0	0.0	0.0	7.0	0.3	0.0	1.2	0.4	5.1	16.4	115.7	1.5	0.6	1.8	0.0	0.8	0.1	0.0	1.9	0.4	0.1	0.1	7.9	3.5	0.0	0.0	0.0	0.0	0.7	39.1	0.0	0.2	0.0	0.4	4.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	10.3	1.1	43.5	0.6	37.4	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	21.8	0.0	0.3	0.0	23.5	0.0	0.5	13.1	22.8	39.8	0.8	0.6	0.6	5.8	1.5	1.0	0.4	0.0	0.0
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754566-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 2969.8;tongue: 1759.1"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 165.7;Fibroblasts: 125.2;Leydig cells: 271.8;Peritubular cells: 220.4;Smooth muscle cells: 102.6;Theca cells: 311.0"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1774.3;ASC TERT1: 742.0;HHSteC: 599.9;HSkMC: 700.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		310000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610"	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.43e-6)"	650.0	414.0	37.3	45.4	40.6	0.4	394.9	32.5	49.2	581.9	26.1	699.9	28.1	565.1	101.6	112.3	495.1	97.9	1463.9	30.0	43.6	69.0	42.3	126.6	5.7	76.7	48.5	455.2	50.5	4.2	17.5	40.2	73.7	271.2	44.0	21.1	115.9	194.7	2969.8	39.1	180.0	278.2	50.8	15.7	362.1	60.6	53.8	6.2	99.5	1759.1	2.7	537.3	290.6	49.3	0.6	0.7	2.1	2.5	1774.3	742.0	1.2	83.0	1.3	4.9	9.3	1.1	0.4	0.7	0.6	252.4	0.0	0.2	0.4	0.7	3.9	0.9	0.5	0.4	1.3	0.5	599.9	0.2	0.9	700.3	0.0	19.1	0.9	2.2	5.4	0.3	0.5	1.0	0.2	0.3	0.4	1.9	1.2	2.3	0.6	1.5	0.5	0.7	0.0	0.1	0.8	0.7	0.1	0.2	0.7	0.3	0.3	0.5	0.1	153.2	0.9	17.3	0.6	1.0	2.8	0.3	20.5	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	40.6	32.5	49.2	30.0	43.6	76.7	48.5	73.7	50.8	53.8	49.3	11.1	3.2	0.6	1.6	0.1	1.8	0.4	0.0	3.4	7.8	0.5	0.5	29.7	0.0	0.0	0.0	0.0	2.5	0.1	0.1	0.0	0.1	27.0	4.9	165.7	3.6	0.0	5.2	0.2	0.0	2.5	125.2	4.1	3.5	0.0	3.6	17.5	0.3	5.0	0.0	0.5	0.0	0.0	0.3	3.6	18.9	271.8	2.7	1.8	0.0	0.6	44.5	0.0	0.0	0.1	0.2	0.0	220.4	0.1	0.4	0.0	0.4	0.0	2.8	26.3	38.0	102.6	2.3	1.4	1.9	2.0	4.8	1.8	311.0	0.0	0.5
HTD2		ENSG00000255154	"Hydroxyacyl-thioester dehydratase type 2"	P86397	3	58306262-58320193	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.1"	"Cell type enhanced"	"Detected in some"		"Club cells: 1.3;granulocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066812, HPA077228"	Approved		Supported	Nucleoli,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Mitochondria	Nucleoli	"HPA066812: AB_2685727, HPA077228: "	"unprognostic (1.95e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	7.7	7.2	4.3	6.5	5.0	7.2	8.7	7.3	5.5	6.8	4.7	8.9	12.1	8.4	5.9	8.7	7.8	6.8	12.5	4.8	5.6	11.1	15.2	5.7	6.8	3.6	4.6	12.1	7.4	12.0	5.7	6.7	4.6	7.1	9.1	9.2	7.4	8.6	44.1	7.9	8.7	7.6	4.3	7.2	7.0	7.4	4.5	6.6	10.4	37.8	8.0	6.9	4.9	5.5	10.4	7.1	10.9	8.7	11.6	11.2	15.1	13.8	10.2	17.0	14.4	15.9	7.7	19.9	4.0	10.1	12.8	8.7	18.5	12.6	16.8	11.0	13.1	13.7	16.1	13.9	11.3	16.7	11.4	15.1	15.1	17.3	11.4	11.0	14.6	14.3	12.2	19.9	11.1	6.4	11.2	8.9	17.2	10.2	17.3	7.2	7.2	14.7	12.5	13.8	7.0	10.5	8.4	9.4	17.2	12.1	10.9	15.9	8.1	14.5	10.8	14.3	17.2	15.4	27.6	15.7	12.7	11.9	9.8	17.9	19.2	29.2	19.7	23.7	21.5	28.1	20.0	25.2	20.2	27.6	27.5	21.3	13.6	24.9	20.4	24.5	15.6	15.7	4.3	5.0	7.3	5.5	4.8	5.6	3.6	4.6	4.6	4.3	4.5	5.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ICMT	"HSTE14, PCCMT, PPMT"	ENSG00000116237	"Isoprenylcysteine carboxyl methyltransferase"	O60725	1	6221193-6235972	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 112.8"	"Low region specificity"	"Detected in all"			"HPA032024, HPA032025"	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA032024: AB_2674115, HPA032025: AB_10601819"	"unprognostic (1.95e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.27e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.99e-3)"	22.6	23.0	12.4	13.6	18.1	4.0	15.8	18.2	13.1	20.3	17.7	20.9	19.6	20.1	20.9	21.6	16.2	13.1	27.1	12.5	12.9	25.9	13.6	14.9	10.2	12.6	14.9	9.1	17.4	26.8	22.0	21.0	12.7	17.3	17.4	28.7	17.1	18.9	53.0	19.2	18.3	21.9	12.3	9.1	15.7	5.2	14.5	14.9	18.1	82.6	11.0	17.4	16.0	12.0	35.8	32.6	43.7	43.0	131.2	51.8	18.7	84.9	56.1	48.7	36.9	35.0	28.2	39.0	31.7	66.7	42.0	47.4	50.5	35.6	51.5	78.8	51.3	26.8	46.0	26.8	25.5	42.5	36.4	33.3	23.5	51.2	19.2	32.4	38.5	31.6	26.5	29.8	55.7	22.3	43.2	29.6	29.7	64.1	46.0	35.8	61.5	22.6	59.3	25.8	59.2	28.8	41.3	96.3	37.2	48.4	25.2	35.4	48.1	55.3	21.7	65.4	61.6	27.7	57.8	30.5	27.1	96.5	29.3	2.6	1.9	1.6	3.1	2.2	2.7	1.1	2.5	3.1	1.7	1.8	2.1	1.8	0.6	1.8	1.9	2.7	1.4	1.9	12.4	18.1	18.2	13.1	12.5	12.9	12.6	14.9	12.7	12.3	14.5	12.0	18.0	22.4	12.1	5.9	7.7	6.2	9.6	12.2	7.4	18.0	16.3	9.8	39.3	15.7	19.6	29.5	31.3	57.6	12.3	40.7	13.7	21.9	3.5	19.5	18.8	18.1	22.8	14.9	10.2	22.2	85.7	19.6	12.8	16.9	5.1	13.9	21.8	23.9	29.1	48.8	9.4	21.4	12.2	12.0	7.0	5.1	20.8	9.8	7.2	7.5	12.1	18.9	10.3	2.0	5.4	26.8	12.2	26.4	18.3	14.1	45.5	36.9	41.7	58.8	13.1	9.9	22.1	15.4	26.8	28.2	10.4	32.0	10.4	13.9	23.1	14.7
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2"	P48735	15	90083045-90102477	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 492.6;skeletal muscle: 1302.3;tongue: 1611.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 732.5;Distal tubular cells: 1168.0;Extravillous trophoblasts: 586.7;Syncytiotrophoblasts: 573.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 425.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		NA	NA		5200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	32.8	10.5	56.5	60.2	67.8	161.1	51.1	57.1	59.8	36.6	76.6	95.9	97.2	29.0	12.5	140.6	32.7	31.7	492.6	47.2	55.0	208.3	274.7	32.0	77.1	61.0	61.3	13.6	128.7	104.0	15.5	87.3	54.4	76.2	84.1	5.4	163.1	90.4	1302.3	61.8	84.3	79.8	52.9	36.8	175.7	5.3	71.6	148.7	16.0	1611.3	66.0	53.3	49.4	57.6	61.3	33.5	169.9	169.8	23.3	28.3	144.5	74.5	110.8	68.0	72.6	16.1	51.1	72.7	21.0	61.2	65.1	20.8	25.1	22.4	32.0	143.8	16.9	122.9	12.7	119.7	28.1	85.1	118.2	59.7	12.7	16.3	13.0	82.1	141.0	246.4	18.9	59.3	53.0	175.3	425.0	131.2	51.8	81.9	14.3	352.0	122.4	213.7	105.6	71.3	244.5	125.3	92.1	359.8	29.9	94.2	290.9	256.9	34.0	120.4	17.0	16.1	34.9	101.5	20.5	9.0	38.4	175.0	71.2	45.0	112.8	75.6	105.9	199.1	53.2	70.1	77.0	120.1	136.9	47.7	42.9	71.8	22.9	99.9	252.1	79.4	72.4	163.4	56.5	67.8	57.1	59.8	47.2	55.0	61.0	61.3	54.4	52.9	71.6	57.6	16.9	6.4	21.0	40.1	64.2	39.9	98.8	91.6	12.5	6.2	90.5	48.1	445.9	114.4	95.8	75.4	10.4	732.5	84.0	70.0	1168.0	252.8	5.6	96.4	25.7	41.6	61.7	193.8	11.8	288.8	586.7	44.7	88.2	50.9	31.6	29.2	38.2	283.1	263.7	10.1	8.3	158.3	229.9	77.7	101.1	3.2	14.0	79.0	58.7	5.6	85.3	20.9	119.4	16.6	27.3	116.6	105.0	35.3	185.9	170.3	69.6	205.0	167.9	5.4	13.1	60.8	73.4	0.6	15.6	113.3	67.1	573.0	88.1	14.7	305.1	140.1
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384652-9448127	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: AB_2683180"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	37.9	29.1	24.1	31.3	25.7	22.7	40.4	27.3	30.7	35.7	27.5	34.6	27.2	33.9	29.2	37.9	31.3	31.8	50.4	23.2	28.0	41.4	38.5	28.9	30.1	27.6	27.4	33.1	33.8	38.9	13.0	41.1	27.3	32.1	34.1	47.8	33.3	33.2	110.3	25.3	26.0	43.4	26.8	22.9	25.6	12.7	27.4	31.8	54.0	93.4	34.8	51.8	22.8	29.9	148.7	110.8	130.6	104.4	129.4	165.7	104.4	176.0	112.4	127.1	136.4	99.1	132.6	138.1	62.5	136.3	115.5	113.5	187.5	136.7	210.7	66.3	154.5	114.3	118.8	100.1	80.7	177.0	83.3	106.7	144.8	84.0	195.6	129.5	152.8	46.7	174.7	80.5	167.9	60.3	107.5	86.3	129.0	136.3	130.2	111.4	205.5	63.0	105.3	137.5	51.7	101.5	78.6	153.5	129.1	103.2	70.7	87.6	120.9	155.6	107.4	162.0	190.9	23.2	95.3	93.6	102.0	93.6	86.4	0.1	1.5	0.3	1.4	2.6	2.7	1.9	1.5	2.0	3.2	1.4	1.9	1.7	0.7	3.5	3.8	1.4	1.5	1.0	24.1	25.7	27.3	30.7	23.2	28.0	27.6	27.4	27.3	26.8	27.4	29.9	41.3	67.3	71.5	19.6	46.4	144.0	103.3	44.8	68.9	40.1	65.5	42.4	131.9	25.8	59.7	35.0	58.4	52.8	39.7	27.2	33.2	34.2	4.6	55.9	92.5	55.7	31.1	50.9	43.9	42.2	63.8	58.0	47.4	99.5	37.9	56.5	25.0	46.8	35.3	35.3	49.7	38.8	32.6	48.0	92.2	7.1	28.0	56.6	39.2	17.8	39.2	31.8	13.4	28.1	44.9	45.5	32.9	35.7	47.6	150.6	26.5	45.7	48.4	39.8	13.1	96.2	71.0	21.6	19.8	82.2	147.9	36.7	37.7	49.0	50.9	127.4
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell shape"	"Integrin, Receptor"	"Congenital muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 262.3"	"Group enriched"	"Detected in many"	6	"Astrocytes: 87.5;Cardiomyocytes: 124.5;Sertoli cells: 164.3;Skeletal myocytes: 65.8;Smooth muscle cells: 110.6"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 309.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA		1200000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Nuclear speckles, Vesicles"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (9.59e-5)"	133.4	8.2	18.5	18.5	21.2	1.8	69.0	15.9	30.2	28.7	16.1	97.8	17.7	45.5	12.3	23.9	56.1	30.8	157.9	34.5	17.8	11.5	10.2	15.5	6.4	21.2	21.1	19.1	5.1	6.1	12.6	1.9	20.3	33.9	8.9	2.4	14.9	37.3	262.3	16.0	27.4	95.2	16.4	10.2	35.2	8.9	23.8	3.4	26.1	154.1	3.3	46.5	25.5	21.0	0.2	4.1	7.5	12.3	66.5	13.4	0.7	5.4	8.7	11.7	11.8	8.4	6.5	2.3	7.4	3.4	0.9	1.1	5.1	0.3	10.0	0.2	3.8	0.8	2.8	3.2	0.5	0.3	2.7	19.1	0.2	64.2	0.3	309.1	0.2	2.2	0.9	1.6	37.8	5.3	0.3	3.1	20.9	1.7	0.4	0.1	28.7	0.6	0.2	0.2	0.9	2.8	0.6	0.2	48.0	4.0	0.9	13.9	0.0	1.3	12.4	0.8	8.4	3.2	2.2	0.9	57.8	8.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.5	21.2	15.9	30.2	34.5	17.8	21.2	21.1	20.3	16.4	23.8	21.0	11.9	0.0	0.0	87.5	0.3	1.9	0.5	0.1	0.6	2.4	1.2	3.4	124.5	2.8	0.0	1.8	4.2	0.0	0.3	0.7	0.0	0.3	0.3	1.1	1.2	9.5	7.7	0.4	17.6	0.0	0.1	5.0	0.5	1.1	0.0	6.2	0.7	1.4	0.6	0.0	9.4	1.8	0.0	1.9	2.7	0.1	6.5	2.2	3.6	9.4	0.0	3.4	0.0	6.6	3.7	0.3	0.1	6.4	0.1	0.8	2.6	0.8	0.1	0.6	164.3	65.8	110.6	4.1	2.9	0.7	2.3	0.1	0.5	0.3	0.9	0.3
JPH2	JP-2	ENSG00000149596	"Junctophilin 2"	Q9BR39	20	44106590-44187188	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.2;skeletal muscle: 120.4"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 64.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.3;EFO-21: 15.0;fHDF/TERT166: 19.1;HeLa: 12.6;SiHa: 12.9"	"Low region specificity"	"Detected in some"							HPA052646	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA052646: AB_2681899"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.61e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-2)"	6.0	1.9	0.5	4.5	0.6	0.1	5.7	0.4	0.7	15.1	0.7	63.3	2.1	51.6	2.9	11.9	30.0	3.5	85.2	0.4	0.5	1.4	0.3	5.2	0.2	1.1	1.1	3.9	0.3	0.1	1.2	3.8	0.8	23.8	4.5	0.2	5.8	22.1	120.4	3.8	11.8	27.5	0.9	1.3	16.0	0.8	0.6	0.1	1.5	48.3	0.1	40.5	10.6	0.7	7.5	0.8	0.4	0.0	0.3	0.4	1.5	2.2	4.1	5.4	2.3	15.3	5.9	0.0	15.0	19.1	6.1	10.5	0.0	0.5	2.1	0.0	0.0	0.0	12.6	0.1	0.1	0.3	0.0	0.7	1.1	2.7	3.7	3.3	0.0	0.0	0.0	0.0	7.3	4.3	0.0	0.2	0.3	0.0	0.9	1.7	3.4	0.0	0.4	0.1	0.0	0.1	12.9	3.1	0.1	8.6	10.8	0.1	0.3	2.4	2.7	0.5	4.7	0.1	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.7	0.4	0.5	1.1	1.1	0.8	0.9	0.6	0.7	0.2	0.0	0.0	0.3	0.0	6.6	0.5	0.9	0.0	0.0	0.4	5.1	64.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.8	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.2	0.0	6.6	15.9	12.8	0.0	1.5	0.0	2.0	0.5	0.1	0.0	0.2	0.1
KBTBD12	"FLJ46299, KLHDC6"	ENSG00000187715	"Kelch repeat and BTB domain containing 12"	Q3ZCT8	3	127915232-127987671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 13.8;skeletal muscle: 58.8;tongue: 25.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 43.4;Early spermatids: 32.0;Excitatory neurons: 29.9;Microglial cells: 74.0"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 5.1"							NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (3.60e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.49e-2)"	0.3	0.2	1.3	0.3	1.5	0.2	0.2	1.6	1.6	0.2	2.7	1.8	0.8	0.3	0.1	0.7	0.9	0.7	13.8	1.6	0.6	1.2	0.0	0.2	0.1	0.7	0.7	0.1	4.0	0.0	0.5	0.1	0.7	0.5	1.2	0.7	1.9	0.2	58.8	0.3	0.7	0.7	0.5	0.0	2.0	1.0	0.7	0.0	0.0	25.8	0.0	0.8	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.6	1.6	1.6	0.6	0.7	0.7	0.7	0.5	0.7	1.2	0.0	3.2	3.7	43.4	0.0	0.1	0.1	0.0	0.0	1.0	0.4	0.1	12.1	0.0	1.4	1.8	6.2	0.0	0.1	2.3	1.9	0.1	32.0	1.3	0.0	0.2	2.4	1.7	29.9	9.3	0.0	0.7	7.1	0.8	0.0	0.1	0.0	0.0	0.1	1.7	15.7	5.8	0.0	0.0	1.0	3.2	0.0	0.3	0.0	74.0	0.0	1.6	0.0	3.0	2.2	5.9	5.8	0.0	0.1	0.0	1.4	0.0	1.2	0.9	0.0	1.6	1.0	6.2	5.7	0.0	0.3	0.0	0.0	0.1	1.9	0.1
KCNMA1	"KCa1.1, mSLO1, SLO"	ENSG00000156113	"Potassium calcium-activated channel subfamily M alpha 1"	Q12791	10	76869601-77638369	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 138.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 471.1;Bipolar cells: 409.8;Excitatory neurons: 1023.7;Inhibitory neurons: 635.9;Oligodendrocyte precursor cells: 708.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4;non-classical monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"BJ: 100.8;hTERT-HME1: 115.3;PC-3: 159.6;U-138 MG: 112.6;U-87 MG: 109.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054648	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA054648: AB_2682556"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.29e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.99e-3)"	10.9	12.6	36.2	8.9	38.0	1.0	15.8	1.0	45.0	54.4	4.2	118.2	7.3	138.7	31.4	33.7	47.8	22.4	3.7	36.4	10.1	11.4	19.2	9.6	7.8	4.8	15.2	13.9	8.0	0.2	26.9	4.8	5.7	48.3	21.1	40.2	42.8	76.1	96.6	5.0	23.3	92.8	1.0	24.1	33.6	5.8	15.6	2.1	3.0	18.7	3.5	44.3	24.6	28.4	0.3	30.3	0.1	0.3	4.6	24.8	0.3	100.8	89.2	23.9	11.8	6.7	0.6	0.0	0.7	75.9	56.8	0.2	0.0	59.0	14.6	60.9	0.6	0.0	0.0	0.0	45.0	0.0	0.4	17.4	10.7	38.3	115.3	84.0	9.8	0.5	0.0	0.0	42.6	1.2	1.9	0.2	1.8	0.2	159.6	0.1	3.6	0.1	15.3	0.2	9.1	1.1	0.0	2.5	0.1	11.9	12.2	0.1	65.4	112.6	12.7	20.6	90.0	0.0	0.2	0.0	109.8	0.1	45.1	0.0	0.1	0.0	0.0	2.4	0.0	0.7	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.1	36.2	38.0	1.0	45.0	36.4	10.1	4.8	15.2	5.7	1.0	15.6	28.4	0.9	0.0	4.3	471.1	2.8	2.0	71.7	5.7	17.6	409.8	30.4	43.9	3.5	5.7	4.8	1.8	60.5	0.3	0.5	2.8	29.4	3.3	74.4	20.9	17.9	3.4	4.9	0.0	1023.7	10.7	0.2	16.2	0.5	29.7	0.0	1.9	2.5	27.3	10.8	6.7	635.9	59.6	46.8	106.0	3.9	63.1	3.7	36.7	48.0	133.0	4.0	52.3	0.0	708.2	33.9	8.7	1.4	1.2	8.7	64.0	1.4	0.9	0.1	17.2	6.6	20.6	19.2	3.4	2.5	7.7	0.3	0.3	0.7	177.2	1.7	2.4
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783787-40840452	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Hearing, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.1;intestine: 5.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 5.1;Inhibitory neurons: 9.7;Muller glia cells: 4.2;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 5.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HEK 293: 2.2;K-562: 2.6;MCF7: 1.4;REH: 1.3;THP-1: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA018305: AB_1855556"	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	0.9	0.1	0.1	0.3	0.6	0.0	0.6	0.2	1.7	0.9	2.4	5.4	0.4	2.8	0.1	1.0	2.3	0.3	0.6	0.2	0.2	0.1	0.1	0.5	0.0	0.7	5.1	0.5	0.4	0.2	0.3	0.5	0.7	1.1	0.3	0.4	1.4	1.1	3.2	0.6	1.2	1.5	0.8	0.0	1.3	0.2	0.1	0.3	0.2	1.0	0.0	2.3	0.7	2.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.2	0.9	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.2	0.0	1.1	0.2	0.0	0.6	0.2	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	1.7	0.2	0.2	0.7	5.1	0.7	0.8	0.1	2.0	0.3	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	1.8	1.5	2.1	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	1.2	0.2	0.2	0.1	0.3	1.8	0.8	5.1	0.2	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	2.2	0.0	9.7	1.2	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.2	0.0	2.5	1.5	0.6	0.5	0.7	0.3	0.2	0.0	0.0	0.0	0.3	6.6	2.0	2.8	0.2	0.7	1.0	0.4	0.0	0.0	0.1	1.1	0.1
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lung: 23.5;skeletal muscle: 86.0;tongue: 45.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Enteroendocrine cells: 32.5;Theca cells: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 69.2;RPMI-8226: 28.9;RT4: 48.2;U-266/84: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA014864: AB_1852155"	"unprognostic (5.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.47e-3)"	"unprognostic (9.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	2.9	1.1	2.6	3.8	2.9	0.0	6.2	3.9	4.0	7.8	9.5	12.5	3.7	3.2	2.6	6.0	3.9	5.4	6.6	2.9	4.2	5.0	3.8	23.5	0.6	10.5	7.9	1.0	9.8	2.9	1.2	11.0	12.5	6.5	5.0	0.4	11.2	3.1	86.0	5.6	5.4	3.3	5.3	1.0	9.5	3.9	4.3	1.4	2.3	45.5	2.0	6.8	6.3	4.4	8.5	1.4	0.7	0.0	1.6	0.8	3.8	2.8	8.5	1.7	2.0	0.1	17.1	0.0	0.9	3.0	1.9	2.7	20.7	0.1	1.8	0.0	5.7	0.0	0.2	0.1	8.1	0.2	0.7	0.7	12.9	0.1	1.2	15.5	0.4	3.9	0.4	0.0	1.0	2.2	0.0	0.0	10.2	11.5	0.2	2.4	69.2	28.9	1.8	48.2	20.3	0.7	0.0	5.3	6.1	4.8	2.8	0.0	0.2	2.7	0.0	0.2	21.6	0.1	34.9	0.1	15.2	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.9	3.9	4.0	2.9	4.2	10.5	7.9	12.5	5.3	4.3	4.4	3.8	28.9	8.2	0.0	0.0	13.9	16.8	6.9	21.1	0.2	11.5	7.0	0.5	18.6	6.8	11.0	0.0	0.6	0.0	10.9	0.0	21.5	0.3	0.9	0.6	5.9	32.5	0.0	0.3	0.4	3.5	12.1	8.2	0.9	1.3	4.3	2.5	5.4	0.5	0.0	16.9	5.6	14.2	0.0	4.5	1.2	1.5	0.4	21.4	1.9	0.7	0.1	0.0	7.1	2.5	2.4	4.9	3.8	1.2	13.6	4.1	5.5	1.7	0.2	6.6	13.5	10.6	0.3	3.4	8.0	5.8	0.8	0.6	30.6	10.3	7.1
KIAA1217	"DKFZP761L0424, ETL4, SKT"	ENSG00000120549	KIAA1217	Q5T5P2	10	23694746-24547848	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 108.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 609.1;Inhibitory neurons: 1251.8;Oligodendrocyte precursor cells: 255.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 82.6;Karpas-707: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004941	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA004941: AB_2130659"	"unprognostic (3.60e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-1)"	28.4	16.5	9.8	3.5	12.1	0.2	30.5	2.2	9.6	15.7	42.2	13.1	12.9	6.0	13.3	30.9	16.9	14.7	17.8	27.5	2.0	18.0	17.5	14.4	2.6	6.0	11.2	13.1	13.6	42.8	6.5	20.9	5.7	20.5	14.7	23.7	39.2	22.5	108.4	17.6	11.3	3.3	0.5	7.5	17.4	15.7	4.2	12.6	33.6	52.7	9.3	12.1	19.1	17.2	19.5	9.7	3.8	0.1	2.4	6.8	82.6	3.7	6.0	8.6	18.2	16.6	30.3	1.0	18.6	7.6	17.6	31.5	4.7	36.2	9.5	7.2	3.4	0.4	23.1	19.4	4.2	0.0	0.3	25.3	22.8	19.0	5.2	3.9	0.0	1.7	0.0	75.7	4.4	6.8	10.8	0.6	8.5	18.9	8.7	0.8	22.0	16.2	20.1	25.3	2.4	1.3	9.4	31.4	0.0	38.3	15.2	0.0	20.3	13.1	14.1	52.9	4.9	33.4	30.4	0.1	43.4	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.8	12.1	2.2	9.6	27.5	2.0	6.0	11.2	5.7	0.5	4.2	17.2	149.7	38.5	34.4	27.4	1.0	121.3	74.1	58.0	145.1	13.6	38.8	39.0	39.1	24.3	73.7	33.1	8.4	50.2	0.4	52.5	3.9	32.3	33.7	64.5	19.6	34.4	23.9	0.0	609.1	26.2	21.2	23.3	50.0	85.9	1.3	6.6	25.0	24.8	5.3	0.0	1251.8	22.8	26.4	14.6	7.8	11.3	17.7	1.3	1.8	30.0	0.0	93.6	0.0	255.9	10.3	24.1	22.7	33.1	3.1	36.8	15.4	6.3	36.9	3.1	13.1	19.6	20.4	0.8	1.1	96.4	51.0	65.1	2.2	14.2	19.4	43.7
KLHL23	"FLJ37812, MGC22679, MGC2610"	ENSG00000213160	"Kelch like family member 23"	Q8NBE8	2	169694488-169776989	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 132.5;Cone photoreceptor cells: 89.6;Sertoli cells: 170.9;Smooth muscle cells: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047593			Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Actin filaments"		"HPA047593: "	"unprognostic (4.77e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.09e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.87e-3)"	6.9	2.1	8.1	6.1	9.6	1.7	6.2	13.2	9.9	9.6	0.2	20.8	11.1	25.6	4.0	12.0	8.9	6.7	8.0	9.8	7.2	6.6	5.9	5.9	3.1	3.7	5.8	17.9	7.2	6.4	3.3	12.8	4.6	13.6	13.9	13.6	8.0	12.5	12.0	1.6	11.8	25.0	4.0	2.8	5.1	10.9	7.6	11.1	8.1	16.3	2.9	8.7	3.9	6.3	17.0	8.6	64.5	18.3	3.6	1.3	43.7	8.0	6.1	14.4	15.8	18.0	14.4	10.6	6.7	0.8	20.9	2.6	67.7	5.8	21.9	37.7	33.2	31.3	16.9	29.9	5.4	44.2	4.7	2.5	4.7	6.0	10.2	9.3	11.2	38.3	43.5	1.4	4.8	8.2	65.0	17.9	52.7	9.0	6.7	20.7	55.1	1.1	13.1	49.9	83.4	57.1	12.7	1.2	7.8	20.3	10.6	14.2	4.2	5.8	18.6	5.7	13.6	4.9	4.9	47.3	4.5	13.0	9.0	0.0	0.0	0.0	0.7	0.0	0.9	0.3	0.6	0.5	0.1	0.3	1.0	1.0	0.0	3.4	0.0	0.9	0.8	0.3	8.1	9.6	13.2	9.9	9.8	7.2	3.7	5.8	4.6	4.0	7.6	6.3	13.7	3.2	8.7	0.0	1.1	1.5	6.9	2.8	7.4	132.5	15.0	17.1	52.9	14.3	6.7	0.0	89.6	5.6	3.8	14.6	3.9	15.6	4.6	2.4	12.8	12.6	31.8	9.7	0.0	30.5	9.6	11.2	4.1	5.5	0.0	27.5	7.5	11.8	0.9	40.4	0.0	21.2	28.5	0.8	1.9	3.7	2.5	1.3	0.0	0.0	0.2	14.6	5.2	0.0	0.0	16.1	13.6	8.6	0.4	17.2	9.7	16.9	4.9	34.8	170.9	11.4	102.6	3.4	20.9	4.7	1.0	1.2	5.5	13.8	20.9	4.1
KLHL31	"bA345L23.2, BKLHD6, KBTBD1"	ENSG00000124743	"Kelch like family member 31"	Q9H511	6	53647916-53665756	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 51.3;skeletal muscle: 146.1;tongue: 34.8"	"Cell type enriched"	"Detected in some"	33	"Cardiomyocytes: 248.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (7.27e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.67e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.09e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	8.6	0.8	0.2	0.2	0.5	0.0	3.1	0.2	0.3	0.2	0.7	0.2	0.4	0.2	0.8	0.7	0.8	0.2	51.3	0.1	0.3	0.2	0.4	0.2	0.1	0.3	0.2	0.3	0.4	0.0	0.4	0.1	0.3	1.3	0.2	0.4	1.2	0.1	146.1	1.3	0.3	0.0	0.3	0.1	0.3	0.3	0.3	0.1	0.9	34.8	0.2	0.3	0.4	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.0	0.3	0.1	0.6	0.4	0.0	0.1	0.0	0.5	0.7	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.2	0.0	0.8	0.0	0.2	0.2	1.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.3	0.1	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.0	0.0	0.7	0.0	0.6	0.8	0.7	0.0	0.5	0.9	0.9	248.9	0.0	0.5	0.0	0.0	1.0	0.1	0.6	0.0	0.1	0.4	2.0	0.3	1.7	0.0	3.2	0.2	0.4	0.2	7.5	0.5	3.1	0.0	0.9	0.0	0.2	0.2	0.0	0.2	0.1	2.0	0.3	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.5	0.0	0.2	0.0	0.1	0.6	0.0	0.2	0.2	0.1	0.0	3.7	2.2	0.0	0.2	0.0	0.4	0.8	0.3	0.4	0.3	0.4
KLHL38	C8ORFK36	ENSG00000175946	"Kelch like family member 38"	Q2WGJ6	8	123645527-123652950	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 56.7;skeletal muscle: 268.3;tongue: 76.9"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Group enriched"	"Detected in some"	5	"breast cancer: 1.3;melanoma: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.7;SK-BR-3: 2.8;U-2197: 4.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA024770, HPA027115"	Uncertain		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA024770: AB_10599286, HPA027115: AB_10599950"	"unprognostic (8.62e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.02e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.73e-6)"	"unprognostic (8.46e-3)"	"unprognostic (3.82e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.84e-2)"	0.2	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.5	0.2	0.1	0.9	0.1	1.3	0.0	2.5	0.7	0.7	56.7	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.1	1.3	0.0	1.5	0.0	0.8	0.1	0.0	0.7	0.1	268.3	0.2	0.2	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	76.9	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.9	0.0	0.5	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL41	"KBTBD10, Krp1, SARCOSIN"	ENSG00000239474	"Kelch like family member 41"	O60662	2	169509702-169526258	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	42	"skeletal muscle: 5038.6;tongue: 3473.7"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 108.1;Skeletal myocytes: 251.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 10.8;prostate cancer: 3.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HSkMC: 21.6;LHCN-M2: 35.4;RH-30: 55.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021165, HPA021753, HPA021760"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091"	"unprognostic (2.44e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.65e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.52e-1)"	1.5	0.5	1.7	0.2	1.4	0.0	2.0	3.1	1.8	1.0	1.4	1.4	0.1	0.8	1.5	75.1	1.2	6.7	100.3	1.2	1.6	0.8	0.9	2.7	0.3	0.9	2.5	1.1	1.1	0.5	5.8	0.1	1.5	50.0	0.3	16.1	52.1	0.7	5038.6	4.6	0.8	0.6	0.9	0.8	1.3	2.6	5.1	1.7	2.2	3473.7	0.3	5.9	0.9	1.4	0.0	0.1	0.0	0.6	0.4	2.7	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.2	0.2	0.0	21.6	0.5	0.3	0.0	0.2	0.1	0.2	0.1	0.0	35.4	0.1	0.1	0.2	0.0	0.0	0.2	0.0	55.9	0.0	0.2	0.1	0.7	0.1	0.1	0.0	1.5	0.1	0.0	0.1	0.0	0.4	0.2	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.4	3.1	1.8	1.2	1.6	0.9	2.5	1.5	0.9	5.1	1.4	0.0	0.0	0.5	1.3	0.0	0.1	0.5	0.1	0.0	2.4	0.2	0.1	108.1	0.0	2.0	0.0	8.4	0.0	0.0	0.1	0.0	0.5	5.8	1.3	0.2	1.0	1.2	0.0	4.1	0.5	0.0	6.4	0.0	0.1	0.0	0.2	0.4	0.2	0.2	0.0	4.6	0.1	0.0	0.3	0.0	2.9	0.9	0.8	0.0	3.7	0.0	0.7	0.0	1.5	2.3	0.7	0.1	1.2	0.0	0.3	0.0	0.3	4.1	5.8	0.0	251.8	1.8	4.1	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.1
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699320-49792682	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.4;tongue: 94.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 316.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046852, HPA077643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA046852: AB_2679840, HPA077643: "	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	20.8	10.6	13.6	16.9	15.3	29.7	11.7	14.3	19.6	13.7	9.3	17.0	12.3	13.8	11.3	25.4	12.4	14.6	31.9	16.0	15.0	13.8	23.4	17.2	18.4	14.4	13.5	8.3	10.4	12.6	7.1	14.9	14.3	15.8	16.6	33.4	10.4	19.1	145.4	16.2	12.2	25.6	16.1	13.6	13.4	28.5	15.9	19.9	19.2	94.2	20.2	20.1	11.0	17.8	41.3	28.3	53.0	44.6	53.2	58.1	26.6	73.3	60.8	63.5	46.0	86.2	37.6	89.2	14.4	86.6	42.7	47.1	64.1	59.5	105.2	53.8	44.7	65.3	25.4	101.1	51.8	98.7	40.6	42.9	42.3	53.3	69.8	41.7	79.7	36.9	36.7	23.4	88.8	19.1	53.2	53.7	61.4	57.8	19.7	68.6	52.1	27.3	39.1	33.8	22.2	34.8	27.1	33.3	29.5	43.8	19.8	39.3	73.0	46.7	37.5	43.0	49.8	18.8	27.9	76.7	28.4	44.9	47.2	10.3	3.8	3.6	6.7	4.5	9.3	4.9	6.7	6.6	4.2	2.8	6.4	5.9	2.2	6.7	6.0	2.3	8.5	3.4	13.6	15.3	14.3	19.6	16.0	15.0	14.4	13.5	14.3	16.1	15.9	17.8	44.3	67.3	33.8	64.9	35.2	43.1	30.5	21.4	43.9	29.9	23.4	15.0	76.5	21.5	25.7	12.9	33.3	15.5	31.8	26.0	17.6	49.0	316.7	57.4	35.7	44.2	30.5	39.1	90.6	53.7	17.7	30.0	27.0	40.7	33.0	25.4	30.4	36.2	33.1	52.2	83.9	18.4	20.3	37.3	38.7	168.8	22.1	41.9	19.6	55.3	47.1	49.0	35.0	73.4	85.6	51.7	15.0	50.0	36.9	41.7	14.3	28.1	45.8	65.7	26.3	29.1	32.1	66.1	31.8	52.9	49.9	10.5	38.6	61.9	24.9	33.1
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160495007-160565571	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	20.2	8.1	4.4	12.0	5.4	15.2	11.1	7.2	10.8	11.1	2.7	16.9	8.8	12.7	8.5	16.5	9.0	9.7	23.3	5.8	7.3	11.1	12.2	11.0	10.4	6.2	5.5	9.0	13.2	11.0	6.3	11.9	6.5	11.6	8.5	13.2	10.5	12.4	124.6	11.3	9.8	13.5	5.9	11.2	12.1	12.2	5.5	11.2	10.3	59.8	12.0	14.3	11.8	6.9	103.4	29.9	20.0	32.7	30.3	27.8	39.7	70.7	39.6	41.0	33.0	38.5	32.1	52.6	73.8	59.9	52.5	45.8	27.4	38.2	50.2	77.0	20.5	52.8	15.2	9.0	37.7	49.3	33.8	22.0	18.5	38.5	76.6	27.5	53.9	26.5	44.2	33.5	45.5	13.8	38.0	17.7	53.9	33.7	31.4	33.9	41.6	50.4	21.9	22.9	23.3	24.8	60.8	29.7	55.7	22.8	33.7	14.4	72.9	39.4	36.0	37.3	87.9	80.4	50.4	96.3	30.9	45.4	31.6	7.7	2.3	2.9	1.8	3.5	2.5	2.3	1.6	2.6	1.7	1.5	1.3	2.0	4.2	4.0	5.7	1.5	2.7	1.8	4.4	5.4	7.2	10.8	5.8	7.3	6.2	5.5	6.5	5.9	5.5	6.9	70.5	38.5	25.1	40.1	62.8	123.6	87.3	24.3	60.3	58.6	59.4	48.1	158.8	30.0	38.4	11.0	79.2	26.1	54.5	65.0	35.2	36.5	24.3	71.2	63.2	60.7	28.7	38.1	48.5	37.7	25.3	55.1	45.9	92.1	31.6	57.6	37.5	34.7	39.2	53.8	52.9	38.1	28.5	47.9	97.2	18.4	33.8	80.0	44.4	49.6	43.2	57.5	28.8	45.8	69.2	77.4	44.3	34.6	65.2	86.5	32.0	40.2	40.6	69.6	32.9	102.4	67.4	38.2	25.3	85.3	126.0	40.6	60.6	36.1	43.7	104.4
KY	FLJ33207	ENSG00000174611	"Kyphoscoliosis peptidase"	Q8NBH2	3	134599923-134651636	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease"	"Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 16.3;skin 1: 9.6;tongue: 27.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 15.0;Excitatory neurons: 10.0;Inhibitory neurons: 11.6;Late spermatids: 6.4;Oligodendrocyte precursor cells: 24.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.0;NB-4: 1.1;U-2197: 2.7;U-87 MG: 8.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"HPA036492, HPA036668"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA036492: AB_10672222, HPA036668: AB_2675239"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.47e-1)"	0.0	2.7	1.7	0.2	1.8	0.3	0.8	1.6	2.9	0.8	0.1	0.9	0.4	1.9	0.8	2.0	1.9	0.4	3.1	1.6	1.7	0.3	0.0	0.1	0.0	1.9	2.3	0.9	0.0	2.2	3.3	0.0	2.1	2.2	0.2	1.7	0.8	1.7	16.3	9.6	0.2	4.2	1.5	0.1	0.7	0.3	2.0	0.9	3.0	27.7	0.0	0.6	0.6	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	8.1	0.7	0.0	5.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	1.6	2.9	1.6	1.7	1.9	2.3	2.1	1.5	2.0	1.9	0.0	0.0	0.0	15.0	0.0	0.6	0.1	0.0	0.0	0.4	0.1	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	10.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	1.0	0.0	2.5	0.0	24.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668507-86736072	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	26	"heart muscle: 1423.0;skeletal muscle: 2945.6;tongue: 1809.4"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 1825.0"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.7;melanoma: 2.5;prostate cancer: 3.6;stomach cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.0;hTERT-RPE1: 3.3;SCLC-21H: 4.9;SK-MEL-30: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		750000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	11.1	1.4	12.8	2.8	39.6	0.4	6.5	29.8	29.0	10.1	0.1	36.2	2.4	15.1	4.9	54.5	17.3	3.1	1423.0	14.7	23.3	2.0	0.8	5.1	0.5	55.5	36.9	6.4	1.3	0.5	2.4	2.7	46.2	38.1	5.3	0.7	20.8	25.2	2945.6	4.8	8.8	23.7	26.4	0.6	9.0	4.7	38.4	0.7	5.2	1809.4	0.3	7.0	10.3	78.4	0.1	0.1	0.2	1.7	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.4	0.4	0.7	0.0	0.0	0.0	0.9	3.0	0.2	0.0	0.0	3.3	0.0	0.3	0.1	1.0	0.0	0.8	0.2	0.1	0.2	0.2	0.2	0.0	1.1	0.0	0.0	0.6	4.9	0.9	0.2	0.1	2.4	0.7	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.2	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.8	39.6	29.8	29.0	14.7	23.3	55.5	36.9	46.2	26.4	38.4	78.4	1.5	0.0	0.0	1.0	0.0	1.0	0.5	0.2	0.0	1.5	0.2	0.3	1825.0	0.0	0.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	23.4	0.1	0.4	15.5	0.0	0.0	4.5	1.1	0.0	31.5	0.0	0.2	0.0	0.9	0.0	0.0	0.1	0.0	2.6	0.0	4.1	0.0	1.2	19.6	11.1	0.5	1.8	1.9	0.0	0.7	0.0	1.5	245.1	0.1	0.0	6.8	0.0	0.3	0.0	0.1	0.1	4.1	39.5	48.0	54.9	1.0	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2
LGALSL	"GRP, HSPC159"	ENSG00000119862	"Galectin like"	Q3ZCW2	2	64453969-64461381	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 90.6;skin 1: 93.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 95.6;Rod photoreceptor cells: 152.8;Suprabasal keratinocytes: 137.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.5;neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 50.2;CACO-2: 35.6;HAP1: 72.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046079	Approved		Approved	Nucleoplasm		NA	NA		4100000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA046079: AB_10967075"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.77e-2)"	9.3	16.9	7.1	4.1	8.3	8.1	17.2	9.5	8.7	8.8	8.6	12.6	10.1	7.2	8.9	24.6	5.3	6.3	13.5	7.4	8.6	9.2	9.6	15.9	2.1	5.7	5.4	6.4	6.3	19.2	7.5	10.6	5.7	15.5	11.8	90.6	9.3	7.1	60.1	93.6	10.9	7.3	5.4	6.0	8.8	4.3	5.8	2.9	5.3	18.2	15.8	4.4	10.0	6.6	11.6	7.5	20.7	50.2	0.7	0.2	6.2	2.9	8.1	6.3	6.0	35.6	2.4	0.0	4.7	1.6	12.2	14.3	72.8	13.7	5.0	13.8	19.1	0.2	4.0	17.8	6.2	3.4	4.4	3.1	8.6	2.6	9.7	5.6	3.9	7.7	0.1	3.5	0.2	9.3	4.9	0.6	16.8	7.1	8.8	5.3	12.0	3.5	7.5	8.5	3.5	13.1	10.5	7.2	6.2	12.7	5.1	0.5	1.7	4.0	12.4	2.5	6.2	14.7	7.1	10.0	0.0	2.1	5.4	0.0	0.1	1.5	0.0	0.0	0.7	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.4	7.1	8.3	9.5	8.7	7.4	8.6	5.7	5.4	5.7	5.4	5.8	6.6	28.9	22.4	66.2	2.3	6.0	67.6	25.5	9.7	29.0	31.9	39.0	20.8	16.5	10.0	6.3	11.0	33.3	1.4	1.6	45.2	15.6	6.2	11.8	10.9	8.1	18.2	9.1	0.8	6.6	13.3	2.7	14.8	23.4	23.0	1.3	4.1	17.9	11.9	1.0	13.5	6.0	38.6	6.1	6.6	14.4	6.3	8.1	26.2	10.6	1.9	2.4	95.6	2.1	5.0	2.4	19.9	22.6	4.5	29.8	24.1	31.0	14.3	1.6	152.8	19.7	15.1	45.9	8.1	5.1	51.9	137.0	1.5	2.7	2.8	24.3	36.2
LIMS1	"PINCH, PINCH1"	ENSG00000169756	"LIM zinc finger domain containing 1"	P48059	2	108534355-108687246	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 379.6;Macrophages: 405.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 402.5"									"HPA058455, HPA061230"	Approved		Approved	"Focal adhesion sites,Cytosol"		NA	NA		10000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723, HPA061230: AB_2684456"	"unprognostic (1.79e-1)"	"unprognostic (8.82e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (7.51e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.11e-1)"	41.0	45.0	7.0	33.8	10.4	32.9	28.9	9.4	8.4	22.7	10.8	22.1	16.7	35.8	11.6	26.9	31.5	31.2	38.0	6.9	11.4	16.7	20.1	37.0	37.9	12.9	11.0	20.5	15.0	12.0	8.0	32.2	12.8	19.5	18.0	11.5	17.6	26.7	99.1	14.2	20.0	35.8	11.3	21.0	22.2	16.8	15.0	21.4	24.8	35.8	32.8	30.0	17.6	15.9	44.7	49.0	19.0	22.8	30.8	44.5	91.6	49.0	56.0	37.1	37.6	85.3	93.7	43.1	145.4	63.0	55.0	28.3	29.0	50.2	49.3	106.7	52.0	225.6	32.1	45.8	70.4	42.7	402.5	43.5	45.5	98.3	80.3	44.2	135.9	37.3	81.0	58.2	115.4	36.5	41.4	31.4	37.5	29.0	49.6	52.2	65.9	35.0	70.2	79.5	34.3	46.3	76.6	32.5	34.5	25.0	16.8	39.6	184.2	166.6	75.6	37.5	101.2	56.4	81.6	60.6	139.3	47.6	43.6	211.9	69.6	196.2	16.6	119.3	30.5	18.7	72.3	22.4	59.4	18.0	19.2	7.3	31.6	35.9	156.2	7.7	89.0	140.3	7.0	10.4	9.4	8.4	6.9	11.4	12.9	11.0	12.8	11.3	15.0	15.9	143.5	99.3	55.6	80.6	43.2	74.1	63.0	65.1	63.7	26.2	34.9	37.0	61.6	38.6	53.4	29.5	54.2	45.1	40.6	19.2	39.2	80.9	22.5	266.8	122.9	187.6	118.1	84.5	32.6	233.5	130.3	109.4	32.6	379.6	101.4	107.0	76.1	34.6	189.0	15.2	34.6	24.0	48.8	181.1	265.4	12.0	81.4	405.4	44.4	115.2	118.5	69.2	41.2	54.3	66.8	122.3	17.2	88.0	76.3	82.1	33.5	44.0	84.8	18.8	65.7	116.2	161.2	45.4	51.1	75.2	77.0	27.9	82.4	51.3	32.4	66.4
LIMS3		ENSG00000256977	"LIM zinc finger domain containing 3"	P0CW19	2	109898428-109924868	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 6.5;fallopian tube: 6.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.6;Distal tubular cells: 1.9;Exocrine glandular cells: 1.2;NK-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 12.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 14.1;HMC-1: 41.3"									HPA058455	Uncertain		Approved	"Focal adhesion sites,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol	"Focal adhesion sites"	"HPA058455: AB_2683723"										"unprognostic (2.23e-2)"								1.2	1.7	0.2	2.6	0.2	0.4	0.7	0.2	0.4	1.3	0.2	0.5	0.7	6.5	1.7	1.6	6.4	1.3	1.9	0.2	0.3	2.8	0.2	0.5	0.6	0.4	0.3	2.3	0.9	0.5	0.6	1.5	0.4	0.5	1.2	0.4	1.0	1.0	5.7	0.2	0.8	1.5	0.2	0.5	0.7	1.2	0.3	1.0	0.6	2.0	0.4	1.7	0.3	0.5	0.1	0.1	1.8	2.1	0.7	0.6	0.0	2.2	0.0	0.4	0.9	2.2	0.0	0.0	6.5	0.4	4.2	1.2	0.0	2.6	1.8	3.5	0.0	14.1	0.6	1.3	1.9	2.5	41.3	3.0	1.5	1.6	1.9	0.0	3.5	0.0	3.0	2.3	4.6	0.1	0.0	0.3	2.2	1.4	0.8	2.6	4.4	1.5	1.2	2.2	0.6	5.0	5.7	0.0	1.2	0.1	0.0	0.7	10.4	8.8	8.1	4.6	0.4	0.0	0.0	2.8	1.2	0.0	2.6	5.6	3.2	12.3	0.7	5.4	1.4	0.6	4.7	1.5	2.4	0.2	0.8	0.3	0.6	1.2	5.7	0.2	6.1	8.5	0.2	0.2	0.2	0.4	0.2	0.3	0.4	0.3	0.4	0.2	0.3	0.5	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.3	0.1	0.6	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1
LIX1L	MGC46719	ENSG00000271601	"Limb and CNS expressed 1 like"	Q8IVB5	1	145933423-145958017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063598			Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA063598: AB_2685055"	"unprognostic (5.21e-2)"	"unprognostic (4.09e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.85e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.95e-1)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (5.27e-4)"	21.0	19.0	14.6	15.2	15.1	6.4	16.0	13.8	13.1	27.1	15.6	23.0	6.7	27.6	11.1	9.8	21.1	15.6	16.3	12.9	13.5	9.8	10.2	15.6	20.4	15.0	15.2	36.9	5.8	7.5	16.3	16.2	14.0	16.2	9.2	19.0	9.4	20.8	34.8	8.1	13.3	25.7	13.9	20.8	11.3	6.6	15.8	16.6	10.8	31.5	20.8	21.1	16.9	15.0	7.3	10.3	31.0	34.5	63.4	53.5	0.4	16.3	29.4	24.8	18.1	0.8	6.7	19.6	17.5	33.1	9.3	0.4	14.6	13.6	23.3	18.2	4.5	10.9	11.0	10.4	20.8	26.2	24.8	32.9	6.2	20.3	29.3	39.9	48.7	25.8	16.4	30.6	39.9	0.2	34.6	21.8	9.0	0.1	13.2	23.2	15.6	32.4	25.7	0.2	11.1	31.6	33.5	0.1	24.9	12.8	1.2	20.3	38.0	41.9	11.5	27.6	27.8	24.5	18.7	19.9	29.5	21.4	20.7	4.0	2.2	3.9	5.7	2.2	7.0	3.0	6.6	5.8	2.1	3.1	6.1	8.0	3.7	3.8	3.8	3.3	5.4	2.6	14.6	15.1	13.8	13.1	12.9	13.5	15.0	15.2	14.0	13.9	15.8	15.0	29.7	0.0	5.8	11.1	23.1	11.3	10.6	10.8	11.4	17.1	3.8	7.5	17.5	14.3	4.9	11.0	8.4	1.4	18.6	2.8	3.9	9.6	10.4	2.3	21.6	36.7	12.6	23.5	5.1	10.0	4.3	28.4	2.6	3.5	5.1	10.8	45.7	19.6	21.1	13.5	6.1	1.4	8.2	24.3	43.8	3.6	35.8	18.8	28.4	15.9	27.4	28.1	35.0	8.5	7.0	11.0	1.2	56.4	17.8	7.5	0.1	7.7	3.0	13.6	26.3	16.8	37.9	24.1	4.7	3.1	7.7	0.8	37.4	21.4	2.1	4.2
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501807-8574668	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 573.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 287.6;Ductal cells: 122.0;Endothelial cells: 161.9;Pancreatic endocrine cells: 114.1;Smooth muscle cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"T-reg: 20.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 20.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 88.9;HSkMC: 124.9;hTEC/SVTERT24-B: 93.8;U-2197: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No		6600	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	131.4	14.3	9.5	45.6	9.5	0.1	97.5	13.5	10.8	27.2	38.8	18.1	9.0	90.3	18.4	36.1	57.8	67.2	90.6	14.0	9.7	33.0	9.7	131.7	17.3	14.0	11.0	65.8	37.7	30.0	8.7	54.5	12.1	34.8	7.0	15.2	42.2	16.8	573.4	28.8	20.1	63.3	13.2	55.6	46.4	11.3	12.6	4.7	18.5	260.9	10.2	110.6	31.5	14.8	9.4	52.0	8.6	6.6	62.0	34.6	8.9	37.9	19.4	20.5	50.0	38.8	11.5	0.0	4.2	44.2	8.8	0.8	4.9	9.9	8.4	16.0	3.6	11.6	3.5	7.6	88.9	0.0	1.1	124.9	0.2	93.8	0.7	11.9	10.1	0.0	0.0	0.0	26.8	6.7	0.0	0.1	16.8	12.0	2.3	0.2	28.2	0.1	19.1	3.6	0.3	21.3	6.4	31.1	20.6	23.9	40.7	0.1	5.0	20.4	40.3	83.0	25.9	5.1	6.2	2.6	4.1	2.9	27.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	2.9	0.6	3.3	0.3	0.0	0.1	0.0	0.0	0.0	1.0	20.5	0.3	9.5	9.5	13.5	10.8	14.0	9.7	14.0	11.0	12.1	13.2	12.6	14.8	287.6	9.6	10.7	2.0	2.1	31.6	42.1	7.4	9.6	13.0	20.4	17.0	14.7	14.3	13.5	5.5	10.4	3.9	1.7	1.4	3.9	122.0	1.1	9.6	77.7	161.9	12.1	0.0	0.8	48.5	4.2	64.5	7.1	4.8	10.2	44.2	30.7	12.6	3.4	97.6	1.2	2.4	4.1	0.8	47.0	2.3	11.5	3.2	53.4	29.0	9.0	38.9	1.0	4.0	8.7	114.1	0.9	32.4	8.0	8.4	0.3	45.5	12.0	8.0	0.0	57.0	112.9	6.4	9.1	29.0	27.1	4.4	5.3	21.5	4.7	7.5
LMOD3		ENSG00000163380	"Leiomodin 3"	Q0VAK6	3	69106065-69123032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 111.2;skeletal muscle: 459.8;tongue: 228.2"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 278.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 1.6"	"Region enriched"	"Detected in single"	4	"midbrain: 2.3"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	4	"HSkMC: 2.9"	"Not detected"	"Not detected"							HPA036034	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA036034: AB_10673494"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (3.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.96e-1)"	0.2	0.1	0.3	0.2	0.4	0.2	0.1	0.3	0.5	0.1	0.2	0.1	0.2	0.0	0.2	6.4	0.0	0.3	111.2	0.3	0.3	0.1	0.1	0.5	0.2	0.3	2.3	0.0	0.4	0.0	0.9	0.5	0.3	3.8	0.1	1.3	9.0	0.4	459.8	0.2	0.2	0.1	0.1	0.7	0.4	0.1	0.2	0.1	0.1	228.2	0.0	0.8	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.3	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.2	1.6	0.2	0.4	0.2	0.2	0.2	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.4	0.2	0.4	0.2	0.4	0.1	0.3	0.4	0.3	0.5	0.3	0.3	0.3	2.3	0.3	0.1	0.2	0.5	0.5	0.0	0.0	0.3	6.2	2.3	1.5	2.1	0.0	5.0	2.4	1.8	278.1	5.7	1.3	0.0	39.6	0.8	10.0	2.4	0.0	1.0	1.6	3.4	1.2	2.4	0.0	0.0	0.1	0.0	2.1	8.2	0.0	10.0	17.8	0.5	0.7	1.2	0.7	6.7	2.0	1.9	6.1	2.2	28.1	0.5	0.3	2.2	12.4	0.0	3.9	1.0	13.4	0.0	0.3	1.1	0.2	1.2	0.9	2.6	6.1	0.4	0.3	18.1	0.0	33.1	3.4	0.6	0.1	0.8	1.4	0.4	8.2	0.9	1.1	2.5
LRP12	"FLJ12929, ST7"	ENSG00000147650	"LDL receptor related protein 12"	Q9Y561	8	104489231-104589258	"Disease related genes, Human disease related genes, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 42.7;Excitatory neurons: 78.7;Inhibitory neurons: 53.7;Oligodendrocyte precursor cells: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"basophil: 47.0"	"Lineage enriched"	"Detected in many"	32	"granulocytes: 47.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017245	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane,Mitochondria"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center, Plasma membrane, Mitochondria"		"HPA017245: AB_1857532"	"unprognostic (2.17e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.87e-4)"	"unprognostic (2.96e-2)"	"unprognostic (3.96e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	5.7	4.7	5.1	3.9	8.8	2.2	4.3	4.7	9.4	6.4	3.1	4.8	3.1	16.5	4.0	4.1	5.8	7.5	13.6	13.8	5.3	6.5	1.5	4.6	1.6	1.8	2.3	6.1	4.5	10.0	3.1	5.3	1.1	6.5	4.8	6.1	3.8	5.9	9.3	3.1	3.0	18.5	2.4	3.7	2.8	4.9	3.1	12.9	6.8	17.2	2.3	7.6	3.2	3.9	18.5	10.6	21.1	37.1	23.4	18.4	4.7	51.5	51.3	17.6	24.6	2.4	17.7	0.0	20.2	49.0	21.2	8.1	8.6	22.0	37.7	34.3	8.2	28.7	4.7	0.8	14.4	0.4	22.1	24.8	15.4	29.5	23.7	63.4	9.1	21.9	6.2	0.0	63.9	3.0	26.5	0.6	5.3	1.6	18.2	2.1	20.5	4.0	13.9	0.8	27.0	16.4	16.4	0.7	44.6	15.8	5.0	5.6	25.7	48.1	31.0	15.7	33.6	23.8	20.2	0.2	25.9	0.0	53.9	47.0	0.3	5.8	0.2	0.8	1.4	0.0	1.0	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.5	0.4	0.1	0.4	5.1	8.8	4.7	9.4	13.8	5.3	1.8	2.3	1.1	2.4	3.1	3.9	4.4	16.0	2.2	42.7	0.2	11.5	6.3	12.3	10.8	17.5	3.9	4.3	11.7	7.2	5.2	14.7	6.2	0.2	1.7	2.0	0.0	4.6	4.3	4.4	16.4	5.9	14.4	2.5	78.7	4.5	0.5	12.6	1.5	5.5	8.2	10.9	4.2	0.8	5.3	28.6	53.7	2.5	10.2	7.9	14.3	2.7	8.7	8.2	7.2	9.4	6.1	3.1	1.0	64.3	25.2	5.1	0.3	9.1	0.1	7.7	1.5	3.8	5.3	8.3	6.6	8.2	11.3	8.5	12.0	3.2	10.9	0.3	3.9	4.5	2.3	5.2
LRRC14B		ENSG00000185028	"Leucine rich repeat containing 14B"	A6NHZ5	5	191495-196334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 34.0;skeletal muscle: 113.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.6"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 43.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038046, HPA038047"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"		"Nucleoplasm, Cytosol"		"HPA038046: AB_10672504, HPA038047: AB_2675806"	"unprognostic (7.63e-4)"	"unprognostic (4.25e-3)"	"unprognostic (8.50e-3)"	"unprognostic (7.63e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.79e-2)"		"unprognostic (6.07e-3)"		"unprognostic (9.68e-2)"		"unprognostic (6.43e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.78e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.19e-1)"	0.0	0.0	0.2	0.0	0.5	0.3	0.1	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	34.0	0.0	0.8	0.1	0.0	0.0	0.0	0.6	0.5	0.1	0.0	0.0	0.1	0.0	0.6	0.5	0.0	0.9	0.4	0.0	113.8	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.4	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	4.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	10.1	43.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.5	0.9	0.3	0.0	0.8	0.6	0.5	0.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC2		ENSG00000163827	"Leucine rich repeat containing 2"	Q9BYS8	3	46515385-46580099	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 45.3;skeletal muscle: 165.0;tongue: 94.1"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 198.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.2;HEL: 4.2;LHCN-M2: 4.1;TIME: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039138, HPA064844"			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA039138: AB_10795461, HPA064844: "	"unprognostic (1.32e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.24e-1)"	2.4	0.7	1.5	0.7	3.6	0.8	1.9	1.1	2.8	3.5	0.2	1.9	0.7	4.8	2.4	1.4	2.4	3.0	45.3	2.7	0.1	4.5	5.6	1.2	0.5	0.4	0.4	5.2	1.1	0.9	1.2	0.9	0.3	2.1	1.6	0.3	2.2	0.3	165.0	1.9	0.8	4.0	0.2	2.8	1.8	0.8	0.1	3.2	22.1	94.1	0.7	2.3	2.0	1.4	0.1	0.0	0.1	0.1	0.6	1.4	0.1	0.5	1.0	0.3	0.5	0.0	0.1	0.2	0.1	7.2	0.0	0.1	2.5	0.0	0.9	0.3	0.0	4.2	0.3	0.0	0.1	0.1	0.0	0.1	0.0	2.8	0.0	2.3	0.1	0.5	0.0	0.2	4.1	0.0	0.5	0.1	1.0	0.3	0.1	0.1	0.0	0.2	0.0	0.2	0.3	0.8	0.5	0.1	1.0	0.7	0.1	0.5	3.2	0.1	0.3	1.6	1.1	0.2	0.2	1.9	0.1	0.1	0.9	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.5	0.1	1.5	3.6	1.1	2.8	2.7	0.1	0.4	0.4	0.3	0.2	0.1	1.4	1.6	9.6	1.1	2.0	0.2	1.9	1.1	0.6	0.6	0.1	0.8	1.3	198.4	7.2	0.0	1.8	0.0	0.1	0.0	0.2	9.8	0.6	2.3	0.3	1.6	4.0	3.0	0.0	12.5	1.0	0.0	11.9	3.1	0.4	10.2	2.5	5.0	10.2	2.0	0.0	11.2	1.8	0.0	0.8	5.7	2.9	0.6	0.6	10.6	3.7	0.0	0.4	0.0	3.5	0.7	1.0	0.4	0.0	3.0	0.6	0.0	0.8	0.7	0.2	0.0	32.7	2.6	0.6	0.7	0.0	2.4	0.1	2.1	7.9	1.9	0.4
LRRC38		ENSG00000162494	"Leucine rich repeat containing 38"	Q5VT99	1	13474973-13514003	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 19.6;skeletal muscle: 44.5;tongue: 14.7"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 19.3;Inhibitory neurons: 10.6"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 0.5;lung cancer: 0.8;testis cancer: 0.6;urothelial cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.2;MOLT-4: 16.7;PC-3: 11.5;U-138 MG: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA038778	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA038778: AB_10673294"	"unprognostic (5.13e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.45e-3)"		"unprognostic (1.72e-1)"		"unprognostic (2.70e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.23e-1)"		"unprognostic (7.81e-2)"	"unprognostic (4.47e-2)"		"unprognostic (1.05e-1)"	0.4	19.6	0.2	0.0	0.3	0.1	0.6	2.9	1.1	0.2	0.5	0.1	0.0	0.1	0.2	0.3	0.1	0.1	1.4	0.3	0.6	0.1	0.0	0.0	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.5	0.5	0.2	0.0	3.0	0.6	0.0	44.5	1.2	0.0	0.0	1.1	0.0	0.1	0.4	0.1	1.3	0.0	14.7	0.0	0.3	0.7	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	11.5	0.1	0.1	1.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	18.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	2.9	1.1	0.3	0.6	1.3	1.3	0.5	1.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.3	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.5	0.1	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
LRRC39	"MGC14816, myomasp"	ENSG00000122477	"Leucine rich repeat containing 39"	Q96DD0	1	100148448-100178273	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 107.0;retina: 117.9;skeletal muscle: 431.0;tongue: 172.9"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 96.4;Cone photoreceptor cells: 60.5;Early spermatids: 204.8;Hofbauer cells: 76.4;Inhibitory neurons: 62.2;Rod photoreceptor cells: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA077159	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA077159: AB_2732333"	"unprognostic (7.68e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.38e-4)"	2.2	9.8	3.5	1.5	3.6	1.5	1.9	2.8	4.7	1.6	1.1	1.8	1.0	1.4	1.4	4.2	1.7	1.1	107.0	2.8	3.7	1.7	2.6	1.7	2.4	3.8	2.9	1.6	1.6	5.3	2.3	4.2	2.5	4.2	0.6	117.9	2.9	0.5	431.0	3.8	1.7	0.7	1.8	2.3	1.6	6.5	4.2	1.1	1.9	172.9	0.9	1.7	1.3	3.6	0.4	0.5	1.8	2.4	0.4	0.8	1.5	0.8	0.3	0.3	0.7	0.1	1.1	2.0	0.9	0.3	0.4	1.1	0.2	0.2	0.7	0.3	1.7	0.9	2.4	0.4	0.2	0.6	1.1	1.5	0.3	0.3	0.1	0.5	0.3	1.5	0.9	1.7	0.5	0.3	1.0	2.4	0.8	0.5	0.6	1.0	0.8	0.8	0.3	0.6	0.7	2.5	0.5	0.7	6.7	0.6	0.6	1.4	0.5	1.0	0.9	1.3	1.6	3.2	1.6	0.7	1.7	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	2.8	4.7	2.8	3.7	3.8	2.9	2.5	1.8	4.2	3.6	0.3	0.0	1.3	6.8	0.4	0.1	0.1	0.0	0.0	13.1	0.3	0.1	96.4	0.0	0.0	0.0	60.5	0.5	0.3	0.3	0.0	0.2	204.8	0.2	0.5	1.8	0.0	0.0	14.6	0.6	0.6	3.8	0.0	0.5	1.3	0.2	0.7	0.2	76.4	18.5	62.2	0.0	0.0	0.3	0.0	21.7	2.1	8.0	0.0	1.9	0.8	8.1	1.0	5.5	10.2	0.3	0.1	0.4	0.5	0.1	0.0	0.0	0.7	74.2	0.0	8.6	1.4	9.9	1.2	0.0	0.1	0.7	0.4	0.4	0.0	0.0
LRRFIP1	"FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP"	ENSG00000124831	"LRR binding FLII interacting protein 1"	Q32MZ4	2	237627587-237813682	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 322.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006979	Approved		Supported	Cytosol		NA	NA		580000	"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA006979: AB_1079282"	"unprognostic (2.07e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.99e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.64e-2)"	44.2	21.0	11.3	49.2	9.0	86.8	34.0	3.8	11.0	34.1	23.0	63.2	35.9	64.3	15.7	58.2	32.1	39.4	69.7	11.7	10.8	51.7	48.9	61.7	45.4	7.3	6.9	16.0	21.2	55.1	14.8	41.4	7.0	40.9	40.3	6.4	38.0	31.2	111.0	23.7	35.9	58.8	5.9	45.7	49.6	5.4	9.4	43.5	37.8	50.7	52.6	69.4	43.4	7.3	99.1	50.1	17.5	45.9	25.4	55.6	77.7	67.4	62.3	37.8	37.2	19.2	64.6	8.4	27.4	108.8	81.2	80.9	54.0	100.4	80.2	322.6	34.7	78.0	55.1	54.8	58.5	104.2	71.0	23.9	205.8	88.2	216.0	50.6	59.8	54.0	58.4	77.8	79.5	47.8	60.5	79.5	29.6	73.3	45.1	87.9	125.3	80.1	122.0	141.8	46.3	24.0	33.5	76.2	92.2	37.6	42.9	129.2	99.4	42.4	41.1	49.5	77.0	15.8	14.3	53.2	63.4	102.7	51.0	78.5	104.1	248.4	74.8	97.5	55.1	55.9	89.0	77.3	84.1	60.1	46.1	52.2	326.2	46.9	168.9	73.1	76.7	61.4	11.3	9.0	3.8	11.0	11.7	10.8	7.3	6.9	7.0	5.9	9.4	7.3	236.4	487.2	307.3	35.6	249.6	307.0	391.9	166.0	113.3	46.4	128.6	86.2	160.3	127.2	269.9	172.9	37.5	111.2	347.1	319.5	52.8	229.7	7.9	368.3	88.2	213.0	190.5	62.4	175.9	333.0	359.2	109.1	159.0	426.3	241.0	56.9	122.0	149.1	175.8	21.9	237.5	168.3	79.3	271.2	721.3	7.9	29.8	398.9	167.2	57.1	365.0	25.1	213.1	111.1	12.5	389.6	220.6	23.3	146.6	430.5	152.8	49.5	286.1	6.0	78.9	147.3	182.9	10.1	27.4	179.3	243.1	25.3	288.5	158.3	150.0	588.4
MAP2K6	"MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3"	ENSG00000108984	"Mitogen-activated protein kinase kinase 6"	P52564	17	69414697-69553865	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 40.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 53.9;Glandular and luminal cells: 82.7;Oligodendrocytes: 52.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 8.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 22.0;neutrophil: 45.9;plasmacytoid DC: 78.3"	"Group enriched"	"Detected in all"	9	"dendritic cells: 78.3;granulocytes: 45.9;monocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"A549: 40.0;AN3-CA: 21.4;HUVEC TERT2: 28.4;MOLT-4: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007744, HPA031134"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"CAB007744: AB_562318, HPA031134: AB_10603016"	"prognostic favorable (2.27e-6)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.61e-3)"	"unprognostic (9.52e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.09e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-2)"	5.2	1.3	4.2	8.4	4.0	15.9	20.4	11.6	4.0	27.0	7.6	30.7	10.3	6.1	3.2	3.1	4.5	7.2	1.4	2.7	6.2	5.5	12.2	1.8	8.0	5.4	3.8	3.1	8.3	0.3	1.6	1.6	3.9	3.3	31.7	5.8	2.5	3.1	40.5	2.0	10.8	3.3	4.4	4.0	7.4	1.3	5.7	11.5	3.3	21.1	5.9	3.3	1.2	7.7	0.1	40.0	17.6	21.4	7.4	4.0	2.5	0.3	5.8	1.6	2.4	1.2	1.7	1.1	14.2	0.8	1.3	1.9	6.1	0.8	0.5	1.3	3.2	0.1	10.3	11.4	7.4	1.7	1.3	19.0	0.5	0.3	0.0	1.4	28.4	5.3	0.1	2.5	0.0	0.3	21.6	0.7	12.5	0.9	7.3	7.7	1.8	0.5	7.8	5.4	7.8	11.8	1.7	1.3	3.9	9.3	5.4	2.3	5.1	1.9	2.3	1.6	0.5	1.7	2.2	0.5	1.6	2.5	1.5	2.5	22.0	4.0	2.8	2.6	5.0	4.1	3.1	3.5	7.1	5.2	3.6	3.4	45.9	4.7	1.1	78.3	5.0	6.2	4.2	4.0	11.6	4.0	2.7	6.2	5.4	3.8	3.9	4.4	5.7	7.7	11.2	3.2	6.7	27.7	7.7	2.7	4.1	0.8	8.6	5.2	14.3	29.1	1.3	5.7	3.6	0.0	2.1	9.7	29.2	42.3	23.5	1.9	10.2	53.9	11.5	7.9	45.6	5.0	26.0	4.1	6.6	5.0	9.2	82.7	1.3	13.4	4.2	2.5	6.2	3.3	22.4	22.9	0.0	6.8	7.4	2.9	4.4	6.9	3.6	24.4	9.6	31.8	10.3	32.6	52.5	1.1	16.7	3.8	10.7	1.3	14.5	1.5	4.2	4.2	0.0	3.9	5.7	0.1	1.8	4.8	4.3	0.8	13.3	1.4	30.6	2.8
MAP3K20	"MLK7, MLTK, MLTKalpha, MLTKbeta, MRK, ZAK"	ENSG00000091436	"Mitogen-activated protein kinase kinase kinase 20"	Q9NYL2	2	173075435-173268015	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 261.9;tongue: 279.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 57.5;Alveolar cells type 2: 57.7;Cytotrophoblasts: 52.6;Endometrial stromal cells: 96.7;Granulosa cells: 100.7;Smooth muscle cells: 83.2;Theca cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 15.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 15.5;monocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 176.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017205	Approved		Supported	Cytosol		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA017205: AB_1858933"	"unprognostic (2.90e-2)"	"unprognostic (9.99e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.83e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.41e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.19e-2)"	71.0	11.4	9.5	20.5	9.7	4.7	21.4	10.3	8.5	44.9	15.7	65.8	13.0	76.4	18.6	50.0	48.0	31.4	195.7	9.3	12.1	7.5	25.2	22.5	9.8	13.8	14.7	69.5	11.7	49.3	3.8	27.6	11.2	44.0	20.9	2.5	12.4	57.1	261.9	14.1	19.2	75.0	11.1	12.5	31.5	10.6	12.5	11.5	16.4	279.7	10.2	56.1	21.2	9.4	34.6	28.6	22.0	29.1	62.7	92.5	13.8	121.9	94.7	55.9	59.6	19.5	22.2	26.5	31.2	122.5	48.8	22.9	33.1	64.6	124.2	52.0	22.0	43.3	30.5	4.1	24.8	39.3	43.8	74.7	27.2	105.2	164.2	46.3	37.5	28.5	19.8	4.9	36.8	14.8	24.8	19.0	12.2	28.9	16.0	36.2	45.0	0.1	13.6	19.6	12.9	12.4	47.0	11.3	19.7	35.6	12.9	20.9	37.9	176.3	71.4	53.1	27.9	0.1	0.1	5.5	126.2	10.6	18.9	0.2	9.4	0.0	1.0	8.3	1.0	1.6	0.8	1.7	15.5	2.5	0.0	0.8	2.6	0.5	8.2	0.3	0.8	3.4	9.5	9.7	10.3	8.5	9.3	12.1	13.8	14.7	11.2	11.1	12.5	9.4	57.5	38.5	57.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	20.0	44.4	0.0	0.0	7.4	11.0	0.0	52.6	2.3	0.0	1.9	43.9	0.0	36.7	96.7	14.1	0.0	0.0	0.0	27.6	21.9	36.5	0.0	35.6	5.1	100.7	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	15.5	0.0	0.0	0.0	0.0	38.6	0.0	0.0	1.4	0.0	0.0	1.9	13.1	0.0	0.0	0.0	83.2	0.0	0.0	0.0	0.0	21.6	3.6	70.5	0.0	0.0
MAP3K7CL	"C21orf7, TAK1L, TAKL, TAKL-1, TAKL-2, TAKL-4"	ENSG00000156265	"MAP3K7 C-terminal like"	P57077	21	29077471-29175889	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.2;tongue: 45.6"	"Cell type enhanced"	"Detected in many"		"Macrophages: 77.2;monocytes: 24.7;Smooth muscle cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 53.1"	"Group enriched"	"Detected in all"	8	"B-cells: 22.8;granulocytes: 53.1;monocytes: 14.1"	"Cell line enriched"	"Detected in many"	4	"RH-30: 231.7"					"Not detected"	"Not detected"			"HPA030079, HPA042439"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA030079: AB_2673299, HPA042439: AB_10794422"	"unprognostic (2.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.00e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.39e-3)"	"prognostic unfavorable (8.31e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.10e-2)"	5.4	7.1	6.5	8.3	4.2	4.3	3.8	2.7	6.0	4.4	1.8	3.5	2.3	6.0	4.9	3.6	4.8	5.5	29.2	4.5	5.1	6.4	5.4	10.5	9.5	6.8	5.2	5.1	7.9	3.0	3.8	2.8	5.0	7.1	3.7	2.5	2.5	3.3	41.2	4.9	4.9	5.7	4.0	6.2	3.5	5.3	4.0	3.8	3.2	45.6	9.1	5.1	3.1	6.0	3.3	1.0	0.4	1.3	0.6	18.9	0.7	5.1	11.6	10.6	29.4	5.5	1.4	22.5	1.6	19.7	0.4	0.0	0.4	15.5	51.8	6.1	0.2	3.0	3.1	0.4	2.8	0.0	0.2	6.5	26.8	37.6	38.5	5.4	2.2	0.9	3.1	12.0	55.9	0.7	0.8	0.2	1.6	2.5	1.3	0.1	231.7	0.4	1.4	0.9	1.7	0.9	0.0	0.0	1.6	4.3	0.3	1.6	2.3	23.5	18.8	5.5	0.8	5.6	1.8	1.2	4.1	2.2	5.3	53.1	14.1	3.4	1.7	11.3	3.9	18.0	1.2	1.7	2.0	22.8	1.8	3.1	21.1	2.1	5.3	2.2	3.1	95.7	6.5	4.2	2.7	6.0	4.5	5.1	6.8	5.2	5.0	4.0	4.0	6.0	4.0	0.0	3.0	5.9	9.4	8.5	7.5	5.8	2.8	2.5	1.7	1.1	1.5	2.8	1.2	0.0	2.1	0.4	3.3	0.7	0.0	1.4	1.2	2.0	2.3	4.9	4.8	0.8	4.0	1.5	0.5	3.7	0.5	1.8	1.3	1.7	1.4	4.5	3.3	0.0	6.2	2.9	0.0	16.5	5.8	1.3	0.6	77.2	5.4	16.9	24.7	1.4	19.6	14.1	3.6	4.0	3.1	4.5	1.0	3.1	4.8	3.9	2.0	1.7	19.7	19.2	47.7	1.2	1.7	3.1	9.5	0.4	4.9	3.4	1.8	2.9
MAST2	"KIAA0807, MAST205"	ENSG00000086015	"Microtubule associated serine/threonine kinase 2"	Q6P0Q8	1	45786987-46036122	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 170.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 66.9;Inhibitory neurons: 86.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039722, HPA040155"	Approved		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA039722: AB_10795294, HPA040155: AB_10793957"	"unprognostic (7.80e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (4.31e-8)"	"unprognostic (8.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (6.85e-13)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.90e-1)"	18.3	11.8	16.2	11.0	15.5	8.0	18.7	15.4	17.5	57.4	7.3	39.1	21.9	43.5	12.8	14.7	31.2	19.0	65.3	15.2	19.4	12.2	18.9	17.8	8.9	19.7	27.7	51.9	9.2	13.9	27.0	8.6	26.4	40.0	25.3	24.0	18.4	15.4	170.6	14.6	30.7	26.3	14.6	7.2	24.0	56.3	18.3	5.8	13.2	73.1	11.1	46.9	28.8	15.7	31.7	25.1	24.7	19.2	30.7	41.4	27.6	32.2	22.8	29.4	32.6	29.4	10.1	48.8	15.2	38.6	59.9	15.7	30.1	18.8	30.4	23.7	16.4	22.2	29.2	27.4	28.4	12.0	27.3	34.1	23.7	49.8	37.0	35.2	27.5	12.5	17.3	14.6	34.2	21.9	17.7	12.5	20.4	21.2	28.2	25.6	40.7	9.4	16.1	16.8	34.0	20.6	38.0	50.4	16.3	26.9	22.8	11.9	27.9	55.7	36.8	30.1	33.0	19.5	18.9	17.5	38.0	16.0	24.2	0.0	0.3	0.4	0.3	0.2	0.4	0.0	0.2	0.4	0.6	0.1	0.1	0.2	0.0	0.5	1.5	0.0	0.0	0.2	16.2	15.5	15.4	17.5	15.2	19.4	19.7	27.7	26.4	14.6	18.3	15.7	5.5	0.0	2.0	32.0	2.3	4.2	4.1	3.0	8.0	15.8	8.2	6.7	46.5	4.3	5.5	3.7	54.2	6.1	2.4	66.9	1.9	4.6	38.0	4.4	17.0	7.3	12.1	6.5	45.4	6.3	4.8	12.0	12.8	7.8	0.0	13.0	3.6	6.6	6.2	5.0	86.6	24.6	0.0	2.8	7.8	57.7	9.0	5.3	7.2	30.9	2.5	3.7	7.2	52.3	52.5	8.3	33.9	10.1	5.5	10.7	50.2	5.7	3.1	12.8	6.6	11.7	9.0	28.0	13.2	6.3	2.7	5.5	3.5	12.4	22.4	7.4
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Muscle protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	38	"heart muscle: 13154.5;skeletal muscle: 40709.4;tongue: 29085.2"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 5182.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.3"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 175.6"	"Low region specificity"	"Detected in many"							"CAB000060, HPA003123"	Enhanced					NA	NA	13500000	140000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	8.1	4.6	1.2	1.5	1.2	0.3	43.4	1.2	2.2	2.9	0.9	14.6	1.8	2.3	0.3	736.1	18.7	4.1	13154.5	1.0	1.9	2.8	5.8	14.9	5.3	1.4	1.4	5.3	26.9	16.1	10.6	3.1	1.2	214.2	12.9	0.2	367.1	0.5	40709.4	23.0	11.1	1.4	1.2	2.1	3.8	4.5	1.5	0.8	8.5	29085.2	1.8	1.3	4.5	1.0	1.9	7.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	4.6	0.7	0.1	0.3	1.0	0.8	0.2	0.0	0.0	5.4	0.3	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.5	0.5	0.0	19.2	0.1	0.6	0.0	1.9	2.3	0.9	0.5	8.0	0.0	6.4	1.5	0.2	19.0	175.6	0.0	0.3	39.4	0.1	0.4	0.5	1.2	2.2	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.2	1.2	1.2	2.2	1.0	1.9	1.4	1.4	1.2	1.2	1.5	1.0	0.3	0.0	0.0	0.3	0.1	0.3	4.3	12.5	0.0	0.0	30.7	23.9	5182.1	0.0	30.8	0.0	0.0	0.1	0.5	3.8	0.0	4.7	20.1	20.2	0.1	40.7	11.5	0.0	0.0	0.2	0.0	145.2	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.0	0.1	114.6	14.2	0.0	0.4	70.0	0.0	2.1	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.7	0.0	21.8	2.6	0.1	19.9	0.0	0.0	420.9	42.0	0.3	0.7	0.6	0.1	0.3	2.8	0.1	2.9	15.1
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235133-46286297	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: AB_2674152"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	16.8	12.0	10.0	20.3	11.5	19.7	13.6	8.9	10.7	14.7	17.0	15.1	14.0	16.5	8.3	14.3	15.2	14.2	15.1	8.5	7.8	13.0	9.7	16.0	21.0	10.8	10.4	17.6	15.4	16.9	9.2	16.3	9.5	14.2	15.0	12.8	13.7	13.4	41.3	13.8	16.1	17.1	9.4	19.6	15.4	14.1	11.0	21.7	16.0	28.7	21.5	13.6	11.2	14.6	38.0	36.3	41.8	45.5	33.1	41.4	38.0	40.8	48.1	37.1	30.2	33.1	21.9	53.6	32.9	43.2	40.3	21.9	55.9	34.0	32.7	55.7	50.8	87.9	35.0	25.9	29.6	40.6	47.7	31.7	28.7	51.2	35.2	25.4	40.7	31.7	107.3	39.6	43.3	21.1	43.5	26.8	72.3	40.0	30.2	56.3	26.6	48.9	17.8	34.1	35.2	37.6	52.4	33.7	39.0	31.5	46.0	41.2	51.6	39.1	29.7	33.1	31.0	71.8	86.2	33.0	35.3	38.0	51.8	0.6	2.0	1.6	2.3	1.9	2.4	1.1	1.3	2.6	1.9	1.6	1.2	1.3	1.2	1.1	1.1	1.6	1.8	2.1	10.0	11.5	8.9	10.7	8.5	7.8	10.8	10.4	9.5	9.4	11.0	14.6	17.3	9.6	18.9	28.1	21.3	7.0	7.1	9.0	22.2	21.8	13.8	13.0	4.7	14.3	12.7	11.0	20.9	11.4	20.6	17.5	1.9	11.3	3.5	16.8	23.7	14.8	12.0	18.5	28.0	14.2	11.7	12.8	27.0	17.7	8.8	20.1	11.7	18.6	15.4	16.8	34.2	19.2	10.2	19.7	8.4	4.3	18.3	18.6	10.6	34.7	24.3	9.3	16.5	37.2	35.3	15.9	8.6	14.3	21.6	14.0	13.8	6.6	15.5	21.7	19.7	17.9	12.9	19.7	15.0	21.2	10.4	9.3	19.1	16.0	17.9	7.9
MCU	"C10orf42, CCDC109A, FLJ46135"	ENSG00000156026	"Mitochondrial calcium uniporter"	Q8NE86	10	72692131-72887694	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 53.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 68.3;Inhibitory neurons: 65.6;Oligodendrocyte precursor cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016480	Approved		Supported	Mitochondria		No	No		17000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA016480: AB_2071893"	"unprognostic (2.42e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.05e-1)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (1.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.48e-2)"	6.1	3.8	2.8	7.4	2.5	19.9	5.7	10.4	3.6	8.3	6.4	28.7	27.8	8.9	3.0	14.2	10.8	12.7	7.8	3.9	2.8	10.6	7.0	10.2	4.9	3.4	3.2	4.9	5.5	10.0	1.9	12.8	3.2	5.8	30.8	2.3	6.7	5.7	41.8	6.8	24.5	13.5	3.0	5.0	43.2	4.3	3.3	5.7	6.4	53.7	7.7	14.9	5.1	2.8	41.7	66.1	16.8	12.2	25.0	28.0	17.1	25.0	35.5	24.5	26.0	39.6	38.6	17.7	19.6	30.8	13.3	36.9	22.2	29.8	32.5	19.5	20.8	22.1	23.5	22.1	19.5	56.0	17.9	28.7	24.9	22.0	46.6	38.4	29.8	18.5	14.0	12.9	23.0	24.3	15.2	12.0	18.5	45.2	13.6	15.7	35.8	4.7	32.7	22.4	17.8	7.9	30.8	34.1	7.5	20.2	6.8	14.5	24.3	11.8	19.9	25.7	16.9	9.4	12.8	12.1	15.8	27.5	9.2	1.8	6.7	18.6	3.0	7.3	3.1	3.5	2.9	3.6	5.8	1.7	2.3	2.6	8.8	2.2	8.9	2.0	5.2	4.2	2.8	2.5	10.4	3.6	3.9	2.8	3.4	3.2	3.2	3.0	3.3	2.8	13.7	35.3	17.0	21.2	4.2	11.7	14.4	8.9	10.8	3.0	5.9	3.9	6.6	8.6	22.0	18.4	2.1	7.3	4.8	38.2	1.9	11.1	14.5	23.3	9.9	9.7	8.4	10.8	58.2	25.2	10.1	7.2	68.3	26.4	8.2	3.4	8.9	5.8	6.7	0.0	65.6	28.2	12.2	6.0	2.9	7.2	5.3	6.7	8.8	37.5	5.7	5.4	2.1	72.4	40.3	40.7	15.6	4.1	5.7	9.7	19.8	8.6	22.6	3.9	13.1	6.8	12.1	5.1	5.2	6.2	12.4	9.3	5.0	12.7	24.5	26.8
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 697.1;tongue: 601.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		14000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	76.9	163.4	68.0	51.4	73.6	71.9	73.9	62.1	83.9	67.4	81.3	118.7	112.7	69.2	34.7	144.9	66.8	38.0	367.5	73.5	69.9	121.7	215.5	60.7	62.4	66.7	61.4	64.1	118.3	90.5	70.7	45.2	67.0	67.3	80.3	40.2	98.8	56.8	697.1	119.5	94.4	60.0	56.3	75.6	103.2	60.2	64.1	60.4	62.3	601.9	66.2	85.6	82.4	66.6	176.5	278.4	99.2	250.7	110.3	121.2	172.0	113.9	145.8	159.4	143.2	246.2	204.7	261.3	51.1	151.1	172.6	174.4	256.3	170.0	112.7	192.1	368.3	144.6	138.7	229.9	135.2	229.3	144.6	153.7	149.7	155.2	229.3	124.9	150.9	160.5	466.3	149.4	149.7	389.6	206.4	402.1	222.8	306.6	344.3	164.3	121.7	379.9	149.9	225.5	247.4	226.9	114.6	567.5	247.0	124.9	323.4	260.0	117.7	160.0	151.6	175.5	232.7	166.5	148.1	290.8	138.6	289.1	249.1	95.4	129.9	63.3	102.4	148.8	107.1	122.2	113.7	111.2	176.0	110.2	109.0	102.6	34.0	107.4	164.2	157.2	156.6	175.8	68.0	73.6	62.1	83.9	73.5	69.9	66.7	61.4	67.0	56.3	64.1	66.6	98.8	51.3	65.9	7.8	110.2	135.9	190.8	437.9	118.4	68.0	151.8	165.5	486.2	135.8	217.3	115.8	18.8	328.1	104.9	242.3	448.0	269.8	263.7	108.0	97.9	96.8	169.7	97.2	13.0	333.1	334.0	112.6	111.1	104.8	54.5	150.9	88.5	246.6	248.1	72.3	15.0	280.6	288.9	132.6	113.5	161.5	99.4	117.6	181.5	9.4	171.4	85.7	126.7	8.0	12.8	255.0	252.1	99.3	149.8	197.3	433.3	466.3	139.0	67.3	85.5	114.7	150.9	157.8	65.3	256.6	166.1	294.8	105.4	233.4	372.7	234.7
MED14	"CRSP150, CRSP2, CSRP, CXorf4, EXLM1, RGR1, TRAP170"	ENSG00000180182	"Mediator complex subunit 14"	O60244	X	40648305-40735858	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064182			Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA064182: AB_2685204"	"unprognostic (5.21e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.95e-3)"	"unprognostic (4.38e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.64e-1)"	10.8	10.2	11.7	12.5	13.4	22.4	9.8	13.3	15.9	11.8	15.2	14.3	17.9	11.2	20.4	13.9	9.7	9.6	14.5	11.7	13.2	11.3	15.1	11.0	17.3	13.0	12.1	13.1	12.0	18.7	10.7	13.2	13.5	11.0	14.7	19.2	9.6	9.4	60.7	16.5	13.9	10.1	10.8	11.1	12.4	5.1	14.3	24.9	14.6	33.4	18.6	14.2	12.6	16.0	44.3	21.4	33.8	30.0	14.7	19.0	6.9	17.1	21.3	24.1	30.6	19.8	21.4	25.4	11.4	21.8	51.7	32.7	57.8	27.1	35.9	23.3	43.5	25.7	25.8	18.1	15.8	27.2	25.4	13.7	16.3	35.3	30.5	28.5	29.5	16.6	17.7	24.1	25.5	22.8	25.1	24.2	37.5	27.9	24.7	12.6	36.1	25.6	23.3	20.2	21.6	19.2	40.6	18.3	19.2	62.7	26.8	16.1	26.9	24.5	25.6	31.1	21.2	22.4	24.6	25.2	23.7	18.4	18.1	1.9	1.5	2.8	1.9	3.2	2.2	1.6	1.8	1.8	2.5	1.5	2.0	1.6	0.8	3.5	1.8	1.3	1.8	1.2	11.7	13.4	13.3	15.9	11.7	13.2	13.0	12.1	13.5	10.8	14.3	16.0	12.6	16.0	12.0	36.9	17.5	23.7	11.7	8.4	11.4	16.5	13.9	9.8	14.1	11.5	12.1	12.9	18.8	6.3	22.2	24.0	5.9	8.4	0.8	16.9	14.8	12.9	20.4	8.4	30.9	10.0	5.4	11.3	29.6	21.6	10.8	21.5	8.2	20.9	9.3	18.5	35.6	19.0	8.2	15.6	17.4	1.0	8.7	17.3	12.4	27.2	16.0	6.3	12.3	41.7	63.5	13.9	15.0	8.6	23.8	17.6	19.1	9.2	6.8	16.3	26.3	12.7	14.2	20.5	7.7	18.7	30.3	6.6	16.7	12.5	17.2	27.3
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 555.4;tongue: 246.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 471.5;Excitatory neurons: 735.7;Inhibitory neurons: 759.5;Microglial cells: 730.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 29.7;basal ganglia: 58.6;cerebral cortex: 75.3;hippocampal formation: 55.7"	"Group enriched"	"Detected in many"	4	"classical monocyte: 72.0;intermediate monocyte: 82.6;memory B-cell: 141.6;myeloid DC: 95.2;naive B-cell: 187.9;non-classical monocyte: 71.5;plasmacytoid DC: 100.3"	"Group enriched"	"Detected in many"	5	"B-cells: 187.9;dendritic cells: 100.3;monocytes: 82.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 103.6;HEL: 229.3;Karpas-707: 121.6;REH: 261.8;WM-115: 145.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 70.0;cerebral cortex: 253.1;hippocampal formation: 220.0;olfactory bulb: 66.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	28.9	26.8	29.7	39.2	58.6	11.1	17.5	0.0	75.3	18.8	0.0	15.9	6.9	25.9	7.3	13.6	17.3	28.5	35.2	55.7	0.0	10.4	10.5	21.3	62.9	0.0	0.0	34.9	5.6	9.3	6.3	45.5	0.0	20.0	15.4	34.2	9.0	17.7	555.4	4.9	11.2	31.5	0.0	43.8	12.7	9.4	0.0	12.8	21.7	246.8	77.7	21.3	7.6	11.0	1.6	0.0	7.1	0.0	7.7	4.6	0.2	2.2	4.5	0.3	1.0	0.2	1.0	103.6	0.6	12.0	2.5	3.1	9.6	9.1	0.2	31.7	12.5	229.3	12.3	0.0	2.8	10.4	0.6	21.6	0.0	0.3	0.0	1.4	35.1	0.0	12.3	121.6	9.0	0.0	0.3	0.1	2.2	0.1	8.4	261.8	63.1	50.5	0.0	1.2	0.0	8.3	0.0	0.7	29.5	3.9	0.3	58.0	40.4	5.6	1.0	0.6	5.4	92.0	11.5	62.0	1.5	70.1	145.2	0.6	72.0	0.2	0.2	82.6	0.1	141.6	0.2	0.1	95.2	187.9	0.2	0.2	24.3	16.7	71.5	100.3	0.5	34.4	29.7	58.6	0.0	75.3	55.7	0.0	0.0	0.0	0.0	0.0	0.0	11.0	367.4	32.1	52.0	117.5	471.5	10.7	4.2	0.0	7.4	22.6	5.2	26.5	86.4	10.0	21.7	1.8	214.8	0.8	138.6	9.2	27.4	0.8	11.0	0.8	13.4	197.5	1.2	59.1	735.7	12.7	1.2	26.8	2.0	1.0	5.1	107.5	283.4	3.4	171.1	5.0	759.5	1.5	0.0	205.8	127.5	8.6	29.8	205.1	67.6	730.7	202.7	61.8	8.2	119.6	18.7	0.4	3.0	71.8	314.7	2.1	0.2	0.8	3.7	202.9	335.2	72.7	257.6	4.0	29.5	2.5	8.4	1.6	12.2	58.6	6.3	2.3
MID2	"FXY2, MRX101, RNF60, TRIM1"	ENSG00000080561	"Midline 2"	Q9UJV3	X	107825755-107931637	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 14.5;Inhibitory neurons: 21.5;Urothelial cells: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	6	"T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 41.5;Karpas-707: 35.5;MCF7: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (8.28e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.69e-4)"	"unprognostic (6.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-1)"	"unprognostic (5.97e-3)"	11.2	9.2	5.2	3.9	6.1	0.4	7.2	4.4	4.2	8.3	4.2	6.0	1.8	9.4	8.0	13.6	8.8	7.7	3.1	3.5	12.1	6.0	5.4	6.4	4.4	7.4	7.1	9.3	9.6	12.9	3.2	4.4	9.1	10.3	3.6	14.8	11.1	9.6	12.9	9.6	2.6	15.8	6.3	3.8	4.4	2.1	9.0	2.3	13.2	18.5	5.2	10.6	7.5	4.8	8.4	7.1	0.2	11.2	8.8	12.3	0.1	5.9	15.0	5.0	3.6	0.6	1.5	0.0	7.5	11.7	8.3	5.2	4.1	12.1	1.1	0.0	5.5	0.0	4.2	0.0	13.5	0.0	0.0	8.0	13.3	0.1	14.5	9.1	41.5	0.5	0.0	35.5	5.6	26.8	0.1	0.0	1.2	0.3	13.0	0.0	3.2	0.0	6.3	7.5	0.6	0.0	12.6	0.5	18.6	3.9	4.6	0.5	8.2	0.0	2.1	9.9	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.8	1.4	0.0	0.2	1.6	1.1	0.0	0.0	0.0	0.0	0.1	0.4	5.2	6.1	4.4	4.2	3.5	12.1	7.4	7.1	9.1	6.3	9.0	4.8	3.1	3.2	0.0	8.1	0.4	3.1	3.3	0.9	4.0	1.9	2.3	1.8	0.6	1.5	1.1	0.0	0.0	0.0	0.3	0.3	1.9	1.8	1.1	1.0	1.7	2.6	0.0	0.0	14.5	1.5	0.0	1.5	1.1	1.5	0.0	0.3	2.2	1.8	0.1	0.0	21.5	0.2	0.0	0.0	0.0	1.4	0.0	0.2	3.6	7.5	0.0	0.8	0.0	8.0	7.4	1.1	0.0	0.7	1.1	4.2	0.5	0.8	2.3	3.9	0.0	1.9	2.1	0.2	0.4	3.9	3.7	0.0	1.7	0.8	0.4	11.4
MIOS	"FLJ20323, MIO, Sea4, Yulink"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566875-7608932	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA042928: AB_10795610, HPA052223: AB_2681768"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"	10.0	9.5	7.0	15.2	6.6	18.8	14.5	12.1	8.7	12.3	26.8	11.3	8.8	9.9	10.4	22.9	10.8	9.9	11.9	5.7	9.3	12.6	17.3	11.7	22.4	6.7	7.4	13.3	17.3	28.1	8.9	11.6	6.1	21.7	13.0	18.8	13.5	11.2	85.5	18.1	9.3	12.2	6.7	15.3	13.4	19.2	7.2	16.2	9.3	51.1	29.9	13.9	14.3	8.2	42.4	18.8	21.8	26.4	17.1	35.9	18.3	32.9	26.8	20.6	20.6	23.2	16.5	37.1	9.9	19.7	55.3	37.6	23.1	24.2	27.0	14.8	19.5	9.5	22.5	16.1	24.3	40.1	10.2	30.9	29.0	18.3	46.2	20.1	18.2	12.4	47.2	29.4	88.0	29.1	9.2	17.0	45.3	21.3	19.8	27.4	33.4	36.3	19.0	21.3	23.0	37.2	17.7	49.1	19.3	40.5	26.7	35.1	15.7	31.3	33.2	17.4	27.7	25.9	30.9	33.2	27.6	23.0	37.2	0.0	5.4	8.8	4.3	9.9	3.6	10.1	4.6	4.2	7.6	8.8	6.0	4.9	0.6	5.4	5.0	4.5	5.1	4.0	7.0	6.6	12.1	8.7	5.7	9.3	6.7	7.4	6.1	6.7	7.2	8.2	8.2	9.6	11.9	18.6	30.3	12.1	14.8	6.6	15.4	8.2	13.2	10.8	18.2	12.8	9.2	7.3	12.5	16.8	12.2	9.0	17.6	11.7	38.5	22.7	11.4	7.5	4.2	15.6	22.9	17.5	8.7	9.3	16.3	18.6	9.5	15.4	6.8	17.0	15.5	11.8	21.0	7.2	4.1	22.7	12.2	57.9	5.9	18.4	7.2	27.2	10.1	9.4	13.4	23.1	18.2	14.1	11.3	7.5	19.4	24.9	6.7	11.3	11.0	17.0	13.1	13.1	9.3	36.0	30.4	24.8	18.9	21.2	15.3	15.3	11.1	19.7
MITF	"bHLHe32, MI, WS2, WS2A"	ENSG00000187098	"Melanocyte inducing transcription factor"	O75030	3	69739464-69968336	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Albinism, Cancer-related genes, Deafness, Disease variant, Microphthalmia, Osteopetrosis, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 133.5;Melanocytes: 585.2;Oligodendrocyte precursor cells: 166.9;Oligodendrocytes: 240.3"	"Cancer enriched"	"Detected in all"	4	"melanoma: 39.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 5.2;classical monocyte: 9.4;intermediate monocyte: 3.3;myeloid DC: 6.1;non-classical monocyte: 5.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 6.1;granulocytes: 5.2;monocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 89.1;SK-MEL-30: 254.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002578, HPA003259"	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB002578: AB_564111, HPA003259: AB_1079381"	"unprognostic (3.29e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.94e-1)"	"prognostic favorable (8.35e-10)"	"unprognostic (6.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.73e-1)"	13.8	4.4	5.1	3.8	9.2	1.7	10.0	9.4	6.3	51.3	21.2	18.8	2.8	46.2	4.5	8.9	10.3	16.8	31.1	5.2	9.3	20.0	2.2	9.7	3.4	12.5	9.5	18.7	4.2	16.8	3.8	3.3	10.4	8.4	4.5	1.2	5.1	14.1	50.6	11.0	5.8	46.0	7.0	2.0	9.4	2.3	10.3	2.2	7.6	43.3	1.5	10.6	16.6	13.8	17.2	12.2	1.3	5.1	18.8	0.3	2.0	16.9	9.9	7.8	4.8	6.1	0.8	0.0	4.0	0.3	21.6	8.6	3.7	9.4	8.6	0.0	2.5	37.1	24.5	0.3	4.5	0.8	89.1	15.3	3.9	2.2	8.6	29.1	2.4	0.0	12.3	5.2	5.4	1.2	0.7	1.0	0.7	0.7	8.3	0.1	1.9	7.7	45.2	9.0	0.4	1.9	8.8	3.1	254.1	2.0	0.7	2.3	0.1	3.8	13.3	5.1	3.5	0.6	1.0	0.1	7.7	2.6	9.2	5.2	9.4	0.0	0.0	3.3	0.0	0.0	0.0	0.1	6.1	0.0	0.0	0.0	0.7	1.1	5.9	0.5	0.0	3.1	5.1	9.2	9.4	6.3	5.2	9.3	12.5	9.5	10.4	7.0	10.3	13.8	4.6	28.9	6.8	34.3	0.2	42.8	3.6	16.7	7.4	1.6	1.8	1.8	109.5	11.5	18.2	14.7	0.0	1.3	0.6	0.4	50.9	14.7	1.6	24.5	94.3	7.4	1.2	8.6	14.7	8.8	1.0	38.3	9.7	71.2	106.8	10.9	4.6	2.1	45.8	6.7	133.5	0.3	12.2	30.8	30.9	3.4	44.4	24.3	585.2	50.6	10.6	1.4	0.0	166.9	240.3	7.7	0.0	50.4	0.4	5.2	0.2	24.3	12.5	0.2	13.1	17.8	22.6	4.0	6.3	7.2	18.9	1.1	3.8	5.5	0.6	7.1
MRLN	"Linc-RAM, LINC00948, M1, MLN, MUSER1"	ENSG00000227877	Myoregulin	P0DMT0	10	59736692-59756041	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 269.3;tongue: 147.3"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 118.8;Proximal tubular cells: 25.8;Respiratory ciliated cells: 35.7;Rod photoreceptor cells: 37.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Region enriched"	"Detected in some"	4	"cerebellum: 4.5"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"RH-30: 13.3"	"Region enriched"	"Detected in many"	11	"cerebellum: 21.6"											NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 49: Ciliated cells - Cilium organization"					"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.54e-1)"	"unprognostic (3.17e-3)"		"unprognostic (9.77e-2)"		"unprognostic (1.09e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	0.1	0.2	0.4	0.1	0.4	0.3	0.2	4.5	0.7	0.5	0.4	0.2	1.0	0.5	0.8	1.2	5.1	0.7	0.1	0.4	0.2	8.1	0.2	0.7	0.1	0.5	0.3	0.3	2.8	0.0	12.0	0.1	1.0	1.3	0.1	30.6	7.0	0.1	269.3	0.6	1.1	0.1	0.1	0.5	1.0	0.8	0.3	0.3	0.3	147.3	0.1	0.0	0.1	0.6	0.0	0.8	0.4	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.6	1.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.7	0.2	1.8	1.1	0.1	0.0	0.6	1.0	0.0	0.6	0.0	0.1	0.0	0.1	0.1	1.0	0.0	1.1	0.0	1.0	0.2	0.2	0.8	0.5	13.3	0.0	0.0	0.2	0.6	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.3	0.6	0.2	0.5	0.1	0.1	0.4	0.3	0.0	1.7	0.3	0.4	0.6	0.1	0.4	0.5	0.3	0.3	0.2	0.6	0.2	0.5	1.2	0.3	0.3	0.4	0.3	0.0	0.4	0.4	4.5	0.7	0.4	0.2	0.5	0.3	1.0	0.1	0.3	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.1	1.0	0.0	1.8	0.0	2.1	0.0	0.1	1.5	0.0	0.2	5.6	118.8	0.8	0.7	0.0	0.0	1.3	0.2	6.4	0.4	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.5	0.6	0.3	0.0	0.4	0.0	0.1	0.0	25.8	35.7	37.8	0.0	10.1	0.2	2.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0
MSANTD3	"C9orf30, MGC17337"	ENSG00000066697	"Myb/SANT DNA binding domain containing 3"	Q96H12	9	100427143-100451734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062662			Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA062662: AB_2684826"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (6.66e-5)"	"prognostic unfavorable (3.23e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.61e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (3.22e-7)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.16e-2)"	12.3	11.3	8.6	13.7	8.6	13.2	10.0	11.4	15.0	12.1	5.1	14.3	6.8	14.3	8.3	10.0	8.2	14.0	18.9	9.6	9.7	15.5	13.8	15.2	7.4	9.3	10.7	8.8	11.3	11.4	10.1	10.5	9.4	10.8	6.6	8.4	9.8	9.2	22.4	8.1	8.2	14.3	6.5	6.4	11.0	5.9	8.6	9.0	12.9	27.5	8.3	16.3	10.5	13.8	54.0	47.3	30.2	34.2	44.3	50.8	38.7	74.8	72.6	66.6	47.1	28.6	48.5	31.4	37.4	65.6	154.1	60.0	19.8	68.6	73.6	47.6	15.3	14.6	34.8	22.3	46.7	21.8	18.4	22.8	28.6	58.5	108.5	60.9	75.9	25.4	26.0	11.6	92.3	35.2	29.5	14.3	49.4	53.7	74.7	34.4	85.4	9.7	63.3	14.0	39.6	46.2	25.4	22.4	63.9	36.6	10.0	24.6	91.3	93.7	115.7	71.6	116.1	17.0	34.2	14.7	130.7	13.6	72.9	8.0	0.4	2.3	2.6	0.2	3.8	2.6	2.3	3.2	1.0	2.7	2.8	2.4	0.3	3.6	0.1	0.6	2.0	1.7	8.6	8.6	11.4	15.0	9.6	9.7	9.3	10.7	9.4	6.5	8.6	13.8	17.3	16.0	4.2	0.7	4.6	5.9	9.6	9.3	22.2	16.5	7.5	9.1	17.6	8.6	6.7	7.3	2.1	33.3	7.7	1.7	31.3	27.7	1.7	12.5	22.0	16.1	9.6	10.3	4.3	24.5	13.9	16.8	5.6	16.0	3.8	12.9	12.5	10.1	10.6	20.2	4.2	3.7	6.1	2.6	7.7	4.3	7.5	17.8	7.2	1.0	24.5	14.5	7.2	2.5	2.8	49.6	4.6	8.6	5.5	7.6	1.5	9.3	6.3	7.9	6.6	19.1	17.7	2.9	12.8	12.6	4.3	10.8	8.1	7.9	5.7	5.9
MSTN	GDF8	ENSG00000138379	Myostatin	O14793	2	190055700-190062729	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 10.1;tongue: 15.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.7;Cone photoreceptor cells: 4.2;Early spermatids: 17.8;Late spermatids: 4.2;Muller glia cells: 19.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"LHCN-M2: 25.9;RH-30: 52.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB009963	Approved				"Secreted in other tissues"	NA	NA		7600000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"CAB009963: AB_2148798"	"unprognostic (8.45e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.86e-4)"	"unprognostic (7.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-3)"	"unprognostic (7.72e-3)"	"unprognostic (1.12e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.67e-4)"	0.4	0.9	0.6	0.0	0.6	0.0	0.3	0.7	0.9	1.2	0.1	0.6	0.2	0.8	0.5	1.1	0.3	0.1	0.3	0.7	0.5	0.5	0.1	0.2	0.0	0.6	0.6	0.4	0.2	0.0	0.6	0.0	0.6	0.4	0.4	3.1	0.4	0.1	10.1	0.5	0.2	0.3	0.4	0.2	0.2	0.3	0.5	0.0	0.4	15.3	0.0	0.2	0.5	0.5	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.9	0.7	0.5	0.6	0.6	0.6	0.4	0.5	0.5	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.1	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	17.8	0.1	0.1	0.1	0.0	0.0	1.4	0.2	0.0	1.4	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	0.0	0.0	19.1	0.0	0.5	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.7	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MTERF4	"MGC61716, MTERFD2"	ENSG00000122085	"Mitochondrial transcription termination factor 4"	Q7Z6M4	2	241072169-241102332	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027097	Uncertain		Supported	Mitochondria,Cytosol		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA027097: AB_10603879"	"unprognostic (4.58e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"prognostic favorable (3.48e-4)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-1)"	15.4	15.7	8.7	22.7	10.6	23.8	21.8	17.5	14.5	21.8	6.7	18.2	16.1	25.3	16.1	19.4	19.0	14.2	17.3	9.1	10.3	15.7	20.4	17.0	38.8	9.1	8.3	27.9	17.5	16.2	15.3	14.2	9.6	33.8	19.9	29.4	19.8	18.1	54.4	17.6	22.0	20.1	6.4	22.0	18.3	10.2	9.1	25.1	34.7	41.8	30.8	14.8	16.0	12.7	17.2	14.9	29.7	16.4	38.2	17.5	22.1	27.4	31.5	25.8	36.0	10.5	23.2	24.7	10.0	31.0	30.8	17.6	41.0	38.5	33.8	35.4	28.9	32.2	30.5	46.5	25.5	40.2	23.3	29.0	37.8	30.2	35.6	32.8	30.2	32.4	29.4	10.5	31.9	24.0	28.2	26.4	33.7	35.5	25.8	27.7	33.1	14.1	24.8	31.5	26.2	22.9	20.3	26.8	20.7	19.5	19.6	19.4	39.3	23.4	23.0	27.3	25.7	28.0	7.9	61.2	19.8	24.1	21.4	8.3	10.8	24.9	18.6	10.5	22.7	32.3	29.1	26.8	12.3	31.8	46.0	36.7	3.4	18.1	8.7	9.1	32.5	22.1	8.7	10.6	17.5	14.5	9.1	10.3	9.1	8.3	9.6	6.4	9.1	12.7	20.7	12.8	27.7	40.8	45.6	0.0	20.3	0.0	15.9	0.0	19.8	23.9	19.8	27.1	13.0	20.2	0.0	30.2	34.1	12.1	41.1	24.1	49.2	11.7	19.1	22.4	10.9	22.9	31.2	24.6	28.2	18.6	14.3	12.0	11.4	37.9	20.0	30.6	24.8	0.0	28.8	20.7	0.0	24.5	0.0	61.0	23.3	17.0	0.0	25.3	31.6	0.0	42.2	33.2	39.8	23.7	20.7	26.4	44.8	22.0	43.4	51.4	17.5	0.0	39.5	22.7	18.4	59.0	34.3	23.4	0.0	23.7	37.0	42.9	17.2	17.1
MYF5	bHLHc2	ENSG00000111049	"Myogenic factor 5"	P13349	12	80716912-80719671	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 5.6;tongue: 8.9"	"Cell type enriched"	"Detected in single"	1159	"Skeletal myocytes: 347.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"LHCN-M2: 478.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041691			Supported	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA041691: AB_10796780"						"unprognostic (2.65e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	478.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	347.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MYH3	"HEMHC, MYHC-EMB, MYHSE1, SMHCE"	ENSG00000109063	"Myosin heavy chain 3"	P11055	17	10628526-10657309	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 29.0;seminal vesicle: 18.3;skeletal muscle: 20.6"	"Cell type enriched"	"Detected in many"	7	"Early spermatids: 411.9"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 3.3;prostate cancer: 4.6;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	26	"HSkMC: 59.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA021808	Enhanced					NA	NA		29000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA021808: AB_1854242"	"unprognostic (1.70e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.19e-4)"	"unprognostic (3.35e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.84e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.24e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.17e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.49e-1)"	1.6	0.9	1.8	1.1	1.7	0.8	1.5	1.5	1.9	2.9	1.5	7.9	1.1	3.4	1.2	9.1	2.6	0.5	1.0	1.6	1.6	2.1	3.3	1.2	1.3	1.8	1.8	2.3	2.4	0.3	1.5	0.4	1.7	29.0	1.0	1.8	1.5	18.3	20.6	2.8	2.5	1.7	1.4	2.6	1.7	4.6	1.8	3.0	3.4	6.0	0.6	4.4	3.8	1.8	0.2	1.1	0.8	1.1	1.0	0.3	1.0	0.8	0.4	0.5	0.5	1.0	0.1	0.7	0.3	0.4	0.2	1.1	0.5	0.2	1.0	0.7	0.9	1.0	0.3	1.6	0.3	0.6	1.4	59.6	0.4	0.6	0.8	0.1	0.1	1.3	0.4	0.1	0.2	0.7	1.0	2.3	0.9	0.3	0.6	0.8	0.8	0.3	0.3	0.3	0.0	0.4	0.4	0.0	0.3	0.7	0.3	0.3	0.3	0.1	1.0	0.3	0.1	1.3	1.1	0.3	0.3	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.7	1.5	1.9	1.6	1.6	1.8	1.8	1.7	1.4	1.8	1.8	0.5	0.0	9.8	4.6	0.7	2.9	0.9	0.1	0.6	4.9	0.7	1.8	3.6	1.5	0.7	0.0	6.2	0.4	0.8	0.9	0.0	0.6	411.9	0.5	0.8	1.4	0.0	2.7	3.9	0.6	0.8	1.1	1.1	0.5	7.6	0.8	0.4	0.6	0.1	0.0	3.4	0.5	0.0	0.8	0.3	56.0	2.8	1.2	1.8	1.9	0.2	1.8	0.0	7.5	5.4	0.7	0.2	2.6	0.0	1.5	1.8	0.3	0.3	4.6	0.0	5.5	0.8	10.7	4.2	0.3	1.6	0.5	1.4	0.2	0.8	0.3
MYH7	"CMD1S, CMH1, MPD1"	ENSG00000092054	"Myosin heavy chain 7"	P12883	14	23412740-23435660	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	71	"heart muscle: 7569.2;skeletal muscle: 14554.3;tongue: 5378.8"	"Cell type enriched"	"Detected in some"	127	"Cardiomyocytes: 10295.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 12.2;prostate cancer: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	31	"HSkMC: 11.4"	"Low region specificity"	"Detected in many"							"HPA001239, HPA001349, CAB015384"	Enhanced		Uncertain	"Focal adhesion sites"		NA	NA		43000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"		"CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (6.49e-2)"	"unprognostic (8.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.30e-1)"	"unprognostic (7.33e-3)"		"unprognostic (8.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.28e-2)"	2.0	1.3	1.4	0.0	1.9	0.1	2.5	0.1	1.1	0.3	1.4	1.2	0.5	0.4	0.0	129.2	0.1	1.1	7569.2	1.2	2.9	0.9	1.4	3.2	1.5	0.8	1.6	0.7	7.8	0.0	1.5	0.0	0.9	76.8	0.0	0.0	37.0	0.0	14554.3	4.8	0.9	0.0	0.9	0.5	0.9	1.4	3.2	0.1	1.8	5378.8	0.1	0.2	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.9	0.1	1.1	1.2	2.9	0.8	1.6	0.9	0.9	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10295.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	80.9	0.0	0.0	0.2	3.1	0.0	70.5	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.7	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	52.2	51.2	0.1	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
MYL1		ENSG00000168530	"Myosin light chain 1"	P05976	2	210290150-210315174	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	88	"skeletal muscle: 21805.2;tongue: 15591.3"	"Cell type enriched"	"Detected in some"	246	"Skeletal myocytes: 492.9"	"Group enriched"	"Detected in some"	18	"head and neck cancer: 36.0;prostate cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HSkMC: 51.4"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 4.0"	"Low region specificity"	"Detected in all"			"HPA046859, HPA063034, HPA073827"	Enhanced				"Intracellular and membrane"	NA	NA		21000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"			"HPA046859: AB_2679842, HPA063034: AB_2684927, HPA073827: "						"prognostic unfavorable (6.59e-4)"									"unprognostic (1.88e-1)"			2.3	0.5	0.1	0.0	0.1	0.0	3.3	0.0	0.1	0.1	0.0	1.1	0.0	0.5	0.0	212.7	0.0	0.0	2.0	0.1	0.0	0.7	1.0	0.9	0.0	0.0	0.0	0.6	1.1	0.0	0.4	0.0	0.0	164.2	0.0	0.0	170.2	0.0	21805.2	4.0	0.7	0.0	0.0	0.4	0.7	0.5	0.0	7.4	2.3	15591.3	0.9	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	11.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	492.9	2.0	0.1	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.1
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750922	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 30.1;tongue: 72.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 7.8;Inhibitory neurons: 7.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 8.0;Proximal tubular cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEL: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	1.2	0.5	0.6	0.3	0.6	0.8	1.0	0.6	0.9	0.6	0.7	0.4	0.3	0.6	0.7	1.3	0.5	0.4	1.4	0.7	0.7	3.0	0.5	1.2	0.4	0.4	0.5	0.4	0.9	0.9	1.3	0.6	0.4	0.7	0.3	0.8	2.4	0.6	30.1	1.4	0.6	0.3	0.4	0.6	0.6	0.4	0.6	0.3	0.8	72.1	0.7	0.6	0.8	0.6	0.1	0.1	0.3	0.6	0.5	0.6	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.6	0.9	0.4	0.1	1.0	0.1	0.2	0.3	0.1	0.3	7.2	0.4	0.0	0.2	0.2	0.3	0.8	0.3	0.0	0.6	0.3	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.2	0.0	0.5	0.0	0.0	0.4	0.1	0.5	0.3	0.1	0.1	0.3	0.5	0.2	0.5	0.4	0.2	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.9	0.7	0.7	0.4	0.5	0.4	0.4	0.6	0.6	0.5	3.2	1.1	1.6	0.5	0.1	0.1	0.5	0.6	1.0	0.6	0.3	1.9	1.5	1.0	0.0	0.0	0.3	0.1	0.2	0.0	0.3	0.4	0.1	0.7	0.6	1.2	0.0	7.8	0.2	0.0	0.5	0.0	0.2	0.0	0.6	1.1	0.2	0.3	1.7	7.2	0.0	0.0	0.8	1.2	0.2	0.3	0.4	0.0	4.7	1.1	0.3	0.0	8.0	2.9	0.0	0.0	1.5	0.0	0.2	0.1	4.5	0.3	0.3	0.0	0.8	0.3	0.0	0.3	0.3	0.9	0.3	0.2	0.4	0.3	0.2
MYO18B	BK125H2.1	ENSG00000133454	"Myosin XVIIIB"	Q8IUG5	22	25742144-26031045	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 120.8;skeletal muscle: 262.7;tongue: 55.6"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 95.5;Early spermatids: 61.4;Late spermatids: 37.3;Skeletal myocytes: 32.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.8"	"Region enhanced"	"Detected in single"		"thalamus: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.6;REH: 15.0;RH-30: 30.5;U-2 OS: 13.2;U-266/70: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA000953	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Centrosome"		"HPA000953: AB_1079440"	"unprognostic (3.28e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.93e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.96e-3)"	"unprognostic (3.93e-7)"	"unprognostic (1.14e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.65e-1)"	0.2	0.1	0.3	0.1	0.1	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	120.8	0.1	0.3	0.1	0.0	0.1	0.1	0.3	0.8	0.0	0.1	0.0	0.2	0.0	0.3	1.0	0.0	0.0	2.7	0.0	262.7	0.5	0.0	0.0	0.2	0.0	1.5	10.2	2.3	1.9	0.1	55.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	5.3	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.0	4.0	0.0	0.4	1.6	0.0	0.0	0.0	15.0	30.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.2	0.0	0.0	9.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.1	0.3	0.3	0.8	0.3	0.2	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.2	1.2	0.0	0.0	1.8	0.0	0.0	1.7	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	37.3	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.7	0.9	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1
MYOC	"GLC1A, JOAG1, TIGR"	ENSG00000034971	Myocilin	Q99972	1	171635417-171652688	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 110.8"	"Cell type enriched"	"Detected in some"	6	"Fibroblasts: 244.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA027364	Uncertain				"Secreted to extracellular matrix"	NA	NA		25000000		"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 50: Fibroblasts - ECM organization"			"HPA027364: AB_10602036"	"unprognostic (2.02e-2)"	"unprognostic (4.65e-2)"		"unprognostic (4.44e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.33e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.94e-4)"	"unprognostic (5.35e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.24e-1)"	47.1	1.1	0.0	0.0	0.0	0.0	19.2	0.2	0.0	1.8	0.0	13.0	3.5	16.5	4.9	19.6	15.3	1.5	18.3	0.0	0.1	0.2	0.1	7.4	0.1	0.5	0.1	1.3	3.0	0.1	0.2	0.2	0.2	5.3	3.5	0.0	14.0	6.4	33.8	4.7	4.8	2.9	0.0	0.0	50.2	1.4	0.1	14.1	28.7	110.8	0.2	22.6	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.2	0.0	0.1	0.1	12.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.1	3.1	0.0	0.0	0.1	0.0	0.0	244.4	11.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	1.0	8.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.6	2.4	0.1	0.0	0.0	0.0	0.0	0.0	15.1	6.3	0.1	0.1	1.1	0.0	0.0	1.1	0.2	0.0	0.0
MYOM1		ENSG00000101605	"Myomesin 1"	P52179	18	3066807-3219968	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 412.8;skeletal muscle: 845.6;tongue: 435.6"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 1346.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HAP1: 13.5;HMC-1: 3.5;HSkMC: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014305, HPA049193"	Enhanced					NA	NA		33000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA014305: AB_1854257, HPA049193: AB_2680670"	"unprognostic (2.51e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (8.94e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	15.1	2.2	7.5	1.3	9.0	0.6	4.1	7.8	6.4	3.0	3.4	14.1	1.9	6.4	2.9	14.1	6.8	14.6	412.8	5.7	11.5	1.5	24.7	1.5	1.3	11.1	12.0	2.9	11.5	0.4	1.6	1.6	11.3	12.4	2.4	2.0	5.3	4.5	845.6	1.6	4.6	11.9	8.6	0.9	3.2	5.7	8.0	0.8	2.8	435.6	0.7	7.6	2.4	8.6	0.0	0.1	0.2	0.0	0.7	0.7	0.3	0.4	0.5	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	13.5	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.0	3.5	6.2	0.3	0.2	0.0	0.3	0.0	0.2	0.0	0.4	0.2	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.0	0.6	0.0	0.2	7.5	9.0	7.8	6.4	5.7	11.5	11.1	12.0	11.3	8.6	8.0	8.6	1.2	0.0	0.5	49.0	1.7	1.7	2.3	0.7	0.0	2.1	1.0	0.8	1346.0	27.1	1.2	0.0	2.1	0.9	2.7	7.4	0.0	0.6	11.7	1.1	0.4	12.0	0.0	0.8	3.5	6.3	0.1	27.4	6.6	1.0	0.0	3.4	2.5	19.1	0.3	1.7	7.1	0.7	4.1	1.3	2.1	14.1	2.1	1.3	0.0	7.5	1.5	0.2	2.1	24.6	13.5	1.5	88.9	4.1	0.1	0.8	0.5	0.3	2.1	1.6	6.6	24.6	40.8	4.4	5.4	0.1	1.3	2.2	1.3	1.3	0.6	0.6
MYOT	"LGMD1, LGMD1A, TTID"	ENSG00000120729	Myotilin	Q9UBF9	5	137867858-137887851	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	61	"skeletal muscle: 2183.8;tongue: 2038.6"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 40.9;Skeletal myocytes: 42.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037733, HPA037734"	Enhanced					NA	NA		9100		"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"			"HPA037733: AB_10697082, HPA037734: AB_2675638"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.85e-4)"	"unprognostic (8.03e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.56e-4)"	"unprognostic (1.72e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	0.8	1.7	5.7	1.4	9.3	0.0	0.8	5.8	9.8	3.3	3.9	8.0	2.1	0.4	0.5	34.6	0.7	0.7	17.0	5.4	5.8	0.9	0.4	0.2	0.1	6.2	7.2	0.4	0.4	1.1	0.5	0.0	6.0	20.0	1.6	0.5	19.4	3.7	2183.8	1.0	3.1	1.0	5.3	0.6	1.9	0.2	6.8	0.2	1.0	2038.6	0.3	2.3	3.7	7.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	9.3	5.8	9.8	5.4	5.8	6.2	7.2	6.0	5.3	6.8	7.8	0.0	0.0	0.0	0.3	0.2	0.3	0.6	0.0	1.2	0.0	0.0	0.1	40.9	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	0.0	2.3	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.7	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.9	0.5	3.6	0.0	0.0	0.0	0.0	2.0	8.2	0.0	0.1	0.0	0.1	0.3	0.3	0.2	0.1	0.8	0.0	42.0	1.3	0.2	0.2	0.2	0.0	0.0	0.3	0.1	0.5	0.1
MYOZ3	"CS-3, CS3, FATZ-3, FRP3"	ENSG00000164591	"Myozenin 3"	Q8TDC0	5	150660882-150679368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"skeletal muscle: 234.2;tongue: 198.4"	"Cell type enriched"	"Detected in some"	6	"Peritubular cells: 44.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.3;NTERA-2: 9.2;REH: 14.8;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039166	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 37: Myocytes - Muscle contraction"			"HPA039166: AB_10671871"	"unprognostic (2.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.77e-2)"	"unprognostic (9.19e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.19e-2)"	"unprognostic (7.21e-3)"	"unprognostic (7.31e-9)"	"unprognostic (2.19e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.20e-2)"	0.4	0.5	1.9	0.1	1.5	1.1	0.6	1.3	0.8	1.7	0.1	0.3	0.3	1.5	1.4	5.4	0.8	1.4	5.3	1.4	2.6	0.6	0.1	0.8	0.1	8.0	2.6	0.9	0.2	0.0	1.3	0.1	3.0	4.2	0.2	0.2	3.3	1.0	234.2	0.2	0.7	0.8	5.6	0.2	0.5	3.8	2.7	0.4	0.7	198.4	0.0	0.7	0.5	2.8	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.2	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.5	0.7	0.0	0.0	0.1	0.0	0.7	1.4	9.2	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.6	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	1.5	1.3	0.8	1.4	2.6	8.0	2.6	3.0	5.6	2.7	2.8	3.5	0.0	0.0	1.0	0.1	0.4	0.4	0.5	0.6	1.1	1.7	1.5	2.9	0.0	0.1	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.3	0.5	0.7	2.5	0.0	0.0	0.9	0.2	0.3	1.8	0.0	1.4	0.0	4.3	2.9	0.0	0.2	0.0	3.0	0.3	2.0	0.3	1.1	1.2	3.1	0.7	0.0	1.0	0.1	0.5	1.0	0.0	0.2	0.0	0.1	44.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	7.0	0.8	0.4	1.5	0.0	0.4	0.7	0.5	0.4	0.5	0.1
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 64.1;skeletal muscle: 283.6;tongue: 172.8"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 114.2"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 39.8;fHDF/TERT166: 112.3;HBF TERT88: 25.6;LHCN-M2: 47.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA036299, HPA061494"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Vesicles"	Cytosol	"HPA036299: , HPA061494: AB_2684539"	"unprognostic (4.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"unprognostic (8.62e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.94e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.88e-8)"	"unprognostic (4.63e-5)"	"unprognostic (9.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.47e-1)"	0.1	0.3	0.2	0.2	0.1	0.6	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.1	0.1	2.2	0.0	0.1	64.1	0.8	0.8	0.0	0.0	0.0	0.2	0.6	0.2	0.1	0.6	0.0	0.0	0.1	0.1	1.7	0.1	1.7	2.7	0.0	283.6	0.1	0.1	0.2	0.0	0.1	0.8	0.9	0.0	0.1	0.0	172.8	0.0	0.1	0.0	0.3	2.9	1.3	0.0	0.0	0.7	4.1	0.1	39.8	19.7	14.4	5.4	0.0	0.1	0.1	0.0	112.3	20.5	0.7	0.0	0.2	25.6	0.4	0.0	0.0	14.6	0.0	0.3	0.0	0.1	1.6	0.0	7.9	0.9	3.6	0.4	0.0	0.0	0.2	47.6	8.6	0.0	0.1	0.0	0.0	1.3	0.0	2.2	0.0	0.1	0.1	0.1	0.0	5.7	0.9	0.2	0.1	0.0	0.0	1.1	0.7	0.2	4.1	0.1	0.1	0.0	0.0	4.6	0.1	4.2	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.8	0.8	0.6	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.2	0.0	114.2	0.0	0.0	0.0	25.0	0.0	0.0	1.8	0.0	0.0	1.0	1.5	0.1	0.7	0.0	0.0	0.5	0.2	0.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.4	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.1
NAA25	"C12orf30, FLJ13089"	ENSG00000111300	"N-alpha-acetyltransferase 25, NatB auxiliary subunit"	Q14CX7	12	112026689-112108796	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 146.0;Oligodendrocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039322	Approved		Supported	"Golgi apparatus,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA039322: AB_10697548"	"unprognostic (1.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (9.09e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.18e-2)"	5.5	6.1	4.6	6.0	5.0	9.8	6.8	6.4	8.1	6.8	8.5	6.8	3.9	5.5	4.3	7.6	5.8	3.7	5.6	5.3	5.1	4.6	5.6	4.9	6.6	5.6	4.7	7.0	6.9	5.9	4.3	5.3	7.7	5.4	4.2	14.8	4.9	4.4	14.9	7.5	4.8	5.4	3.6	5.3	4.9	5.1	4.9	6.0	5.7	9.9	6.9	6.4	6.7	8.0	16.7	16.1	14.8	11.9	8.1	14.0	17.9	15.3	12.4	18.3	12.4	16.2	8.6	28.9	14.4	12.3	10.5	19.2	32.8	13.0	25.1	16.6	22.9	23.6	15.9	15.0	13.2	34.0	13.7	12.1	15.9	21.3	21.8	15.5	16.1	12.6	35.3	3.7	16.7	13.5	19.6	24.9	22.1	34.2	18.6	21.5	15.2	19.7	14.0	27.0	19.1	10.5	16.9	19.8	15.0	14.0	19.3	13.4	13.7	15.2	13.6	17.0	21.3	15.0	30.4	33.0	19.4	14.7	15.5	0.0	1.7	0.5	2.4	1.9	3.7	2.5	3.0	2.3	3.5	2.8	4.2	4.1	0.0	1.6	2.5	3.7	2.5	1.6	4.6	5.0	6.4	8.1	5.3	5.1	5.6	4.7	7.7	3.6	4.9	8.0	16.1	9.6	16.2	44.1	23.3	66.7	34.5	17.1	22.8	38.9	18.9	12.4	23.5	12.8	26.5	7.3	146.0	25.6	20.4	10.1	3.9	15.3	26.5	15.1	23.9	17.4	16.2	17.0	71.6	19.4	21.6	17.8	15.8	14.8	20.3	20.7	15.4	19.4	14.0	23.5	68.0	11.9	28.5	15.4	25.2	8.6	17.4	16.5	16.0	30.0	83.8	13.0	12.3	48.2	109.6	17.4	7.5	12.8	15.7	61.5	7.4	4.7	25.0	67.7	6.6	28.7	22.7	31.5	29.5	28.5	70.2	22.6	15.3	20.0	14.7	48.1
NAA35	"bA379P1.1, FLJ21613, FLJ22643, MAK10"	ENSG00000135040	"N-alpha-acetyltransferase 35, NatC auxiliary subunit"	Q5VZE5	9	85941146-86025462	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021547	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA021547: AB_1853505"	"unprognostic (5.87e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-2)"	7.7	12.2	6.9	6.3	7.3	6.6	9.3	9.8	7.0	8.9	8.2	11.1	8.6	9.4	7.8	10.9	8.4	5.7	8.8	6.9	7.2	8.4	8.7	7.1	6.2	6.3	6.0	9.9	10.8	9.4	12.0	7.4	6.2	9.7	10.5	14.3	10.1	6.8	17.4	9.1	8.1	7.0	6.4	6.5	8.8	15.4	8.4	7.3	10.4	13.2	7.2	9.0	9.1	8.9	25.4	15.8	17.7	13.5	9.8	13.1	24.8	15.5	15.1	16.1	13.1	12.4	15.7	8.4	8.5	15.4	13.1	34.9	15.0	18.4	16.8	22.3	13.1	21.6	19.9	14.6	16.6	30.4	17.6	13.1	15.2	17.0	24.6	12.4	14.0	15.6	25.3	15.6	14.9	14.6	15.7	16.0	17.8	28.0	18.2	14.4	26.9	12.6	17.3	20.4	16.7	15.5	17.6	15.8	13.6	17.0	11.9	11.7	14.0	11.2	12.4	16.9	15.0	22.3	29.1	5.7	16.3	12.5	10.2	1.7	2.5	5.1	3.4	2.6	4.3	9.5	3.5	3.1	3.0	9.3	4.6	3.4	1.3	3.5	1.9	2.2	3.1	2.6	6.9	7.3	9.8	7.0	6.9	7.2	6.3	6.0	6.2	6.4	8.4	8.9	14.6	3.2	14.1	58.4	16.8	16.3	20.2	19.0	19.9	25.5	18.0	13.1	23.3	18.6	22.8	11.0	22.9	22.6	14.9	20.2	1.9	19.7	8.7	29.4	18.6	14.3	20.9	14.5	51.8	25.8	18.9	13.6	16.3	22.5	12.0	32.9	9.3	9.8	12.2	21.9	58.7	14.5	30.5	11.0	8.4	5.3	9.3	10.7	14.2	52.5	12.3	18.7	14.4	44.7	68.8	18.3	16.6	11.7	17.1	22.0	12.0	8.9	33.7	36.6	13.1	21.4	24.7	56.7	36.3	17.7	16.6	31.1	15.8	24.4	16.6	19.2
NDUFB10	PDSW	ENSG00000140990	"NADH:ubiquinone oxidoreductase subunit B10"	O96000	16	1959538-1961975	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 774.5;skeletal muscle: 1298.5;tongue: 1013.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1191.7;Late spermatids: 1040.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073189	Supported					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA073189: AB_2686579"	"unprognostic (3.56e-1)"	"prognostic favorable (7.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (9.43e-6)"	"unprognostic (1.24e-1)"	"unprognostic (5.21e-2)"	"unprognostic (4.43e-1)"	"unprognostic (8.76e-2)"	132.0	132.6	143.8	58.1	151.3	72.6	123.2	156.7	173.0	103.8	139.2	215.8	132.1	123.4	90.4	130.8	109.9	48.1	774.5	148.5	150.6	195.7	206.4	91.1	64.6	147.6	144.8	88.4	155.6	175.0	87.5	60.7	149.8	115.2	115.2	64.6	139.9	86.9	1298.5	122.6	144.9	71.7	142.9	106.5	186.4	104.0	147.7	69.0	102.9	1013.2	74.1	135.3	105.4	149.2	103.2	311.7	146.2	170.9	144.9	137.9	144.9	126.2	159.7	149.9	100.9	233.3	139.9	209.5	208.5	165.9	77.4	215.4	161.5	197.8	113.5	192.4	598.3	162.5	242.1	269.6	185.6	266.7	150.8	154.1	180.2	141.3	160.6	161.3	177.7	191.8	153.6	206.6	195.1	457.9	316.6	284.9	183.8	287.6	335.7	367.6	151.3	461.5	222.7	110.8	320.9	203.1	236.6	390.3	172.4	85.9	232.8	181.6	149.7	132.5	124.1	189.3	139.9	326.8	274.0	283.3	95.0	131.6	142.8	280.4	288.9	273.4	210.5	254.0	206.7	257.6	258.5	266.3	309.0	230.0	203.5	213.8	160.5	215.8	225.8	331.2	346.3	355.0	143.8	151.3	156.7	173.0	148.5	150.6	147.6	144.8	149.8	142.9	147.7	149.2	216.7	115.4	84.9	22.2	146.8	170.5	168.9	296.0	186.7	95.6	208.5	307.2	1191.7	261.7	165.1	218.8	18.8	355.8	135.2	589.3	982.2	299.7	341.7	163.5	132.6	174.2	203.8	173.0	10.9	414.9	333.2	181.2	167.7	142.0	111.1	145.8	163.5	417.6	321.7	79.1	13.4	478.8	229.9	200.9	195.2	1040.9	158.1	160.0	277.5	10.3	252.8	236.6	150.4	11.1	22.7	298.8	488.9	156.1	209.0	136.1	918.2	877.6	209.4	112.1	190.7	171.6	260.2	195.4	123.2	240.0	182.7	200.0	150.1	142.8	489.6	192.1
NDUFC1	KFYI	ENSG00000109390	"NADH:ubiquinone oxidoreductase subunit C1"	O43677	4	139266880-139302551	"Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"heart muscle: 83.5;skeletal muscle: 268.3;tongue: 158.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1840.3;Distal tubular cells: 1136.7;Proximal tubular cells: 1449.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044556, HPA062427"	Enhanced		Approved	Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA044556: AB_10794402, HPA062427: "	"unprognostic (6.07e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.76e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (2.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"prognostic favorable (7.25e-4)"	9.5	15.3	19.9	8.0	20.4	9.1	11.0	22.4	28.6	7.4	21.3	18.6	23.8	8.1	14.3	10.5	10.5	5.4	83.5	19.6	20.8	26.7	24.1	8.8	10.1	20.3	21.0	10.0	14.8	22.9	15.8	5.9	21.6	9.7	19.0	23.5	18.9	14.4	268.3	13.2	18.6	7.4	19.5	10.4	17.0	12.7	20.5	8.6	14.8	158.5	11.0	8.6	7.9	22.4	21.4	5.9	19.2	30.8	17.7	22.7	20.5	20.1	13.1	11.1	10.4	13.1	23.7	7.7	7.7	15.5	14.9	10.5	38.6	18.2	15.0	13.0	13.5	11.9	13.5	23.0	18.1	11.2	10.1	24.5	18.2	14.4	21.6	16.8	17.5	17.8	25.3	33.8	11.0	17.8	17.8	32.1	16.3	44.1	11.7	14.9	10.6	52.6	24.6	14.2	14.6	14.7	13.8	23.2	10.5	15.6	23.7	23.2	8.1	24.2	6.4	13.0	13.5	23.2	49.5	18.5	18.9	26.7	13.8	26.2	10.1	13.1	8.5	10.3	11.6	7.1	11.7	11.5	8.9	15.9	10.5	11.4	3.0	10.1	14.2	16.2	18.2	10.8	19.9	20.4	22.4	28.6	19.6	20.8	20.3	21.0	21.6	19.5	20.5	22.4	201.8	89.8	145.7	15.7	95.8	140.2	173.3	402.7	185.0	120.4	240.3	349.6	1840.3	221.6	240.1	439.6	33.3	147.4	71.7	343.0	1136.7	270.3	409.9	333.5	115.5	162.7	221.4	175.2	10.9	336.9	166.2	176.9	158.0	196.8	73.3	151.2	133.5	432.9	225.1	119.5	14.3	340.5	276.7	102.0	65.7	70.9	169.3	115.6	266.8	6.5	185.5	446.6	79.3	8.0	13.3	265.3	355.8	206.5	155.6	173.7	471.7	1449.6	297.1	139.1	98.6	159.3	184.4	439.0	197.4	290.1	179.3	118.1	83.5	224.7	343.7	176.0
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"NEDD4 E3 ubiquitin protein ligase"	P46934	15	55826922-55993660	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.6;tongue: 58.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Alveolar cells type 2: 116.7;granulocytes: 73.2;Oligodendrocyte precursor cells: 69.9;Respiratory ciliated cells: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol		NA	NA		6500	"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	6.2	3.6	1.7	4.0	2.0	6.2	6.9	1.9	2.0	5.4	1.9	5.7	4.1	7.1	2.9	4.3	3.5	5.6	4.5	1.5	2.7	6.7	27.4	5.3	3.1	2.5	1.9	4.0	1.8	5.4	2.1	15.6	2.6	5.5	4.4	4.5	3.1	7.6	67.6	9.2	8.1	8.0	2.0	4.9	3.4	1.8	2.2	5.6	7.1	58.1	3.0	5.6	4.4	2.6	21.5	32.8	9.0	8.8	11.5	18.5	14.1	40.0	62.9	29.1	28.5	14.5	6.3	4.8	10.4	15.4	70.2	34.6	9.7	26.3	48.2	11.1	5.6	26.1	7.2	7.9	59.0	10.6	2.3	30.8	64.7	35.2	58.9	14.2	24.3	14.9	11.5	0.0	86.4	10.7	15.2	0.1	2.2	10.9	5.1	10.5	67.5	3.1	11.9	42.3	0.7	5.1	17.4	12.5	15.7	15.8	15.2	8.8	84.5	63.9	20.6	13.5	66.0	3.4	8.1	12.3	42.0	24.6	15.7	0.0	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	1.7	2.0	1.9	2.0	1.5	2.7	2.5	1.9	2.6	2.0	2.2	2.6	35.9	93.0	116.7	28.4	1.6	12.1	3.4	5.5	8.6	0.7	4.6	8.0	5.7	7.2	44.8	0.0	22.9	23.2	2.0	5.2	1.9	3.3	1.7	1.7	13.3	31.1	0.0	17.5	4.2	5.8	7.5	18.5	5.1	1.6	73.2	4.2	17.5	20.5	4.7	0.0	11.9	4.0	2.0	2.2	2.3	1.6	5.6	8.8	1.8	30.0	1.1	8.6	6.2	69.9	28.7	2.9	0.8	7.2	1.9	4.5	25.8	13.4	75.5	6.7	0.0	11.5	17.7	5.3	7.2	7.1	10.4	13.8	9.4	4.8	5.6	1.9
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002444-113019861	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA069654: AB_2686164"	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	6.7	6.7	4.7	7.0	5.4	10.6	8.8	6.9	6.5	6.5	6.3	7.0	7.1	8.4	10.3	6.0	6.5	7.4	8.4	5.2	4.9	6.3	5.9	6.4	12.3	5.8	5.3	8.1	8.2	6.9	6.6	6.7	5.6	6.6	5.4	11.7	6.9	6.1	18.7	10.8	7.0	5.8	5.1	8.8	8.3	11.3	5.3	9.4	11.5	7.7	7.8	6.7	5.3	7.9	13.6	10.9	17.3	13.0	5.5	10.1	9.2	12.6	8.1	6.9	4.7	10.1	8.5	17.6	6.6	4.3	9.6	13.7	12.7	5.8	9.4	3.5	8.0	27.3	10.0	7.5	10.0	17.4	9.4	15.7	10.0	5.5	14.2	18.8	6.1	17.2	9.5	13.5	5.2	8.6	15.1	10.3	18.1	12.0	14.0	12.1	13.7	9.3	7.8	11.2	11.9	17.3	7.3	9.1	21.4	12.7	10.4	14.7	12.4	9.4	9.3	3.6	9.1	13.3	11.2	20.6	15.2	13.6	7.0	1.9	1.3	1.6	2.2	1.6	2.3	1.8	2.6	1.9	1.8	1.4	3.2	3.2	0.8	4.3	0.7	1.3	1.2	1.4	4.7	5.4	6.9	6.5	5.2	4.9	5.8	5.3	5.6	5.1	5.3	7.9	16.3	9.6	12.8	0.0	7.6	0.0	0.0	0.0	0.0	0.0	17.4	16.9	0.0	0.0	10.5	18.4	0.0	18.4	23.4	0.0	17.6	14.1	0.0	11.9	20.7	6.3	0.0	0.0	0.0	12.6	15.5	9.3	0.0	16.1	17.7	24.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	4.5	0.0	0.0	14.8	8.7	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	20.4	9.1	33.9	0.0	0.0
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 404.8;skeletal muscle: 676.9;tongue: 548.9"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 152.2;LHCN-M2: 135.1;RH-30: 108.5"	"Region enhanced"	"Detected in all"		"basal ganglia: 40.4"	"Group enriched"	"Detected in all"	4	"basal ganglia: 9.0;midbrain: 13.4;pons: 10.0;thalamus: 25.2"	"HPA011185, HPA011904"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA		2900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	42.8	22.3	2.3	24.5	3.1	0.6	16.2	1.7	1.6	21.9	2.5	89.2	10.2	79.0	10.7	49.4	47.5	28.7	404.8	1.3	1.8	8.0	5.6	25.2	5.6	1.4	3.3	15.2	10.0	1.5	1.4	10.6	1.5	62.5	15.7	0.6	11.5	69.8	676.9	6.8	26.7	70.6	1.2	8.6	44.1	5.7	4.7	2.1	10.3	548.9	1.8	49.7	19.5	1.7	26.0	1.5	4.5	0.2	79.5	75.3	12.3	152.2	65.5	29.8	20.2	4.6	0.2	0.0	8.6	54.7	34.4	3.4	3.3	14.3	53.3	0.7	3.4	6.2	7.5	1.5	59.3	1.3	0.2	56.6	3.3	40.7	23.8	65.2	22.8	6.0	0.3	0.0	135.1	0.0	29.9	1.8	23.8	0.0	18.6	24.3	108.5	0.2	35.5	1.2	0.1	1.1	13.3	0.0	1.0	29.9	0.0	3.5	23.4	71.7	53.6	31.2	76.1	0.2	0.2	0.1	4.0	2.8	0.2	0.0	1.7	0.0	0.2	1.0	0.0	0.7	0.1	0.2	0.9	0.5	0.3	0.1	1.4	0.3	0.8	0.6	0.0	3.6	2.3	3.1	1.7	1.6	1.3	1.8	1.4	3.3	1.5	1.2	4.7	1.7	8.3	105.8	4.9	11.4	2.1	1.8	0.9	4.6	1.2	2.7	1.4	33.1	2329.6	0.0	5.4	0.0	4.2	0.8	4.1	0.4	1.9	15.3	24.0	2.6	24.2	17.4	0.0	1.7	26.6	32.4	4.0	93.2	1.1	3.2	1.3	29.7	38.6	1.5	1.2	1.7	27.6	0.5	0.0	4.4	2.2	9.0	73.3	44.9	0.0	16.9	5.8	0.7	0.0	24.6	27.3	21.8	0.1	346.1	0.3	1.3	5.3	0.7	0.4	3.8	216.9	70.4	177.2	0.7	3.6	0.8	0.9	0.3	2.3	13.0	2.1	0.4
NFE2L1	"FLJ00380, LCR-F1, NRF1, TCF11"	ENSG00000082641	"Nuclear factor, erythroid 2 like 1"	Q14494	17	48048329-48061545	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1357.5;tongue: 858.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063384, HPA065424"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063384: AB_2684998, HPA065424: AB_2685488"	"unprognostic (3.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.44e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.20e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (5.79e-6)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.01e-2)"	154.3	130.5	109.3	75.0	99.3	31.1	91.1	101.6	98.3	103.5	225.0	107.6	106.0	149.4	88.2	126.0	130.6	97.3	430.8	112.4	146.3	159.6	104.0	83.3	63.8	135.0	131.1	148.8	65.2	115.2	82.5	100.6	131.0	95.7	80.1	67.1	92.1	123.5	1357.5	121.1	113.3	141.0	116.3	113.0	79.0	69.3	126.8	62.3	132.6	858.4	59.2	89.7	86.3	138.2	122.2	265.4	172.0	147.4	349.8	168.2	128.6	193.7	269.2	135.1	149.8	327.6	137.6	139.8	379.2	244.6	175.2	245.5	122.5	154.5	144.7	239.9	104.1	78.8	181.0	111.1	418.6	178.0	122.1	232.6	380.7	246.7	267.2	228.7	214.6	93.5	142.5	377.4	169.4	103.3	115.5	56.0	113.0	110.0	101.4	80.1	241.8	136.4	150.0	181.0	105.8	160.2	132.4	89.0	272.4	222.5	175.7	120.5	291.2	324.2	141.4	112.3	197.4	626.6	460.1	134.1	310.4	73.6	191.3	14.2	11.8	4.0	3.4	6.5	2.0	5.2	3.1	3.5	2.6	4.9	2.4	2.7	26.1	3.0	8.7	12.9	1.2	1.3	109.3	99.3	101.6	98.3	112.4	146.3	135.0	131.1	131.0	116.3	126.8	138.2	60.1	57.7	49.4	25.1	15.8	55.7	19.3	45.0	34.1	68.8	39.2	33.8	303.1	50.1	34.4	77.3	35.5	22.7	14.7	150.7	25.4	41.3	8.1	57.9	92.0	66.3	30.1	11.6	24.5	36.2	21.5	47.9	27.5	58.8	28.4	89.3	80.3	126.7	36.0	72.3	28.0	51.5	38.7	32.8	18.9	10.6	102.2	23.8	21.4	20.6	31.5	25.4	15.5	9.0	14.4	51.8	64.8	83.8	17.4	33.8	100.3	39.1	49.5	34.8	59.2	39.3	53.8	30.0	35.5	25.9	48.4	22.3	14.2	44.6	49.4	24.4
NIPSNAP2	GBAS	ENSG00000146729	"Nipsnap homolog 2"	O75323	7	55951793-56000181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"heart muscle: 266.5;skeletal muscle: 645.5;tongue: 784.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 226.9;Endometrial ciliated cells: 107.5;Proximal tubular cells: 106.8"	"Cancer enhanced"	"Detected in all"		"glioma: 73.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 301.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063084	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA063084: AB_2684938"	"unprognostic (6.88e-2)"	"unprognostic (6.53e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.02e-8)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.65e-3)"	"unprognostic (3.59e-1)"	61.2	70.3	46.0	25.4	48.4	39.2	59.0	47.2	56.9	45.4	50.8	56.0	31.4	41.1	36.6	49.0	50.4	27.5	266.5	45.1	49.5	63.8	14.5	36.9	26.4	45.2	48.7	34.7	49.2	70.4	27.1	31.0	47.1	53.4	53.8	27.6	79.2	55.9	645.5	21.9	32.4	46.6	49.0	26.1	46.5	20.5	50.0	40.1	86.5	784.2	28.7	40.8	26.0	47.6	301.3	52.3	67.5	112.6	38.7	65.8	33.1	24.7	58.2	69.7	53.5	36.5	64.9	43.8	40.5	46.6	67.5	39.1	51.4	52.2	68.7	27.9	75.4	31.1	27.6	46.9	54.6	68.0	30.2	60.3	78.4	23.8	64.5	79.1	74.6	62.2	56.2	41.9	54.8	13.4	68.1	70.4	66.7	66.5	52.3	68.0	31.3	90.8	94.6	46.7	71.7	80.8	56.2	67.0	78.3	53.0	129.9	72.3	43.9	31.7	47.4	11.3	52.0	34.1	30.9	81.2	35.1	41.9	95.7	48.2	86.6	39.1	22.6	86.4	27.2	37.7	28.8	23.8	91.7	37.0	34.2	25.2	15.3	41.9	69.1	38.1	37.9	72.4	46.0	48.4	47.2	56.9	45.1	49.5	45.2	48.7	47.1	49.0	50.0	47.6	45.4	51.3	57.7	0.0	10.3	0.0	0.0	0.0	0.0	0.0	80.4	63.8	0.0	0.0	43.3	62.5	0.0	76.0	20.1	0.0	226.9	74.8	0.0	107.5	56.1	22.1	0.0	0.0	0.0	57.2	56.4	23.4	0.0	57.6	16.4	64.7	0.0	0.0	88.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.0	39.8	0.0	0.0	0.0	0.0	46.2	0.0	0.0	5.2	0.0	0.0	106.8	88.2	0.0	0.0	0.0	26.7	0.0	0.0	0.0	0.0	51.4	12.3	74.0	0.0	0.0
NIPSNAP3B	FLJ11275	ENSG00000165028	"Nipsnap homolog 3B"	Q9BS92	9	104764129-104777764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 20.4;tongue: 19.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 11.8;Cardiomyocytes: 21.6;Excitatory neurons: 10.7;Microglial cells: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"REH: 3.0;SH-SY5Y: 2.1;THP-1: 2.2;U-266/70: 2.3"									HPA042491	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA042491: AB_2678023"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.25e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.81e-2)"	6.6	5.1	1.8	1.1	1.9	0.7	4.3	1.2	2.2	2.3	1.6	1.1	0.5	3.1	3.4	1.0	1.9	1.3	12.8	1.9	2.0	1.5	0.5	1.4	1.5	1.5	1.5	3.3	1.9	1.0	2.7	3.0	1.6	2.7	0.9	2.5	1.4	3.6	20.4	1.3	1.2	1.6	1.2	2.0	1.1	1.0	1.8	0.8	2.0	19.5	1.8	0.9	1.5	1.5	0.0	0.3	0.4	0.1	0.4	0.4	0.7	0.1	0.2	0.2	0.1	0.3	0.3	0.8	0.1	0.2	0.0	0.0	0.2	0.1	0.2	0.0	0.5	1.4	1.2	0.1	0.4	0.2	0.4	0.4	0.1	0.3	0.0	0.5	0.1	0.7	1.2	0.0	0.0	0.2	0.6	1.2	0.2	0.0	0.2	3.0	0.0	0.1	0.1	0.0	0.9	2.1	1.2	0.0	0.1	0.2	1.1	2.2	0.1	0.2	0.4	0.2	0.1	2.3	0.8	0.2	0.0	0.2	0.0	2.8	0.0	0.6	0.0	0.1	0.1	0.7	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	1.8	1.9	1.2	2.2	1.9	2.0	1.5	1.5	1.6	1.2	1.8	1.5	11.8	0.0	1.1	2.0	8.5	0.4	1.5	0.8	1.2	4.0	0.9	1.7	21.6	0.0	0.3	3.7	0.0	0.8	0.1	0.0	5.9	0.7	0.0	2.2	2.0	3.4	1.2	5.9	10.7	0.2	0.2	3.9	2.6	1.2	1.3	2.5	6.1	0.3	6.2	0.0	9.8	0.3	4.1	0.9	3.9	0.9	2.5	3.0	0.0	16.9	4.1	1.2	0.0	4.5	1.1	0.2	0.0	6.8	2.3	0.3	0.0	0.4	3.2	0.5	0.0	2.0	3.7	0.8	1.1	1.7	0.9	0.8	1.1	0.8	0.2	0.2
NME6	"IPIA-ALPHA, NM23-H6"	ENSG00000172113	"NME/NM23 nucleoside diphosphate kinase 6"	O75414	3	48290722-48301685	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017909	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA017909: AB_1854530"	"unprognostic (7.31e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (1.98e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.50e-2)"	8.7	7.7	6.3	10.4	6.4	8.1	12.1	9.2	6.3	10.2	8.7	11.6	13.2	9.3	8.5	12.1	14.8	8.9	13.5	7.1	6.5	11.1	10.3	10.2	12.2	5.9	6.3	12.4	11.6	12.4	6.0	14.2	5.7	9.5	11.5	7.6	10.9	8.7	17.7	10.0	10.4	12.4	4.9	9.6	11.5	6.2	6.4	9.4	12.2	17.2	13.7	9.6	9.0	6.3	30.0	19.1	24.3	18.3	18.2	23.4	22.1	27.2	18.3	37.5	27.3	30.5	26.5	30.1	14.0	20.5	36.5	10.1	21.9	27.2	24.1	36.1	21.3	17.9	24.1	26.6	25.7	24.3	20.7	19.7	33.8	34.4	42.9	19.3	19.8	21.1	33.9	23.6	14.0	13.9	21.4	11.3	22.3	19.5	23.3	12.7	22.9	25.3	21.2	23.6	7.7	12.7	19.8	21.0	26.1	17.8	23.9	22.5	22.1	8.3	33.0	21.2	39.4	27.0	40.9	26.1	16.3	31.9	18.4	47.3	33.4	76.4	40.9	36.0	36.6	43.5	37.4	35.2	39.9	38.0	28.1	27.2	37.3	40.4	42.1	34.5	33.5	25.1	6.3	6.4	9.2	6.3	7.1	6.5	5.9	6.3	5.7	4.9	6.4	6.3	13.1	28.9	20.7	2.3	16.4	5.0	8.5	18.2	9.6	11.9	14.1	13.6	10.4	15.7	19.4	9.2	14.6	49.5	18.4	8.2	39.2	24.8	2.6	16.1	17.5	12.8	4.2	8.0	2.5	30.1	41.6	12.4	11.7	11.8	10.1	22.8	7.9	7.9	34.4	10.1	3.2	10.8	12.2	9.3	9.7	1.7	11.8	13.7	16.0	1.9	23.4	17.6	18.6	2.5	2.7	31.3	8.3	7.2	10.8	12.8	16.6	16.4	30.6	11.5	13.1	7.7	12.2	9.3	15.0	12.4	4.1	19.7	14.7	15.1	12.8	7.1
NRAP		ENSG00000197893	"Nebulin related anchoring protein"	Q86VF7	10	113588714-113664070	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 2363.9;tongue: 1144.8"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 534.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 8.2;prostate cancer: 3.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037953, HPA037954, HPA075074"	Enhanced		Approved	"Vesicles,Intermediate filaments,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"	"Vesicles, Cytosol"	"HPA037953: AB_2675755, HPA037954: AB_10672394, HPA075074: "	"unprognostic (1.13e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.39e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.16e-1)"		0.3	0.1	0.1	0.0	0.5	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	24.8	0.0	0.2	428.6	0.2	0.0	0.1	0.5	0.4	0.1	0.0	0.2	0.1	0.4	0.0	0.3	0.0	0.0	20.4	1.0	0.0	22.1	0.0	2363.9	0.8	0.1	0.0	0.0	0.1	0.3	0.6	0.3	0.0	0.4	1144.8	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	534.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.4	0.1	0.0	3.7	0.0	0.0	0.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	4.8	0.0	0.0	0.3	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	57.3	3.3	1.0	2.3	0.0	0.1	0.0	0.2	0.0	0.5	0.0
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 267.3"	"Group enriched"	"Detected in many"	9	"Early spermatids: 597.7;Late spermatids: 1672.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm		NA	NA		58000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA053661: AB_2682221"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	48.2	36.8	33.3	48.2	33.9	48.5	34.2	33.6	42.3	31.1	37.2	32.5	32.3	31.1	20.2	40.4	29.7	31.0	58.5	34.4	35.5	26.5	55.7	34.3	43.8	35.2	34.6	32.6	40.1	60.9	32.8	40.2	37.8	38.6	35.3	48.1	28.7	30.5	267.3	51.4	31.4	38.4	33.6	40.9	35.2	95.6	36.5	54.9	33.1	182.0	46.7	36.5	28.4	38.1	166.8	91.0	94.2	133.4	98.9	145.5	106.8	165.6	143.9	116.6	123.5	65.6	65.3	108.3	84.7	128.4	157.6	95.1	136.5	127.9	156.2	127.7	66.1	129.5	125.4	62.9	97.9	114.4	95.4	117.2	102.1	169.7	160.0	105.0	125.7	113.1	174.7	71.7	153.4	62.9	105.0	45.2	161.5	71.8	97.4	101.6	106.4	122.6	92.8	94.7	86.5	65.2	148.0	124.8	94.5	185.7	79.3	152.5	102.4	103.8	94.2	114.2	146.0	103.9	168.4	100.1	120.8	146.6	120.1	44.5	33.8	50.0	23.2	35.1	23.3	23.2	21.5	26.0	33.7	15.6	20.9	22.7	67.8	29.8	28.3	27.5	26.9	33.1	33.3	33.9	33.6	42.3	34.4	35.5	35.2	34.6	37.8	33.6	36.5	38.1	43.5	35.3	69.0	0.0	58.9	0.0	46.3	0.0	38.7	73.3	38.2	31.0	0.0	28.6	34.7	27.6	81.3	56.8	94.3	11.1	31.3	48.1	597.7	63.1	78.8	39.4	18.2	85.8	0.0	64.0	45.5	40.1	56.6	55.4	35.3	74.6	30.4	59.9	44.3	62.2	0.0	19.5	0.0	44.6	0.0	1672.1	66.2	72.5	0.0	0.0	70.3	45.9	55.6	0.0	0.0	57.6	13.7	59.0	126.1	41.9	30.1	19.6	59.0	71.8	59.2	64.5	38.2	39.0	28.1	57.7	0.0	82.5	52.8	65.9	21.6	42.3
NUDT19	RP2	ENSG00000213965	"Nudix hydrolase 19"	A8MXV4	19	32691961-32713796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042761			Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA042761: "	"unprognostic (1.20e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.35e-3)"	"unprognostic (6.61e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.35e-4)"	5.1	11.7	4.0	4.1	4.1	8.4	4.6	3.9	4.5	3.9	9.4	6.9	7.1	3.6	5.4	11.1	3.6	2.9	10.6	4.1	5.1	6.3	6.9	6.4	5.8	4.6	4.3	3.7	8.4	7.1	4.0	4.5	4.8	7.5	7.3	8.3	6.9	3.5	23.9	8.9	6.2	4.3	4.3	5.2	8.1	2.8	4.6	3.1	3.6	13.0	5.1	6.3	5.6	4.6	21.5	24.7	2.7	24.0	8.1	10.5	0.2	11.9	4.4	8.7	8.2	14.0	11.6	0.1	14.0	13.8	6.7	13.7	16.7	13.9	11.4	24.8	10.0	27.7	9.3	5.0	11.2	20.9	8.2	8.5	18.1	7.4	17.8	10.1	13.0	4.2	21.6	15.3	15.9	14.3	0.1	19.3	2.9	5.9	11.5	0.1	5.2	12.1	14.4	15.7	10.7	15.4	21.2	17.7	15.9	4.7	9.8	25.4	10.4	11.9	7.7	12.0	21.5	17.8	16.3	6.9	14.4	20.0	11.2	11.1	26.5	15.4	18.2	36.7	20.0	13.0	18.9	22.6	19.5	9.4	14.9	20.4	5.1	32.2	42.4	15.9	23.6	11.9	4.0	4.1	3.9	4.5	4.1	5.1	4.6	4.3	4.8	4.3	4.6	4.6	5.9	12.8	14.5	7.5	6.4	21.9	9.4	4.6	8.0	14.5	12.0	6.6	22.8	2.8	6.2	7.3	12.5	11.0	9.1	10.6	27.4	2.9	7.7	8.5	9.3	7.3	12.1	10.3	5.9	11.5	11.5	6.6	3.1	10.7	1.3	11.3	13.2	12.5	14.3	3.3	6.7	12.7	8.2	17.6	11.6	3.7	4.1	10.2	12.4	4.7	10.7	4.6	4.1	6.6	7.4	12.0	13.1	9.4	4.1	12.0	15.7	18.8	6.5	30.4	0.0	6.9	7.4	1.6	2.2	9.9	31.5	7.8	9.1	22.3	18.4	10.6
PACSIN3	SDPIII	ENSG00000165912	"Protein kinase C and casein kinase substrate in neurons 3"	Q9UKS6	11	47177522-47186443	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 161.8;skeletal muscle: 480.9;tongue: 279.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 112.0;Extravillous trophoblasts: 60.6;Muller glia cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 127.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039480, HPA043904"	Approved	Approved	Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"HPA039480: AB_2676531, HPA043904: AB_2678725"	"unprognostic (1.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	14.4	66.5	19.6	4.5	28.2	0.4	18.4	24.5	20.9	33.3	18.8	50.2	4.7	33.5	11.4	52.6	29.1	7.2	161.8	18.0	19.4	14.8	43.6	15.9	2.0	33.8	27.5	23.2	33.1	11.0	6.2	16.1	32.1	35.2	2.7	4.5	40.8	20.6	480.9	41.4	11.3	21.2	25.0	4.5	33.5	4.5	25.4	2.0	24.5	279.4	5.2	21.5	31.8	39.0	56.4	27.1	12.5	51.5	10.3	10.2	59.8	19.4	24.6	33.9	19.1	40.8	7.3	0.3	5.9	9.2	23.0	90.0	23.7	40.2	13.0	8.7	44.8	8.4	105.5	91.7	19.9	2.0	8.4	28.2	52.3	17.9	28.3	27.2	15.3	15.2	18.4	0.7	13.9	106.7	0.7	40.8	15.5	43.7	58.7	33.1	48.0	9.0	14.3	49.3	0.3	42.6	28.2	17.9	24.6	24.6	127.3	6.9	6.9	57.6	62.5	7.5	47.1	10.1	4.4	5.3	18.6	19.2	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	19.6	28.2	24.5	20.9	18.0	19.4	33.8	27.5	32.1	25.0	25.4	39.0	6.1	0.0	8.1	4.9	0.3	35.9	29.1	25.1	30.7	0.7	32.2	24.3	112.0	38.6	18.1	5.5	0.0	31.0	0.6	0.2	9.8	37.7	0.0	3.1	8.4	7.8	0.0	2.7	0.8	15.5	60.6	12.6	9.7	6.2	0.0	3.0	8.6	33.1	6.0	0.0	1.1	0.2	14.2	1.6	4.6	0.4	16.1	1.0	17.8	2.8	0.0	63.6	0.0	0.0	9.5	41.0	0.0	12.4	2.6	56.8	1.5	24.3	5.0	3.2	32.9	18.5	25.4	0.2	7.5	39.7	29.8	18.3	0.7	4.8	1.4	29.8
PARVB	CGI-56	ENSG00000188677	"Parvin beta"	Q9HBI1	22	43999211-44172939	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.9;tongue: 170.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 113.2;Hofbauer cells: 90.6;Macrophages: 78.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 20.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 158.0;RPMI-8226: 159.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062601, HPA072217"	Enhanced		Approved	Cytosol		NA	NA		24000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA062601: AB_2684803, HPA072217: "	"unprognostic (2.41e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.65e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.05e-3)"	42.6	30.7	26.7	21.3	19.4	43.4	33.0	18.7	24.3	21.8	22.6	21.8	7.4	22.2	13.5	11.9	19.2	10.7	86.9	34.1	24.7	23.0	14.4	29.7	19.2	23.3	25.7	27.1	11.9	18.5	24.3	21.4	26.9	17.0	8.6	10.5	11.4	13.7	195.9	14.2	18.6	22.9	20.8	35.3	15.0	6.6	28.3	9.4	12.8	170.6	16.1	23.9	16.7	19.7	23.5	27.7	0.4	19.1	28.1	35.5	0.1	32.4	20.1	20.9	15.6	28.9	13.8	0.2	17.5	87.2	16.4	0.9	45.9	2.1	11.5	33.1	28.5	100.4	45.8	0.2	46.5	76.5	86.7	55.4	24.0	15.2	0.2	15.0	158.0	0.4	36.6	67.0	22.9	15.9	0.4	50.4	9.8	20.4	18.7	0.2	0.8	159.5	0.5	0.6	24.6	17.1	8.6	1.6	84.9	3.3	15.9	30.7	99.2	19.0	20.0	29.4	3.4	16.2	15.3	0.7	82.8	22.1	106.0	6.9	6.8	1.6	1.0	7.1	1.6	6.2	1.7	1.5	7.2	6.4	0.4	0.9	4.7	0.8	2.9	14.9	2.4	9.5	26.7	19.4	18.7	24.3	34.1	24.7	23.3	25.7	26.9	20.8	28.3	19.7	70.3	0.0	10.6	5.2	48.2	5.2	3.4	1.3	4.0	11.2	8.3	9.4	55.0	4.3	0.9	1.8	16.7	1.0	29.0	0.3	27.4	1.5	6.6	8.0	12.6	63.7	1.2	113.2	15.1	3.1	10.8	18.4	4.1	11.7	64.7	20.2	53.2	12.5	90.6	6.7	12.5	0.7	6.1	49.7	39.5	21.6	19.9	78.7	19.6	28.1	44.7	8.9	9.2	2.5	5.9	4.7	0.0	10.9	58.1	5.1	0.0	30.0	3.8	15.2	6.6	18.2	14.2	1.9	5.8	0.7	4.4	1.8	16.7	2.3	0.6	1.5
PCBD2	"DCOH2, DCOHM"	ENSG00000132570	"Pterin-4 alpha-carbinolamine dehydratase 2"	Q9H0N5	5	134905120-135007959	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 49.4;tongue: 42.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036428	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"		"HPA036428: AB_10670103"	"unprognostic (3.70e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.22e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.57e-2)"	"unprognostic (6.34e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.50e-1)"	5.3	7.7	7.3	4.8	8.5	7.6	6.0	7.8	7.6	4.3	11.0	6.1	9.5	4.2	4.1	8.3	5.7	4.6	17.1	6.4	7.5	10.2	11.9	4.9	5.9	8.7	7.7	5.1	8.0	13.0	3.8	3.5	8.0	5.4	7.0	9.9	9.6	3.8	49.4	9.2	8.1	3.6	6.8	5.8	8.2	3.2	8.1	5.5	9.6	42.7	6.1	4.5	4.9	10.8	7.5	7.2	9.4	6.9	5.7	5.2	5.2	6.0	5.2	3.8	3.8	12.0	17.5	8.7	8.8	4.4	6.1	6.5	5.6	5.9	3.4	12.3	3.1	6.0	9.5	7.1	5.4	7.1	3.6	3.4	7.1	3.6	7.6	5.1	4.3	7.7	7.7	12.2	6.9	13.0	7.5	12.3	5.1	11.5	6.9	10.9	8.4	9.7	8.1	7.4	7.2	9.2	10.4	6.0	9.1	7.1	13.0	9.4	5.9	6.4	4.3	7.1	8.1	10.6	15.7	5.5	7.8	8.8	4.8	5.7	5.1	5.4	3.6	4.5	2.9	4.5	4.0	3.4	4.4	4.2	3.8	4.3	2.8	4.0	4.6	7.7	3.9	2.7	7.3	8.5	7.8	7.6	6.4	7.5	8.7	7.7	8.0	6.8	8.1	10.8	4.2	9.6	10.3	28.7	8.8	3.6	6.4	15.8	7.4	13.5	11.7	8.4	32.5	20.0	12.5	16.5	12.5	13.6	10.1	13.6	21.5	17.1	8.4	7.9	6.1	6.9	4.2	31.5	10.6	18.2	24.4	5.8	13.3	8.7	6.3	22.4	7.1	23.1	24.6	23.5	12.9	9.5	20.3	10.0	9.6	3.5	7.2	10.2	5.4	17.8	26.9	14.8	7.2	13.0	20.6	17.8	6.2	2.2	13.1	7.1	26.5	26.3	11.9	45.9	0.0	9.0	7.4	5.2	11.5	13.8	6.0	10.1	7.8	9.5	15.9	8.7
PDE4C	DPDE1	ENSG00000105650	"Phosphodiesterase 4C"	Q08493	19	18208652-18248200	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 255.9;Gastric mucus-secreting cells: 141.2;Paneth cells: 251.4;Proximal enterocytes: 73.0;Skeletal myocytes: 106.5;Undifferentiated cells: 103.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.2;cerebral cortex: 1.1"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;Hep G2: 2.0;U-87 MG: 4.4"									"HPA048975, HPA054218"	Approved		Approved	"Midbody ring,Centrosome,Cytosol"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-10)"	"unprognostic (2.73e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.45e-2)"	1.4	0.6	0.2	0.1	1.2	0.5	0.7	0.0	1.1	3.2	0.0	4.3	0.7	3.4	3.4	0.7	3.0	1.1	4.4	0.2	0.0	4.8	1.3	3.4	0.2	0.0	0.0	1.8	0.7	0.2	2.8	3.7	0.0	2.3	0.6	0.2	0.5	2.7	8.3	0.3	2.4	1.8	0.0	2.1	3.8	2.5	0.0	0.0	1.1	21.3	0.1	1.0	1.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	2.9	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.0	0.1	0.0	0.2	0.3	0.0	1.2	0.0	0.2	0.0	0.1	0.4	0.9	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.7	0.2	0.2	0.0	0.1	0.0	0.3	0.0	0.6	0.3	0.1	4.4	0.1	0.0	1.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.0	0.0	0.2	1.2	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.2	10.6	2.0	0.8	5.5	5.8	8.6	5.2	3.9	0.2	0.4	35.3	4.3	22.4	0.0	6.2	2.1	0.0	255.9	0.0	0.0	32.9	0.1	0.1	4.6	7.2	0.0	8.2	0.0	4.3	6.3	141.2	0.1	4.5	0.0	1.1	0.3	0.5	0.0	2.1	55.2	4.1	1.4	4.5	38.4	0.6	2.1	1.8	0.0	0.4	1.9	1.0	0.5	0.9	0.0	251.4	4.1	1.6	1.8	73.0	0.0	9.4	3.0	46.0	106.5	17.2	1.9	2.2	28.6	3.8	1.1	1.2	0.0	103.3	17.3
PDE4DIP	"CMYA2, KIAA0454, KIAA0477, MMGL"	ENSG00000178104	"Phosphodiesterase 4D interacting protein"	Q5VU43	1	148808181-149048286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"heart muscle: 729.5;skeletal muscle: 2164.0;tongue: 1379.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 702.6;Rod photoreceptor cells: 272.3;Syncytiotrophoblasts: 309.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 289.6;ASC TERT1: 233.8;K-562: 222.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012678			Supported	"Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"		"HPA012678: AB_1855123"	"unprognostic (2.14e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.31e-2)"	"unprognostic (6.73e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	32.9	16.9	103.0	20.9	82.9	15.8	22.3	142.7	106.1	28.0	32.4	22.5	24.2	17.4	73.5	37.9	19.8	19.5	729.5	115.5	118.5	42.0	63.5	36.1	21.7	102.2	95.6	8.6	21.4	84.6	53.1	68.5	109.7	29.2	25.4	173.3	34.9	22.9	2164.0	26.1	29.4	18.8	96.8	17.2	29.7	9.2	139.9	12.1	16.9	1379.7	23.2	24.0	17.1	114.9	39.2	7.5	10.6	11.6	289.6	233.8	60.7	45.2	42.3	42.7	55.7	35.5	24.1	19.8	13.7	64.5	121.3	19.8	25.7	31.5	72.1	14.7	36.8	10.0	16.2	14.2	76.2	8.8	10.2	167.5	61.9	181.7	97.8	96.9	17.1	16.3	222.1	45.0	76.8	66.2	6.9	5.4	37.1	32.3	15.9	14.6	26.5	7.7	25.4	39.9	50.1	4.7	44.1	123.4	36.1	44.7	37.5	11.7	22.9	49.3	11.2	124.7	100.9	19.9	29.6	29.1	200.6	8.0	30.2	10.6	5.7	4.5	5.3	6.1	5.5	12.0	10.6	7.1	7.0	11.0	8.1	4.5	1.3	4.9	2.1	3.0	14.4	4.8	103.0	82.9	142.7	106.1	115.5	118.5	102.2	95.6	109.7	96.8	139.9	114.9	5.7	51.3	45.1	81.3	24.0	28.8	9.9	19.8	23.3	71.0	16.1	11.3	702.6	24.3	45.4	69.9	114.7	184.6	9.5	24.0	62.6	13.1	38.9	41.1	14.2	15.7	43.2	7.4	85.8	7.1	148.3	54.2	20.4	27.0	13.9	6.1	5.3	80.8	45.0	33.7	81.1	32.0	20.3	46.1	90.4	50.0	10.5	68.7	55.2	6.5	21.5	45.7	14.4	65.9	41.5	4.5	25.1	9.8	37.5	4.1	48.8	20.7	88.0	272.3	32.9	131.2	40.1	8.7	15.9	14.6	16.3	309.2	24.0	4.2	24.2	4.3
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 138.6;tongue: 125.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 115.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Plasma membrane"	Mitochondria	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	23.5	21.6	16.5	12.2	19.9	7.4	16.6	21.6	21.9	13.3	9.4	22.8	20.1	14.2	13.3	17.2	10.0	12.3	77.8	21.1	14.5	21.5	31.0	12.7	11.9	16.6	17.2	11.7	21.5	21.0	15.4	24.4	16.5	18.9	20.6	27.1	20.4	16.0	138.6	14.6	15.0	17.8	13.4	11.1	23.1	27.8	19.7	13.2	14.3	125.2	14.8	15.0	11.7	21.1	20.4	54.3	29.9	11.9	20.7	25.5	28.5	38.9	30.1	40.3	38.9	69.3	18.8	27.2	24.7	31.4	49.1	39.4	58.9	31.9	41.1	25.8	47.2	26.9	54.6	82.3	45.0	50.7	30.7	25.6	37.9	23.2	31.5	23.8	31.1	23.9	57.9	25.4	33.1	35.7	32.2	29.9	25.2	54.2	30.5	27.0	53.5	23.8	62.1	54.7	32.0	23.3	33.8	48.1	52.2	29.3	54.8	29.9	21.0	30.4	35.5	32.3	42.7	24.4	53.3	35.7	23.9	24.2	32.5	14.0	19.4	17.5	15.4	21.4	14.3	18.8	14.4	12.7	27.5	16.0	17.2	12.6	3.9	22.1	34.6	7.4	22.1	14.7	16.5	19.9	21.6	21.9	21.1	14.5	16.6	17.2	16.5	13.4	19.7	21.1	9.0	35.3	24.6	34.3	14.5	26.0	21.4	26.7	15.4	25.8	15.1	11.4	115.3	20.0	26.0	5.5	29.2	62.9	9.0	14.4	64.6	21.4	52.6	15.1	12.2	13.0	9.0	13.5	85.4	14.3	34.9	20.6	16.3	16.6	5.7	16.5	11.7	23.6	26.4	20.2	80.3	17.2	42.7	18.6	13.6	54.0	10.8	14.7	21.4	24.4	23.2	21.0	9.2	40.2	53.4	16.7	15.9	13.5	14.1	22.4	15.0	30.7	19.8	26.7	0.0	14.5	18.8	57.2	36.1	17.9	25.4	83.0	13.4	27.5	20.0	19.7
PDK4		ENSG00000004799	"Pyruvate dehydrogenase kinase 4"	Q16654	7	95583499-95596516	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2300.1;tongue: 1216.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 681.3;Cardiomyocytes: 764.5;Kupffer cells: 464.0;Proximal enterocytes: 654.2;Smooth muscle cells: 489.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 107.8;thyroid cancer: 89.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 32.5;eosinophil: 38.1;intermediate monocyte: 63.5;myeloid DC: 16.8;non-classical monocyte: 39.8"	"Group enriched"	"Detected in many"	12	"dendritic cells: 16.8;granulocytes: 38.1;monocytes: 63.5"	"Cell line enriched"	"Detected in many"	7	"ASC diff: 482.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056731	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA056731: AB_2683218"	"unprognostic (3.18e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.47e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.12e-1)"	451.2	216.3	32.4	33.4	48.0	2.5	388.7	32.9	43.0	76.3	222.0	278.9	72.3	89.0	10.4	151.5	153.5	80.6	480.4	40.0	35.3	127.8	223.4	120.4	24.0	44.5	41.8	240.8	549.3	18.2	39.9	104.8	45.3	91.2	42.6	2.0	60.2	529.5	2300.1	91.9	163.3	62.2	34.8	99.0	173.1	13.3	39.8	13.8	72.1	1216.5	13.5	187.5	95.2	59.4	0.0	37.7	1.5	9.5	482.2	0.8	0.4	0.0	0.0	0.0	0.0	0.0	12.8	0.0	5.3	1.7	1.6	0.0	0.1	0.0	0.0	0.0	1.3	0.2	66.8	0.0	4.5	0.0	0.0	5.3	0.0	0.0	0.0	0.2	2.4	0.0	1.7	0.0	0.2	0.9	0.0	0.4	0.1	0.0	2.1	0.0	0.0	0.3	23.5	2.6	0.5	2.7	0.0	3.0	8.6	2.4	1.3	1.1	0.0	0.0	0.8	2.1	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.3	32.5	38.1	0.0	63.5	0.1	0.4	0.0	0.0	16.8	1.5	0.0	0.0	2.5	3.3	39.8	0.5	0.0	14.2	32.4	48.0	32.9	43.0	40.0	35.3	44.5	41.8	45.3	34.8	39.8	59.4	681.3	32.1	16.0	154.4	6.0	10.5	279.2	9.2	19.9	0.1	95.9	40.6	764.5	30.0	36.1	378.9	0.0	5.9	3.9	67.7	13.7	7.2	14.9	151.0	52.1	108.0	55.4	9.3	0.4	5.5	0.7	326.9	158.5	347.5	5.1	19.9	199.2	130.5	49.8	0.0	1.2	96.0	6.1	464.0	21.5	6.7	134.2	204.8	90.7	19.7	19.8	8.4	1.0	7.1	26.2	6.2	46.3	44.8	6.4	110.0	654.2	74.2	66.3	0.4	164.3	293.2	489.7	1.8	1.0	12.3	9.2	10.9	5.3	18.7	60.5	157.4
PDLIM1	"CLIM1, CLP-36, CLP36, hCLIM1"	ENSG00000107438	"PDZ and LIM domain 1"	O00151	10	95237572-95291012	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 675.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 805.9;Basal respiratory cells: 763.8;Paneth cells: 769.2;Proximal enterocytes: 1059.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 189.7;memory B-cell: 223.8;naive B-cell: 213.0"	"Group enriched"	"Detected in all"	7	"B-cells: 223.8;granulocytes: 189.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 766.3;Hep G2: 635.3;HHSteC: 731.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017010, CAB072838, CAB072840"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		93000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"	"Plasma membrane, Cell Junctions"	"CAB072838: , CAB072840: , HPA017010: AB_1855147"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.11e-1)"	301.7	32.4	10.7	91.5	10.8	25.0	236.0	10.2	18.5	133.1	30.2	220.0	179.4	115.0	91.8	182.3	155.3	114.9	393.2	11.7	10.9	82.8	160.3	337.2	104.5	20.4	12.7	35.6	98.3	65.9	29.5	141.1	14.1	116.9	218.5	36.9	166.1	114.7	675.1	136.8	249.0	146.0	14.0	148.3	148.3	13.7	13.8	105.9	194.7	290.0	123.7	276.3	165.3	11.2	274.4	181.8	12.4	0.4	64.1	43.3	277.1	82.6	266.4	218.8	356.5	387.0	429.8	0.3	21.9	233.8	110.4	766.3	91.5	498.1	220.6	0.2	132.0	277.9	50.1	635.3	731.0	0.1	13.2	125.5	257.0	111.9	400.6	233.2	396.8	24.2	60.0	70.3	52.7	51.4	0.8	4.9	24.6	137.7	137.2	234.1	10.0	98.4	114.4	268.9	48.3	18.9	91.2	84.6	0.9	293.8	68.2	125.7	345.1	84.5	19.7	0.7	0.7	31.2	0.1	91.6	92.5	0.2	41.0	0.4	2.4	189.7	11.9	0.8	0.1	223.8	2.3	14.1	31.0	213.0	0.5	8.1	7.5	8.9	1.5	3.2	2.2	44.5	10.7	10.8	10.2	18.5	11.7	10.9	20.4	12.7	14.1	14.0	13.8	11.2	435.0	76.9	123.5	0.0	145.6	366.3	805.9	763.8	244.7	10.1	100.6	131.4	266.2	223.1	250.2	51.5	29.2	538.2	20.5	657.0	15.6	420.1	8.4	218.6	319.3	359.3	101.3	41.6	0.9	172.5	116.7	149.2	100.9	113.0	12.6	47.2	459.7	100.4	50.0	1.7	0.4	488.9	152.5	19.4	105.2	8.0	5.0	88.8	40.9	2.8	8.8	11.6	32.0	0.0	0.0	227.0	769.2	0.7	103.5	256.5	1059.7	109.0	316.4	59.5	315.5	21.0	213.1	4.3	35.7	170.4	197.9	117.0	25.8	1.9	419.2	554.3
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"heart muscle: 629.5;skeletal muscle: 1163.5;tongue: 576.0"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 1844.2"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 219.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 219.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		1200000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Focal adhesion sites"	"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	41.7	26.0	20.5	25.6	25.2	59.7	39.5	22.4	22.4	27.4	84.9	34.1	33.3	94.8	11.3	72.3	40.5	47.5	629.5	21.4	27.7	34.9	82.7	22.0	16.2	30.9	30.1	27.2	30.2	12.2	17.5	67.7	25.0	88.5	30.8	18.2	40.2	68.9	1163.5	21.5	34.4	105.9	22.7	24.1	31.0	12.7	26.3	10.9	25.5	576.0	21.1	45.8	27.6	21.0	31.4	87.2	33.6	13.0	71.7	51.3	13.0	71.6	59.9	40.1	32.6	80.8	66.3	12.0	72.0	72.3	21.0	31.8	46.5	68.2	65.9	24.1	19.3	43.7	53.8	32.2	103.7	14.6	38.3	66.4	58.4	96.1	74.0	177.9	93.5	13.2	19.2	12.5	86.2	29.8	15.0	4.8	11.4	66.7	36.6	7.2	24.7	11.1	45.0	94.6	16.5	21.8	38.9	88.7	20.3	26.7	10.3	5.2	113.7	103.7	17.3	46.1	44.1	9.5	13.0	12.7	56.5	10.3	24.9	219.7	23.4	21.0	12.1	40.6	9.7	10.5	12.0	12.8	19.5	7.6	7.9	10.4	22.6	9.2	44.6	6.6	11.8	15.2	20.5	25.2	22.4	22.4	21.4	27.7	30.9	30.1	25.0	22.7	26.3	21.0	107.4	44.8	23.6	184.1	22.1	194.4	380.3	92.1	63.7	4.7	90.2	67.4	1844.2	62.9	82.9	49.7	31.3	13.7	18.5	180.0	13.7	95.0	19.2	68.7	11.8	117.2	109.4	27.6	4.9	95.1	96.5	97.8	84.6	108.7	52.0	29.1	137.8	207.0	38.8	1.7	20.7	107.4	36.7	60.6	75.3	9.1	41.3	59.8	62.2	104.0	41.6	86.2	12.3	181.5	43.1	139.2	166.8	66.5	23.2	300.7	117.5	73.6	70.0	35.8	78.9	96.7	134.7	23.8	34.4	107.3	157.0	23.8	31.1	6.8	74.0	217.5
PDLIM7	ENIGMA	ENSG00000196923	"PDZ and LIM domain 7"	Q9NR12	5	177483394-177497606	"Predicted intracellular proteins"	"Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 570.3;skeletal muscle: 661.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 164.8;Exocrine glandular cells: 242.1;Pancreatic endocrine cells: 320.1;Peritubular cells: 223.0;Sertoli cells: 164.3;Smooth muscle cells: 157.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 177.1;eosinophil: 121.2;neutrophil: 438.7"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 438.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018794, HPA048815"	Approved		Enhanced	"Actin filaments,Focal adhesion sites"		NA	NA		1700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Actin filaments, Focal adhesion sites"		"HPA018794: AB_1855155, HPA048815: AB_2680530"	"unprognostic (7.70e-3)"	"unprognostic (3.75e-2)"	"unprognostic (9.27e-3)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.18e-3)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.19e-10)"	"unprognostic (6.72e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.68e-2)"	74.3	26.7	23.0	74.5	27.2	50.3	58.2	18.8	39.8	183.7	30.2	570.3	31.5	489.5	28.8	64.5	236.0	45.0	79.9	22.3	27.6	52.8	16.0	84.7	15.1	23.9	23.4	94.2	15.1	9.6	66.3	33.2	24.9	245.3	24.9	5.7	42.3	200.7	661.5	38.0	111.7	177.6	20.8	84.5	156.1	37.6	28.5	11.5	37.1	70.5	7.6	315.4	125.0	20.5	115.8	25.8	120.7	89.4	32.5	59.9	118.9	232.4	132.8	128.9	89.0	50.9	109.6	20.4	220.4	156.4	69.5	59.5	19.7	160.6	30.3	27.5	27.6	73.6	92.2	52.6	83.6	38.8	237.3	132.0	29.1	115.6	51.5	191.9	85.4	18.3	52.4	15.3	102.5	103.9	7.0	88.6	75.7	23.2	108.8	144.4	101.3	14.0	89.1	29.6	17.5	35.8	91.5	16.9	44.6	39.9	24.3	31.3	292.9	153.8	168.1	60.5	211.7	4.0	4.7	24.1	73.3	44.2	35.7	177.1	46.7	121.2	5.3	22.9	6.3	9.6	3.1	7.2	26.7	5.3	3.0	4.0	438.7	2.3	29.3	1.9	7.0	23.9	23.0	27.2	18.8	39.8	22.3	27.6	23.9	23.4	24.9	20.8	28.5	20.5	36.6	0.0	0.6	11.1	7.5	14.5	47.1	106.8	6.2	6.3	7.6	65.3	21.0	4.3	20.9	25.8	14.6	12.5	4.4	5.5	25.4	164.8	27.0	7.5	44.8	51.0	3.5	9.4	13.9	242.1	53.3	65.0	9.7	7.3	17.2	18.6	51.0	1.6	64.0	8.4	7.4	2.1	36.7	16.6	18.3	49.3	44.7	44.9	10.6	5.6	31.0	16.2	1.0	2.0	1.7	320.1	33.6	223.0	3.2	30.4	1.0	15.7	13.2	22.6	164.3	24.6	157.7	11.6	38.7	12.2	15.8	14.1	10.8	18.2	3.1	25.3
PDZRN3	"KIAA1095, LNX3, SEMACAP3, SEMCAP3"	ENSG00000121440	"PDZ domain containing ring finger 3"	Q9UPQ7	3	73382431-73624941	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 256.0;Excitatory neurons: 183.1;Inhibitory neurons: 258.3;Microglial cells: 329.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"AF22: 32.1;ASC diff: 57.0;ASC TERT1: 29.6;BJ hTERT+: 42.0;HSkMC: 41.4;U-87 MG: 30.4"	"Group enriched"	"Detected in many"	4	"amygdala: 15.1;basal ganglia: 8.1;cerebral cortex: 19.5;hippocampal formation: 16.1;white matter: 7.2"	"Low region specificity"	"Detected in many"			"HPA038822, HPA061420"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA038822: AB_10675952, HPA061420: AB_2684512"	"unprognostic (3.22e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.35e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.65e-7)"	"unprognostic (8.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.86e-3)"	29.9	35.7	14.9	10.2	16.3	0.0	24.0	8.5	20.9	45.2	58.0	84.0	9.2	64.1	24.5	27.8	26.7	27.4	48.0	16.7	10.6	10.7	2.1	14.9	4.5	13.0	11.8	69.4	6.9	0.8	4.6	17.5	11.0	31.7	13.9	6.3	20.9	29.0	91.8	17.3	24.4	38.4	13.1	2.4	38.7	6.4	17.1	2.9	3.6	22.4	1.4	46.7	32.0	13.2	0.0	0.0	32.1	0.1	57.0	29.6	0.1	16.9	42.0	5.0	3.2	16.2	0.0	0.1	0.1	22.8	0.8	0.0	0.0	0.0	4.8	0.0	2.2	0.0	0.0	0.0	9.5	0.0	0.1	41.4	0.0	13.8	0.1	6.0	0.0	0.0	0.0	0.0	4.9	2.1	0.0	0.2	4.6	0.0	0.2	0.0	8.4	0.1	0.0	0.0	3.7	10.5	0.0	7.8	12.7	9.2	4.5	0.0	0.0	20.6	1.5	23.6	2.2	0.7	0.0	0.2	30.4	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	14.9	16.3	8.5	20.9	16.7	10.6	13.0	11.8	11.0	13.1	17.1	13.2	5.9	0.0	0.0	256.0	0.5	2.4	9.7	0.0	1.8	19.3	7.5	7.6	65.0	0.0	0.0	5.5	6.2	0.5	2.7	1.0	1.9	0.0	0.4	2.1	45.2	2.3	21.1	0.0	183.1	0.4	0.5	25.2	2.0	3.3	0.0	35.0	0.0	0.0	0.8	0.0	258.3	9.1	0.0	0.0	2.9	1.3	23.3	0.7	16.0	329.8	0.0	22.5	0.0	21.6	5.5	0.3	0.9	28.2	0.1	10.9	0.1	7.1	0.0	1.9	0.0	4.6	19.6	0.5	6.2	2.9	1.8	0.8	0.5	12.4	3.9	6.3
PERM1	"C1orf170, MGC13275, RP11-54O7.8"	ENSG00000187642	"PPARGC1 and ESRR induced regulator, muscle 1"	Q5SV97	1	975204-982093	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	55	"heart muscle: 68.8;skeletal muscle: 194.5;tongue: 135.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 3.8;Breast myoepithelial cells: 3.9;Cardiomyocytes: 21.5;Early spermatids: 6.0;Late spermatids: 5.8;Spermatocytes: 4.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA031711, HPA031712"	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA031711: AB_10669636, HPA031712: AB_2674005"	"unprognostic (3.67e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.58e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.96e-2)"	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	2.0	0.2	0.0	68.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	2.4	0.0	194.5	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	135.8	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.8	0.0	1.2	0.7	3.8	3.9	21.5	0.0	0.0	1.8	0.0	0.1	0.0	0.1	1.9	0.2	6.0	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	1.6	0.5	4.3	0.4	1.1	0.0	0.3	0.0	0.0	0.1	2.3
PFKM	"PFK-1, PFKX, PPP1R122"	ENSG00000152556	"Phosphofructokinase, muscle"	P08237	12	48105139-48146404	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 1570.1;tongue: 1393.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 345.9;Horizontal cells: 121.1;Muller glia cells: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002117	Approved		Approved	"Endoplasmic reticulum"		NA	NA		410000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA002117: AB_1855245"	"unprognostic (4.60e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (5.85e-6)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (5.93e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.29e-3)"	"unprognostic (6.73e-2)"	"prognostic favorable (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.30e-2)"	18.7	54.2	50.4	11.0	50.9	8.0	15.0	58.1	59.3	28.2	50.1	34.2	10.4	36.1	14.3	38.6	29.2	15.9	298.6	49.4	63.3	46.0	8.4	14.9	8.0	54.5	51.1	45.1	10.9	136.2	36.5	12.0	58.7	29.0	16.1	85.5	29.2	39.0	1570.1	14.4	16.0	35.1	46.1	11.8	23.0	50.7	62.1	9.3	21.5	1393.9	10.2	27.7	19.2	43.4	32.9	30.6	98.4	87.5	97.2	72.5	20.2	85.4	80.2	77.1	54.4	76.3	40.5	192.9	69.6	44.1	44.9	36.0	90.1	91.2	70.9	5.5	43.9	54.7	64.7	1.9	54.3	2.9	30.9	102.1	50.4	69.2	107.3	125.1	85.9	3.7	64.6	91.7	71.5	25.8	69.5	5.1	67.7	36.0	93.9	115.7	55.7	141.3	48.4	32.5	111.5	82.6	51.0	75.9	86.5	78.7	80.3	11.2	75.8	34.0	46.5	49.5	72.1	52.8	145.3	106.4	62.4	6.8	28.5	0.3	2.9	7.8	2.1	2.5	0.9	8.8	3.5	2.1	5.6	8.3	4.3	2.4	0.7	2.1	2.1	0.9	3.5	3.1	50.4	50.9	58.1	59.3	49.4	63.3	54.5	51.1	58.7	46.1	62.1	43.4	8.6	16.0	8.4	30.3	6.9	7.4	21.7	22.1	15.9	43.3	5.6	9.1	345.9	12.8	10.8	22.0	43.8	2.8	0.9	3.4	66.5	10.6	43.1	5.5	18.0	17.3	9.1	8.6	23.2	2.5	3.8	27.1	6.6	2.4	1.3	17.3	13.9	2.7	4.1	121.1	30.0	9.1	34.6	3.8	3.7	27.0	30.7	4.3	55.2	3.7	11.3	125.7	4.1	15.6	3.4	3.5	1.9	47.8	4.6	7.9	2.7	30.6	11.2	51.1	26.3	37.6	24.5	52.1	14.4	9.2	5.3	2.5	3.3	24.0	10.1	9.7
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 1132.9;skeletal muscle: 4350.5;tongue: 1754.5"	"Group enriched"	"Detected in many"	6	"Early spermatids: 539.1;Late spermatids: 1891.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		38000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		4.1	3.7	32.9	0.1	37.7	0.1	2.9	40.9	43.1	2.8	28.9	2.1	2.0	1.8	0.7	58.9	2.3	2.4	1132.9	29.3	45.0	10.6	1.8	2.0	0.3	33.8	39.8	2.0	2.1	4.0	13.5	0.1	46.0	16.5	0.3	4.3	33.6	0.6	4350.5	1.8	1.3	0.5	30.8	1.2	1.7	193.9	46.8	23.9	5.1	1754.5	0.5	0.7	1.9	39.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	65.8	7.0	0.0	0.3	0.4	0.1	0.7	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	32.9	37.7	40.9	43.1	29.3	45.0	33.8	39.8	46.0	30.8	46.8	39.8	0.7	0.0	0.0	6.8	1.2	1.1	0.3	0.1	0.6	15.6	0.2	0.6	0.0	0.0	0.3	0.0	10.4	0.0	0.0	0.2	80.3	0.1	539.1	4.0	0.4	1.5	22.9	0.0	0.1	0.5	0.0	0.6	1.5	5.6	0.0	0.4	0.0	0.3	0.0	0.0	0.7	0.4	4.1	0.3	1.4	1891.7	7.8	1.5	1.8	1.9	0.0	5.6	0.0	1.0	0.5	0.3	1.2	6.0	1.4	0.2	0.4	9.2	0.1	4.6	26.3	78.3	18.6	187.6	7.0	0.2	0.6	0.0	0.6	0.1	0.2	0.5
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950370	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 452.5;Late spermatids: 661.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	12.9	8.2	10.4	12.0	11.5	11.8	12.5	15.4	13.0	10.8	9.4	10.9	6.0	11.8	7.3	11.9	9.2	10.8	11.5	11.2	10.4	7.8	8.2	10.0	14.2	11.6	11.1	13.2	6.8	12.1	5.4	11.7	11.1	10.3	8.4	14.4	9.5	10.8	32.3	8.1	7.8	11.6	9.5	14.7	8.2	11.8	11.8	14.7	10.2	17.6	13.9	10.5	8.5	14.7	18.1	14.2	24.4	36.0	17.3	19.7	22.5	20.2	19.1	19.8	17.2	41.4	13.1	30.1	17.9	27.1	24.4	10.7	22.6	28.2	24.1	13.7	9.6	55.8	26.3	15.6	17.3	27.2	20.8	15.6	38.8	21.0	32.2	23.5	22.1	21.0	23.3	18.8	23.1	10.8	27.6	15.9	12.0	11.9	17.5	20.0	35.9	17.9	15.9	12.4	21.9	17.9	36.0	41.0	18.4	21.8	32.6	20.0	31.1	43.7	9.9	23.0	21.0	17.2	22.0	21.5	32.2	19.5	22.9	17.3	11.2	33.1	12.4	11.5	13.6	15.0	12.5	14.6	10.6	11.1	14.0	14.7	25.9	16.0	16.9	9.9	7.2	9.0	10.4	11.5	15.4	13.0	11.2	10.4	11.6	11.1	11.1	9.5	11.8	14.7	51.2	38.5	41.8	28.4	131.1	34.8	76.6	52.5	31.3	77.4	49.8	53.5	62.2	31.5	43.5	38.6	98.0	106.7	191.0	16.3	37.2	29.8	452.5	39.8	41.6	46.3	36.0	37.6	49.7	19.9	52.5	53.6	23.0	34.7	142.4	41.2	47.2	18.2	54.5	114.4	49.5	27.9	30.5	62.7	84.3	661.6	35.8	87.1	39.2	62.8	62.6	50.0	105.0	34.2	55.2	24.1	26.5	53.4	76.9	60.0	14.0	24.8	50.2	80.7	19.7	65.5	50.6	60.4	47.0	29.8	28.3	22.3	127.8	30.1	28.8	55.4
PHKB		ENSG00000102893	"Phosphorylase kinase regulatory subunit beta"	Q93100	16	47461123-47701523	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	Calmodulin-binding	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 159.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073380			Approved	"Golgi apparatus"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA073380: AB_2686598"	"unprognostic (2.87e-3)"	"unprognostic (2.41e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.98e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (3.89e-9)"	"unprognostic (3.56e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (2.53e-2)"	29.7	42.4	15.8	21.9	16.2	28.2	36.1	18.3	19.5	33.8	34.1	39.0	37.8	26.8	32.8	34.5	25.6	30.6	32.7	14.3	21.3	47.2	30.1	30.0	26.2	15.8	16.0	24.2	26.6	56.7	21.6	37.1	18.6	36.2	41.5	18.9	46.1	32.2	159.0	18.9	38.0	32.1	13.8	29.0	40.4	30.6	18.9	31.0	54.1	80.7	29.0	26.5	21.2	16.6	36.7	53.3	60.3	39.1	41.2	38.8	74.9	42.8	41.2	30.1	15.0	29.4	62.2	44.5	63.5	62.7	23.7	50.6	57.0	66.9	42.3	13.8	29.8	42.1	45.4	98.3	37.0	46.2	47.7	35.1	33.4	20.3	38.2	65.4	59.8	53.5	58.8	27.4	43.7	26.3	45.2	44.1	25.5	61.1	39.8	75.7	73.3	74.3	59.2	31.1	31.5	35.8	70.9	92.4	12.0	66.1	36.0	37.7	66.5	54.4	25.4	28.0	22.9	31.1	24.6	57.2	34.5	30.2	22.7	11.1	21.0	18.4	11.8	18.9	15.3	30.6	12.2	9.7	20.6	34.7	11.8	11.7	10.4	18.5	23.7	13.9	15.8	12.6	15.8	16.2	18.3	19.5	14.3	21.3	15.8	16.0	18.6	13.8	18.9	16.6	49.3	19.2	38.0	66.9	46.8	8.9	17.5	28.8	18.8	34.9	28.7	23.4	61.2	32.9	39.9	42.3	100.1	48.5	29.3	43.1	23.5	19.6	64.7	33.5	31.1	42.9	30.5	40.1	109.8	15.6	26.3	28.8	47.9	38.3	18.3	52.6	39.3	30.9	28.4	23.5	149.0	37.8	20.3	58.7	17.0	89.8	25.4	45.1	8.8	104.0	72.2	25.8	32.0	133.2	118.4	27.2	26.4	35.7	28.1	30.2	48.9	35.9	26.7	71.8	26.3	33.3	30.6	53.9	19.5	47.2	7.2	33.8	24.7	74.9	38.6	26.7
PHTF2	DKFZp434D166	ENSG00000006576	"Putative homeodomain transcription factor 2"	Q8N3S3	7	77798792-77957503	"Predicted membrane proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.7;tongue: 57.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 109.1;Inhibitory neurons: 94.6;Oligodendrocyte precursor cells: 91.5;Oligodendrocytes: 144.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 25.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012312	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA012312: AB_2668649"	"unprognostic (1.96e-1)"	"unprognostic (2.60e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.99e-3)"	"unprognostic (5.36e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.09e-7)"	"unprognostic (8.28e-3)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (5.53e-2)"	7.9	4.8	3.7	13.1	4.6	12.3	7.1	5.0	6.3	8.7	2.7	6.0	4.0	8.7	5.2	8.6	5.4	10.7	13.0	4.6	3.8	5.7	6.3	7.6	18.1	4.1	3.2	8.2	4.5	26.3	4.6	11.0	3.7	6.7	6.6	7.2	5.0	8.0	112.7	6.8	8.0	11.9	3.9	12.8	4.4	10.0	3.9	9.1	6.5	57.7	17.6	11.7	5.8	7.2	34.6	15.5	20.9	42.6	17.8	19.5	17.3	59.6	54.1	34.9	39.3	26.6	27.3	31.0	4.8	46.4	37.8	27.9	30.1	15.5	49.3	20.9	24.0	12.7	16.7	7.8	19.3	16.9	33.5	11.6	14.5	20.4	30.4	22.4	12.6	17.1	21.0	53.1	37.7	21.7	14.0	10.9	18.9	9.6	18.2	13.8	42.3	25.4	9.6	45.9	20.0	27.9	33.4	37.5	21.9	30.5	39.7	13.0	12.9	59.7	31.9	34.0	35.5	24.9	31.1	38.3	18.9	26.7	52.5	14.1	2.7	4.6	1.8	11.7	3.7	8.2	5.6	1.7	2.8	5.3	1.7	1.8	1.6	5.1	25.4	1.2	8.2	2.7	3.7	4.6	5.0	6.3	4.6	3.8	4.1	3.2	3.7	3.9	3.9	7.2	12.8	6.4	15.2	31.6	54.0	15.9	20.9	9.0	21.1	8.7	13.2	10.0	23.8	14.3	10.8	7.3	12.5	13.7	18.4	8.9	0.0	4.4	27.4	8.1	20.9	9.6	5.4	8.4	109.1	6.7	8.6	18.3	7.7	12.5	39.2	26.7	18.9	5.7	11.7	3.3	94.6	6.6	22.4	32.7	32.6	4.5	12.2	39.7	10.6	47.8	11.1	4.7	10.3	91.5	144.4	5.7	5.6	13.5	34.8	9.0	2.3	2.2	9.7	9.0	13.1	15.1	15.3	47.6	39.2	14.4	17.8	14.8	54.2	14.7	4.8	21.5
PITX2	"ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS"	ENSG00000164093	"Paired like homeodomain 2"	Q99697	4	110617423-110642123	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.0;skeletal muscle: 43.2;urinary bladder: 29.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 19.2;Fibroblasts: 69.6;Paneth cells: 20.6;Proximal enterocytes: 39.7;Skeletal myocytes: 49.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"hypothalamus: 17.8;thalamus: 6.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.8;HEK 293: 10.5;LHCN-M2: 25.1;RH-30: 20.5"					"Group enriched"	"Detected in some"	25	"hypothalamus: 5.4;midbrain: 1.5"	"HPA050074, HPA062728"			Enhanced	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA050074: AB_2681005, HPA062728: AB_2684851"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.61e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-15)"	"unprognostic (6.97e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.98e-2)"	"unprognostic (9.91e-2)"	0.2	0.0	0.0	7.8	0.2	0.0	0.4	0.0	0.0	1.6	0.0	3.8	0.0	0.1	0.0	2.6	0.2	1.1	2.0	0.0	17.8	0.2	0.0	0.0	0.0	0.1	2.8	0.0	0.5	0.0	16.1	42.0	0.2	0.9	0.2	0.0	13.5	0.1	43.2	1.5	3.1	0.5	0.2	0.0	0.5	0.5	6.8	0.0	0.0	12.3	0.0	29.8	3.8	0.0	1.4	2.6	0.0	1.0	2.4	2.1	4.0	0.8	0.4	2.6	2.0	24.8	0.0	0.0	5.2	5.1	3.2	0.4	0.1	0.0	1.4	0.0	10.5	0.0	2.0	0.0	8.8	0.0	5.0	2.5	0.2	0.5	0.0	0.8	0.0	2.7	0.6	0.0	25.1	0.7	2.7	0.0	0.4	0.0	0.5	0.0	20.5	0.0	0.4	3.4	0.0	0.0	2.0	3.3	0.3	0.4	0.2	0.0	0.0	3.1	7.5	0.0	4.1	0.1	0.1	1.0	1.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	17.8	0.1	2.8	0.2	0.2	6.8	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.2	0.0	0.1	0.3	19.2	0.0	0.1	0.0	0.0	5.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.4	5.7	69.6	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	9.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.2	39.7	2.3	0.0	0.0	0.0	49.8	5.4	2.3	7.0	1.7	0.1	10.5	0.0	0.0	14.1	0.1
PKIA	PRKACN1	ENSG00000171033	"CAMP-dependent protein kinase inhibitor alpha"	P61925	8	78516340-78605267	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 1160.4;tongue: 953.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 104.8;Cardiomyocytes: 367.0;Excitatory neurons: 103.3;Inhibitory neurons: 78.2;Muller glia cells: 82.8;Oligodendrocyte precursor cells: 82.9"	"Cancer enhanced"	"Detected in many"		"glioma: 15.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 21.4"	"Lineage enriched"	"Detected in many"	9	"T-cells: 21.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 63.9;HUVEC TERT2: 104.0;RT4: 100.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042791	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA042791: AB_10795761"	"unprognostic (3.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.59e-6)"	"unprognostic (8.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.65e-3)"	"unprognostic (3.25e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.52e-3)"	2.5	9.5	44.4	5.6	49.3	2.7	4.1	41.4	49.2	2.2	11.9	3.5	1.2	3.1	3.0	21.5	5.3	8.2	185.9	49.8	44.0	4.7	0.2	8.6	7.6	25.4	34.3	5.8	1.4	108.1	8.0	1.6	36.0	20.3	2.8	33.7	6.2	5.3	1160.4	9.2	2.5	2.6	35.2	4.1	1.6	1.3	48.1	26.3	34.2	953.8	11.0	9.5	3.6	36.2	0.6	0.3	34.2	0.0	18.5	4.8	0.2	32.1	6.3	3.4	7.2	0.0	5.3	14.8	0.2	4.8	3.3	0.5	11.3	10.3	22.3	63.9	24.6	18.5	3.7	0.2	1.2	0.0	10.3	7.7	1.5	0.0	9.6	45.5	104.0	19.8	0.0	15.8	51.4	5.4	28.3	0.0	8.1	0.0	35.3	0.0	29.3	0.0	18.7	100.2	16.6	32.5	4.1	26.4	0.0	8.9	0.0	0.1	41.2	7.8	6.4	1.8	19.2	6.5	6.9	4.9	36.9	0.1	9.8	0.0	0.0	0.0	0.5	0.1	0.4	2.3	9.1	1.8	0.1	2.2	7.7	4.6	0.4	1.7	0.1	0.2	21.4	2.5	44.4	49.3	41.4	49.2	49.8	44.0	25.4	34.3	36.0	35.2	48.1	36.2	0.6	3.2	2.8	104.8	9.8	5.9	8.8	4.5	19.9	40.2	2.6	6.5	367.0	0.0	2.0	1.8	2.1	3.1	2.7	0.4	1.9	0.0	13.9	0.9	0.2	9.1	10.2	4.2	103.3	0.2	2.8	12.3	0.0	1.3	5.7	18.6	2.5	0.0	0.7	58.9	78.2	0.8	6.1	0.0	1.1	5.9	0.0	3.9	3.6	15.0	0.5	82.8	0.0	82.9	17.9	1.5	0.1	0.4	2.3	6.1	0.0	0.1	1.0	6.9	0.0	22.9	4.8	0.4	0.6	13.9	13.8	3.4	8.0	0.1	0.3	3.6
PPP1R1A		ENSG00000135447	"Protein phosphatase 1 regulatory inhibitor subunit 1A"	Q13522	12	54575387-54588659	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 259.7;skeletal muscle: 831.6;tongue: 271.1"	"Cell type enriched"	"Detected in many"	4	"Distal tubular cells: 1348.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 8.8;NTERA-2: 29.4;RPTEC TERT1: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007811, HPA041542"	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB007811: AB_598171, HPA041542: AB_2677542"	"unprognostic (6.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (8.49e-3)"	"unprognostic (7.49e-2)"	241.3	2.6	37.1	1.1	73.6	0.3	169.8	26.1	45.7	1.6	20.4	29.6	3.0	2.2	0.7	10.3	3.8	1.5	110.9	38.9	36.9	259.7	138.1	1.0	0.5	29.0	32.0	7.7	14.2	20.8	1.8	0.0	26.0	7.9	1.8	14.6	9.7	3.2	831.6	7.6	13.2	3.3	25.5	0.5	27.8	2.2	31.6	0.2	2.6	271.1	0.5	5.4	1.5	34.1	0.0	0.0	3.9	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	5.4	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	29.4	0.0	0.0	0.0	0.0	0.2	32.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	73.6	26.1	45.7	38.9	36.9	29.0	32.0	26.0	25.5	31.6	34.1	7.9	0.0	0.0	3.3	3.4	0.1	0.0	0.0	0.0	2.2	23.7	40.6	300.7	5.7	0.0	18.4	0.0	0.0	0.5	0.0	1348.0	3.5	1.6	10.4	0.5	4.6	2.4	2.7	3.1	0.4	0.1	24.5	0.0	13.8	0.0	21.0	6.4	218.4	0.6	112.7	1.8	2.1	0.0	3.8	0.0	1.9	1.2	1.6	0.0	0.0	0.0	3.7	0.0	0.0	0.5	2.5	0.1	1.2	0.0	0.3	0.5	156.8	0.0	2.8	0.0	19.2	21.6	0.2	5.9	0.0	0.3	0.0	0.9	4.2	2.0	0.2
PPP1R3A	"GM, PPP1R3"	ENSG00000154415	"Protein phosphatase 1 regulatory subunit 3A"	Q16821	7	113876777-114075920	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	64	"heart muscle: 40.8;skeletal muscle: 152.9;tongue: 104.1"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 157.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"THP-1: 14.6"	"Region enriched"	"Detected in single"	12	"thalamus: 1.1"	"Not detected"	"Not detected"			"HPA070440, HPA073138"	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA070440: , HPA073138: "						"unprognostic (8.96e-3)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	0.0	152.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	104.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.8	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP1R3C	"PPP1R5, PTG"	ENSG00000119938	"Protein phosphatase 1 regulatory subunit 3C"	Q9UQK1	10	91628442-91633071	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 908.0;tongue: 448.5"	"Group enriched"	"Detected in many"	8	"Astrocytes: 201.8;Cardiomyocytes: 232.0;Hepatocytes: 64.2;Muller glia cells: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 41.9;HHSteC: 51.7;hTERT-RPE1: 85.4;LHCN-M2: 102.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027041	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA027041: AB_1855649"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.44e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.61e-3)"	14.1	12.2	39.3	3.4	51.5	0.0	9.9	39.8	44.6	97.1	21.4	16.2	4.0	10.3	12.0	106.8	10.2	14.4	170.5	40.1	42.9	11.6	164.2	12.3	1.4	44.1	55.1	10.2	18.7	4.5	5.7	15.6	43.9	29.1	4.1	83.2	28.4	35.7	908.0	17.0	5.8	15.4	39.6	3.0	17.5	2.5	42.4	0.5	2.7	448.5	6.2	19.8	136.7	38.0	0.0	6.6	1.8	26.8	11.9	5.6	0.0	29.8	23.2	12.0	12.8	0.0	2.2	0.0	1.2	28.0	4.8	1.6	0.7	3.2	22.0	0.0	0.1	0.4	41.9	4.8	51.7	0.0	0.0	19.1	5.2	7.6	0.4	85.4	3.0	0.0	14.4	0.0	102.5	1.0	0.0	0.0	1.7	0.0	0.0	0.0	6.4	0.0	1.1	26.2	0.9	1.8	0.0	0.0	0.0	0.0	0.2	4.5	20.3	5.3	5.2	7.0	4.3	0.2	0.6	0.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	51.5	39.8	44.6	40.1	42.9	44.1	55.1	43.9	39.6	42.4	38.0	2.4	0.0	0.0	201.8	0.4	4.6	9.3	0.8	0.6	9.7	4.8	2.5	232.0	1.5	0.2	3.7	0.0	0.2	0.0	0.3	7.9	3.1	0.1	0.3	0.7	3.5	10.1	0.0	1.7	11.4	0.5	11.9	0.0	0.6	0.0	0.4	2.5	64.2	1.4	18.5	3.0	0.5	2.0	1.6	1.5	0.1	2.8	0.6	12.4	5.6	0.0	133.1	0.0	3.5	0.5	4.0	0.1	7.5	0.0	2.5	0.0	1.8	0.4	12.8	0.0	9.4	18.6	0.7	1.7	5.4	4.0	0.3	0.7	0.1	0.1	0.7
PPP2R3A	"PPP2R3, PR130, PR72"	ENSG00000073711	"Protein phosphatase 2 regulatory subunit B''alpha"	Q06190	3	135965728-136147894	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 51.2;skeletal muscle: 180.5;tongue: 117.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 115.3;Oligodendrocytes: 201.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 37.4;BJ hTERT+: 35.3;RPTEC TERT1: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035829, HPA035830, HPA065338"	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"		"HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475"	"unprognostic (3.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (8.92e-2)"	"prognostic favorable (1.15e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.91e-4)"	3.1	3.4	3.3	2.3	7.2	0.2	7.1	4.3	5.0	5.2	3.9	8.0	2.0	7.7	5.1	8.3	4.1	5.0	51.2	4.2	4.9	22.0	1.1	3.9	0.6	5.7	5.5	5.6	3.4	11.7	1.8	2.8	5.3	5.9	5.4	2.6	8.9	6.5	180.5	18.9	2.3	9.6	4.3	1.1	7.4	7.2	6.0	0.6	3.1	117.6	1.2	4.5	4.0	13.7	37.4	2.0	10.3	5.0	8.1	10.2	11.9	28.5	35.3	13.2	16.3	2.4	2.4	0.1	10.7	29.3	9.5	4.7	4.3	10.0	28.3	0.1	1.4	1.6	1.0	0.1	5.8	0.0	1.4	9.3	8.5	16.8	7.8	13.3	12.8	1.0	1.0	0.1	19.2	6.2	0.3	0.2	7.2	0.4	6.9	0.1	15.1	0.1	46.2	1.4	0.7	5.7	4.7	5.7	10.9	9.2	9.1	0.5	8.4	13.7	7.5	18.8	12.7	0.4	1.0	0.1	10.1	0.8	4.9	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	3.3	7.2	4.3	5.0	4.2	4.9	5.7	5.5	5.3	4.3	6.0	13.7	7.9	28.9	27.6	51.6	2.8	26.4	19.5	7.1	19.4	5.7	19.9	15.5	115.3	8.6	10.0	55.2	0.0	10.9	6.7	25.3	21.5	20.6	8.4	9.9	19.0	11.4	13.1	0.4	35.2	9.9	15.4	14.8	21.9	16.1	3.8	15.7	8.6	2.9	2.5	3.3	47.2	6.9	6.1	2.4	9.8	10.7	24.5	3.2	28.4	13.1	9.6	8.9	2.1	72.4	201.1	17.2	10.6	18.4	1.5	17.8	21.7	40.1	8.1	2.6	6.6	29.0	14.0	10.1	18.6	15.3	33.2	10.4	3.4	6.7	8.9	15.6
PPP3CB	"CALNA2, CALNB, CNA2, PP2Bbeta"	ENSG00000107758	"Protein phosphatase 3 catalytic subunit beta"	P16298	10	73436433-73496024	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 379.3;tongue: 179.7"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 119.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008233, HPA008823"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA008233: AB_1855661, HPA008823: AB_2668148"	"unprognostic (3.05e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.28e-2)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	44.8	37.5	40.5	29.8	51.1	19.8	32.1	49.5	63.1	30.3	26.7	41.4	24.2	40.3	34.5	33.1	30.9	28.3	41.3	56.9	29.5	28.1	21.8	23.5	34.9	25.4	25.2	39.6	25.3	39.2	30.6	25.5	28.7	39.1	29.6	57.0	26.6	39.8	379.3	26.3	22.6	48.2	27.2	25.3	24.3	29.0	29.1	32.9	23.5	179.7	36.1	34.3	24.3	44.9	53.7	29.0	50.9	53.0	71.4	98.3	24.5	48.0	65.7	46.1	45.4	18.6	26.8	47.1	15.3	70.0	21.8	28.1	41.6	36.9	64.5	66.6	34.0	20.3	25.0	35.5	42.7	45.2	40.2	70.1	43.5	43.6	58.1	84.7	32.3	40.6	25.6	54.0	94.1	16.9	40.7	41.6	20.7	23.3	83.8	26.9	27.7	22.4	45.1	25.6	27.2	31.5	28.1	69.5	36.4	42.1	52.4	43.2	35.6	36.6	33.7	29.5	66.1	35.8	105.3	33.0	45.3	64.0	21.3	2.2	2.0	3.5	4.0	2.7	4.8	2.7	4.3	4.4	2.1	2.3	3.4	5.1	1.1	3.5	1.7	4.0	7.8	1.9	40.5	51.1	49.5	63.1	56.9	29.5	25.4	25.2	28.7	27.2	29.1	44.9	23.0	3.2	14.3	72.5	31.6	25.6	29.8	13.2	27.3	54.8	25.7	16.9	48.9	14.3	12.8	18.4	20.9	21.0	23.7	11.1	62.6	18.1	11.8	20.0	24.2	21.5	42.6	30.7	119.5	19.4	16.8	32.6	20.4	18.8	21.0	35.4	18.9	14.2	20.3	38.7	111.0	13.2	18.3	31.7	24.2	9.9	33.5	25.2	26.6	51.5	29.6	34.8	18.6	79.4	54.4	16.7	12.9	29.0	34.1	27.1	13.4	34.2	17.6	30.1	6.6	41.8	36.4	43.8	49.2	32.1	31.5	22.2	27.3	28.4	13.1	22.1
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105273218-105454062	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 79.7;Syncytiotrophoblasts: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol		NA	NA		1700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857"	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	17.3	17.4	7.2	14.6	8.1	14.3	17.7	7.4	12.0	15.2	7.8	32.1	23.6	15.8	12.1	21.1	13.0	8.7	22.5	8.8	7.3	11.3	19.0	16.2	13.6	6.7	7.7	16.0	19.2	20.5	13.0	17.8	6.8	11.6	37.5	15.4	18.6	9.0	84.8	33.4	25.6	15.3	6.6	14.3	18.7	21.4	8.8	16.4	12.3	46.9	16.2	21.4	17.5	8.5	22.3	26.9	27.9	32.1	63.1	37.1	27.7	28.6	27.0	37.2	39.0	35.9	14.2	28.5	26.8	33.9	35.0	33.3	41.8	86.5	42.7	41.8	37.4	38.1	21.7	40.0	25.3	40.5	26.2	35.8	53.4	27.6	71.7	28.0	35.4	50.1	67.4	49.8	45.5	38.8	25.8	41.4	27.9	44.2	25.0	41.1	48.4	18.3	28.2	53.8	36.0	51.8	25.3	42.0	21.7	35.3	17.9	61.9	36.1	17.3	23.9	21.6	36.2	14.2	9.7	38.5	30.4	42.6	56.6	5.5	15.2	8.4	16.3	16.8	16.8	9.3	14.2	17.1	16.5	6.9	12.9	15.5	0.8	19.9	22.7	7.0	13.6	13.5	7.2	8.1	7.4	12.0	8.8	7.3	6.7	7.7	6.8	6.6	8.8	8.5	6.3	3.2	6.7	22.9	10.1	10.8	6.8	12.0	5.7	5.1	6.0	5.5	14.8	7.2	13.6	7.3	14.6	28.2	14.5	19.3	5.9	10.4	1.4	6.6	15.1	10.1	19.3	11.2	79.7	11.7	35.9	10.6	24.5	11.6	13.4	11.2	7.5	15.1	15.0	13.5	48.3	29.4	10.2	14.2	10.8	3.2	10.8	13.3	5.4	27.2	19.1	3.3	5.2	28.6	18.7	18.0	29.1	9.1	11.0	5.3	18.5	8.8	4.8	10.4	0.0	8.3	10.3	3.9	18.8	12.9	8.5	67.9	16.1	14.4	38.2	8.5
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 33.6;skeletal muscle: 124.5;tongue: 112.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.9;dendritic cells: 22.4;NK-cells: 32.0;Oligodendrocyte precursor cells: 24.6;Oligodendrocytes: 75.2;T-cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.0;MAIT T-cell: 18.0;memory CD4 T-cell: 24.5;memory CD8 T-cell: 24.5;naive CD4 T-cell: 19.1;naive CD8 T-cell: 17.9;NK-cell: 13.3;T-reg: 39.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 13.3;T-cells: 39.7"	"Cell line enhanced"	"Detected in many"		"HEL: 57.8;JURKAT: 40.0;MOLT-4: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"		"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (3.51e-2)"	0.8	0.7	5.3	5.2	8.5	5.7	0.9	6.1	6.3	1.6	12.1	1.4	1.5	2.5	8.3	2.2	3.9	1.5	0.3	5.5	8.2	10.9	1.0	5.3	12.3	6.5	8.6	1.3	3.4	0.7	0.8	0.2	6.4	1.8	1.7	1.5	1.4	1.1	124.5	0.3	3.3	0.7	5.5	5.0	2.1	1.1	7.2	33.6	14.9	112.6	9.4	2.2	0.6	9.8	0.1	5.3	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.2	0.4	3.4	0.3	0.0	0.0	0.0	0.0	3.3	6.0	0.0	0.0	3.9	57.8	0.0	0.4	0.7	2.8	0.6	0.3	3.5	0.1	0.2	0.0	0.5	40.0	12.8	0.1	0.0	0.0	43.9	8.0	5.8	0.5	0.0	8.5	1.3	0.0	11.6	2.9	0.4	2.1	0.0	0.0	0.0	3.4	0.0	5.8	0.0	0.0	5.6	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	2.4	0.1	0.3	23.0	0.4	18.0	0.1	24.5	24.5	0.2	0.0	19.1	17.9	1.6	13.3	0.0	0.0	39.7	10.5	5.3	8.5	6.1	6.3	5.5	8.2	6.5	8.6	6.4	5.5	7.2	9.8	0.2	3.2	7.0	22.9	0.8	0.0	0.3	0.3	0.6	1.6	0.3	0.3	0.4	0.0	0.7	1.8	0.0	0.0	22.4	0.0	7.9	0.3	2.1	0.5	1.2	0.2	1.8	8.0	13.7	0.8	0.1	0.7	1.5	3.0	1.3	8.2	1.1	0.0	0.5	0.0	14.7	0.5	0.0	1.3	0.5	5.6	0.0	1.7	0.0	7.5	0.8	1.2	32.0	24.6	75.2	0.1	0.1	0.0	10.2	0.2	0.0	0.3	0.9	0.4	0.0	4.2	0.4	1.0	2.2	0.5	0.0	0.0	31.7	0.3	0.4	0.1
PRKRA	"DYT16, HSD14, PACT, RAX"	ENSG00000180228	"Protein activator of interferon induced protein kinase EIF2AK2"	O75569	2	178431292-178451512	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	RNA-binding	"Disease variant, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 307.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004648, HPA034996, HPA034997"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB004648: AB_425767, HPA034996: AB_2674402, HPA034997: AB_2674403"	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-3)"	"unprognostic (8.99e-2)"	"prognostic favorable (5.45e-4)"	"unprognostic (1.38e-1)"	"unprognostic (6.78e-2)"	28.7	21.9	22.1	13.8	22.6	18.2	26.4	24.6	31.3	23.6	25.3	36.4	13.7	28.7	25.7	22.8	23.4	17.5	37.2	22.8	24.9	29.7	20.2	21.2	16.9	25.0	22.5	23.4	25.4	26.2	22.5	11.5	24.2	23.4	20.1	30.9	22.6	24.3	100.7	31.2	19.7	29.4	25.2	15.9	26.0	24.3	23.1	20.4	22.1	72.7	20.4	32.1	22.0	27.1	24.6	18.4	48.2	20.8	49.2	56.7	39.6	35.4	37.7	46.4	50.8	50.9	33.8	51.0	39.8	43.6	30.9	21.0	42.0	28.5	50.9	43.9	25.0	29.2	17.0	46.7	58.6	21.2	16.1	32.2	69.3	44.0	49.7	46.0	46.8	32.8	26.7	34.9	62.9	25.3	46.3	52.2	46.7	42.3	33.5	38.5	89.0	46.6	52.4	25.5	30.2	39.4	21.9	20.2	48.3	36.3	30.6	27.4	20.8	32.0	42.6	33.8	29.9	52.5	33.7	62.6	40.8	35.1	20.7	5.4	24.7	25.9	18.1	25.5	26.2	34.3	28.4	22.7	37.2	26.4	31.4	25.8	5.1	25.2	26.3	49.7	38.3	30.9	22.1	22.6	24.6	31.3	22.8	24.9	25.0	22.5	24.2	25.2	23.1	27.1	35.1	16.0	33.4	23.2	37.7	63.1	90.0	89.3	30.1	53.6	48.1	40.3	43.5	20.0	39.9	25.8	43.8	37.7	49.3	16.9	125.2	51.4	149.5	43.6	36.2	34.5	47.9	19.1	39.5	41.6	53.2	42.7	19.4	27.0	28.5	40.5	21.8	18.5	30.4	10.1	46.4	35.5	93.6	19.8	69.4	307.9	39.4	26.4	69.4	21.5	38.6	49.2	9.2	30.7	47.1	36.0	25.1	37.2	42.5	94.7	30.8	89.0	30.6	86.2	46.0	45.6	66.7	78.7	57.6	43.7	78.4	43.4	33.6	47.0	39.6	73.0
PRR16	DSC54	ENSG00000184838	"Proline rich 16"	Q569H4	5	120464300-120687332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 30.4"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 171.6;Inhibitory neurons: 188.9"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.3;BJ hTERT+: 83.9;fHDF/TERT166: 102.1;HSkMC: 62.5;hTERT-RPE1: 103.0;LHCN-M2: 97.9;U-138 MG: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049254	Approved		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Midbody, Cytosol"	"HPA049254: AB_2680693"	"unprognostic (1.71e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.61e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-8)"	"unprognostic (3.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.38e-3)"	11.0	2.8	2.0	5.2	2.1	0.2	7.9	6.1	3.5	14.9	0.0	5.1	1.7	11.8	1.5	1.8	7.0	5.7	12.7	2.2	5.1	3.0	0.9	9.8	1.1	3.4	1.8	5.6	2.0	1.1	1.7	9.7	3.2	9.3	4.5	7.0	2.6	2.4	26.4	4.0	5.0	8.2	0.7	2.5	4.0	2.4	2.3	0.7	4.4	30.4	0.9	9.5	10.0	1.4	3.7	0.0	8.0	0.0	22.2	77.3	0.0	37.0	83.9	51.5	39.1	0.0	0.2	0.0	0.0	102.1	9.3	0.0	8.1	0.9	53.8	0.0	1.9	0.0	1.2	0.0	21.5	0.2	0.1	62.5	8.9	15.4	48.0	103.0	1.7	0.0	0.1	0.1	97.9	0.0	0.0	0.0	0.9	0.0	1.4	0.0	6.2	0.0	4.3	0.0	0.3	16.1	0.1	0.0	1.1	6.1	0.1	0.1	0.5	117.9	13.3	3.8	19.4	0.3	0.0	0.0	6.7	0.2	4.1	0.1	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.3	2.0	2.1	6.1	3.5	2.2	5.1	3.4	1.8	3.2	0.7	2.3	1.4	1.4	0.0	0.0	14.0	0.4	1.3	6.2	0.0	0.0	7.5	1.5	1.9	3.2	0.0	0.0	0.0	14.6	0.1	0.1	0.0	0.0	0.1	16.8	0.9	18.9	0.8	0.0	0.0	171.6	0.0	0.0	13.5	0.0	0.8	0.0	0.2	0.4	0.0	0.5	15.2	188.9	0.0	0.0	1.8	2.7	11.6	2.8	1.0	1.8	9.4	0.1	2.6	0.0	7.5	3.9	0.2	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.7	0.0	1.4	9.6	0.9	1.4	0.5	0.6	0.5	0.4	3.1	0.0	0.7
PRR32	CXorf64	ENSG00000183631	"Proline rich 32"	B1ATL7	X	126819729-126821786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"tongue: 22.4"	"Cell type enriched"	"Detected in single"	13	"Cardiomyocytes: 1.3"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 3.5;hippocampal formation: 10.7;pons and medulla: 13.5;thalamus: 8.2"	"Not detected"	"Not detected"			HPA048386	Uncertain		Approved	"Nuclear speckles,Plasma membrane,Centrosome"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear speckles, Centrosome"	"HPA048386: AB_2680380"					"unprognostic (7.10e-3)"	"unprognostic (7.97e-2)"				"unprognostic (3.79e-1)"						"unprognostic (2.98e-2)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	4.1	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	22.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSME4	"KIAA0077, PA200"	ENSG00000068878	"Proteasome activator subunit 4"	Q14997	2	53864069-53970993	"Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.8"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 238.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060922	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060922: AB_2684386"	"unprognostic (2.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (7.26e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (4.76e-2)"	"unprognostic (6.67e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-1)"	7.4	8.6	5.3	8.1	8.8	16.1	12.1	5.7	7.4	15.4	11.1	9.8	5.9	16.1	6.2	8.8	8.0	11.9	16.9	6.4	7.1	7.0	16.6	8.0	11.1	7.1	7.0	6.7	7.9	8.3	6.8	8.5	6.4	10.0	8.4	8.9	14.5	7.4	59.8	7.2	7.1	15.0	5.0	9.5	10.6	33.6	8.1	10.7	14.4	45.2	12.2	13.2	8.1	12.6	28.0	18.3	27.6	8.5	9.1	19.4	18.1	29.1	25.6	29.3	23.6	28.3	10.6	38.7	26.1	29.4	14.1	18.1	32.1	23.5	52.7	29.4	18.8	59.8	18.3	38.5	11.7	32.1	17.1	14.8	14.2	33.1	26.6	12.1	30.4	10.1	48.1	24.0	26.3	10.9	19.5	15.4	26.7	13.7	15.4	22.8	41.9	25.3	15.7	27.1	20.6	23.1	18.2	23.9	14.8	17.4	18.1	12.7	39.6	25.5	21.4	19.7	27.0	17.1	16.6	24.9	20.1	26.4	16.1	0.5	0.1	0.5	0.7	0.3	0.4	0.6	0.4	0.4	0.3	0.9	0.5	0.7	0.4	0.6	0.2	0.4	0.3	0.1	5.3	8.8	5.7	7.4	6.4	7.1	7.1	7.0	6.4	5.0	8.1	12.6	20.0	16.0	35.0	58.1	33.1	75.8	72.4	37.4	60.9	20.6	40.0	19.6	63.5	20.0	45.4	22.0	45.9	16.1	51.0	20.1	3.9	20.8	99.7	60.0	49.6	27.3	40.6	28.8	100.3	37.1	12.8	27.2	41.3	97.0	28.5	34.9	18.5	34.3	19.5	25.2	83.5	19.5	30.5	28.7	47.7	92.5	21.1	35.1	28.4	71.2	28.0	15.7	36.0	64.3	238.5	43.6	9.3	10.5	61.3	92.5	8.7	10.3	39.0	27.8	13.1	48.9	26.5	36.0	18.0	79.3	66.1	29.7	42.6	14.0	18.8	107.3
PTGES3L		ENSG00000267060	"Prostaglandin E synthase 3 like"		17	42968088-42980433	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	7	"heart muscle: 41.4;skeletal muscle: 124.3;tongue: 95.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 45.6;Cone photoreceptor cells: 8.4;Early spermatids: 13.1;Spermatocytes: 8.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 4.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 4.1"	"Cell line enhanced"	"Detected in many"		"THP-1: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.80e-4)"	"unprognostic (9.24e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.08e-2)"	0.9	0.6	1.9	1.4	3.1	3.0	1.1	2.1	2.8	1.5	1.8	13.2	1.4	8.2	1.4	3.4	2.5	1.6	41.4	1.9	1.5	0.6	0.3	0.7	1.1	1.6	1.5	0.6	0.5	0.4	1.3	0.5	1.8	2.9	2.8	1.7	2.4	3.4	124.3	1.0	2.5	7.2	1.1	0.7	3.4	2.2	1.5	0.6	0.8	95.1	0.9	5.7	1.2	2.4	0.8	0.6	1.9	2.8	0.1	0.3	1.6	1.2	0.5	1.0	0.6	1.7	0.7	0.7	0.5	0.5	1.0	1.6	1.4	1.5	1.9	0.5	0.7	4.3	3.1	3.1	0.1	0.8	7.1	0.5	1.1	2.2	1.8	0.7	0.3	3.1	1.8	1.4	2.1	0.7	2.8	2.1	1.8	2.2	0.6	1.4	6.3	0.7	1.7	1.5	1.5	4.9	1.3	3.4	2.0	2.2	1.9	16.7	0.4	2.0	1.8	0.6	1.2	3.0	2.1	0.8	0.3	1.0	0.7	0.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.5	0.3	0.1	4.1	0.1	0.4	1.9	3.1	2.1	2.8	1.9	1.5	1.6	1.5	1.8	1.1	1.5	2.4	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.8	1.5	1.3	45.6	0.0	0.1	0.0	8.4	0.1	2.9	1.4	0.0	1.4	13.1	1.2	0.4	1.0	1.8	0.0	0.0	0.2	0.6	2.4	0.0	1.1	0.0	0.8	0.7	0.1	1.1	0.0	0.0	0.9	0.0	0.6	0.7	4.5	0.6	2.1	0.0	0.0	1.7	0.8	1.0	0.0	0.0	0.7	2.8	0.4	0.0	0.7	1.1	0.5	0.9	2.6	0.0	2.7	2.5	8.2	3.4	0.0	0.0	0.1	0.2	4.8	1.1	0.3
PTGES3L-AARSD1		ENSG00000108825	"PTGES3L-AARSD1 readthrough"	Q9BTE6	17	42950526-42980528	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 17.3;tongue: 10.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.5;granulocytes: 3.8;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"	"Cell line enhanced"	"Detected in many"		"RH-30: 4.9;THP-1: 10.8"									"HPA021408, HPA022869, HPA023714"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear membrane, Cytosol"		"HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412"	"unprognostic (6.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.34e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.13e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.91e-4)"	"unprognostic (1.83e-1)"	0.4	0.2	0.1	0.8	1.0	0.7	0.4	0.0	0.8	0.7	0.2	4.3	0.8	3.2	0.4	1.1	1.0	0.8	3.0	0.3	0.3	0.3	0.2	0.4	0.2	0.1	0.1	0.3	0.3	0.3	1.2	0.2	0.0	1.3	1.8	0.6	0.6	1.7	17.3	0.3	1.2	5.6	0.0	0.2	1.5	3.3	0.0	0.2	0.3	10.6	0.2	1.9	0.6	0.3	0.6	0.0	1.7	1.8	0.1	0.0	0.4	1.2	1.5	0.8	0.7	1.2	0.1	0.1	1.2	0.2	0.5	0.0	0.3	0.8	1.2	0.7	0.2	4.1	1.7	2.5	0.0	0.5	2.7	0.0	0.5	1.3	0.0	0.5	0.3	1.1	1.3	0.3	1.6	0.0	1.4	0.4	0.4	2.5	0.4	0.7	4.9	0.5	0.2	0.3	0.8	2.4	1.0	0.3	1.1	2.3	0.5	10.8	0.0	0.5	0.9	0.0	0.4	2.9	0.8	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.0	0.0	0.8	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0
PUDP	"DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A"	ENSG00000130021	"Pseudouridine 5'-phosphatase"	Q08623	X	6667865-7148158	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000292, HPA072672"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA000292: , HPA072672: AB_2732208"	"unprognostic (1.84e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.00e-3)"	"unprognostic (3.22e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (3.42e-2)"	8.3	9.1	8.3	12.4	8.8	3.5	8.8	9.2	8.6	9.3	10.6	17.4	18.0	6.4	4.8	8.4	19.9	8.2	20.4	8.0	10.3	15.1	9.8	11.9	16.8	9.0	8.7	10.4	6.7	8.4	3.7	20.1	9.7	6.9	12.3	7.4	11.1	7.7	33.0	5.1	12.3	10.9	8.8	8.9	19.3	4.4	10.1	13.3	10.3	20.2	14.1	9.2	7.2	9.6	48.0	42.1	68.4	28.3	34.7	34.0	11.8	14.8	15.7	18.6	18.7	64.2	28.7	21.9	31.5	16.5	61.5	14.4	31.7	37.9	28.1	20.1	60.4	23.4	15.7	35.7	16.3	20.7	24.4	16.5	14.6	50.7	23.0	12.1	56.2	27.2	45.3	17.8	29.3	23.3	22.5	30.6	29.1	19.9	21.1	16.2	26.0	60.8	26.7	18.0	15.4	16.1	12.7	24.4	25.5	59.6	27.2	18.9	17.4	10.4	6.6	43.7	13.0	55.6	0.2	33.8	15.9	11.5	21.5	2.6	17.8	2.2	7.4	18.9	7.6	8.1	7.8	7.1	13.6	5.9	5.8	6.5	1.9	6.8	19.3	4.3	12.2	10.1	8.3	8.8	9.2	8.6	8.0	10.3	9.0	8.7	9.7	8.8	10.1	9.6	6.6	12.8	4.6	0.0	7.8	0.0	4.1	0.0	5.7	3.9	5.2	3.9	0.0	15.7	3.7	18.4	4.2	48.0	2.4	20.8	9.8	21.1	0.4	10.7	5.3	7.0	0.0	3.4	0.0	16.9	27.6	4.6	10.2	6.1	1.3	10.7	6.8	11.1	22.1	5.0	0.0	10.7	0.0	19.8	0.0	1.6	6.2	8.3	0.0	0.0	13.2	11.9	1.0	0.0	0.0	19.7	20.8	4.9	14.6	8.0	23.5	24.6	5.1	3.9	6.6	6.1	4.0	11.1	15.9	6.0	0.0	28.2	4.8	9.4	14.6	6.1
RAB12		ENSG00000206418	"RAB12, member RAS oncogene family"	Q6IQ22	18	8609437-8639382	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 96.4;Inhibitory neurons: 46.3;Microglial cells: 45.9;Oligodendrocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040727	Approved		Approved	Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA040727: AB_10794858"	"unprognostic (7.92e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.11e-2)"	36.8	26.2	27.0	17.8	29.8	13.6	27.9	31.6	33.9	28.3	21.6	34.9	11.8	29.7	19.6	28.8	26.7	18.5	85.4	30.0	31.3	31.4	36.5	30.3	20.9	25.3	27.3	31.0	13.4	21.7	21.3	30.0	25.8	22.7	16.9	22.6	18.0	29.7	193.8	31.5	20.2	34.3	28.3	28.0	19.2	12.0	32.7	15.2	19.8	106.6	20.8	29.0	25.3	27.2	33.1	19.4	22.1	23.2	64.3	54.2	12.2	44.0	60.2	49.1	57.4	26.3	29.7	11.3	41.7	53.1	36.8	20.6	25.7	47.1	59.3	4.5	20.8	9.7	20.7	27.7	59.5	12.8	9.8	53.9	65.2	36.3	45.9	50.6	60.2	10.0	15.0	15.8	48.2	35.9	14.8	12.9	14.3	113.8	18.0	10.2	53.6	10.9	48.5	43.8	36.5	25.8	33.6	45.1	57.6	31.0	13.2	19.5	50.6	56.6	33.0	57.2	67.7	10.6	6.6	9.8	42.4	11.8	37.0	4.5	0.9	1.0	0.8	1.5	1.1	1.3	0.9	0.9	0.7	1.1	1.1	1.1	1.6	1.5	2.4	1.7	1.0	0.5	27.0	29.8	31.6	33.9	30.0	31.3	25.3	27.3	25.8	28.3	32.7	27.2	34.1	12.8	19.3	31.6	3.8	6.5	1.7	1.9	2.8	15.1	11.6	12.2	96.4	1.5	8.3	3.7	6.2	1.8	7.1	1.6	3.9	2.3	0.0	8.1	14.1	16.1	5.4	3.2	41.6	1.3	1.4	14.5	4.6	7.6	6.3	9.4	16.4	16.0	1.7	11.8	46.3	2.5	2.0	16.6	12.3	0.4	3.4	9.3	3.6	45.9	4.5	14.1	2.1	23.6	43.3	3.2	1.7	4.5	2.4	6.3	2.2	5.9	7.0	7.7	0.0	13.2	13.6	1.0	1.5	4.5	8.4	1.1	4.5	12.3	3.1	4.5
RAPGEF1	"C3G, GRF2"	ENSG00000107263	"Rap guanine nucleotide exchange factor 1"	Q13905	9	131576770-131740074	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 228.6"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 131.2;Langerhans cells: 108.6;Microglial cells: 123.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006426, HPA075984"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA006426: AB_1856070, HPA075984: AB_2686771"	"unprognostic (1.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (5.66e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.73e-2)"	37.3	24.0	41.4	53.9	72.6	53.2	26.8	27.0	37.1	20.4	37.9	31.9	23.9	25.6	8.0	23.6	25.5	23.7	57.8	40.8	40.2	23.0	23.0	43.3	56.1	35.8	36.9	16.3	47.8	20.1	16.4	56.4	32.3	21.5	23.4	27.5	20.2	21.4	228.6	21.9	35.3	30.4	25.6	41.9	29.1	15.9	43.8	35.1	22.7	104.8	63.1	25.8	18.2	20.2	34.5	39.4	39.1	39.6	39.1	42.0	149.2	29.0	59.0	33.0	23.6	49.0	22.1	61.9	35.6	58.8	70.7	61.4	45.1	40.5	16.4	144.6	18.6	18.3	67.2	26.2	32.8	76.1	80.4	32.2	73.0	43.3	51.0	33.1	60.4	70.8	49.7	119.1	43.4	35.7	54.0	27.0	39.6	34.1	35.2	53.0	91.0	86.8	14.9	41.1	33.0	32.9	42.5	39.8	42.3	39.0	38.1	63.1	64.4	88.1	36.7	56.4	44.7	39.8	37.3	122.0	41.9	32.0	21.6	3.1	1.2	1.6	3.4	2.2	2.0	4.9	2.3	2.3	1.4	2.9	0.5	1.5	1.3	1.3	2.4	1.6	1.8	1.6	41.4	72.6	27.0	37.1	40.8	40.2	35.8	36.9	32.3	25.6	43.8	20.2	73.5	6.4	13.8	27.1	35.6	18.7	9.3	10.9	5.2	19.5	10.8	13.5	16.2	14.3	12.3	5.5	14.6	22.7	49.7	23.3	5.9	8.2	2.6	13.0	9.4	43.0	12.1	1.7	47.5	18.6	35.3	11.8	17.9	17.8	20.3	14.0	22.5	17.4	26.4	131.2	66.6	14.9	8.2	23.9	108.6	2.5	8.7	51.6	32.0	123.7	59.8	19.7	27.8	61.3	24.7	17.1	19.1	12.0	88.0	11.7	16.8	9.2	16.7	13.4	6.6	13.4	10.3	5.1	11.8	5.6	11.4	51.7	31.0	5.8	14.0	10.8
RBFOX2	"FOX-2, HNRBP2, HRNBP2, RBM9"	ENSG00000100320	"RNA binding fox-1 homolog 2"	O43251	22	35738736-36028824	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 378.7;Inhibitory neurons: 418.1;Oligodendrocyte precursor cells: 237.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006240, HPA006455, HPA075862"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA006240: AB_1079750, HPA006455: , HPA075862: "	"unprognostic (3.17e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.08e-2)"	28.4	21.9	16.4	12.3	21.7	0.2	27.0	38.8	41.9	49.0	0.0	59.2	11.7	67.5	21.6	34.7	40.4	25.2	37.0	24.3	11.7	18.7	25.8	25.6	5.9	6.9	3.3	63.0	18.7	26.2	27.5	32.6	5.2	31.4	21.4	15.5	23.7	29.7	77.1	23.7	23.4	52.7	1.1	9.9	28.9	25.7	7.3	10.0	28.5	44.3	8.5	43.1	36.5	17.8	46.2	27.4	110.3	64.8	62.4	111.2	36.8	89.9	123.6	67.1	72.0	60.1	21.3	28.2	41.2	108.9	41.9	46.5	40.2	41.7	95.9	19.2	36.6	16.7	26.5	22.3	18.8	4.4	11.6	77.3	53.1	59.6	73.3	64.8	86.8	7.0	13.7	3.9	80.3	14.0	4.5	2.7	40.5	19.7	42.0	7.6	92.0	7.9	50.1	47.5	34.1	106.0	110.3	15.5	31.0	57.0	16.9	6.8	105.5	96.4	54.4	54.7	41.2	2.8	9.4	38.3	42.7	6.8	51.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.4	21.7	38.8	41.9	24.3	11.7	6.9	3.3	5.2	1.1	7.3	17.8	34.3	67.3	38.5	189.4	1.0	37.1	50.6	57.3	57.5	20.8	31.4	34.5	62.2	31.5	40.4	27.6	0.0	69.9	0.9	17.9	35.2	53.0	24.8	17.8	60.8	45.9	57.0	0.8	378.7	32.1	89.1	67.8	15.8	25.0	2.5	30.6	40.7	26.0	10.5	117.8	418.1	24.7	18.3	1.3	14.7	9.4	79.6	1.8	16.0	183.6	2.6	16.9	0.0	237.2	130.0	77.4	10.7	93.3	1.4	57.4	22.5	18.7	20.9	6.7	52.6	74.5	93.3	42.2	25.6	31.0	33.8	29.0	2.5	48.2	23.8	61.1
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281361-17293871	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 142.1;skeletal muscle: 313.0;tongue: 105.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 193.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 58.7;RH-30: 59.7;T-47d: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	5.4	0.5	3.7	1.7	4.1	0.1	3.7	0.1	5.7	13.9	2.5	9.7	1.6	31.2	16.8	7.4	24.0	2.6	142.1	4.5	4.9	0.9	1.1	1.3	0.5	1.6	1.9	2.1	0.2	2.1	5.5	0.6	0.7	9.9	7.4	0.4	4.1	5.8	313.0	1.4	3.6	29.3	0.6	1.2	2.1	4.2	3.0	0.8	2.1	105.7	0.3	8.8	3.6	2.2	1.5	9.3	12.0	0.0	0.0	0.0	0.0	18.7	6.8	12.4	13.0	0.0	1.1	0.0	5.7	13.4	19.5	0.0	11.5	0.4	22.3	0.0	0.4	0.0	1.0	6.4	0.5	0.0	1.1	6.4	0.0	2.4	0.5	15.8	1.6	0.0	0.0	0.0	58.7	2.8	0.0	0.2	4.1	0.0	1.4	0.1	59.7	0.0	0.0	0.0	7.8	0.9	0.2	0.0	0.2	9.3	28.2	0.4	0.0	4.2	10.0	0.0	16.2	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.1	0.1	5.7	4.5	4.9	1.6	1.9	0.7	0.6	3.0	2.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	1.1	0.0	2.3	3.2	0.8	193.2	0.0	1.8	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.6	33.5	13.6	1.5	4.8	0.0	11.6	0.0	13.4	6.4	0.0	9.9	1.3	0.5	0.4	0.0	0.3	1.7	6.6	4.5	0.0	0.0	0.7	1.9	0.0	0.3	1.8	1.9	0.0	0.7	0.0	0.5	0.4	0.3	2.2	0.7	0.0	0.3	0.0	0.6	21.9	0.0	6.6	23.9	19.7	0.4	7.3	0.2	1.0	0.8	0.5	0.0	3.0	0.1
RCOR3	FLJ10876	ENSG00000117625	"REST corepressor 3"	Q9P2K3	1	211258377-211316385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007413, HPA007621, HPA071997"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (4.02e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (5.75e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-3)"	16.9	15.6	11.3	10.7	16.1	31.7	19.7	21.8	16.6	20.3	9.2	19.6	12.1	19.1	21.4	14.5	18.2	12.4	22.7	11.1	14.3	15.7	15.9	14.5	15.2	13.4	12.0	26.7	19.7	20.8	16.9	14.9	14.6	23.9	13.8	30.5	19.5	24.5	65.2	19.2	18.7	14.0	11.5	18.6	16.2	33.7	12.6	19.2	31.9	51.7	14.6	18.8	18.0	22.3	15.5	13.9	25.1	14.4	21.3	20.2	26.4	18.3	18.3	20.0	20.2	12.0	20.9	22.8	11.6	23.7	13.9	23.4	20.6	18.2	15.4	21.5	10.9	21.4	22.6	17.0	23.4	34.2	19.8	22.0	16.6	21.9	27.3	22.4	11.8	23.2	21.0	29.2	29.9	11.2	16.8	18.8	27.2	11.3	14.4	17.8	49.6	27.3	17.2	28.5	16.0	32.5	46.7	24.3	33.6	24.1	29.9	23.3	17.1	17.5	19.7	23.2	20.4	23.5	18.4	30.1	15.2	19.6	15.9	27.2	12.4	45.9	8.8	12.5	11.8	15.4	9.4	9.7	13.7	11.4	16.0	11.6	20.8	19.8	14.3	14.5	12.7	8.8	11.3	16.1	21.8	16.6	11.1	14.3	13.4	12.0	14.6	11.5	12.6	22.3	23.1	38.5	44.4	67.6	23.0	14.5	10.7	16.4	29.6	43.7	29.0	25.9	73.4	24.3	24.9	14.7	35.5	26.7	30.2	16.6	21.5	10.4	70.4	22.0	37.4	17.7	34.2	29.8	121.9	15.4	14.8	24.0	28.1	26.6	19.6	21.7	21.8	20.8	20.5	23.5	101.1	17.3	16.2	22.3	14.2	122.6	22.4	24.6	23.2	49.6	22.2	24.1	14.4	87.9	131.6	10.4	15.8	27.1	28.1	12.5	24.1	22.8	22.2	47.7	0.0	33.2	24.8	65.4	35.1	33.1	16.9	25.4	22.6	22.7	17.5	9.0
RHOBTB1	KIAA0740	ENSG00000072422	"Rho related BTB domain containing 1"	O94844	10	60869438-61001440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 144.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 135.5;Horizontal cells: 334.8;Oligodendrocytes: 155.5;Syncytiotrophoblasts: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040205, HPA040226"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA040205: AB_2676883, HPA040226: AB_10795377"	"unprognostic (1.25e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.57e-2)"	7.8	13.9	5.6	4.1	6.6	0.9	7.1	5.2	7.8	15.7	5.3	8.1	6.6	14.5	2.4	3.0	10.9	11.5	13.5	4.6	4.7	30.8	6.8	10.6	2.8	6.1	6.1	10.2	9.2	8.6	3.2	37.1	6.3	7.7	4.8	24.3	2.1	9.9	144.2	3.6	5.6	12.1	4.9	14.9	20.8	15.1	7.6	1.9	3.3	19.6	1.2	7.4	7.5	7.8	0.2	12.0	17.8	0.0	8.3	7.3	0.0	5.3	4.8	4.3	6.4	0.6	0.2	0.0	21.9	28.0	2.0	0.3	5.3	1.6	5.0	0.0	4.8	1.1	8.8	67.3	9.0	1.4	0.4	10.6	3.0	2.6	2.7	16.5	20.6	3.8	10.2	0.0	19.1	0.4	5.2	0.0	7.7	0.2	7.9	4.5	24.9	6.4	14.1	0.7	4.9	19.0	6.3	6.9	6.9	11.1	1.4	2.4	18.5	8.2	21.1	0.2	5.9	0.0	0.0	0.0	4.1	3.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	5.6	6.6	5.2	7.8	4.6	4.7	6.1	6.1	6.3	4.9	7.6	7.8	13.7	16.0	8.7	3.6	1.0	1.8	1.0	0.5	0.6	3.4	3.7	2.5	29.5	1.5	2.3	1.8	135.5	66.1	0.2	0.7	1.9	3.8	75.2	11.0	14.7	13.6	8.3	3.8	74.3	16.0	3.4	8.6	34.1	4.5	0.0	59.0	17.9	9.6	11.3	334.8	23.1	7.7	4.1	21.5	1.4	35.3	8.1	14.1	1.8	57.1	0.4	16.0	0.0	14.1	155.5	16.4	2.5	4.9	0.1	1.2	1.5	36.4	10.2	25.1	6.6	16.7	11.8	2.8	1.4	0.6	1.4	302.4	0.8	15.2	4.3	0.4
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179759-11348330	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 280.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol		NA	NA		710000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (4.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.18e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.47e-2)"	36.4	9.3	6.7	13.5	16.3	6.8	22.3	19.1	14.3	18.7	0.8	22.6	16.7	22.0	10.3	16.2	13.6	15.6	17.0	12.1	3.5	14.5	16.5	16.9	10.1	1.7	4.4	19.0	11.7	12.8	5.9	24.9	1.4	17.4	26.2	13.5	14.6	18.1	30.4	8.5	19.2	27.9	2.0	16.4	14.1	7.8	6.4	8.4	13.9	28.9	8.8	21.1	11.0	10.4	17.5	41.7	33.8	33.2	59.7	41.6	21.6	40.4	37.7	25.8	27.1	39.8	37.2	21.9	23.4	64.5	31.3	18.9	24.7	23.4	40.6	31.2	14.7	43.8	70.6	79.7	21.4	24.7	12.1	32.6	14.6	31.9	22.6	21.0	42.0	11.9	38.6	8.6	38.8	14.8	18.2	12.7	18.8	36.9	25.3	21.7	74.2	7.0	14.0	48.8	15.9	16.9	79.6	27.4	27.4	25.5	11.3	13.6	57.3	52.9	38.2	21.2	36.0	6.8	8.9	18.8	22.8	28.2	75.4	0.9	0.4	0.4	0.6	0.4	0.7	0.3	0.4	0.4	0.3	0.5	0.4	0.4	0.6	0.8	0.4	0.6	0.4	0.2	6.7	16.3	19.1	14.3	12.1	3.5	1.7	4.4	1.4	2.0	6.4	10.4	114.5	115.4	79.1	81.3	16.0	39.9	43.0	15.3	21.1	35.7	33.5	41.1	107.0	37.1	53.1	22.0	58.4	26.3	20.4	97.7	1.9	27.1	11.0	53.6	141.2	90.3	21.2	22.5	280.4	39.5	19.1	64.0	18.3	55.3	29.0	36.9	56.0	43.1	19.6	80.8	158.1	92.2	10.2	20.3	27.0	4.9	43.8	30.4	23.2	107.7	20.6	38.4	15.5	99.0	66.9	39.1	43.6	78.6	16.2	53.5	45.3	15.7	32.7	48.5	131.5	70.0	118.5	30.3	24.6	19.9	27.8	31.5	18.5	34.2	54.8	40.7
RPL3L		ENSG00000140986	"Ribosomal protein L3 like"	Q92901	16	1943974-1957606	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 943.6;tongue: 422.7"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 134.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049136	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"		"HPA049136: AB_2680648"	"unprognostic (2.53e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.27e-4)"	"unprognostic (6.38e-4)"	"unprognostic (4.36e-2)"	"unprognostic (3.48e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.60e-2)"	0.3	0.4	0.9	0.2	0.6	1.7	1.4	1.7	0.8	0.0	1.0	0.2	0.6	0.3	0.4	8.5	0.1	0.5	174.0	0.5	0.4	0.4	0.3	0.2	0.4	0.1	0.0	0.3	11.5	0.0	0.1	0.2	0.1	4.2	0.0	1.2	6.9	0.1	943.6	0.7	0.5	0.0	0.0	0.4	0.2	6.4	0.1	0.1	0.4	422.7	0.1	0.2	0.1	1.0	1.1	1.2	0.3	1.1	0.0	0.0	0.7	0.5	0.0	0.0	0.0	4.0	2.1	0.6	0.7	0.0	1.0	1.1	0.1	0.1	0.0	0.5	0.6	0.4	0.9	1.4	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.7	0.0	0.7	0.4	2.8	0.0	0.6	0.8	1.0	0.6	1.2	2.5	0.4	0.3	0.9	0.1	0.4	1.6	0.5	0.5	1.4	0.6	0.7	0.7	0.6	0.6	0.6	1.4	0.8	0.4	1.2	0.6	0.5	0.8	0.2	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.4	0.2	0.3	0.1	0.4	0.3	0.3	1.2	0.2	0.3	0.4	0.1	0.1	0.9	0.6	1.7	0.8	0.5	0.4	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.2	0.0	0.0	0.1	0.6	134.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	7.9	0.0	0.1	1.3	0.0	5.3	0.1	0.0	0.2	2.9	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	23.7	2.2	0.7	2.4	0.0	0.4	0.0	0.2	0.1	0.1	0.5
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306245-58324695	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 40.8;tongue: 39.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	5.1	5.7	3.1	4.6	3.2	4.8	5.0	5.9	4.1	4.6	2.0	6.8	6.8	5.5	3.7	5.9	4.9	4.2	10.9	3.2	2.9	9.1	11.5	4.1	4.0	3.0	2.2	5.5	6.1	7.7	5.9	4.0	3.1	4.7	6.4	5.1	4.9	4.4	40.8	5.3	6.9	7.1	1.7	5.8	5.4	5.1	3.1	6.5	5.5	39.0	6.0	5.2	5.0	3.4	12.3	10.4	11.5	8.2	6.6	9.0	12.3	9.9	11.7	14.5	17.1	15.9	8.0	13.8	2.4	14.4	13.7	7.2	17.6	15.8	14.8	10.6	8.5	12.0	11.9	8.4	7.8	24.4	10.7	8.4	12.1	18.6	16.3	5.2	12.1	18.2	12.0	7.8	14.3	6.5	16.2	7.9	11.9	10.5	17.9	6.8	8.4	14.0	9.6	18.9	6.9	11.8	10.2	9.8	11.9	7.3	11.0	8.6	11.1	10.4	11.7	10.5	20.4	13.0	28.3	22.3	11.2	17.1	6.7	2.1	3.4	2.6	2.1	2.8	3.0	2.1	2.7	3.2	3.9	3.0	3.2	3.5	4.0	5.5	6.0	3.9	1.8	2.1	3.1	3.2	5.9	4.1	3.2	2.9	3.0	2.2	3.1	1.7	3.1	3.4	9.0	9.6	11.9	6.2	8.2	31.2	8.1	21.1	17.1	26.3	8.2	7.6	28.4	7.2	11.8	3.7	25.0	8.4	9.4	14.9	11.7	5.7	0.8	8.2	12.4	10.6	9.6	7.6	18.4	6.2	5.9	11.5	13.3	8.2	3.8	11.5	11.4	21.3	6.2	18.5	18.2	11.8	16.2	11.0	20.0	1.7	12.5	9.7	23.2	13.1	9.2	13.2	7.2	10.6	11.2	7.8	7.6	9.8	14.2	8.1	16.2	11.4	9.7	28.3	0.0	14.1	13.7	11.9	15.3	20.4	43.0	10.3	9.2	15.0	13.7	6.5
RWDD2B	"C21orf6, GL011"	ENSG00000156253	"RWD domain containing 2B"	P57060	21	29004384-29019360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA018316	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA018316: AB_1845702"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.67e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	0.6	0.9	0.6	0.5	0.5	0.3	0.7	0.9	1.0	0.7	0.2	0.6	0.3	0.6	1.0	0.7	0.6	0.7	1.4	0.7	0.4	0.9	1.2	0.5	1.0	0.8	0.4	0.5	0.8	1.0	0.7	0.6	0.7	0.7	0.7	1.1	0.9	0.7	3.5	1.2	0.4	0.8	0.2	0.6	0.6	0.9	0.6	0.6	1.0	2.9	0.8	0.6	0.4	1.1	1.2	0.6	1.0	1.6	4.6	1.9	0.2	1.2	1.9	1.6	1.9	1.4	1.0	2.1	1.3	2.1	1.0	0.7	1.4	1.4	1.4	1.3	1.0	3.0	0.7	1.0	2.4	0.3	0.1	2.1	1.3	1.8	2.5	1.7	2.0	0.9	1.2	2.0	2.2	2.4	0.6	1.2	1.4	3.4	1.1	0.4	1.2	2.8	1.7	1.4	1.8	2.6	3.0	1.6	3.2	0.7	2.8	1.7	1.5	2.1	1.2	1.5	0.5	2.7	2.7	1.2	1.7	1.9	1.9	3.0	0.4	0.3	0.6	0.3	0.4	0.8	0.3	0.5	0.3	0.6	0.2	0.4	1.1	0.4	0.7	0.5	0.1	0.3	0.6	0.5	0.9	1.0	0.7	0.4	0.8	0.4	0.7	0.2	0.6	1.1	9.0	16.0	14.3	2.6	5.3	3.3	3.2	12.0	7.4	2.4	11.0	11.6	29.9	21.5	7.7	12.9	0.0	12.6	8.7	3.2	29.4	9.0	14.7	6.4	12.9	8.3	12.0	6.5	5.2	9.2	11.2	10.7	7.1	6.1	1.3	5.0	5.7	23.1	8.2	0.0	4.7	7.0	10.2	6.0	3.9	12.5	11.1	4.6	8.8	1.9	12.9	6.9	16.5	5.5	2.9	8.0	8.3	13.5	5.3	4.9	6.7	27.4	4.5	1.3	6.6	10.3	9.6	41.5	17.7	13.2	4.7	6.4	6.2	22.9	6.1	3.3
SESN1	"PA26, SEST1"	ENSG00000080546	"Sestrin 1"	Q9Y6P5	6	108986437-109094819	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 137.2;Excitatory neurons: 134.9;Inhibitory neurons: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 48.0;NK-cells: 58.9;T-cells: 74.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 80.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073659			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA073659: AB_2686622"	"unprognostic (2.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.47e-5)"	"unprognostic (2.68e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-3)"	"prognostic favorable (2.07e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.95e-2)"	30.7	26.6	29.1	23.2	30.7	50.2	42.3	29.8	35.9	29.9	29.8	31.6	20.2	31.7	26.6	22.7	32.5	18.5	36.2	31.1	29.4	16.7	29.2	25.6	33.8	27.9	27.9	62.6	31.6	50.3	25.8	53.4	28.7	25.1	23.9	25.0	18.3	23.6	151.2	43.1	38.1	32.9	28.7	37.0	31.0	42.0	29.9	21.9	32.1	140.0	33.8	28.3	28.2	30.8	3.5	5.7	25.7	12.2	32.1	40.6	80.5	13.8	15.7	4.7	9.0	10.9	3.6	29.3	11.4	10.2	3.7	4.1	7.0	27.6	5.8	2.6	34.7	13.0	6.9	40.9	19.7	5.1	12.7	44.2	43.0	8.5	13.7	20.5	24.7	8.3	9.7	20.5	23.3	6.9	11.3	16.4	10.6	5.7	3.6	9.0	7.3	13.7	10.1	17.4	6.3	12.7	7.5	4.7	5.7	41.3	4.5	33.5	15.3	3.6	7.1	3.3	4.5	20.5	12.5	12.0	7.9	12.8	7.9	11.9	2.7	3.4	34.4	6.3	74.6	13.3	32.4	27.3	2.7	48.0	39.6	20.8	10.0	58.9	8.7	5.4	15.1	20.3	29.1	30.7	29.8	35.9	31.1	29.4	27.9	27.9	28.7	28.7	29.9	30.8	13.9	64.1	22.4	79.0	37.3	6.5	4.9	7.4	25.0	23.8	14.2	14.5	30.0	17.2	15.2	14.7	45.9	57.8	22.9	12.7	9.8	4.3	137.2	10.3	15.2	9.8	15.5	24.2	134.9	5.3	13.7	21.9	28.5	8.2	3.8	17.4	10.8	14.7	44.9	26.9	127.7	10.0	2.0	43.1	11.3	104.8	34.5	56.5	16.0	71.2	9.4	39.1	25.7	64.3	119.1	3.1	11.9	35.3	26.2	9.4	7.8	9.3	26.4	44.3	26.3	43.9	15.9	18.4	16.2	25.4	8.4	44.6	41.8	102.9	13.6	4.3
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing 7, histone lysine methyltransferase"	Q8WTS6	4	139495941-139606699	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	44.7	18.5	17.8	15.1	17.7	9.7	27.3	19.3	17.3	40.5	21.2	23.5	7.3	33.0	12.6	28.1	18.8	26.7	41.0	16.6	19.4	10.1	50.1	19.2	11.7	25.0	20.3	19.6	21.9	34.7	8.8	19.1	24.7	35.1	15.3	11.5	16.2	20.6	106.6	22.7	12.1	34.8	24.6	17.0	20.1	14.4	24.5	10.1	14.1	73.7	15.9	23.4	18.2	29.2	28.4	37.2	13.0	7.8	77.1	65.9	29.6	65.7	67.3	32.4	27.1	22.7	37.2	68.0	25.5	110.5	22.4	13.9	44.3	51.3	52.4	32.8	33.0	8.9	45.5	0.8	38.4	31.9	12.9	57.7	58.6	52.1	54.6	41.2	41.7	27.8	5.5	96.1	42.3	46.8	21.0	4.6	6.4	40.8	23.9	19.7	48.4	37.3	31.5	25.3	55.3	18.5	44.7	63.5	15.3	12.6	25.3	28.0	68.8	57.1	40.7	68.6	55.2	89.6	86.8	42.2	65.9	31.1	28.0	0.5	3.9	0.2	0.3	2.0	2.7	1.0	1.1	1.1	4.4	1.2	0.4	0.2	0.9	0.2	3.2	2.1	3.7	1.2	17.8	17.7	19.3	17.3	16.6	19.4	25.0	20.3	24.7	24.6	24.5	29.2	28.7	6.4	18.8	17.3	8.9	17.2	14.5	14.1	12.5	5.4	24.0	14.7	43.1	20.0	15.0	9.2	12.5	26.2	4.2	4.1	0.0	22.7	1.3	3.5	35.9	29.4	1.2	3.6	21.1	21.2	16.7	39.8	16.8	7.5	2.5	2.9	37.1	70.6	20.4	8.4	42.4	13.6	18.3	31.0	20.9	4.3	23.0	19.5	10.6	19.7	19.0	15.0	0.0	36.2	29.2	22.4	4.1	28.2	13.2	38.4	1.3	4.5	14.0	12.9	19.7	35.2	23.3	3.7	2.7	17.9	22.0	46.1	9.8	9.5	11.7	20.4
SGCA	"A2, adhalin, ADL, DMDA2, LGMD2D, SCARMD1"	ENSG00000108823	"Sarcoglycan alpha"	Q16586	17	50164214-50175928	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 155.6;skeletal muscle: 522.4;tongue: 237.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 128.4;Early spermatids: 162.6;Late spermatids: 705.4;Skeletal myocytes: 195.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 1.4;memory B-cell: 3.3;myeloid DC: 2.2;naive B-cell: 3.3;non-classical monocyte: 1.8"	"Group enriched"	"Detected in many"	15	"B-cells: 3.3;dendritic cells: 2.2;monocytes: 1.8"	"Cell line enriched"	"Detected in some"	16	"LHCN-M2: 78.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007537	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA007537: AB_1079944"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.07e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.15e-2)"	12.2	1.5	1.8	7.3	2.9	0.0	4.3	3.5	2.2	10.1	1.0	53.7	5.3	36.9	1.6	22.8	18.1	11.9	155.6	1.4	1.5	2.7	4.8	29.7	0.5	1.6	1.5	5.1	1.3	0.8	0.9	6.7	1.8	26.0	3.2	0.1	8.7	27.1	522.4	12.4	14.8	23.0	1.1	3.4	24.1	1.7	1.7	2.3	3.4	237.0	0.4	46.5	11.6	4.7	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	78.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.1	0.0	1.4	0.0	3.3	0.0	0.0	2.2	3.3	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.4	1.8	2.9	3.5	2.2	1.4	1.5	1.6	1.5	1.8	1.1	1.7	4.7	1.1	0.0	0.0	0.0	1.3	8.7	0.5	0.4	0.0	0.6	0.1	0.5	128.4	0.0	0.3	0.0	0.0	0.5	1.4	0.0	0.0	0.6	162.6	0.0	0.2	4.6	0.0	0.0	0.0	5.8	0.1	30.4	0.5	0.0	0.0	0.0	2.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	16.5	705.4	3.1	0.8	8.8	1.9	1.9	0.0	0.0	0.0	0.1	4.1	0.0	3.8	0.1	0.6	0.0	2.1	0.0	0.0	13.1	195.2	48.2	2.3	1.9	0.1	9.9	0.3	0.9	0.0	0.0	0.2
SGCG	"A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE"	ENSG00000102683	"Sarcoglycan gamma"	Q13326	13	23180979-23325162	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"heart muscle: 118.8;skeletal muscle: 158.0;tongue: 144.1"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 134.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 66.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA007476	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA007476: AB_1079946"	"unprognostic (5.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-4)"	"unprognostic (3.00e-3)"	"unprognostic (3.61e-2)"		"unprognostic (8.14e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.49e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.07e-1)"	14.3	0.6	0.0	0.1	0.1	0.0	2.2	0.0	1.9	0.4	0.0	1.1	0.1	0.1	8.0	3.3	1.1	0.8	118.8	0.1	0.0	0.3	0.0	4.8	0.0	0.3	0.0	0.2	0.1	2.1	0.3	0.0	0.2	3.2	0.6	0.3	4.3	0.4	158.0	3.4	0.6	0.1	0.0	0.1	0.9	1.5	0.2	0.1	0.1	144.1	0.1	3.0	1.4	0.4	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	66.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	0.2	0.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.1	0.0	0.3	0.0	0.2	0.0	0.2	0.4	0.2	0.0	0.0	0.3	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	134.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	1.3	0.0	0.0	12.5	0.0	0.0	11.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.0	0.0	0.0	3.4	3.0	7.5	0.2	5.4	1.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.2	3.8	13.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 634.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 301.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol		NA	NA		28000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	106.5	38.1	20.5	55.3	22.5	66.2	56.1	21.0	25.4	39.2	15.7	53.7	48.4	35.9	31.0	79.4	27.9	47.0	72.8	19.2	23.7	40.4	45.0	49.0	40.9	25.3	19.7	24.2	64.0	41.3	30.3	57.5	24.4	34.3	57.9	39.0	56.4	36.1	172.0	35.8	47.0	50.3	23.4	46.5	36.3	109.5	21.0	34.1	38.6	98.4	51.9	63.8	41.8	27.4	78.1	28.1	44.2	40.4	180.1	155.1	72.2	115.1	114.5	106.8	112.3	81.4	63.3	39.7	72.0	143.5	132.9	44.5	39.4	75.0	101.2	86.1	28.1	94.7	39.2	87.1	108.7	51.5	92.4	111.8	85.5	118.3	128.7	114.5	171.4	41.7	36.0	108.5	145.1	23.1	46.7	32.7	43.0	56.8	47.6	53.1	184.6	29.7	92.3	132.2	47.9	34.7	64.8	82.4	140.8	65.2	32.7	51.8	151.4	102.2	61.9	129.3	96.5	56.8	56.3	58.6	50.8	52.1	63.5	153.0	59.0	66.5	43.0	64.5	42.4	36.8	40.2	43.8	45.5	35.3	19.1	34.3	301.4	62.4	77.0	43.8	65.4	49.5	20.5	22.5	21.0	25.4	19.2	23.7	25.3	19.7	24.4	23.4	21.0	27.4	192.0	83.3	65.6	39.2	75.0	89.6	119.5	124.1	44.3	31.2	96.9	69.1	157.0	60.1	104.0	55.2	52.1	84.3	145.7	182.0	86.1	145.2	634.6	86.3	104.5	135.4	86.6	64.4	49.9	169.8	203.4	99.7	45.9	110.0	113.5	61.0	157.1	79.4	143.7	16.8	50.5	130.3	128.1	149.2	99.4	236.9	70.2	116.0	81.8	40.3	163.7	71.9	124.6	46.8	65.2	201.7	173.4	85.0	123.9	103.4	108.8	134.0	90.2	55.4	78.9	146.7	111.7	403.5	86.3	100.6	118.1	101.9	90.4	57.1	87.4	199.8
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643421-60658259	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 47.8;salivary gland: 51.1;skeletal muscle: 119.4;tongue: 46.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	5.5	0.4	0.3	0.0	0.5	0.0	1.9	0.5	1.2	15.2	1.0	0.0	0.0	0.0	0.4	1.1	0.8	0.5	0.0	0.3	0.3	0.0	0.0	1.5	0.5	0.3	0.4	0.2	0.3	47.8	19.8	0.0	0.4	13.2	0.0	0.0	51.1	0.2	119.4	0.3	0.0	0.0	0.3	0.0	0.4	1.7	0.5	9.7	1.9	46.3	0.2	1.6	0.8	0.4	15.2	3.5	0.6	28.1	17.0	20.6	0.4	4.1	10.6	4.9	4.0	0.0	8.2	0.0	2.2	0.6	2.1	4.4	10.3	6.4	2.1	0.0	17.1	2.0	1.9	6.8	0.0	0.0	0.2	15.6	4.9	2.3	0.7	36.3	0.3	1.6	5.8	0.0	142.2	2.8	0.0	0.5	0.0	0.0	8.9	0.0	71.9	0.0	5.9	16.3	2.5	0.3	5.0	0.3	6.1	0.5	3.3	0.4	13.9	6.7	5.4	7.9	6.5	0.5	0.1	0.0	1.5	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.2	0.3	0.3	0.3	0.4	0.4	0.3	0.5	0.4	0.8	3.2	1.5	0.0	0.0	0.1	30.7	30.8	0.6	0.0	1.0	0.8	0.9	0.0	33.9	1.8	0.0	0.2	0.0	0.1	1.9	0.0	0.2	1.1	0.1	1.6	0.0	0.0	0.0	0.8	0.4	5.7	0.5	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.5	0.0	0.0	0.6	0.0	0.3	0.0	1.9	0.0	0.8	0.0	1.0	0.1	0.2	0.0	1.2	0.0	27.4	0.0	0.1	67.1	0.2	0.0	77.3	5.1	0.0	25.0	0.1	0.1	0.3	0.1	0.1	0.0	18.3
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341529-48426201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 319.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol		NA	NA		210000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: AB_2685056"	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	24.9	12.6	7.0	14.6	6.6	15.5	17.0	10.5	9.0	21.4	9.0	27.3	13.4	23.6	18.6	38.7	25.7	18.5	40.6	6.1	7.2	18.6	26.7	21.0	16.5	6.9	7.1	22.2	15.1	29.6	7.8	22.2	6.8	25.8	24.0	15.8	19.1	30.2	71.8	32.5	16.3	35.4	6.0	16.3	18.2	40.3	8.1	24.4	20.0	98.8	21.0	26.3	21.9	8.5	32.8	12.7	22.2	22.0	33.9	41.6	15.6	49.3	62.3	43.0	44.5	12.6	26.8	19.4	29.7	56.7	76.7	21.2	91.5	46.1	75.6	16.1	9.5	34.1	17.5	14.4	36.5	31.5	33.4	35.4	67.1	50.0	58.0	32.2	25.8	17.1	22.3	21.1	43.7	16.5	36.4	25.9	9.4	25.7	18.2	20.6	43.1	12.4	38.0	35.4	14.7	18.7	20.0	14.8	21.2	20.4	18.6	22.2	33.0	46.8	44.2	29.9	50.5	28.6	32.1	16.3	36.8	35.2	34.5	9.5	6.5	7.7	6.6	4.7	7.2	5.1	8.1	9.9	6.6	7.5	6.6	7.1	5.8	8.8	7.3	2.3	5.7	3.6	7.0	6.6	10.5	9.0	6.1	7.2	6.9	7.1	6.8	6.0	8.1	8.5	37.2	54.5	38.7	43.8	27.9	84.2	50.6	32.6	38.7	15.8	26.5	19.4	79.6	18.6	32.3	27.6	14.6	29.3	31.7	35.0	21.5	29.9	162.4	145.1	64.7	28.8	25.2	16.6	47.0	34.9	29.1	31.9	28.5	57.4	21.6	20.3	21.8	33.0	21.6	35.3	47.3	34.5	22.4	20.5	31.0	319.2	27.4	29.2	19.6	38.4	37.5	20.7	28.8	54.3	43.1	32.2	27.9	36.9	26.2	53.9	23.4	26.4	85.1	41.0	32.9	54.1	43.1	98.7	48.8	55.0	91.5	75.5	35.0	32.8	25.6	58.3
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 53.7;skeletal muscle: 41.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.8;Excitatory neurons: 33.9;Inhibitory neurons: 47.8;Macrophages: 33.8;Melanocytes: 44.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.7;T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 49.4;HEK 293: 20.2;RPMI-8226: 37.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	2.9	5.5	1.4	3.0	8.6	0.8	0.8	4.2	3.4	0.6	53.7	1.2	8.5	0.5	1.4	0.8	0.8	1.5	2.3	2.0	1.2	10.0	13.5	4.6	0.9	1.1	5.0	0.9	29.7	7.9	1.0	23.7	2.8	1.3	1.8	0.7	3.1	0.2	41.2	15.3	5.0	0.3	0.2	1.8	5.3	4.2	9.6	10.9	2.7	6.0	1.3	1.9	1.2	1.1	0.9	1.0	0.4	2.2	0.1	0.1	3.1	0.0	0.2	0.8	1.2	9.0	0.4	5.2	1.4	0.3	2.5	0.1	49.4	0.1	1.0	0.1	20.2	8.2	0.7	7.4	0.1	7.6	7.4	0.0	0.0	0.1	0.0	0.2	0.0	10.9	1.4	0.2	0.1	3.6	9.8	0.8	14.6	0.2	3.2	5.4	6.8	37.2	0.0	0.5	10.7	3.3	0.2	0.7	1.8	3.6	1.8	0.9	0.1	0.1	1.8	0.5	2.5	2.6	0.1	1.5	0.3	5.8	0.8	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.2	1.7	1.5	0.3	0.1	0.0	0.1	1.6	0.1	1.4	8.6	4.2	3.4	2.0	1.2	1.1	5.0	2.8	0.2	9.6	1.1	0.4	9.6	32.8	2.0	1.5	9.7	10.7	0.0	4.6	6.9	2.0	1.3	9.1	0.0	3.1	5.5	2.1	1.9	0.7	2.1	1.9	0.2	9.0	0.4	0.8	1.4	6.6	1.7	33.9	12.5	1.8	8.9	3.6	1.3	1.3	2.5	4.2	25.4	21.4	1.7	47.8	4.8	0.0	12.4	12.4	8.2	0.0	33.8	44.4	0.0	0.7	1.6	0.0	16.6	0.3	2.0	0.9	0.0	4.8	3.9	10.9	17.7	0.7	0.7	0.0	18.5	1.0	11.6	11.2	1.2	14.8	1.2	5.8	9.2	8.5	1.2
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169485944	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.1;tongue: 84.9"	"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 84.5;Syncytiotrophoblasts: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favorable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	42.2	17.8	3.0	8.3	3.1	8.7	20.9	5.1	4.2	10.5	9.3	11.8	3.5	8.6	6.1	11.3	21.3	25.8	31.2	4.0	3.6	13.0	37.1	19.5	2.6	4.9	3.7	20.5	22.2	24.8	19.0	18.1	4.0	10.5	4.3	7.5	12.5	3.8	124.1	16.5	11.4	6.1	3.7	2.8	19.2	7.8	4.2	4.1	15.7	84.9	2.8	18.1	12.9	3.5	7.4	5.1	11.4	9.0	34.4	12.7	25.0	5.8	4.3	4.6	6.5	20.9	7.6	6.5	6.4	3.9	8.5	7.7	13.9	8.5	5.1	18.8	13.0	6.2	16.7	19.3	18.7	15.8	5.9	15.0	12.2	7.4	18.8	6.4	7.0	11.3	25.3	4.1	7.9	5.0	8.2	7.1	25.8	14.1	7.7	0.0	24.6	7.5	12.2	15.5	9.9	13.3	8.0	13.6	29.2	12.8	8.5	10.1	5.8	5.5	7.7	6.9	11.4	5.6	5.6	2.1	8.1	6.0	7.4	0.0	0.6	1.1	0.3	0.2	1.1	0.4	0.4	0.7	0.7	0.4	1.0	1.0	0.4	0.9	2.0	0.2	0.3	0.2	3.0	3.1	5.1	4.2	4.0	3.6	4.9	3.7	4.0	3.7	4.2	3.5	13.6	9.6	19.3	11.8	7.3	29.6	16.5	4.4	43.9	5.3	34.1	13.6	27.7	7.2	11.4	5.5	2.1	26.9	11.3	10.6	0.0	7.4	4.3	22.6	9.7	3.7	9.0	5.2	15.6	5.3	4.5	52.7	49.5	42.7	10.2	4.1	1.1	29.8	7.0	6.7	22.8	6.4	12.2	2.9	8.8	2.7	6.8	18.3	21.4	7.5	1.0	2.5	2.1	16.1	3.3	9.6	5.4	4.9	14.0	16.5	5.6	2.0	12.7	5.1	0.0	84.5	14.2	6.7	4.1	35.2	50.4	156.4	7.5	3.1	6.7	28.9
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348378-160452577	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 67.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 78.9;Hepatocytes: 68.8;Leydig cells: 33.8;Pancreatic endocrine cells: 57.3;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 27.6;HeLa: 38.1;Hep G2: 23.7;OE19: 12.0;RPTEC TERT1: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029750	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	Cytosol	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavorable (7.26e-4)"	11.7	15.2	2.1	3.8	2.7	0.0	6.6	3.3	2.1	15.9	1.8	8.8	1.7	18.4	27.6	7.7	18.7	11.0	1.5	2.0	3.5	6.3	34.9	16.4	16.2	6.2	3.8	21.1	0.7	0.2	1.3	44.3	4.5	43.4	2.4	0.2	51.8	52.6	67.4	10.7	5.7	26.3	3.3	0.6	6.0	2.6	4.2	0.5	2.0	8.5	4.9	6.2	15.7	3.2	0.0	27.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.4	0.0	0.0	0.0	38.1	23.7	1.2	0.0	0.0	0.8	6.9	3.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	12.0	7.7	0.0	0.0	0.0	13.8	0.0	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.7	3.3	2.1	2.0	3.5	6.2	3.8	4.5	3.3	4.2	3.2	0.6	16.0	78.9	6.2	0.1	4.7	0.3	2.1	2.8	0.2	0.2	0.3	2.9	5.7	6.4	0.0	0.0	0.3	0.1	0.2	5.9	8.2	0.6	0.2	10.2	1.0	0.0	0.0	0.5	3.0	0.3	10.0	12.8	0.3	2.5	0.8	0.0	68.8	0.7	0.0	25.1	1.6	2.0	1.0	2.4	1.6	33.8	0.3	3.6	7.5	0.0	0.0	0.0	19.6	0.2	57.3	0.1	24.5	0.1	6.1	2.1	2.9	0.8	0.1	0.0	29.8	12.3	0.3	0.2	3.7	6.7	0.4	1.2	0.0	2.8	0.8
SLC25A34	DKFZp781A10161	ENSG00000162461	"Solute carrier family 25 member 34"	Q6PIV7	1	15736258-15741392	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	4	"heart muscle: 14.4;intestine: 14.0;skeletal muscle: 37.8;tongue: 47.3"	"Cell type enriched"	"Detected in many"	5	"Proximal enterocytes: 44.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069806			Approved	Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA069806: AB_2686202"	"unprognostic (2.06e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-4)"	"unprognostic (5.74e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.40e-4)"	2.4	4.4	3.7	1.0	3.8	3.4	1.8	6.8	4.8	3.6	2.4	5.7	14.0	3.1	0.8	1.7	2.9	1.5	14.4	3.6	3.4	4.7	5.6	2.4	1.2	3.2	3.1	4.2	4.9	0.6	3.8	1.3	3.5	2.4	2.0	1.9	4.7	0.8	37.8	1.8	13.7	1.1	2.7	3.7	2.2	2.5	3.7	0.5	3.4	47.3	0.5	2.8	2.3	3.6	0.3	0.2	1.5	0.6	0.7	0.3	0.6	0.2	0.1	0.3	0.2	0.6	0.8	0.4	0.3	0.3	0.8	0.3	0.2	0.2	0.3	0.5	0.3	0.7	0.5	0.2	0.2	0.2	0.9	0.3	1.1	0.4	0.1	0.9	0.2	2.0	0.3	1.3	0.2	0.7	1.7	0.9	1.3	0.2	0.4	0.9	1.3	0.4	0.1	0.0	0.3	1.2	0.3	0.4	3.4	1.4	0.7	1.0	0.8	0.7	1.0	1.0	0.2	1.7	1.6	0.3	0.2	0.9	0.6	0.5	0.1	0.1	0.4	0.0	0.9	0.1	0.9	0.6	0.0	0.2	1.2	0.7	0.6	0.6	0.0	0.1	0.4	0.3	3.7	3.8	6.8	4.8	3.6	3.4	3.2	3.1	3.5	2.7	3.7	3.6	0.9	0.0	0.0	6.2	0.4	0.3	0.3	0.6	0.0	2.6	0.5	0.5	2.7	1.5	0.2	0.0	0.0	0.3	0.3	8.8	0.0	0.2	0.3	0.4	1.3	1.2	3.5	0.0	5.1	0.2	0.4	0.8	2.0	1.7	0.0	1.3	2.2	2.3	1.5	3.3	4.6	3.1	0.0	1.9	0.3	1.0	0.9	1.5	0.0	2.8	1.1	1.8	0.0	2.5	1.7	0.3	8.0	0.4	0.0	0.6	44.6	3.7	0.0	1.8	0.0	2.7	0.9	0.6	0.6	1.1	0.1	1.4	0.6	0.4	5.5	0.7
SLC29A2	"DER12, ENT2, HNP36"	ENSG00000174669	"Solute carrier family 29 member 2"	Q14542	11	66362521-66372214	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 90.8;tongue: 47.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.3;CAPAN-2: 53.5;T-47d: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018168	Approved		Uncertain	Nucleoplasm		NA	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA018168: AB_1857077"	"unprognostic (3.20e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.37e-1)"	"unprognostic (5.08e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.38e-3)"	6.7	0.9	4.2	2.5	4.3	0.8	7.4	9.8	5.6	1.9	4.2	5.7	7.8	0.9	3.1	3.3	3.6	1.4	11.9	4.1	4.0	6.9	1.5	4.4	2.8	7.4	6.9	0.7	8.7	12.9	6.1	4.1	8.2	5.2	4.1	3.1	7.2	2.4	90.8	2.8	7.4	0.3	4.1	2.1	9.4	0.5	5.9	2.3	5.4	47.3	1.9	1.2	2.6	3.7	14.2	11.4	8.2	1.8	1.2	0.3	44.3	0.6	0.0	0.4	0.6	20.2	53.5	6.1	10.4	0.1	3.1	12.9	11.4	9.7	0.0	0.5	18.6	11.7	12.4	1.5	1.3	21.9	0.4	0.7	4.3	1.5	4.1	5.2	0.5	5.1	33.0	0.0	0.0	34.5	1.6	31.9	21.8	35.1	8.1	1.3	0.3	26.4	22.2	10.4	16.1	6.6	1.0	18.4	1.2	2.4	55.2	4.1	0.0	0.3	11.2	0.4	0.0	0.3	0.8	0.5	0.9	0.5	0.7	0.0	0.0	0.0	1.3	0.0	0.4	0.2	0.7	1.7	0.3	0.7	1.7	1.7	0.1	0.0	0.0	0.6	0.1	0.5	4.2	4.3	9.8	5.6	4.1	4.0	7.4	6.9	8.2	4.1	5.9	3.7	0.6	3.2	6.3	9.4	2.2	0.6	4.7	5.4	1.2	2.5	7.6	5.8	12.3	4.3	6.5	14.7	12.5	46.4	0.7	6.0	3.9	5.0	0.1	2.1	0.5	0.9	2.4	2.1	11.2	6.7	16.5	1.7	11.2	5.4	4.5	1.8	0.4	0.9	4.4	5.0	10.8	9.2	4.1	0.8	0.4	0.0	0.0	0.5	0.0	2.8	0.9	2.3	0.0	7.5	0.8	3.5	4.7	0.4	1.5	4.7	1.6	0.5	3.8	3.7	0.0	4.4	2.1	0.4	0.5	3.5	0.0	13.5	2.1	0.4	10.6	3.4
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281718-7288257	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8;skeletal muscle: 223.6"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"Hep G2: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			CAB016544	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	16.9	5.2	1.4	0.2	1.7	1.1	11.2	0.9	1.5	9.2	0.9	53.1	0.8	9.3	1.2	5.9	11.3	0.7	98.8	1.3	1.1	2.6	3.7	2.1	0.2	1.0	1.5	3.2	0.8	3.4	4.4	0.6	1.2	9.9	1.1	0.4	6.3	3.3	223.6	4.1	9.7	4.3	1.0	0.3	11.7	3.3	1.3	0.1	4.5	63.2	0.0	27.0	5.6	1.1	0.0	0.0	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	1.7	0.9	1.5	1.3	1.1	1.0	1.5	1.2	1.0	1.3	1.1	1.7	0.0	0.0	1.0	0.0	1.8	0.9	0.3	2.2	0.1	1.5	1.3	135.2	0.0	0.2	0.0	0.0	0.3	0.0	1.0	7.9	0.1	16.6	0.2	0.1	3.7	0.0	10.7	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.3	1.8	2.8	0.1	0.0	0.0	0.8	0.0	0.3	0.3	4.8	0.0	0.1	7.2	1.0	0.0	6.0	0.0	0.0	0.0	0.1	1.2	8.6	0.0	0.8	0.8	0.3	0.4	0.4	32.9	7.0	19.8	1.7	2.2	0.5	1.1	1.0	0.1	0.5	1.0	0.7
SLC7A6	"KIAA0245, LAT-2, LAT3, y+LAT-2"	ENSG00000103064	"Solute carrier family 7 member 6"	Q92536	16	68264516-68301823	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.0"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 55.3;Syncytiotrophoblasts: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050713	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Plasma membrane"	"HPA050713: AB_2681218"	"unprognostic (6.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.84e-4)"	35.3	8.8	1.7	15.5	1.9	8.4	26.9	6.5	3.3	5.5	17.3	8.3	3.9	5.8	11.5	4.5	8.6	4.4	18.5	3.3	2.2	5.9	2.0	10.9	18.6	1.0	1.3	2.7	3.8	2.5	9.6	18.6	1.5	6.2	11.1	5.0	7.3	5.2	75.0	10.2	12.0	7.7	1.0	10.7	6.6	5.1	2.2	37.6	16.7	26.9	21.5	6.8	4.8	1.1	22.6	22.1	16.3	16.8	46.9	27.6	42.9	24.9	18.7	36.9	30.6	97.9	16.2	43.7	19.8	33.4	10.9	33.1	32.0	32.2	39.7	9.5	22.9	23.8	47.3	31.0	7.7	28.2	20.3	19.3	26.1	27.5	13.5	11.4	25.3	21.0	35.1	7.3	20.5	11.7	36.4	19.3	12.4	14.6	8.1	45.0	10.2	36.0	12.0	19.6	23.7	13.5	75.7	20.8	6.8	13.4	30.9	13.3	38.4	24.6	19.0	20.5	32.8	16.7	33.5	50.3	15.6	20.1	17.2	3.4	3.2	2.8	4.3	1.7	5.4	6.8	6.6	4.3	3.6	6.3	11.7	6.7	6.1	7.1	1.4	16.8	3.1	1.5	1.7	1.9	6.5	3.3	3.3	2.2	1.0	1.3	1.5	1.0	2.2	1.1	8.5	41.7	18.8	12.4	18.4	19.6	9.3	8.5	13.6	6.1	5.9	4.8	19.9	2.8	4.9	18.4	37.5	25.1	23.3	7.3	0.0	3.3	5.5	10.7	16.8	12.0	2.4	2.1	39.3	4.0	2.5	12.8	4.1	3.3	4.5	1.8	6.8	1.4	14.6	10.1	40.3	10.5	4.1	8.5	12.1	18.3	5.9	9.9	10.6	55.3	10.0	1.8	14.4	13.0	10.7	5.6	5.9	3.8	16.0	8.0	2.5	0.6	10.4	2.7	0.0	10.8	7.2	17.3	10.9	6.7	21.9	47.9	23.5	4.3	7.8	2.6
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667046-69834978	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.5;skeletal muscle: 7.6;tongue: 11.1"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 10.1;Cardiomyocytes: 14.4;Enteroendocrine cells: 15.6;Excitatory neurons: 8.6;Inhibitory neurons: 30.1;monocytes: 21.2;Oligodendrocyte precursor cells: 26.2;Plasma cells: 14.3;Prostatic glandular cells: 11.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.5;NTERA-2: 3.7;RPMI-8226: 3.6;SCLC-21H: 3.9;U-266/70: 2.1"	"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory bulb: 6.7"	"Region enriched"	"Detected in some"	7	"olfactory bulb: 12.8"	HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.1	0.0	0.3	0.9	0.4	0.9	0.1	0.0	0.4	0.2	0.0	0.2	0.2	0.2	0.0	0.5	0.3	0.2	3.7	0.2	0.6	0.0	0.0	0.1	1.0	0.2	0.0	0.0	0.4	0.0	1.5	0.0	0.2	2.3	0.4	0.7	0.3	0.0	7.6	0.1	0.3	0.1	0.0	0.5	0.2	0.3	0.1	6.5	0.0	11.1	0.9	0.6	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	3.7	0.0	0.6	0.6	0.6	3.6	0.0	0.0	3.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	2.1	0.3	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.6	0.2	0.0	0.2	0.0	0.1	0.1	0.1	3.2	0.0	3.6	3.6	0.3	1.8	0.0	0.6	10.1	0.2	0.3	14.4	0.0	0.6	0.0	2.1	0.0	0.0	0.6	0.0	1.8	0.6	0.4	1.7	2.0	15.6	0.0	8.6	1.3	0.0	4.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	1.7	30.1	2.0	0.0	0.0	3.6	0.6	0.0	0.7	0.0	3.7	21.2	0.5	0.0	26.2	2.2	2.1	0.1	0.0	14.3	11.8	0.0	0.1	0.0	0.3	0.0	3.4	2.0	1.1	2.6	0.4	0.4	0.0	0.1	0.4	1.5	1.5
SMCO1	"C3orf43, DKFZp313B0440, FLJ41923"	ENSG00000214097	"Single-pass membrane protein with coiled-coil domains 1"	Q147U7	3	196506879-196515346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"heart muscle: 41.5;skeletal muscle: 149.2;tongue: 107.0"	"Cell type enriched"	"Detected in some"	34	"Cardiomyocytes: 89.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA061937			Approved	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA061937: AB_2684642"	"unprognostic (4.86e-2)"	"unprognostic (1.62e-1)"		"unprognostic (1.51e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.72e-2)"		"unprognostic (1.73e-1)"		"unprognostic (3.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.94e-2)"		"unprognostic (2.95e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-3)"	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.6	2.4	0.0	0.0	41.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.7	0.0	149.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	107.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.5	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMPX	"Chisel, Csl, DFN6, DFNX4"	ENSG00000091482	"Small muscle protein X-linked"	Q9UHP9	X	21705978-21758116	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"heart muscle: 757.5;skeletal muscle: 1183.4;tongue: 1097.5"	"Cell type enriched"	"Detected in some"	22	"Cardiomyocytes: 807.6"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 7.2;stomach cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"GAMG: 23.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077360			Approved	"Plasma membrane"		NA	NA		62000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"		"HPA077360: AB_2732342"	"unprognostic (7.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.27e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.58e-2)"		"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"		"unprognostic (8.38e-2)"	0.2	0.1	2.6	0.5	2.4	0.1	1.1	3.6	3.8	0.3	0.9	25.6	0.7	0.4	0.0	20.0	0.7	0.5	757.5	1.6	4.1	0.1	1.2	0.5	0.2	1.7	3.3	1.1	0.2	0.0	0.2	0.0	1.5	11.1	3.4	1.7	17.8	0.7	1183.4	0.5	4.1	12.6	1.3	0.1	7.2	0.2	5.3	1.5	0.2	1097.5	0.1	3.2	0.2	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	3.6	3.8	1.6	4.1	1.7	3.3	1.5	1.3	5.3	2.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	807.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	0.0	16.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	35.6	9.5	0.1	0.3	0.0	0.0	0.3	0.1	2.1	0.1	0.0
SMYD1	"BOP, KMT3D, ZMYND22"	ENSG00000115593	"SET and MYND domain containing 1"	Q8NB12	2	88067825-88113384	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 160.4;skeletal muscle: 493.6;tongue: 301.3"	"Cell type enriched"	"Detected in some"	27	"Cardiomyocytes: 208.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.9;stomach cancer: 1.6"	"Region enriched"	"Detected in some"	4	"basal ganglia: 4.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HSkMC: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA062282	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA062282: AB_2684736"	"unprognostic (1.93e-2)"		"unprognostic (2.49e-1)"		"unprognostic (4.09e-2)"	"unprognostic (8.51e-3)"			"unprognostic (2.74e-1)"		"unprognostic (3.91e-1)"			"unprognostic (8.81e-3)"	"unprognostic (1.40e-1)"			0.0	0.0	0.2	0.2	4.1	0.0	5.4	0.1	1.0	0.0	0.0	17.9	2.0	0.0	0.0	7.3	0.0	0.0	160.4	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	2.4	0.0	0.0	0.3	4.0	1.9	0.0	3.9	0.0	493.6	0.1	7.0	28.1	0.1	0.0	7.3	0.3	0.1	0.4	0.1	301.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.1	0.1	1.0	0.4	0.1	0.1	0.2	0.3	0.1	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.7	208.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMYD4	"KIAA1936, ZMYND21"	ENSG00000186532	"SET and MYND domain containing 4"	Q8IYR2	17	1779485-1830634	"Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030059	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA030059: AB_2191728"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.26e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	7.4	6.6	4.1	6.0	3.6	3.4	7.3	8.0	4.5	7.9	3.7	7.5	7.0	6.5	5.0	3.9	7.3	3.6	7.0	3.5	3.5	3.7	4.9	5.6	6.8	3.7	3.2	9.5	6.7	3.6	6.6	4.7	4.0	6.5	4.8	7.6	7.3	5.6	13.7	6.6	7.4	5.9	2.2	6.3	4.9	5.8	4.3	6.2	5.7	10.2	6.5	7.2	6.2	5.6	7.4	13.7	13.5	9.6	9.0	6.1	15.7	11.9	6.7	12.3	12.5	22.0	6.2	19.7	7.8	4.8	8.3	14.2	12.9	7.7	15.3	5.7	13.1	7.2	15.9	6.0	4.5	7.4	6.8	4.4	6.8	12.7	11.1	6.3	6.2	16.6	7.6	7.5	9.7	4.6	13.6	5.3	6.2	8.7	6.6	16.7	6.9	5.0	4.9	8.8	5.5	7.6	11.0	4.5	11.1	10.9	6.7	4.5	5.9	12.0	6.1	10.0	10.4	5.2	7.5	7.1	6.8	6.4	11.9	12.0	2.4	2.3	5.1	3.0	4.3	4.0	3.0	3.3	1.5	2.7	3.4	5.0	1.3	3.1	2.4	4.5	3.5	2.1	4.1	3.6	8.0	4.5	3.5	3.5	3.7	3.2	4.0	2.2	4.3	5.6	22.9	6.4	27.8	6.5	12.9	5.0	9.3	11.9	14.8	19.3	6.9	8.4	6.3	14.3	14.0	7.3	33.3	9.7	16.5	6.9	1.9	5.7	20.2	3.7	8.9	10.9	3.6	9.7	11.7	3.3	10.9	14.2	4.1	3.5	7.6	14.7	17.2	6.7	12.9	26.9	12.1	5.2	12.2	23.3	9.2	5.9	27.1	17.4	5.4	13.1	16.4	7.9	43.3	4.5	7.1	4.2	2.0	24.8	10.1	7.2	23.3	2.9	17.8	19.9	46.0	43.6	23.9	12.6	14.8	5.1	6.7	8.1	12.1	6.1	6.4	3.5
SPAG7	"ACRP, FSA-1, MGC20134"	ENSG00000091640	"Sperm associated antigen 7"	O75391	17	4959226-4967817	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 305.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024032, HPA052394"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA024032: AB_1857410, HPA052394: AB_2681810"	"unprognostic (7.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (4.66e-3)"	"unprognostic (5.51e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.72e-2)"	51.1	56.1	55.4	37.5	56.0	46.0	48.3	58.5	63.5	50.5	56.0	67.1	37.1	67.1	41.0	52.0	68.2	38.0	156.7	56.4	57.4	84.0	69.7	46.0	44.7	58.8	56.1	42.9	45.5	69.3	38.4	52.3	59.4	45.8	38.2	47.6	48.0	40.5	305.3	48.0	45.4	50.3	56.6	51.7	56.6	35.6	58.5	47.2	56.1	215.5	41.7	54.0	47.6	58.8	41.8	90.7	116.9	65.4	79.8	115.5	67.5	80.9	91.8	77.8	59.5	53.7	53.3	52.9	116.6	100.5	54.2	58.6	59.3	123.9	35.1	77.5	52.6	57.6	74.5	75.3	111.3	32.1	82.1	127.4	87.9	66.5	123.9	118.6	99.4	66.9	39.0	53.2	96.2	66.9	58.7	71.2	66.8	58.0	29.0	61.4	74.1	38.3	135.7	52.1	32.8	64.6	68.7	27.3	68.2	59.9	59.2	50.2	96.6	52.4	34.0	26.1	67.2	46.5	40.3	32.5	101.4	45.6	69.1	96.0	88.3	82.6	82.3	72.6	89.7	97.2	77.1	77.9	103.9	81.1	95.5	84.0	23.1	67.3	73.7	105.9	95.0	91.0	55.4	56.0	58.5	63.5	56.4	57.4	58.8	56.1	59.4	56.6	58.5	58.8	40.6	57.7	52.6	11.1	54.6	55.3	103.0	252.0	52.3	62.0	62.9	66.3	135.8	77.2	125.4	99.3	45.9	183.5	61.1	82.0	324.8	161.6	23.0	63.1	49.1	64.2	57.2	33.7	7.3	144.1	183.5	66.1	40.8	48.1	73.4	68.3	70.6	72.4	139.3	92.5	8.1	73.5	156.6	64.9	88.9	21.9	46.0	65.6	104.9	2.8	221.0	89.7	97.9	7.1	12.0	128.8	82.8	42.2	39.4	98.7	116.4	239.3	127.4	69.7	72.3	53.5	70.1	55.8	50.6	52.8	50.2	230.8	52.2	89.5	74.6	105.2
SPEG	"APEG1, BPEG, KIAA1297, MGC12676, MYLK6, SPEGalpha, SPEGbeta"	ENSG00000072195	"Striated muscle enriched protein kinase"	Q15772	2	219434843-219493629	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 174.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.7;Cardiomyocytes: 61.5;Late spermatids: 39.6;Sertoli cells: 46.0;Smooth muscle cells: 32.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 45.9;U-87 MG: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018904	Enhanced		Approved	Vesicles		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA018904: AB_1844924"	"unprognostic (3.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.45e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.29e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-9)"	"unprognostic (1.14e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.95e-4)"	"unprognostic (1.28e-3)"	16.1	6.8	16.8	7.7	18.7	0.0	15.3	15.5	20.7	75.5	9.7	174.8	5.3	89.5	6.2	15.6	70.0	7.3	48.5	19.8	14.5	4.1	1.3	8.7	0.6	16.1	15.8	21.9	3.4	4.4	34.3	4.5	14.6	58.8	3.8	1.0	10.0	25.5	118.0	7.8	31.9	23.1	15.3	2.4	48.1	5.4	15.3	0.5	5.9	21.7	0.2	87.7	42.1	15.6	6.1	0.5	3.1	4.9	1.6	4.7	1.8	13.1	8.5	8.6	6.4	4.5	1.9	0.0	4.5	9.7	4.3	7.2	2.5	3.1	3.4	0.0	1.7	0.0	6.1	0.3	2.1	0.0	0.5	13.2	4.6	7.8	1.9	45.9	0.0	3.2	3.5	0.0	6.1	1.6	0.1	18.8	6.5	0.0	2.4	2.8	7.0	1.1	8.5	0.0	3.4	15.1	0.6	0.0	0.3	14.3	0.3	0.2	0.0	20.6	21.3	2.4	21.1	0.4	0.0	0.2	23.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	18.7	15.5	20.7	19.8	14.5	16.1	15.8	14.6	15.3	15.3	15.6	2.4	0.0	2.2	45.7	0.4	3.2	6.0	1.3	2.8	5.3	10.3	14.6	61.5	4.3	0.1	1.8	2.1	0.6	1.4	4.1	0.0	1.5	21.8	0.9	3.6	2.2	6.7	2.7	20.5	1.2	0.9	10.0	3.6	1.3	0.0	1.0	5.7	3.1	1.1	5.0	20.9	4.1	0.0	5.6	1.9	39.6	10.5	1.6	3.6	4.7	1.4	8.4	0.0	5.0	1.0	0.2	3.2	18.8	0.9	6.5	8.5	4.3	0.1	0.9	46.0	17.1	32.4	11.6	3.7	0.2	1.4	1.4	1.2	0.4	3.5	5.3
SRL	SAR	ENSG00000185739	Sarcalumenin	Q86TD4	16	4189374-4242080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	41	"heart muscle: 280.1;skeletal muscle: 510.3;tongue: 382.3"	"Cell type enriched"	"Detected in some"	16	"Cardiomyocytes: 247.3"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.5;thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HSkMC: 4.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"basal ganglia: 5.3"	"HPA041535, HPA045520"	Enhanced				"Intracellular and membrane"	NA	NA		230000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA041535: AB_2677538, HPA045520: AB_2679358"	"unprognostic (1.24e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.04e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.40e-4)"	"unprognostic (4.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (7.78e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.68e-4)"	3.0	0.4	1.0	1.2	1.0	0.2	1.7	1.0	1.5	3.2	0.8	1.3	0.4	3.0	2.3	9.6	3.1	1.8	280.1	0.8	1.2	1.4	0.4	1.2	0.7	1.2	1.3	1.3	0.6	0.2	0.5	1.3	1.1	5.6	1.1	8.5	6.4	2.6	510.3	1.1	1.7	3.4	1.0	2.2	1.1	1.0	1.1	1.7	2.3	382.3	1.1	1.4	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.0	1.0	1.0	1.5	0.8	1.2	1.2	1.3	1.1	1.0	1.1	1.0	0.5	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.0	247.3	0.0	0.0	1.8	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.4	0.0	0.0	8.5	0.0	0.1	0.0	0.2	2.9	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.3	0.0	1.8	0.1	0.0	1.0	0.0	1.2	0.0	1.0	0.3	0.1	0.0	3.8	0.0	0.3	0.0	0.2	0.0	12.1	6.6	5.5	15.4	0.1	0.2	0.0	0.4	0.0	0.1	0.4	0.0	0.1
STYXL2	DUSP27	ENSG00000198842	"Serine/threonine/tyrosine interacting like 2"	Q5VZP5	1	167094075-167129165	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	42	"heart muscle: 63.6;skeletal muscle: 114.6;tongue: 54.1"	"Cell type enriched"	"Detected in some"	7	"Cardiomyocytes: 143.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 12.8;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RH-30: 14.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA012912			Approved	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA012912: AB_2668767"	"unprognostic (1.26e-2)"		"unprognostic (1.74e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.39e-1)"	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.1	0.1	63.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.7	0.0	0.9	1.6	0.0	114.6	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	54.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	3.6	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SUN1	"FLJ12407, KIAA0810, UNC84A"	ENSG00000164828	"Sad1 and UNC84 domain containing 1"	O94901	7	816615-896435	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Meiosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 343.8;Late spermatids: 576.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008346, HPA008461"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"		"HPA008346: AB_1080462, HPA008461: AB_1080461"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.33e-2)"	72.4	26.9	26.1	17.9	25.4	8.3	60.7	43.4	30.7	75.3	29.1	52.3	33.8	73.3	38.5	43.8	66.1	28.2	77.4	25.2	24.3	44.3	28.2	41.7	23.6	23.5	27.2	84.1	34.1	53.0	59.0	47.3	23.1	39.2	30.2	41.4	44.7	34.0	119.2	87.1	42.1	41.5	23.8	38.8	48.1	45.5	24.3	20.0	44.3	99.1	25.1	38.9	57.4	25.3	128.7	34.2	40.2	65.5	43.4	61.6	39.2	31.7	53.4	58.0	59.0	29.1	139.8	30.5	32.2	43.7	113.5	156.8	33.3	55.9	55.9	13.2	33.3	10.0	51.0	27.8	55.3	15.2	24.3	31.0	65.6	46.3	76.4	53.7	42.7	19.0	41.9	22.4	58.6	44.5	10.1	25.2	56.0	44.3	39.0	21.9	22.3	28.7	59.1	40.7	77.2	49.9	40.1	81.4	31.5	64.6	64.6	15.4	32.5	52.8	47.6	55.1	53.2	20.4	25.6	19.0	36.6	12.7	74.4	11.6	9.4	2.5	4.0	8.3	4.2	6.8	7.9	4.6	7.5	5.5	11.0	7.2	0.5	6.6	6.4	1.5	7.3	6.4	26.1	25.4	43.4	30.7	25.2	24.3	23.5	27.2	23.1	23.8	24.3	25.3	107.0	44.8	36.4	63.0	26.5	106.7	96.9	73.2	50.7	72.4	48.0	38.1	103.7	31.5	68.5	40.5	87.6	37.4	14.1	61.9	27.4	41.5	343.8	168.5	40.3	79.9	40.7	31.5	76.5	23.2	23.5	52.6	60.1	143.7	17.1	73.4	62.4	39.1	17.9	112.7	64.5	45.1	59.0	20.0	34.3	576.2	57.2	16.8	42.7	43.1	16.6	24.0	10.3	48.7	49.8	55.8	68.4	42.5	26.4	84.6	37.7	21.9	163.5	67.6	65.7	53.5	73.4	40.9	49.4	36.1	85.7	38.4	22.0	26.1	38.2	137.4
SVIL		ENSG00000197321	Supervillin	O95425	10	29457338-29736959	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 808.1;tongue: 581.5"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 204.9;Cardiomyocytes: 469.6;Peritubular cells: 260.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 259.3"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 259.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 146.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010878, HPA020095, HPA020138"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		210000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.26e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (5.70e-5)"	26.4	13.4	3.7	22.7	3.9	37.2	22.6	1.3	8.9	45.8	2.5	314.5	14.8	116.2	24.1	92.1	55.5	52.0	165.0	2.2	2.7	15.4	10.4	22.9	12.6	7.0	4.1	83.3	18.5	31.8	8.5	17.9	4.4	70.3	37.1	10.3	40.6	100.0	808.1	26.9	60.1	107.0	4.4	7.6	77.6	11.7	4.9	19.1	35.0	581.5	10.8	173.2	40.3	5.2	71.4	27.9	12.4	5.4	32.1	84.4	22.1	12.6	24.1	4.3	4.7	34.4	63.1	2.4	43.0	4.9	31.9	146.8	8.6	25.6	5.2	1.4	17.6	0.1	33.6	19.9	21.4	8.0	1.5	72.7	24.5	44.2	19.1	71.9	69.6	14.7	0.1	0.4	6.7	19.9	7.7	4.0	7.0	27.8	15.1	15.5	32.1	0.9	40.2	20.1	18.1	14.1	12.3	1.4	34.3	39.8	12.9	7.9	46.3	21.9	23.4	94.4	34.4	0.6	0.8	0.3	64.5	14.0	65.4	43.4	12.1	58.2	11.1	14.0	10.9	0.6	11.2	7.6	7.3	1.0	17.1	10.9	259.3	14.6	29.6	3.0	4.3	3.7	3.7	3.9	1.3	8.9	2.2	2.7	7.0	4.1	4.4	4.4	4.9	5.2	31.3	48.1	30.5	2.3	3.7	70.2	108.0	41.1	204.9	11.7	36.6	67.1	469.6	18.6	53.5	38.6	25.0	29.7	11.3	39.7	7.9	94.1	4.0	26.3	65.8	61.1	23.9	1.7	8.3	42.3	18.5	68.1	7.7	43.6	10.1	35.7	32.2	11.8	10.4	5.0	43.9	31.3	28.5	7.5	45.7	6.8	109.6	25.3	28.4	146.1	16.7	30.6	13.4	28.1	6.6	63.4	40.2	260.7	3.3	131.8	18.4	10.8	42.2	15.0	46.0	90.6	92.9	6.5	11.1	103.8	60.0	24.8	14.6	27.9	39.2	98.3
SYNC	"SYNC1, SYNCOILIN"	ENSG00000162520	"Syncoilin, intermediate filament protein"	Q9H7C4	1	32679906-32703596	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 106.8;smooth muscle: 54.1;tongue: 73.4"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 74.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 121.0;U-138 MG: 113.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028311, HPA063549"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA028311: AB_2672554, HPA063549: "	"unprognostic (3.99e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.99e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.32e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-4)"	10.5	8.5	6.4	15.6	6.1	0.7	5.4	6.7	6.6	9.7	6.1	11.6	6.5	10.9	4.9	17.9	7.4	9.5	17.3	5.8	7.9	2.4	2.2	10.5	6.4	8.3	8.7	3.7	2.6	4.7	0.7	2.5	7.9	13.1	8.7	0.4	9.6	14.6	106.8	2.5	7.3	54.1	9.0	6.2	9.0	9.7	7.4	1.1	4.5	73.4	1.7	12.3	2.9	8.2	8.7	7.0	11.2	19.3	19.4	30.5	6.6	41.9	81.5	28.7	19.6	1.2	24.8	23.9	13.0	121.0	43.4	5.8	1.0	0.7	16.2	12.4	0.8	26.1	22.6	18.0	16.4	33.0	12.0	46.6	2.9	31.6	1.1	86.1	9.0	17.2	19.6	26.2	24.3	4.2	32.0	8.9	5.9	11.2	9.6	34.5	36.5	12.7	32.6	14.2	18.1	1.7	57.1	17.6	21.7	22.2	16.0	10.4	14.4	113.0	19.4	69.4	18.8	11.4	21.1	30.2	39.0	10.4	98.3	5.9	7.7	6.1	6.1	9.6	8.1	6.9	6.9	6.4	9.7	5.2	6.2	7.0	0.9	9.1	9.5	12.3	7.9	12.0	6.4	6.1	6.7	6.6	5.8	7.9	8.3	8.7	7.9	9.0	7.4	8.2	10.6	9.6	9.8	15.7	15.1	22.0	14.2	14.5	8.0	50.2	20.6	7.0	1.0	20.0	14.1	9.2	39.6	9.4	20.7	8.3	5.9	11.7	11.2	12.9	25.0	13.1	7.3	16.0	12.2	5.4	9.3	17.1	0.5	16.3	22.2	12.4	22.9	19.1	5.4	74.0	13.2	8.4	8.2	17.7	23.2	14.8	41.7	7.3	33.8	7.5	11.4	20.0	34.0	15.1	11.6	7.9	7.9	64.3	5.7	16.0	10.7	10.1	6.0	53.9	19.7	16.6	12.8	32.8	36.0	7.2	22.3	5.1	15.3	9.4	12.6	9.4
SYNE2	"DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2"	ENSG00000054654	"Spectrin repeat containing nuclear envelope protein 2"	Q8WXH0	14	63761899-64226433	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 198.5"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 454.6;Rod photoreceptor cells: 568.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 73.8"	"Group enriched"	"Detected in many"	11	"granulocytes: 73.8;T-cells: 38.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 48.8;SiHa: 29.8;U-698: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003435, HPA050204"	Enhanced		Approved	"Nuclear membrane,Intermediate filaments"		No	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear membrane, Intermediate filaments"		"HPA003435: AB_1080162, HPA050204: AB_2681051"	"unprognostic (1.93e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.24e-1)"	"prognostic favorable (3.56e-9)"	"unprognostic (5.05e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.80e-2)"	30.1	6.0	8.8	3.4	9.2	7.9	28.0	21.1	8.7	15.4	89.5	13.3	4.5	18.1	9.9	24.3	14.3	5.5	58.3	9.6	7.6	29.0	19.5	18.4	8.5	7.7	9.6	35.9	37.7	66.6	16.7	9.9	7.5	11.5	4.4	24.8	16.1	3.7	198.5	39.7	11.4	4.6	7.0	10.0	12.4	13.1	11.4	5.5	24.4	96.7	6.1	13.6	19.0	6.9	23.2	8.7	11.0	3.5	11.3	3.2	12.3	1.3	1.6	2.7	4.2	2.8	3.3	48.8	2.3	1.7	2.6	11.0	6.2	3.5	3.2	8.9	3.5	0.4	7.9	0.7	3.0	1.0	0.3	4.4	15.1	3.4	2.2	2.6	7.0	7.5	0.4	4.8	1.8	11.2	6.2	0.3	3.4	5.4	3.3	6.9	14.5	1.8	20.0	13.6	9.9	8.2	29.8	3.8	7.0	5.5	5.0	0.3	7.3	4.2	7.5	1.5	4.5	4.9	3.5	27.5	1.8	0.0	5.7	0.5	0.1	73.8	38.5	0.3	27.6	5.2	24.3	28.0	0.0	5.3	11.8	18.5	30.1	3.9	0.3	1.2	30.1	3.4	8.8	9.2	21.1	8.7	9.6	7.6	7.7	9.6	7.5	7.0	11.4	6.9	414.4	307.7	140.1	8.5	44.9	111.3	138.9	46.4	174.2	27.4	70.3	59.1	261.4	105.8	184.5	202.3	183.5	168.8	226.8	51.0	19.6	108.2	9.4	249.9	71.2	238.8	46.2	10.5	9.5	55.4	65.7	59.6	126.9	365.2	25.9	454.6	73.5	33.3	17.7	6.7	13.9	60.9	59.0	5.7	13.2	14.3	100.9	12.8	48.0	128.4	8.9	107.2	300.7	33.2	6.6	71.7	27.9	53.4	180.3	65.0	35.9	72.2	196.1	568.7	111.7	73.5	167.0	13.0	17.0	104.6	87.5	224.0	222.1	69.5	80.6	80.6
SYNM	"DMN, KIAA0353, SYN"	ENSG00000182253	Synemin	O15061	15	99098217-99135593	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 594.1;skeletal muscle: 624.7;urinary bladder: 406.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 103.5;Cardiomyocytes: 502.5;Muller glia cells: 127.8;Smooth muscle cells: 98.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 28.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 36.8;HeLa: 58.0;WM-115: 124.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017192, HPA040066, HPA044200, HPA077856"	Enhanced		Supported	"Intermediate filaments"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: AB_2686861"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (5.92e-3)"	"unprognostic (3.26e-3)"	37.2	20.3	51.4	26.5	66.0	0.4	56.7	70.1	58.2	11.8	52.5	594.1	27.1	50.8	12.7	169.6	36.5	19.2	144.2	44.4	75.4	6.9	4.8	23.1	4.2	81.7	66.6	14.1	6.3	8.2	23.2	14.0	81.6	150.6	52.0	40.3	25.6	291.3	624.7	17.0	105.7	160.9	71.6	2.9	158.4	5.2	69.3	3.7	11.2	277.1	4.0	406.3	41.0	79.8	6.6	36.8	8.1	21.9	15.9	0.9	0.5	3.7	5.3	2.1	1.3	5.4	4.9	0.0	5.3	5.3	17.7	4.2	5.5	0.1	1.6	0.5	9.0	0.1	58.0	5.4	9.0	0.0	1.0	0.9	0.3	3.7	0.8	6.0	4.3	0.0	0.2	7.4	5.5	3.7	0.7	0.8	7.2	0.7	11.4	0.0	7.5	5.5	2.1	3.6	3.6	4.2	21.9	3.4	13.5	12.7	0.2	3.6	4.8	4.1	0.4	2.9	8.9	0.1	1.0	0.0	0.4	0.0	124.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	51.4	66.0	70.1	58.2	44.4	75.4	81.7	66.6	81.6	71.6	69.3	79.8	14.8	0.0	1.7	15.3	0.9	2.3	0.7	0.9	2.8	12.6	32.7	103.5	502.5	0.0	1.2	0.0	16.7	1.5	6.6	2.1	0.0	0.5	9.5	1.3	1.0	24.2	3.0	0.0	15.6	1.3	0.7	20.3	5.1	4.2	0.0	1.1	3.6	1.3	0.3	42.1	9.8	0.9	0.0	0.0	5.1	4.5	1.2	2.0	5.4	12.2	0.6	127.8	1.0	2.5	14.0	0.2	2.3	4.1	5.4	2.0	0.6	0.3	3.1	10.2	32.9	19.6	98.5	7.9	11.5	2.1	3.7	0.4	5.9	0.2	0.7	0.9
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659207	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 369.6;skeletal muscle: 1296.3;tongue: 502.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 264.7;Distal enterocytes: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 88.4;EFO-21: 72.8;HUVEC TERT2: 72.7;TIME: 178.0;U-87 MG: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033265, HPA034631, CAB037325, HPA071347"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179"	"unprognostic (2.09e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (1.23e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.35e-2)"	91.8	112.1	103.5	21.3	60.7	0.3	48.6	0.0	88.9	23.2	0.8	37.4	31.4	38.7	20.9	31.0	30.8	32.2	369.6	91.2	5.2	60.6	38.5	72.1	10.6	18.2	8.5	34.6	32.9	17.1	21.6	23.8	5.2	46.0	17.5	10.0	21.6	29.1	1296.3	15.4	39.6	38.9	20.6	38.9	34.9	17.0	5.1	6.6	31.1	502.1	11.1	56.8	22.3	34.9	0.5	24.2	0.2	0.3	3.5	3.2	88.4	13.8	18.9	4.6	3.7	21.6	9.7	0.1	72.8	19.9	29.2	8.9	0.1	13.5	1.9	0.2	0.2	0.0	37.4	4.7	19.6	0.0	0.9	3.7	21.3	5.2	3.7	27.5	72.7	0.2	0.2	0.2	4.4	1.6	0.1	0.7	2.8	9.3	11.6	0.5	0.7	0.2	3.4	1.9	8.5	39.3	19.9	21.6	0.7	31.1	1.6	6.6	178.0	17.4	53.2	0.4	3.6	0.8	0.2	1.3	152.5	0.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.5	60.7	0.0	88.9	91.2	5.2	18.2	8.5	5.2	20.6	5.1	34.9	51.1	35.3	12.2	1.3	4.8	4.6	3.0	32.6	1.8	1.9	6.4	2.5	264.7	27.1	17.0	7.3	2.1	14.8	0.5	70.5	0.0	43.7	1.7	0.4	0.4	56.3	13.8	2.7	22.5	34.5	6.0	19.9	4.6	0.5	0.0	40.9	62.8	40.0	2.1	0.0	5.7	8.4	2.0	10.8	5.1	3.4	2.8	0.9	5.4	6.5	24.0	7.2	0.0	2.5	1.3	35.6	24.4	27.8	0.6	5.7	52.6	4.4	7.6	0.8	46.0	18.0	29.2	1.2	0.8	1.4	2.3	25.9	1.6	8.6	11.8	3.6
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 991.6;tongue: 493.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1"	"Group enriched"	"Detected in all"	5	"prostate cancer: 25.7;stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2"	"Region enriched"	"Detected in all"	4	"thalamus: 27.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	57.5	10.8	6.1	47.4	7.9	0.3	35.9	4.1	5.7	55.0	2.2	346.4	34.3	137.1	33.4	197.1	89.5	50.0	66.8	10.7	13.3	8.7	7.0	16.2	10.5	5.4	7.5	39.0	3.8	3.6	7.5	20.8	6.1	180.5	58.0	1.2	16.0	267.4	991.6	17.9	75.5	244.4	9.2	10.2	126.2	6.7	5.8	14.3	16.0	493.5	6.5	226.5	54.0	12.0	0.2	4.2	0.2	0.0	10.5	3.5	0.7	13.4	14.1	0.4	0.5	0.0	0.7	1.5	0.1	57.8	0.9	0.2	0.4	0.3	0.7	5.9	0.1	0.8	1.3	0.0	2.4	0.1	0.2	14.5	0.3	4.0	0.2	3.7	0.2	0.2	0.0	0.7	18.5	0.3	0.7	7.2	1.4	0.0	0.0	0.5	1.5	0.4	0.2	0.3	0.4	83.2	0.4	0.3	0.1	3.3	0.0	7.0	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.6	0.2	0.8	0.1	0.5	0.2	0.0	0.4	0.3	0.4	0.2	0.0	0.4	0.4	0.3	0.2	0.3	0.1	0.0	0.5	0.1	6.1	7.9	4.1	5.7	10.7	13.3	5.4	7.5	6.1	9.2	5.8	12.0	25.5	3.2	1.1	42.7	1.1	13.5	17.9	3.7	46.1	2.5	6.3	30.7	135.4	0.0	0.3	1.8	0.0	1.4	0.5	0.1	0.0	0.1	2.2	6.9	130.0	11.3	0.0	1.7	149.6	1.8	0.5	41.5	0.5	10.6	0.0	16.1	13.9	0.4	1.4	0.0	31.5	0.2	0.0	0.9	11.4	7.0	27.1	3.8	5.4	76.8	12.9	0.0	0.0	6.0	3.0	0.2	0.4	101.5	0.8	24.9	0.1	0.3	2.5	0.5	131.5	93.4	206.1	1.3	0.5	5.3	8.1	0.8	2.6	33.4	0.2	4.0
TACC2	"AZU-1, ECTACC"	ENSG00000138162	"Transforming acidic coiled-coil containing protein 2"	O95359	10	121989163-122254545	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 251.7;skeletal muscle: 387.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 210.1;Syncytiotrophoblasts: 228.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 86.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031020, HPA031021, HPA061394"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		32000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA031020: AB_10669988, HPA031021: AB_2673701, HPA061394: AB_2684500"	"unprognostic (3.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (2.50e-10)"	"unprognostic (7.02e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (8.45e-4)"	"unprognostic (1.61e-1)"	22.1	15.3	18.2	5.3	18.6	0.2	20.9	23.6	22.7	32.3	28.6	91.5	15.3	26.1	9.2	64.2	32.9	12.9	251.7	19.1	18.8	33.9	18.8	68.7	1.0	16.0	16.9	8.8	25.3	36.4	58.7	21.6	14.8	67.7	20.7	7.2	60.7	13.5	387.1	103.3	35.7	22.0	11.8	4.2	49.1	5.8	16.9	5.7	50.7	159.0	5.7	62.4	49.1	17.7	17.8	55.1	26.5	15.2	7.4	7.4	31.7	7.7	20.7	10.5	7.3	22.7	28.9	0.0	7.0	12.3	12.1	58.1	8.5	20.9	10.9	3.0	4.4	0.0	7.7	43.8	11.5	0.0	0.3	3.4	86.0	5.6	36.6	8.6	22.2	0.1	4.5	0.6	10.4	23.5	0.2	9.9	15.7	27.6	24.8	0.3	15.2	8.5	28.9	26.9	17.6	14.2	12.7	52.0	29.5	7.6	10.2	0.4	20.6	4.7	3.5	11.8	14.5	2.4	11.7	0.3	8.7	0.1	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	18.6	23.6	22.7	19.1	18.8	16.0	16.9	14.8	11.8	16.9	17.7	15.5	83.3	94.1	16.3	0.7	33.6	49.7	54.3	33.0	21.6	23.4	14.1	210.1	8.6	70.7	36.8	0.0	53.3	0.4	75.2	1.9	8.2	2.4	88.4	11.0	21.3	30.0	0.0	32.8	14.2	4.4	21.2	38.7	62.8	7.0	0.1	6.1	18.9	6.5	43.7	48.2	38.8	57.0	0.3	4.3	2.6	6.8	1.9	7.2	7.5	0.1	1.1	0.0	80.9	7.6	19.4	47.1	7.5	0.2	49.6	36.5	13.5	84.9	2.7	13.1	27.2	23.7	0.5	8.2	79.5	54.0	228.5	2.6	2.8	41.9	80.5
TCAP	"CMD1N, LGMD2G, T-cap, TELE, telethonin"	ENSG00000173991	Titin-cap	O15273	17	39665349-39666554	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	47	"heart muscle: 5162.1;skeletal muscle: 15829.0;tongue: 5831.4"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 2473.2"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 20.2;prostate cancer: 11.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 5.3;SK-BR-3: 8.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.8"	"Low region specificity"	"Detected in some"			"CAB004591, HPA026477"	Enhanced					NA	NA		36000	"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB004591: AB_628340, HPA026477: AB_1857888"	"unprognostic (5.29e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.32e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-4)"	"unprognostic (2.62e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (4.55e-4)"	4.1	4.2	13.0	0.8	16.2	2.9	5.7	13.7	16.1	3.0	11.4	3.2	0.7	2.2	0.0	188.9	2.5	1.8	5162.1	12.1	13.0	3.1	3.4	8.4	3.3	13.2	14.3	3.5	2.7	0.9	5.3	0.9	13.2	107.1	0.1	1.1	137.6	1.6	15829.0	5.5	2.5	0.8	12.2	3.2	2.6	3.5	14.1	1.0	5.0	5831.4	0.9	1.7	3.0	13.0	0.1	2.5	1.7	2.2	0.2	0.3	0.6	0.4	0.2	0.4	0.5	0.9	1.5	1.0	1.6	0.3	1.7	0.9	0.3	0.0	0.0	0.9	2.6	0.7	2.0	0.4	0.1	0.6	0.3	0.7	0.3	1.0	0.1	1.0	0.2	1.1	1.6	0.3	0.0	1.1	0.7	5.3	1.0	0.9	0.6	0.7	1.5	0.7	0.8	0.2	1.0	1.7	1.3	8.4	1.1	0.9	0.6	1.1	1.1	0.8	1.0	1.4	0.5	3.7	2.0	0.5	0.6	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	13.0	16.2	13.7	16.1	12.1	13.0	13.2	14.3	13.2	12.2	14.1	13.0	3.3	0.0	0.0	8.1	0.7	1.7	0.5	0.3	0.0	1.5	1.5	0.9	2473.2	5.7	0.3	1.8	0.0	0.1	0.3	0.4	1.9	0.3	0.4	0.9	0.5	29.0	3.0	1.3	2.2	0.0	0.0	68.5	1.5	0.6	0.0	0.8	2.2	0.0	0.4	10.1	2.7	1.1	0.0	0.6	2.0	0.1	0.3	2.9	1.8	1.0	0.1	0.8	0.0	1.0	2.6	0.5	0.6	0.4	0.9	0.7	0.5	0.3	0.6	1.7	6.6	336.9	25.4	1.0	1.2	0.0	2.0	0.4	1.9	0.5	1.2	0.7
TEAD1	"AA, TCF13, TEF-1"	ENSG00000187079	"TEA domain transcription factor 1"	P28347	11	12674421-12944737	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 230.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057339, HPA062471"			Enhanced	Nucleoplasm		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA057339: AB_2683413, HPA062471: AB_2684773"	"unprognostic (1.00e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.40e-3)"	"unprognostic (8.39e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.18e-2)"	29.5	12.1	11.1	8.2	11.6	0.0	17.8	8.6	8.5	23.4	30.6	36.1	7.7	26.4	7.1	29.8	19.2	18.5	31.3	14.5	14.8	17.2	13.6	15.9	4.2	15.1	12.3	21.9	15.2	27.1	14.4	33.3	10.5	18.8	13.0	10.5	10.2	20.1	67.5	13.2	11.9	27.2	13.3	7.3	16.4	8.6	15.6	4.2	17.8	72.6	5.6	33.9	14.7	12.9	62.8	52.1	43.9	58.7	59.9	62.1	65.4	89.2	76.2	71.6	69.7	53.8	54.5	0.4	23.0	120.9	32.3	37.0	53.7	35.9	115.5	0.2	17.6	0.0	107.3	18.1	55.8	0.0	4.7	51.8	18.3	50.4	68.2	58.6	15.2	3.9	26.0	0.2	111.2	13.1	0.1	0.6	17.2	14.5	23.5	0.3	64.8	33.2	48.2	37.2	26.9	31.2	90.9	43.1	59.0	63.8	20.0	4.4	32.0	107.8	76.2	84.9	59.5	8.6	17.3	12.0	41.6	0.2	69.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	11.6	8.6	8.5	14.5	14.8	15.1	12.3	10.5	13.3	15.6	12.9	37.9	89.8	21.7	230.8	0.4	99.3	32.2	19.3	39.9	12.9	16.4	20.2	75.0	31.5	33.1	49.7	12.5	24.1	0.2	11.0	1.9	16.6	6.5	80.8	97.4	33.3	46.7	0.0	101.8	12.8	52.4	46.5	18.8	142.9	0.0	57.7	25.7	39.8	3.7	1.7	108.4	13.5	10.2	1.9	16.0	7.2	23.6	1.9	24.9	91.8	0.0	31.2	0.0	121.2	69.7	34.8	8.1	24.0	1.4	69.4	6.7	29.8	53.8	17.5	6.6	73.5	46.7	3.0	22.3	29.9	54.8	12.3	2.0	45.5	10.4	54.6
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Tissue remodeling, Unfolded protein response"	"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 216.7;heart muscle: 167.9;smooth muscle: 251.4;tongue: 214.6"	"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 493.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	46	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	46	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1;THP-1: 7.0;U-2 OS: 2.8;U-266/70: 2.6"	"Region enriched"	"Detected in many"	8	"white matter: 85.7"	"Region enriched"	"Detected in many"	27	"spinal cord: 89.3"	"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		510000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.33e-4)"	216.7	1.2	15.4	5.2	19.6	10.6	26.8	13.8	13.0	2.1	5.0	58.1	2.2	26.8	1.6	6.0	2.5	10.4	167.9	12.2	24.5	0.7	0.3	1.3	1.1	22.3	25.3	4.1	22.8	35.7	14.3	0.2	19.9	9.0	8.7	7.5	46.5	5.7	77.2	2.9	3.3	251.4	21.7	0.3	8.6	8.7	28.0	3.6	27.0	214.6	4.0	3.5	5.8	20.0	0.1	0.0	3.1	0.2	0.2	1.3	0.3	0.1	0.1	0.9	0.3	0.1	0.4	0.1	0.1	0.2	0.8	0.1	0.1	0.4	0.8	0.1	0.4	0.3	0.0	0.2	1.7	0.0	0.0	0.9	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	2.4	0.0	0.0	0.0	0.9	0.0	0.2	0.0	2.5	0.7	0.0	0.0	0.2	1.3	0.0	7.0	0.0	0.0	2.8	0.2	0.2	2.6	0.1	0.4	1.1	2.2	0.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	19.6	13.8	13.0	12.2	24.5	22.3	25.3	19.9	21.7	28.0	20.0	57.0	0.0	1.1	37.2	0.7	0.3	0.1	0.2	2.2	1.3	0.8	1.8	9.1	0.0	0.7	3.7	56.3	0.1	0.5	0.0	0.0	0.2	40.8	0.3	0.8	9.4	9.0	0.0	9.7	0.0	0.0	84.2	0.5	0.3	0.0	5.9	0.4	0.2	0.1	1.7	12.7	0.0	0.0	0.0	0.3	7.2	0.9	2.7	1.8	6.5	0.0	2.2	0.0	60.3	24.0	0.0	0.0	43.6	0.3	1.0	0.0	0.8	0.2	1.9	493.0	78.9	116.9	14.5	2.1	0.6	1.0	0.0	2.1	1.2	0.0	0.0
THOC5	"C22orf19, Fmip, fSAP79, KIAA0983, PK1.3"	ENSG00000100296	"THO complex 5"	Q13769	22	29505879-29555216	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048402			Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA048402: AB_2680387"	"unprognostic (1.16e-1)"	"unprognostic (3.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (6.34e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (9.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.97e-1)"	19.3	11.6	5.4	14.2	7.2	19.0	17.2	9.2	10.1	24.4	3.5	37.5	11.4	31.9	13.6	18.5	20.3	17.2	29.2	6.4	7.3	13.4	13.5	14.7	15.3	8.6	7.1	21.5	14.5	14.1	9.3	11.2	9.6	18.2	13.8	11.1	11.9	20.9	43.7	13.8	17.5	29.3	5.0	15.0	20.3	19.8	7.2	14.7	11.3	40.9	15.1	28.7	17.6	9.6	43.0	28.7	25.8	77.5	47.7	38.1	32.7	79.3	46.7	68.8	68.0	46.8	18.8	26.4	30.2	63.4	40.9	37.8	36.5	42.4	67.0	30.5	38.5	43.6	40.8	53.0	32.5	100.1	35.8	40.6	39.2	67.8	52.1	56.0	51.2	25.9	50.2	26.3	43.3	47.7	31.2	31.1	53.6	36.7	22.1	45.3	62.1	32.7	25.2	32.4	52.6	84.5	44.1	34.8	49.3	33.9	19.7	35.0	35.5	120.6	69.8	28.7	52.0	41.2	42.7	64.9	40.2	40.9	52.5	6.7	15.6	39.4	14.1	19.5	14.1	12.6	11.6	10.3	17.2	10.1	12.1	11.3	42.8	10.6	24.4	4.1	18.3	13.0	5.4	7.2	9.2	10.1	6.4	7.3	8.6	7.1	9.6	5.0	7.2	9.6	8.5	22.4	12.6	7.2	11.1	5.4	7.8	9.5	4.0	10.8	10.7	16.3	17.0	4.3	8.9	3.7	20.9	21.3	9.5	8.2	13.7	20.0	43.6	7.0	11.0	10.1	9.0	16.6	9.5	14.7	22.6	12.1	9.7	6.5	11.4	15.9	7.9	8.6	14.2	8.4	11.0	5.6	6.1	11.7	5.7	125.7	12.8	9.6	8.8	2.8	16.9	7.3	18.6	6.6	6.6	17.4	6.4	12.8	10.4	8.9	18.7	17.9	9.2	25.1	0.0	10.9	19.5	39.2	23.5	9.4	6.1	17.4	11.1	17.9	9.4	5.6
TMEM143	FLJ10922	ENSG00000161558	"Transmembrane protein 143"	Q96AN5	19	48332356-48364059	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 43.6;skeletal muscle: 95.5;tongue: 61.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014476, HPA058645"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli fibrillar center"		"HPA014476: AB_1858092, HPA058645: "	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (1.53e-7)"	"unprognostic (5.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-1)"	6.5	9.0	5.2	2.6	6.0	2.7	5.2	5.3	6.8	4.9	4.3	7.2	4.5	4.3	2.5	4.6	4.5	3.2	43.6	5.2	5.4	10.4	18.1	4.3	3.7	5.5	5.5	4.7	5.7	3.7	5.1	2.7	5.5	5.3	2.7	3.3	5.6	2.6	95.5	5.8	6.8	2.2	4.7	7.7	6.8	4.2	5.7	6.2	6.4	61.2	2.3	6.2	4.3	5.9	4.6	7.4	2.3	4.2	4.5	6.3	4.7	4.2	2.5	2.9	3.7	6.3	5.9	8.6	7.5	2.8	1.4	5.2	2.3	3.0	1.6	10.6	5.2	5.2	6.3	10.1	3.6	4.1	4.8	5.8	3.7	1.5	3.7	3.3	2.4	12.9	3.8	12.5	3.1	2.6	5.9	14.8	2.9	8.7	2.5	8.6	1.4	14.2	3.9	3.4	8.6	8.5	2.5	3.1	2.1	2.6	4.4	2.9	2.9	3.5	3.9	2.6	1.6	24.3	8.2	6.5	2.9	5.4	2.8	1.9	1.2	1.4	2.2	0.7	2.7	2.1	1.7	2.1	1.5	1.5	2.6	1.5	1.0	3.4	1.2	0.6	1.3	1.3	5.2	6.0	5.3	6.8	5.2	5.4	5.5	5.5	5.5	4.7	5.7	5.9	2.3	3.2	1.1	8.1	3.7	0.3	3.0	3.4	2.8	3.3	3.2	1.8	27.0	0.0	2.0	1.8	8.4	9.5	2.8	3.7	13.7	3.5	0.7	2.0	1.4	2.2	3.0	4.8	9.8	2.4	6.1	3.3	5.6	1.3	1.3	4.6	1.4	7.5	5.5	0.0	8.7	4.4	4.1	2.1	1.0	1.3	2.5	2.6	8.8	6.5	2.5	3.9	2.1	5.5	9.9	1.2	7.1	1.2	7.6	0.9	8.5	14.6	5.3	6.7	0.0	2.5	3.1	8.7	5.5	3.1	1.0	3.7	3.6	3.4	4.3	1.2
TMEM182	FLJ30294	ENSG00000170417	"Transmembrane protein 182"	Q6ZP80	2	102736905-103019900	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	24	"heart muscle: 97.6;skeletal muscle: 150.7;tongue: 127.7"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 150.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA045861			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Vesicles"		"HPA045861: AB_2679475"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.12e-4)"	"unprognostic (5.35e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.42e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.36e-2)"	2.7	1.6	2.2	0.7	2.0	0.6	2.3	2.6	2.9	2.9	2.2	1.8	1.9	1.1	5.3	3.9	2.1	1.8	97.6	2.5	3.1	2.1	2.0	1.3	1.8	2.8	2.7	1.5	2.1	3.6	2.6	1.4	3.0	4.0	2.3	1.5	2.0	2.1	150.7	0.5	1.2	1.1	2.5	1.6	2.2	1.4	2.6	1.8	3.0	127.7	1.4	2.2	0.6	2.7	4.9	3.3	2.4	7.3	2.8	2.4	6.9	2.5	2.2	2.4	4.4	10.7	7.3	4.5	9.0	1.4	6.1	3.3	2.6	3.7	5.4	11.6	3.5	6.6	1.4	6.7	3.0	6.2	4.4	3.2	7.6	4.5	5.2	1.9	0.4	6.4	5.2	1.2	3.5	4.6	3.9	5.7	4.2	5.9	3.6	3.4	6.3	3.7	5.7	6.2	5.2	1.9	4.1	3.3	10.3	3.5	3.0	3.2	0.7	4.2	3.5	2.7	3.1	3.9	13.0	5.5	3.8	8.4	6.3	0.0	0.0	0.2	2.5	0.2	2.8	3.6	1.5	1.3	0.9	1.2	2.4	2.4	0.0	2.4	0.3	2.9	0.5	1.1	2.2	2.0	2.6	2.9	2.5	3.1	2.8	2.7	3.0	2.5	2.6	2.7	0.6	22.4	12.3	1.3	3.6	0.4	1.0	1.8	1.2	0.3	8.1	2.4	150.6	0.0	15.3	3.7	0.0	2.3	4.2	0.5	0.0	1.8	0.6	2.4	1.1	2.0	6.6	3.6	6.1	3.3	2.6	6.9	4.1	1.6	3.8	1.2	0.7	2.3	1.2	0.0	10.8	2.6	2.0	0.8	0.7	0.6	0.6	1.3	7.2	6.5	0.1	2.4	1.0	8.5	3.4	2.4	1.1	0.7	2.7	1.0	1.0	2.4	12.8	0.3	0.0	4.6	2.3	1.0	2.4	2.5	0.6	1.1	2.9	1.1	1.8	2.8
TMOD1	"D9S57E, ETMOD, TMOD"	ENSG00000136842	"Tropomodulin 1"	P28289	9	97501180-97601743	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 250.0;tongue: 255.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 60.0;Erythroid cells: 138.9;Horizontal cells: 102.6"	"Group enriched"	"Detected in many"	4	"glioma: 21.6;ovarian cancer: 17.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 38.0;HDLM-2: 155.7;K-562: 53.3;SH-SY5Y: 157.4"	"Low region specificity"	"Detected in all"							HPA051202	Enhanced					NA	NA		9400	"Cluster 40: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA051202: AB_2681387"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.88e-5)"	18.8	65.1	16.8	4.5	19.9	24.2	15.8	25.0	22.0	46.4	16.3	34.8	4.2	54.3	5.6	17.4	27.4	7.4	144.2	18.0	25.7	9.2	28.5	15.5	2.6	20.1	12.1	51.3	23.0	13.9	31.6	2.6	17.3	17.1	6.3	9.2	10.4	9.1	250.0	7.5	12.2	36.3	17.8	3.5	18.4	2.8	12.6	1.0	21.9	255.8	2.4	38.3	25.4	22.6	5.4	1.4	0.0	0.7	6.3	0.6	1.9	1.0	9.1	0.1	0.2	1.2	1.6	0.1	38.0	0.1	8.5	0.4	1.6	0.0	0.0	155.7	5.6	7.4	8.8	0.6	0.2	0.1	12.5	0.5	0.0	0.4	0.0	0.1	0.7	0.2	53.3	0.1	0.1	2.3	0.0	1.0	2.0	1.5	0.6	0.0	5.1	0.1	0.0	1.1	0.6	157.4	4.8	0.1	2.7	2.1	2.0	7.7	0.8	0.0	5.7	4.3	1.1	19.1	4.1	0.2	7.0	5.1	8.4	0.8	0.3	0.5	1.2	0.3	1.1	1.2	1.0	0.7	0.5	2.0	0.6	0.7	0.0	0.7	0.4	0.1	2.2	1.1	16.8	19.9	25.0	22.0	18.0	25.7	20.1	12.1	17.3	17.8	12.6	22.6	4.7	6.4	4.2	2.3	1.9	2.3	1.0	0.0	0.0	1.1	1.6	1.3	60.0	4.3	0.0	0.0	6.2	0.2	1.1	0.0	0.0	0.3	0.8	10.2	14.5	13.0	3.0	138.9	27.6	6.5	0.4	12.8	4.6	27.7	10.8	0.1	27.5	20.2	0.9	102.6	19.3	0.4	0.0	13.7	4.2	0.6	10.2	6.5	17.8	6.5	0.1	2.2	0.0	31.2	5.9	4.7	0.0	6.8	0.4	2.1	0.0	0.2	0.0	1.3	19.7	8.8	23.9	2.6	6.8	0.2	1.0	0.1	3.2	0.1	0.1	0.9
TNFRSF13B	"CD267, IGAD2, TACI"	ENSG00000240505	"TNF receptor superfamily member 13B"	O14836	17	16929816-16972118	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 18.9;lymphoid tissue: 33.0;skeletal muscle: 62.9"	"Group enriched"	"Detected in some"	4	"B-cells: 117.3;Plasma cells: 143.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	41	"memory B-cell: 130.9;naive B-cell: 51.8"	"Lineage enriched"	"Detected in many"	59	"B-cells: 130.9"	"Group enriched"	"Detected in some"	9	"Karpas-707: 167.2;RPMI-8226: 106.7;U-266/70: 72.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030453	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA030453: AB_10601700"	"unprognostic (3.94e-5)"	"unprognostic (1.11e-3)"	"unprognostic (4.88e-2)"	"unprognostic (4.30e-3)"		"unprognostic (1.23e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.61e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.59e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	0.4	0.1	0.3	8.9	0.4	1.1	0.7	0.0	0.5	0.3	0.0	3.4	4.1	0.1	0.0	1.3	0.4	0.5	5.3	0.1	0.3	0.3	0.3	0.8	17.3	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.4	2.5	0.3	2.1	0.3	62.9	0.0	18.9	0.1	0.2	33.0	5.2	0.1	0.4	2.0	0.5	0.0	21.6	2.6	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.2	106.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.6	0.0	13.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	130.9	0.0	0.0	0.0	51.8	0.0	0.1	0.5	0.0	0.0	0.0	2.2	2.7	0.3	0.4	0.0	0.5	0.1	0.3	0.4	0.3	0.9	0.2	0.4	1.2	0.0	0.0	0.0	0.0	117.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.4	1.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.5	32.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	143.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.6	0.0	6.2	0.0	0.0	0.0
TNKS2	"ARTD6, PARP-5b, PARP-5c, PARP5B, PARP5C, pART6, TANK2, TNKL"	ENSG00000107854	"Tankyrase 2"	Q9H2K2	10	91798426-91865475	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036606			Approved	Microtubules		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Microtubules		"HPA036606: AB_10673470"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.53e-1)"	18.4	19.3	14.7	21.2	16.1	38.5	22.2	18.0	17.0	21.1	25.0	14.8	14.9	22.5	19.8	22.8	17.8	20.8	11.1	14.3	14.9	17.4	21.2	19.7	28.1	14.6	15.1	30.3	22.0	21.8	14.4	31.2	15.8	19.6	17.1	31.2	18.5	16.6	55.6	27.3	15.3	20.7	16.0	30.0	19.8	11.8	17.4	37.7	29.6	40.5	29.4	24.1	17.1	19.7	29.1	24.3	48.9	41.7	33.8	30.6	54.5	30.6	55.5	36.5	44.5	21.7	23.2	27.2	14.3	40.0	24.6	30.6	31.0	23.6	51.3	27.7	29.9	22.6	22.9	24.3	32.9	44.0	32.3	31.4	30.6	37.0	65.3	54.8	34.8	24.1	16.9	29.4	38.5	15.6	38.1	29.9	24.6	13.2	16.1	35.2	30.5	20.9	25.0	30.9	12.8	22.9	30.8	13.4	38.7	39.2	32.5	30.3	37.8	19.6	16.5	26.1	29.5	36.7	32.1	34.8	25.9	32.4	17.9	0.2	0.7	1.2	0.9	0.6	0.8	1.0	0.9	0.8	1.0	1.0	0.7	0.6	0.7	1.0	0.6	1.5	0.5	0.4	14.7	16.1	18.0	17.0	14.3	14.9	14.6	15.1	15.8	16.0	17.4	19.7	39.1	41.7	22.3	63.3	51.6	74.6	32.5	23.8	56.9	41.7	38.8	24.0	23.2	8.6	31.0	44.1	47.9	45.2	48.7	19.2	7.9	16.0	4.7	41.1	29.3	37.1	33.0	27.5	77.5	24.5	55.1	30.9	50.4	52.1	2.5	34.8	35.7	35.9	26.1	42.1	78.5	19.3	26.4	55.3	49.4	8.1	31.1	48.4	33.8	67.5	46.5	24.9	37.0	66.9	68.0	29.0	12.3	35.3	45.7	44.7	16.1	16.6	47.4	34.8	46.0	40.5	28.0	19.1	21.7	75.9	109.1	101.0	49.1	30.5	14.9	61.7
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451100-52454041	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	36	"heart muscle: 8734.3;skeletal muscle: 21081.1;tongue: 12403.9"	"Cell type enriched"	"Detected in many"	10	"Cardiomyocytes: 3550.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 27.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 68.2;CAPAN-2: 33.5;EFO-21: 65.2;HeLa: 49.1;Hep G2: 46.1;HSkMC: 67.2;U-2 OS: 97.7"	"Region enriched"	"Detected in all"	4	"cerebral cortex: 87.0"	"Group enriched"	"Detected in some"	6	"midbrain: 7.6;spinal cord: 7.1"	"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"		NA	NA		990000	"Cluster 13: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	8.4	10.9	0.7	0.8	0.8	0.7	19.1	2.7	1.1	7.7	7.3	4.0	1.1	2.8	41.7	387.3	2.8	3.3	8734.3	1.2	0.7	19.2	4.0	78.5	3.9	0.8	0.9	2.4	6.8	1.6	17.6	5.2	1.0	170.1	4.1	0.4	120.8	2.2	21081.1	18.9	3.3	0.8	0.8	2.8	5.7	10.6	0.8	4.3	14.4	12403.9	1.6	5.3	5.4	0.7	0.7	5.2	3.6	0.6	0.2	0.5	8.0	0.4	0.3	0.3	0.4	68.2	33.5	0.5	65.2	9.9	0.1	0.4	0.1	0.3	0.0	1.2	1.6	0.5	49.1	46.1	0.3	0.3	0.1	67.2	1.2	0.0	0.7	0.6	0.0	2.0	0.2	5.1	2.0	0.1	0.2	0.8	0.5	15.1	0.7	0.1	2.9	2.3	3.3	13.0	0.2	0.0	0.5	6.7	0.1	3.9	26.7	0.5	0.0	0.1	97.7	0.8	0.2	2.8	1.3	0.9	0.3	0.7	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.1	0.7	0.8	2.7	1.1	1.2	0.7	0.8	0.9	1.0	0.8	0.8	0.7	0.2	125.0	12.6	0.0	0.3	1.5	1.7	4.0	0.6	0.2	0.5	0.3	3550.1	5.7	7.9	3.7	2.1	59.0	0.1	1.6	27.4	11.8	0.7	66.4	6.7	39.8	330.7	0.4	0.0	13.0	5.1	52.7	0.5	98.8	0.0	0.8	0.7	0.7	4.9	0.0	0.0	1.7	2.0	0.0	1.4	5.8	22.4	2.6	5.4	0.0	0.1	1.2	0.0	0.0	0.0	6.5	0.3	177.6	0.1	0.8	0.5	1.3	2.8	0.1	0.0	241.8	36.0	2.1	1.0	0.1	0.9	31.1	2.8	1.3	2.0	6.8
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132698-55149206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	29	"skeletal muscle: 21567.3;tongue: 13372.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 61.2;Basal squamous epithelial cells: 47.8;Cardiomyocytes: 51.5;Skeletal myocytes: 192.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 211.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 211.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 829.4;RH-30: 638.8"	"Region enriched"	"Detected in many"	5	"thalamus: 125.0"	"Region enhanced"	"Detected in all"		"thalamus: 23.1"	"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		79000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB015168: AB_2206426, HPA058448: AB_2683720"	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavorable (4.66e-4)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	5.7	1.2	42.1	0.4	45.7	3.3	5.0	44.3	55.4	1.9	36.4	2.7	1.0	1.1	1.0	593.5	8.4	1.0	256.7	43.9	38.9	1.3	2.5	8.3	0.4	36.7	41.4	1.5	2.5	2.3	8.5	6.0	38.5	200.4	0.6	0.6	171.2	0.4	21567.3	48.5	2.0	0.4	35.6	1.9	1.9	10.6	40.8	3.4	3.8	13372.6	2.0	1.7	5.8	40.8	178.4	102.3	1.0	22.4	0.0	1.7	33.3	8.0	30.1	11.1	32.7	37.9	115.8	2.6	66.5	3.2	88.8	88.5	24.0	76.0	9.4	11.8	192.2	33.6	11.8	6.7	3.7	2.7	829.4	36.6	121.3	3.4	127.0	125.7	0.5	35.1	171.7	158.6	10.3	168.0	3.4	0.3	21.4	45.0	202.1	113.9	638.8	21.2	26.5	5.8	6.6	49.3	10.7	1.3	57.9	8.5	106.3	102.7	2.9	163.6	238.9	6.5	12.4	1.2	7.0	8.8	171.8	26.4	50.9	2.4	39.4	211.5	0.3	21.7	0.3	0.2	0.3	0.3	37.4	0.4	0.3	0.4	1.9	0.6	10.2	0.9	0.1	12.2	42.1	45.7	44.3	55.4	43.9	38.9	36.7	41.4	38.5	35.6	40.8	40.8	0.0	0.0	0.0	0.7	0.3	61.2	0.6	25.1	47.8	4.5	0.5	5.3	51.5	0.0	2.8	0.0	0.0	2.2	0.0	0.5	0.0	2.1	2.1	9.7	0.3	2.6	2.4	2.7	0.4	0.0	18.0	18.8	0.0	3.4	0.0	22.1	1.4	0.0	12.9	0.0	0.7	0.3	0.0	13.2	3.8	10.7	0.3	8.9	3.6	0.0	25.8	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.7	0.0	192.0	3.5	4.3	34.1	2.5	30.4	3.6	1.6	1.2	0.8	0.2
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 10621.0;skeletal muscle: 12678.0;tongue: 5183.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 13012.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 48.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 14.1;granulocytes: 48.7;monocytes: 19.2"	"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 3141.3;SuSa: 3810.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		NA	NA		120000000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (7.30e-4)"	372.0	103.6	49.8	232.9	53.2	21.6	348.8	52.4	53.9	577.4	59.3	2947.3	289.6	1566.9	250.5	639.0	823.8	288.0	10621.0	53.3	42.2	215.5	94.8	247.1	48.1	42.5	44.3	320.3	383.4	37.5	70.6	206.4	43.7	809.6	523.1	83.9	258.2	1545.5	12678.0	150.7	680.8	1754.9	44.8	134.3	976.5	52.3	50.0	21.1	156.8	5183.6	29.4	1511.0	425.8	42.2	554.5	357.3	418.1	20.9	143.1	89.9	1335.5	1509.1	552.8	905.9	669.2	253.9	107.6	1.7	677.7	1517.1	602.7	295.9	361.8	243.4	597.0	14.5	50.9	81.2	376.3	124.5	403.3	3.8	17.9	125.7	138.0	742.1	198.2	3141.3	243.2	14.7	8.7	20.4	695.3	286.4	25.6	7.1	496.0	129.0	61.1	9.0	146.5	15.8	1308.7	298.8	101.1	71.7	180.9	284.4	65.1	3810.3	204.8	15.3	1095.8	1178.8	572.0	181.6	1094.8	5.9	4.3	7.8	335.9	22.4	842.1	48.7	9.9	4.8	4.0	19.2	3.1	5.5	3.6	4.3	14.1	5.6	4.0	3.6	10.7	1.9	14.3	2.4	6.3	15.6	49.8	53.2	52.4	53.9	53.3	42.2	42.5	44.3	43.7	44.8	50.0	42.2	542.3	57.7	86.3	19.9	12.1	71.9	202.0	344.1	18.2	49.0	450.1	953.1	13012.4	346.0	147.0	318.2	383.7	212.1	20.6	561.3	187.9	2502.6	6.5	147.2	614.4	294.3	267.7	137.0	44.2	1671.1	3094.8	557.1	279.3	211.2	52.0	85.3	175.6	138.1	201.5	52.2	53.2	964.7	183.1	42.5	72.1	27.3	205.0	114.3	81.8	111.5	47.5	47.4	28.8	36.2	6.0	2372.3	623.4	1130.3	8.8	244.3	724.7	361.1	104.2	447.5	1038.7	484.0	1685.9	27.4	82.2	29.4	50.4	103.0	29.0	130.7	385.3	198.2
TPM2	"AMCD1, DA1, NEM4"	ENSG00000198467	"Tropomyosin 2"	P07951	9	35681992-35690056	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 39012.3;tongue: 16773.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 1066.2;Peritubular cells: 2072.1;Sertoli cells: 2222.0;Smooth muscle cells: 2341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	812	"plasmacytoid DC: 398.6"	"Lineage enriched"	"Detected in single"	920	"dendritic cells: 398.6"	"Cell line enhanced"	"Detected in many"		"BJ: 2309.6;fHDF/TERT166: 1289.0;hTERT-RPE1: 1399.1"									"HPA047089, HPA053624"	Approved					NA	NA		140000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (5.56e-2)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (1.43e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-2)"	331.1	285.0	88.0	411.0	89.8	16.7	260.8	92.5	117.3	651.3	127.3	3498.4	217.7	1928.1	201.9	1018.0	849.7	442.4	788.5	84.8	81.1	144.0	41.0	283.1	62.2	86.1	79.2	388.4	73.7	24.1	82.6	142.3	80.5	1219.0	238.0	8.0	393.6	1988.7	39012.3	148.5	636.2	2340.8	78.6	140.1	1252.6	82.9	83.3	26.3	138.9	16773.7	21.2	1630.1	454.9	79.8	375.4	291.2	213.9	33.6	335.4	893.3	129.3	2309.6	934.4	983.0	667.9	12.2	24.2	0.4	213.0	1289.0	144.6	9.2	3.7	291.2	457.0	716.2	10.8	9.1	1054.1	11.8	540.2	2.3	102.7	1067.7	44.9	738.8	0.4	1399.1	235.7	25.3	5.6	0.8	1052.1	15.3	2.7	29.1	269.6	1.5	17.0	18.5	391.5	3.0	31.1	7.2	3.8	13.3	470.0	7.9	18.2	273.8	6.8	27.7	30.0	16.5	585.7	11.6	730.6	0.6	2.7	2.9	34.0	6.5	29.2	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.4	0.2	0.0	398.6	0.0	2.1	88.0	89.8	92.5	117.3	84.8	81.1	86.1	79.2	80.5	78.6	83.3	79.8	110.0	3.2	4.1	10.4	5.9	57.1	81.2	274.1	24.5	0.8	29.9	1066.2	619.5	4.3	42.1	7.3	0.0	12.1	116.7	1.4	0.0	21.4	4.3	20.3	488.3	80.3	2.4	4.0	2.5	5.7	104.8	332.6	99.4	18.7	2.5	142.0	181.3	1.4	32.4	1.7	4.6	1.9	48.8	3.1	77.9	32.4	283.0	24.2	67.6	9.4	6.5	11.7	1.0	3.0	0.4	8.4	0.1	2072.1	2.9	169.8	0.4	1.3	23.5	0.9	2222.0	594.8	2341.4	2.5	27.3	6.7	42.8	14.6	16.0	106.7	2.8	28.7
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease variant, Nemaline myopathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	13	"skeletal muscle: 8905.8;tongue: 6106.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		170000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Actin filaments"	Cytosol	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavorable (6.73e-6)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.39e-5)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	140.7	103.2	95.0	233.2	104.1	590.1	97.1	83.3	116.2	94.9	73.3	199.0	163.5	69.6	73.4	287.4	100.6	136.1	318.5	104.8	101.5	81.5	114.4	178.7	287.3	96.6	101.4	45.4	265.9	91.7	19.6	141.1	101.6	122.3	201.5	60.3	101.5	56.0	8905.8	103.0	167.8	111.6	94.6	208.9	152.8	64.8	93.8	203.0	88.8	6106.5	287.2	183.2	29.7	98.2	529.4	332.8	306.1	225.4	262.1	341.1	317.9	439.0	419.1	597.9	437.7	596.1	513.9	414.6	366.9	500.2	206.4	472.1	320.0	468.7	485.8	315.7	171.9	537.6	234.1	311.7	200.9	728.2	627.5	260.0	246.2	515.8	355.1	224.9	929.4	269.0	411.8	429.7	710.0	342.2	582.0	683.1	714.2	775.9	515.9	510.0	233.2	574.9	405.6	387.4	234.4	409.4	360.0	443.7	419.2	303.9	645.0	788.9	758.8	558.8	353.9	497.3	711.1	332.4	623.0	516.2	490.7	514.7	860.0	932.1	743.2	1729.3	547.2	945.6	480.1	395.2	464.0	504.4	792.6	324.5	347.2	442.6	824.3	386.4	1104.4	392.9	551.5	2029.4	95.0	104.1	83.3	116.2	104.8	101.5	96.6	101.4	101.6	94.6	93.8	98.2	346.0	621.8	343.2	17.6	318.6	149.5	227.6	169.5	127.5	84.2	135.4	88.4	85.0	125.8	275.6	97.5	31.3	127.3	475.7	494.5	105.7	292.1	72.3	353.7	191.1	395.7	141.0	189.8	65.7	347.0	331.0	170.4	245.6	474.2	531.3	119.5	200.3	110.6	559.1	304.5	50.5	291.2	93.6	355.6	504.7	182.3	46.6	648.3	152.9	31.9	704.0	54.5	466.5	12.5	30.6	530.4	363.9	29.7	218.2	204.8	220.1	179.8	230.8	62.8	19.7	155.1	128.5	38.6	67.6	223.6	143.3	101.9	422.6	119.2	302.1	324.6
TRAK1	"KIAA1042, MILT1, OIP106"	ENSG00000182606	"Trafficking kinesin protein 1"	Q9UPV9	3	42013802-42225890	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 168.9;skeletal muscle: 262.4;tongue: 202.6"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 173.0;Cardiomyocytes: 262.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005853, HPA011367"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"	Nucleoplasm	"HPA005853: AB_1854778, HPA011367: AB_2668495"	"unprognostic (5.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.56e-3)"	"prognostic favorable (4.84e-8)"	"unprognostic (3.65e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.61e-3)"	26.0	13.1	23.0	17.1	26.2	18.2	18.0	28.5	27.7	13.7	27.8	27.1	34.5	12.2	10.4	29.3	19.8	26.9	168.9	24.2	19.5	20.1	15.3	24.1	22.8	24.4	30.3	8.5	13.1	32.2	17.7	15.3	21.6	15.4	25.4	96.7	44.1	13.1	262.4	45.1	42.0	16.8	19.1	22.2	61.0	12.1	26.0	17.9	31.4	202.6	22.6	33.8	18.4	21.4	22.2	19.2	37.9	16.4	25.6	24.9	48.9	29.5	33.5	19.0	20.6	12.8	30.7	43.9	15.1	75.2	20.4	10.7	26.5	68.8	20.6	39.6	18.8	30.4	19.9	35.6	12.8	34.6	22.9	21.4	28.9	41.9	38.0	28.1	38.6	11.6	15.7	34.4	24.4	9.2	3.7	18.1	16.4	60.4	14.8	16.1	14.1	36.8	26.3	165.3	23.8	27.9	11.3	16.3	16.2	31.4	14.6	29.3	39.6	16.6	19.2	99.0	17.4	25.7	23.0	38.9	18.2	30.2	16.4	0.9	1.3	0.5	0.6	2.4	0.5	2.4	0.9	0.7	1.5	3.6	0.3	0.9	0.6	1.0	1.4	2.5	0.4	0.7	23.0	26.2	28.5	27.7	24.2	19.5	24.4	30.3	21.6	19.1	26.0	21.4	27.4	32.1	32.4	173.0	23.9	38.0	16.3	32.1	30.1	22.7	18.5	17.7	262.0	24.3	38.1	14.7	100.1	23.0	13.9	61.4	1.9	10.8	1.1	53.3	21.8	23.9	22.8	6.5	62.0	12.3	18.3	14.0	81.1	70.0	10.8	11.5	6.8	10.3	15.7	33.7	81.3	39.5	26.4	15.7	33.4	3.0	1.8	23.3	24.9	97.4	17.9	27.8	4.1	105.1	64.8	24.2	37.1	2.6	5.4	18.5	97.9	10.2	80.6	139.9	32.9	15.9	29.9	1.0	3.9	27.5	43.2	15.7	7.5	4.6	35.6	27.0
TRDN	TRISK	ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.2;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.9"	"Region enriched"	"Detected in some"	10	"olfactory bulb: 11.0"	"Region enriched"	"Detected in some"	23	"olfactory bulb: 28.9"	"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	16.3	2.6	4.2	0.0	3.7	0.0	2.0	4.0	5.8	0.7	3.1	0.4	0.0	1.7	10.4	18.5	12.5	0.2	421.6	3.0	12.5	0.4	0.1	0.4	0.1	6.7	7.0	1.3	0.1	0.0	15.3	0.2	7.9	17.0	0.3	83.5	13.1	0.9	1944.1	0.6	0.2	1.0	9.2	0.1	0.1	5.1	10.2	0.3	0.3	1018.2	0.1	0.0	0.6	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.7	4.0	5.8	3.0	12.5	6.7	7.0	7.9	9.2	10.2	6.3	0.3	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	7.9	0.0	0.3	1145.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	68.0	0.0	0.0	6.0	0.0	0.0	1.1	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.4	35.5	13.1	0.5	1.8	0.0	0.0	765.7	0.0	3.0	3.2	0.0	0.0	11.3	0.0	0.0	0.0	0.2	0.0	21.8	0.0	398.6	7.1	1.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TRIM54	"MURF, MURF-3, RNF30"	ENSG00000138100	"Tripartite motif containing 54"	Q9BYV2	2	27282429-27307439	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"heart muscle: 213.2;skeletal muscle: 580.7;tongue: 177.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 81.7;Ductal cells: 35.5;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 46.5;Skeletal myocytes: 17.9;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.1"	"Immune cell enriched"	"Detected in single"	17	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	17	"NK-cells: 3.6"	"Group enriched"	"Detected in some"	8	"HAP1: 7.3;NTERA-2: 15.6"	"Region enhanced"	"Detected in some"		"amygdala: 3.1"					HPA019690	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"HPA019690: AB_1858306"	"unprognostic (6.98e-3)"	"unprognostic (4.56e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.25e-7)"	"unprognostic (3.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	0.4	9.3	1.5	0.0	0.9	0.0	0.3	0.9	5.1	0.9	0.1	0.3	4.3	0.8	24.5	5.0	0.8	0.2	213.2	2.3	0.0	1.7	0.1	0.2	0.2	0.6	0.3	0.5	0.5	0.0	0.1	0.0	0.3	3.4	0.0	0.0	9.5	0.1	580.7	0.9	2.1	0.0	0.3	0.9	0.1	22.3	0.1	0.1	0.5	177.3	0.0	0.1	0.5	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.2	0.0	1.4	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	15.6	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	1.5	0.9	0.9	5.1	2.3	0.0	0.6	0.3	0.3	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.4	81.7	10.0	0.1	3.7	0.0	0.0	0.3	2.3	0.0	35.5	1.5	0.1	0.0	0.8	0.0	2.7	11.3	42.5	0.0	2.2	0.0	0.2	4.5	0.0	0.4	0.0	0.1	0.0	0.8	1.8	0.0	0.0	0.0	4.7	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.3	46.5	1.9	0.7	0.0	0.2	2.4	3.1	0.2	0.0	0.0	17.9	16.8	6.8	2.4	0.0	0.0	0.0	0.3	0.2	6.4	0.3
TSC2	"LAM, PPP1R160, TSC4, tuberin"	ENSG00000103197	"TSC complex subunit 2"	P49815	16	2047967-2089491	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"GTPase activation"	"Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002225, HPA030409, HPA049679"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848"	"unprognostic (2.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (5.06e-4)"	"unprognostic (4.32e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.96e-2)"	12.6	10.0	3.8	10.2	4.6	10.9	12.6	4.5	6.1	16.7	0.9	15.3	12.4	17.4	7.3	12.0	16.0	10.9	12.6	5.9	1.3	9.6	9.0	12.0	7.7	3.1	1.5	18.4	14.8	14.7	16.5	9.2	2.7	12.4	9.1	17.7	21.3	15.6	31.1	14.4	12.8	11.4	0.1	11.4	15.7	16.2	2.6	11.7	18.6	14.5	7.8	14.0	12.8	12.5	13.5	21.4	28.9	32.5	33.7	28.1	24.3	31.7	21.7	23.4	19.7	25.7	25.4	20.5	27.6	26.2	11.0	22.0	17.5	23.1	17.3	15.5	28.5	19.2	39.6	10.7	23.0	24.0	22.4	33.5	14.3	18.9	13.9	27.9	22.3	14.4	19.0	17.7	21.0	27.0	28.9	7.1	29.8	10.1	21.2	45.3	31.6	25.7	9.4	12.1	22.1	41.3	45.2	29.4	15.3	28.2	26.8	17.5	35.5	24.5	16.5	22.0	16.5	39.0	42.7	40.8	10.2	9.7	29.6	3.2	2.7	2.8	3.1	2.1	2.8	1.8	1.9	1.7	2.5	1.8	1.3	2.1	3.5	1.6	1.7	0.6	1.4	2.2	3.8	4.6	4.5	6.1	5.9	1.3	3.1	1.5	2.7	0.1	2.6	12.5	23.8	25.6	18.9	43.8	16.8	9.2	8.1	10.1	14.8	53.8	23.7	20.2	41.8	21.5	15.3	20.2	93.8	13.0	17.3	34.5	3.9	15.2	13.1	47.8	26.3	25.6	32.5	17.4	22.8	14.1	8.0	19.7	44.9	62.1	8.8	49.0	32.2	38.7	11.4	45.4	22.4	26.6	8.2	17.6	9.9	29.3	28.3	13.8	8.8	15.9	12.1	19.0	36.0	18.6	25.7	21.4	17.5	25.9	14.4	9.4	25.4	8.9	17.8	64.7	13.1	17.2	20.4	18.3	37.7	12.9	9.8	9.3	18.8	31.6	28.9	10.6
TSR1	FLJ10534	ENSG00000167721	"TSR1 ribosome maturation factor"	Q2NL82	17	2322396-2336657	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024434, HPA053087"	Approved		Approved	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA024434: AB_1858413, HPA053087: AB_2682040"	"unprognostic (1.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.95e-3)"	"unprognostic (9.80e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.46e-3)"	18.2	10.9	11.7	17.2	12.1	15.5	17.3	11.2	12.2	10.5	11.5	13.0	9.4	14.8	12.2	20.1	12.3	10.8	17.2	11.5	11.4	12.3	14.8	10.1	15.9	11.7	11.8	15.2	19.9	16.1	8.3	14.6	11.9	13.4	14.6	14.0	12.8	13.9	49.4	19.6	9.4	18.4	12.6	11.0	11.8	18.1	12.4	15.3	11.8	30.7	19.2	22.2	11.8	12.1	80.2	85.1	39.6	77.6	31.6	36.9	80.4	65.5	36.3	39.8	30.6	138.2	33.4	85.5	54.6	52.2	36.4	70.3	86.5	76.8	50.7	39.1	97.3	63.9	66.4	65.5	44.0	59.4	42.3	37.4	48.1	76.6	87.2	43.5	39.5	45.5	84.1	46.5	49.1	49.8	56.6	29.3	94.0	60.0	50.6	59.6	55.1	57.6	49.1	52.5	27.7	61.7	57.6	43.4	45.7	37.6	40.4	26.0	43.9	54.6	43.3	65.7	122.8	33.3	45.7	49.7	53.5	67.3	67.3	1.9	7.1	1.5	8.3	10.5	11.0	7.1	6.8	7.7	11.5	8.7	7.4	9.0	1.3	6.5	11.5	4.8	9.1	6.3	11.7	12.1	11.2	12.2	11.5	11.4	11.7	11.8	11.9	12.6	12.4	12.1	13.5	32.1	29.3	7.2	21.5	34.4	42.8	18.1	31.3	16.2	18.3	13.7	17.6	12.8	30.7	14.7	18.8	29.9	17.3	7.8	3.9	27.7	68.2	18.0	32.6	20.8	10.3	30.5	7.7	16.5	39.7	24.0	18.3	24.8	43.1	24.4	12.5	13.2	16.0	18.5	6.7	12.0	10.2	12.4	10.2	73.6	13.1	14.4	16.0	3.7	18.2	12.6	10.3	3.0	6.4	23.3	5.8	12.0	23.2	35.8	4.8	11.4	21.9	19.7	19.7	36.4	27.7	29.7	47.7	42.2	41.2	24.2	16.1	25.4	15.7	33.1
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 167.2;skeletal muscle: 920.6;tongue: 369.5"	"Cell type enriched"	"Detected in many"	16	"Cardiomyocytes: 24394.9"	"Cancer enriched"	"Detected in single"	4	"head and neck cancer: 1.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 1.9"	"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced					NA	NA		16000000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451"	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	0.6	0.4	2.7	0.5	2.4	4.3	0.5	2.8	4.9	0.3	0.0	0.4	0.4	0.4	0.2	2.7	0.3	0.7	167.2	1.9	3.4	0.2	0.3	1.2	1.4	11.2	4.4	0.7	1.7	0.0	0.8	0.5	6.6	2.7	0.0	1.9	7.0	0.0	920.6	0.8	0.6	0.0	3.2	0.7	0.4	1.6	4.8	0.7	0.6	369.5	0.4	0.2	0.3	5.3	0.3	0.1	0.7	0.4	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.7	0.1	1.0	0.2	0.0	0.7	0.7	0.0	0.0	0.0	1.0	0.8	1.5	1.3	0.4	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.7	0.6	0.7	0.9	0.5	0.1	0.2	0.7	1.0	0.2	0.1	0.7	0.5	1.9	0.6	0.0	0.2	0.4	0.7	0.1	0.5	0.0	0.6	0.3	1.0	0.7	0.0	0.0	0.3	0.2	1.4	0.2	1.4	0.0	0.5	0.3	1.8	0.2	0.5	0.4	0.2	0.1	6.1	0.9	0.7	0.1	5.7	2.0	2.6	1.0	3.6	0.2	0.2	6.0	0.1	2.7	2.4	2.8	4.9	1.9	3.4	11.2	4.4	6.6	3.2	4.8	5.3	10.9	16.0	173.4	43.8	32.1	0.9	1.6	0.0	2.8	102.7	1.7	0.5	24394.9	30.0	6.2	0.0	20.9	0.7	6.8	0.1	1.9	14.1	43.2	3.4	6.8	99.1	4.2	3.0	25.1	28.3	0.3	502.5	3.6	7.2	10.1	0.7	2.5	0.6	0.3	16.8	31.3	0.1	0.0	0.8	0.8	6.4	1.2	26.2	0.0	25.3	0.6	12.0	2.1	11.6	4.9	0.5	0.1	4.5	10.6	0.2	0.3	0.4	2.9	27.8	0.0	1466.9	104.7	9.3	1.5	2.3	0.1	0.4	24.3	2.8	0.5	0.1
TUBA8	TUBAL2	ENSG00000183785	"Tubulin alpha 8"	Q9NY65	22	18110100-18146683	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 128.9;skeletal muscle: 332.2;tongue: 154.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.4;Excitatory neurons: 8.1;Inhibitory neurons: 5.6;Late spermatids: 22.9;Sertoli cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basophil: 2.8;eosinophil: 2.7;neutrophil: 5.0;NK-cell: 10.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 5.0;NK-cells: 10.4"	"Group enriched"	"Detected in many"	5	"NB-4: 30.2;SCLC-21H: 10.9;TIME: 36.3"	"Group enriched"	"Detected in all"	4	"cerebellum: 54.7;olfactory bulb: 53.9"	"Low region specificity"	"Detected in all"			"HPA043684, CAB046031, HPA063394"	Approved		Supported	Microtubules		NA	NA		80000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	Microtubules		"CAB046031: AB_11124541, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (1.07e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.90e-5)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.61e-4)"	7.3	1.9	9.0	1.0	11.8	4.7	7.2	24.3	16.3	2.5	0.8	2.0	0.8	2.7	6.3	4.3	4.8	1.0	128.9	15.0	2.8	2.3	4.3	2.4	3.5	0.6	9.0	2.3	4.4	2.7	14.5	0.6	0.8	2.5	0.5	2.8	4.4	0.6	332.2	4.4	2.6	0.7	1.5	4.2	4.7	52.3	11.5	0.8	6.5	154.7	1.0	2.0	2.2	12.5	0.6	1.1	1.2	1.4	1.8	0.5	0.4	0.6	0.3	1.4	0.8	0.9	1.1	0.9	2.2	0.7	0.4	0.6	2.2	0.4	0.3	0.8	1.6	2.2	1.7	0.9	1.0	1.0	1.0	0.7	0.8	0.8	0.6	0.5	2.0	0.9	0.6	0.9	0.6	3.4	1.0	30.2	1.0	0.5	0.5	0.9	0.5	0.2	0.7	1.1	10.9	1.1	0.6	1.9	1.0	0.5	0.6	4.8	36.3	0.9	1.0	1.0	0.4	2.2	1.3	0.7	0.9	1.4	0.6	2.8	0.7	2.7	0.5	0.6	0.7	0.4	0.4	0.3	0.4	0.6	0.7	0.4	5.0	10.4	0.4	1.0	0.8	17.1	9.0	11.8	24.3	16.3	15.0	2.8	0.6	9.0	0.8	1.5	11.5	12.5	0.2	0.0	1.7	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	4.7	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.3	16.4	0.2	0.1	0.4	0.0	0.0	8.1	1.1	0.0	0.3	0.0	0.2	2.5	0.1	0.7	0.0	0.1	3.3	5.6	0.0	0.0	0.3	0.0	22.9	0.3	0.1	0.0	0.0	0.2	0.1	1.0	3.5	1.7	0.6	0.1	0.4	0.0	0.0	0.4	0.1	0.0	0.2	6.6	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0
TXLNB	"C6orf198, dJ522B19.2, DKFZp451A175, MDP77"	ENSG00000164440	"Taxilin beta"	Q8N3L3	6	139240061-139291998	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"heart muscle: 82.0;skeletal muscle: 300.0;tongue: 189.1"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 260.7;Late spermatids: 67.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.0;HSkMC: 3.0;REH: 2.6;RPMI-8226: 3.8;U-698: 7.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030401, HPA030402, HPA030403"	Enhanced					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA030401: AB_2673459, HPA030402: AB_10602486, HPA030403: AB_2673461"	"unprognostic (1.54e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.05e-4)"	1.1	1.5	0.7	2.5	0.5	0.2	2.2	0.4	0.8	0.9	0.3	1.3	0.6	2.8	0.6	4.4	1.8	2.2	82.0	1.2	1.5	0.1	0.3	1.2	3.1	1.1	1.1	11.4	0.2	2.8	1.2	0.6	1.8	3.0	0.9	0.3	2.4	0.3	300.0	0.6	1.5	2.2	2.0	2.2	0.9	3.8	0.8	7.7	0.3	189.1	3.5	1.1	0.6	1.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.3	0.2	3.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.2	0.2	0.5	0.6	0.1	0.0	0.3	2.6	1.1	3.8	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.9	0.0	0.0	0.0	0.1	0.8	1.4	7.1	0.2	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.8	0.1	0.3	0.0	0.8	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.1	0.7	0.5	0.4	0.8	1.2	1.5	1.1	1.1	1.8	2.0	0.8	1.9	2.0	0.0	0.0	4.9	5.9	0.5	0.3	0.6	0.0	0.1	2.0	0.5	260.7	0.0	1.6	1.8	0.0	0.1	0.7	0.0	0.0	0.0	38.5	4.3	0.3	4.9	0.0	2.7	8.7	0.0	0.0	11.4	0.5	0.4	0.0	0.2	0.7	0.4	1.7	0.0	17.4	0.0	0.0	6.6	6.0	67.2	0.6	4.1	5.4	12.2	0.6	6.5	2.1	2.5	4.0	0.0	0.0	2.2	7.4	0.1	0.0	0.0	17.8	0.1	0.0	25.8	2.2	3.8	1.2	0.3	0.4	0.0	2.0	5.9	0.0	0.1
TXNIP	"ARRDC6, EST01027, HHCPA78, THIF, VDUP1"	ENSG00000265972	"Thioredoxin interacting protein"	Q9H3M7	1	145992435-145996579	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2550.5;NK-cells: 2028.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 951.8;HSkMC: 1276.5;hTCEpi: 664.0;hTERT-RPE1: 781.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031085, HPA053694"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Cytosol	"HPA031085: AB_10601706, HPA053694: AB_2682232"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.22e-3)"	1542.7	466.8	130.3	566.5	159.9	404.7	1396.7	137.1	158.5	846.0	133.8	965.4	223.3	811.8	381.2	428.7	730.3	395.0	745.2	120.3	136.6	532.6	204.0	841.9	800.8	182.0	144.9	382.9	580.5	634.0	192.3	594.0	185.4	352.4	487.5	14.5	567.0	554.5	1446.1	1060.4	810.7	658.7	157.1	946.4	713.4	106.4	159.2	373.7	556.6	2306.2	1068.8	740.9	638.7	217.3	56.5	0.2	13.0	0.9	291.6	951.8	29.7	66.0	131.3	58.5	79.7	35.3	74.6	15.8	379.6	18.1	9.7	15.0	13.0	124.8	154.8	74.2	7.1	45.7	20.2	32.6	13.8	189.7	91.7	1276.5	664.0	119.0	206.7	781.9	23.2	61.8	184.8	121.2	30.2	76.5	31.9	180.2	36.3	112.5	48.5	28.5	107.8	498.3	151.6	122.8	61.7	99.9	283.1	80.5	239.0	26.2	29.1	266.6	56.5	160.1	10.0	304.2	108.7	169.3	170.7	13.8	39.3	86.6	86.3	1059.6	571.2	1219.2	792.2	551.3	729.8	519.3	668.8	710.4	334.4	542.4	650.2	708.5	1246.6	637.1	496.3	154.8	674.5	1684.4	130.3	159.9	137.1	158.5	120.3	136.6	182.0	144.9	185.4	157.1	159.2	217.3	2550.5	227.6	328.5	26.4	1360.4	70.7	236.9	129.8	413.8	6.5	167.4	111.2	526.0	185.8	184.4	272.2	29.2	5.0	1004.6	578.0	450.0	79.7	8.3	179.8	594.5	740.2	164.2	270.8	0.2	53.8	4.1	666.5	160.5	464.2	377.4	53.6	349.8	114.8	231.9	6.7	0.5	320.9	136.3	845.1	184.9	35.5	654.5	730.8	108.5	36.5	892.0	3.6	2028.9	45.2	55.8	225.7	459.4	447.2	639.6	370.7	79.0	169.3	155.8	3.7	1196.5	452.4	398.7	7.6	63.7	160.1	72.2	10.9	1142.8	303.9	186.9	516.2
UACA	"FLJ10128, KIAA1561"	ENSG00000137831	"Uveal autoantigen with coiled-coil domains and ankyrin repeats"	Q9BZF9	15	70654554-70763558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 142.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 293.0;Cardiomyocytes: 175.1;Endothelial cells: 177.4;Microglial cells: 184.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 244.5;BJ hTERT+: 148.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041412, HPA043503, HPA056006"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: "	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (1.03e-4)"	37.7	17.9	10.5	7.8	13.1	1.0	33.0	11.0	12.9	25.1	24.2	14.6	22.2	22.1	21.5	28.9	21.6	32.2	28.0	9.4	11.8	30.8	17.3	30.7	8.0	13.3	12.8	31.2	12.7	12.5	11.5	28.6	13.0	21.6	15.4	11.9	25.3	18.4	142.0	19.4	22.3	16.0	12.1	30.0	15.9	16.1	14.2	4.6	35.6	106.0	6.7	13.2	25.4	14.7	42.7	34.8	15.2	20.2	29.9	127.9	0.1	244.5	148.4	62.7	53.8	58.5	61.5	29.2	65.6	61.4	18.4	48.1	34.4	19.4	78.3	0.1	15.3	16.4	27.9	12.3	38.8	0.4	6.0	60.8	10.7	37.1	28.1	103.3	67.7	6.9	4.1	0.1	78.7	14.0	0.1	2.6	12.7	19.3	18.0	0.0	109.6	0.2	30.3	14.4	4.0	7.6	46.5	7.1	48.9	30.3	13.4	4.9	130.5	3.6	24.8	20.6	39.1	2.3	8.8	0.2	31.4	4.4	27.4	0.1	0.9	0.0	0.0	1.7	0.0	0.5	0.0	0.0	0.8	1.2	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.3	10.5	13.1	11.0	12.9	9.4	11.8	13.3	12.8	13.0	12.1	14.2	14.7	293.0	6.4	6.4	31.6	5.4	11.3	14.6	13.7	10.2	6.3	22.2	33.3	175.1	18.6	19.2	49.7	4.2	1.0	2.1	66.5	3.9	49.0	21.0	75.3	46.3	177.4	9.1	3.0	0.9	48.7	1.9	81.6	33.6	53.0	15.2	34.9	47.5	18.8	9.6	25.2	0.7	33.1	6.1	24.3	8.6	15.2	125.2	15.8	30.2	184.6	9.5	49.4	2.1	6.0	62.0	78.8	35.7	141.1	0.8	21.8	45.3	5.0	61.9	4.2	52.6	53.5	96.2	46.4	35.2	16.4	13.1	1.0	2.9	62.7	24.2	10.9
UBE2D1	"E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A"	ENSG00000072401	"Ubiquitin conjugating enzyme E2 D1"	P51668	10	58334979-58370751	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 138.7;tongue: 65.3"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 194.4;Suprabasal keratinocytes: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 112.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.04e-6)"	"unprognostic (9.71e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.66e-2)"	13.0	11.8	5.3	16.7	5.7	32.4	7.8	6.6	8.1	8.9	4.4	11.4	7.0	12.6	7.5	11.6	7.1	9.5	33.3	6.1	6.2	8.1	8.3	8.9	13.8	6.6	6.4	8.4	5.5	8.9	3.9	8.9	6.6	9.5	12.0	5.4	5.5	6.7	138.7	5.9	8.3	13.6	6.4	13.4	6.4	4.5	6.3	7.8	8.4	65.3	11.4	15.1	5.6	6.7	19.1	10.2	18.8	24.4	37.5	30.0	12.1	12.4	21.2	13.9	20.3	20.9	16.4	0.0	19.0	18.6	10.3	17.1	36.6	18.0	19.5	19.8	21.2	4.9	3.7	12.2	24.4	15.3	11.8	34.8	19.9	14.4	26.8	18.7	28.1	13.1	10.0	7.8	19.1	6.1	16.5	17.1	23.0	11.7	15.7	13.8	16.9	10.6	21.2	11.2	14.0	18.8	24.2	40.3	20.6	28.5	14.8	10.2	22.8	5.3	18.6	18.2	13.7	19.7	16.4	16.8	16.7	31.3	6.2	10.1	38.5	17.8	6.2	27.1	7.2	8.9	7.3	7.9	20.0	9.8	7.5	6.2	112.3	8.2	23.4	8.3	9.8	23.4	5.3	5.7	6.6	8.1	6.1	6.2	6.6	6.4	6.6	6.4	6.3	6.7	41.6	12.8	11.2	5.5	54.3	194.4	94.1	60.6	46.1	23.7	45.6	45.5	92.4	17.2	39.0	27.6	18.8	29.9	41.7	27.4	76.3	62.3	5.0	32.6	46.9	42.5	41.7	12.0	18.5	42.0	50.4	51.9	38.7	51.2	22.9	19.6	27.5	15.6	73.7	16.8	17.1	40.1	69.2	90.6	104.0	3.0	33.2	147.7	53.4	4.7	94.6	17.9	22.6	12.5	21.2	81.2	52.7	32.4	26.4	108.4	16.1	54.3	33.6	16.1	6.6	51.4	59.1	33.5	19.9	47.1	190.2	149.0	42.8	14.9	28.5	118.2
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564029-42693505	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 138.5;Inhibitory neurons: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	11.0	10.7	8.5	12.7	10.1	17.9	12.9	14.1	11.1	10.3	11.3	12.7	14.4	10.9	11.2	9.5	9.4	8.6	11.2	9.0	8.8	12.1	17.2	11.9	12.7	9.0	8.7	12.2	15.6	15.0	8.8	11.7	9.3	10.5	13.8	29.7	12.0	10.0	22.8	12.2	13.8	10.6	8.6	15.3	12.2	6.2	9.1	13.5	13.3	22.3	11.5	10.8	10.4	14.2	18.5	9.0	10.4	16.4	20.9	20.0	14.0	13.8	14.9	12.0	12.4	13.2	7.4	12.5	10.7	15.0	13.9	18.1	15.1	11.8	15.2	17.1	10.6	20.0	13.3	17.3	17.0	19.6	13.1	14.1	12.7	12.0	12.9	14.8	13.7	17.9	23.7	15.4	11.7	14.9	15.4	17.1	9.5	36.2	8.7	13.6	15.5	19.0	13.8	15.7	12.4	9.8	14.0	13.3	13.9	15.7	13.0	18.7	19.8	10.8	8.4	13.5	10.1	14.1	13.4	18.9	5.7	14.5	6.8	17.7	7.1	15.2	6.5	7.3	5.4	5.2	4.2	5.1	5.5	5.2	4.3	4.8	38.5	5.9	9.8	4.1	5.3	3.4	8.5	10.1	14.1	11.1	9.0	8.8	9.0	8.7	9.3	8.6	9.1	14.2	33.5	16.0	24.6	82.6	33.9	16.6	18.1	14.9	28.5	43.0	20.4	15.9	39.3	30.0	22.1	20.2	60.5	17.4	46.6	51.6	17.6	18.5	12.4	27.5	30.8	24.8	12.6	75.1	138.5	15.3	13.4	26.5	34.1	32.9	20.3	31.3	21.8	35.0	13.2	63.9	142.7	22.5	14.2	26.7	28.6	3.9	25.4	26.1	19.6	87.1	43.0	23.5	32.0	123.1	131.4	15.0	29.1	24.0	50.6	22.8	37.2	11.7	27.9	53.5	39.5	30.0	27.2	11.2	10.9	28.1	16.2	17.2	44.0	24.0	21.5	22.7
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3"	Q6ZT12	2	169827454-170084131	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 71.2;tongue: 87.1"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 305.1;Inhibitory neurons: 302.0;Oligodendrocyte precursor cells: 232.2;Oligodendrocytes: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	14.2	12.4	4.4	7.7	5.8	7.4	9.2	5.9	8.5	10.9	2.8	8.8	8.1	10.1	6.9	12.8	8.4	9.3	29.4	8.0	3.3	15.2	21.0	8.8	7.2	2.4	2.7	10.2	11.9	21.5	2.1	8.7	3.3	13.1	8.5	21.2	11.5	10.3	71.2	9.2	7.5	11.1	3.2	8.8	9.3	9.7	3.4	9.5	17.9	87.1	7.3	11.0	2.3	8.4	14.8	12.4	12.9	17.1	25.0	19.7	10.8	26.1	15.0	14.7	11.8	19.1	9.1	16.7	22.2	20.5	12.0	19.0	15.5	13.2	18.2	17.4	13.4	61.1	12.6	20.3	12.4	20.4	18.9	11.9	12.1	19.3	12.9	11.7	14.8	8.3	32.4	17.6	25.6	14.0	13.3	10.0	10.1	14.9	10.2	12.6	21.1	17.8	10.5	20.5	25.1	13.7	18.4	16.7	10.6	10.2	10.9	11.4	18.9	22.1	9.0	17.5	16.7	14.2	11.9	15.1	18.2	11.8	12.5	0.0	0.6	0.5	0.9	0.6	1.3	0.6	0.5	0.8	0.9	0.3	0.9	1.2	0.6	0.8	0.5	0.7	1.0	0.4	4.4	5.8	5.9	8.5	8.0	3.3	2.4	2.7	3.3	3.2	3.4	8.4	19.0	44.8	26.9	162.6	16.3	25.9	12.4	14.8	20.5	46.3	15.8	8.9	109.7	17.2	20.0	12.9	81.3	19.7	22.9	17.1	3.9	8.7	7.6	16.8	21.9	26.4	16.7	24.4	305.1	11.0	8.4	22.2	23.4	22.0	16.5	22.7	30.4	39.0	10.2	63.9	302.0	11.3	22.4	20.9	18.7	10.2	25.7	18.7	16.0	110.5	18.7	61.7	14.4	232.2	288.0	10.7	15.0	19.2	21.3	20.9	15.3	10.0	13.4	51.5	26.3	29.0	21.8	12.4	8.6	22.9	29.0	23.0	18.1	17.3	13.2	17.2
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000277-74009085	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	80	"skeletal muscle: 393.2;tongue: 263.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Late spermatids: 14.0;NK-cells: 6.2;Skeletal myocytes: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 15.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	1.2	1.7	2.5	1.3	2.6	2.2	1.3	3.9	3.0	1.4	2.3	1.7	0.7	1.4	2.0	2.9	1.5	0.8	2.4	2.7	2.1	1.7	1.3	1.4	1.3	2.4	2.1	1.1	1.1	0.9	2.7	0.5	2.3	1.8	0.7	4.0	3.7	0.7	393.2	1.4	1.7	0.8	1.8	3.1	1.2	3.9	2.4	1.6	2.6	263.1	0.7	1.4	0.9	2.8	0.2	1.8	1.7	1.5	0.7	0.3	0.3	0.5	0.4	0.4	0.2	0.4	0.4	0.9	0.2	0.3	0.2	1.9	0.7	0.3	0.7	15.8	0.5	0.3	2.4	0.2	0.5	1.1	1.4	0.4	1.1	1.1	0.1	0.3	0.5	0.9	0.4	1.2	0.6	1.0	0.7	1.4	0.9	1.4	1.1	1.4	3.6	0.5	0.9	0.5	0.9	1.0	0.4	0.7	0.6	0.3	0.2	1.0	0.3	0.2	1.1	0.6	1.1	1.4	1.5	0.7	0.2	1.0	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.5	2.6	3.9	3.0	2.7	2.1	2.4	2.1	2.3	1.8	2.4	2.8	0.8	0.0	0.0	1.6	0.8	0.1	0.1	0.5	0.6	2.3	1.0	1.1	0.7	0.0	1.1	0.0	0.0	0.3	2.0	0.3	0.0	0.3	15.4	1.2	1.1	0.6	0.0	0.4	1.6	0.5	0.2	0.4	0.0	0.8	0.0	0.7	1.1	0.3	0.7	0.0	1.6	0.5	2.0	0.8	0.0	14.0	0.0	0.6	0.0	1.0	0.7	0.8	6.2	0.5	0.6	0.4	0.1	0.7	0.5	0.2	0.3	0.1	3.0	2.1	0.0	6.5	0.5	1.5	0.8	0.4	0.3	0.3	1.5	0.3	0.6	0.1
UNC45B	"CMYA4, UNC45"	ENSG00000141161	"Unc-45 myosin chaperone B"	Q8IWX7	17	35147817-35189345	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Chaperone, Developmental protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	59	"heart muscle: 100.3;skeletal muscle: 196.6;tongue: 151.9"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 201.8;Late spermatids: 59.4"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 0.9;testis cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.1"	"Group enriched"	"Detected in some"	11	"BEWO: 1.7;HSkMC: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA017861			Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA017861: AB_1847012"	"unprognostic (7.17e-2)"	"unprognostic (6.47e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.49e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.13e-6)"	"unprognostic (6.77e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.21e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	100.3	0.2	0.1	0.1	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.1	0.0	0.0	2.5	0.0	196.6	0.1	0.0	0.1	0.1	1.4	0.4	1.3	0.1	0.4	0.0	151.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.2	0.5	0.0	0.0	0.1	0.6	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	201.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	24.6	0.0	0.0	2.3	0.0	2.7	0.4	0.0	0.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	59.4	0.6	0.1	0.0	1.9	0.0	0.0	1.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	4.5	0.2	0.7	0.0	0.1	0.0	1.1	0.5	0.0	0.1
UPK3A	UPK3	ENSG00000100373	"Uroplakin 3A"	O75631	22	45284949-45295874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"prostate: 21.3;skeletal muscle: 35.0;urinary bladder: 48.0"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 15.0;monocytes: 22.6;Prostatic glandular cells: 54.1;Proximal enterocytes: 29.8;Urothelial cells: 24.5"	"Group enriched"	"Detected in many"	6	"prostate cancer: 35.3;urothelial cancer: 78.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 86.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 86.6;monocytes: 32.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 29.9;RT4: 48.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018407, HPA018415"	Enhanced		Uncertain	"Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear membrane"	"Nuclear bodies"	"HPA018407: AB_1858641, HPA018415: AB_1858640"	"unprognostic (1.27e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.98e-5)"	"unprognostic (1.69e-2)"	"unprognostic (4.82e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.05e-3)"	0.2	0.1	0.1	0.5	0.1	1.5	0.2	0.1	0.4	0.0	0.3	1.0	0.0	0.1	0.1	0.3	0.3	0.9	0.1	0.1	0.2	0.1	0.0	0.2	0.9	0.2	0.1	0.1	0.2	4.9	0.7	0.0	0.2	21.3	0.7	0.0	2.8	0.2	35.0	0.0	1.3	0.1	0.1	1.1	0.1	0.1	0.1	0.7	2.3	4.5	0.8	48.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	4.6	0.0	0.1	0.0	0.2	0.0	48.9	0.1	0.0	0.2	0.8	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	21.2	0.0	0.0	25.8	0.0	1.2	0.0	0.1	86.6	0.5	0.0	0.0	3.6	0.4	32.0	32.9	0.0	7.4	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.7	1.2	0.1	15.0	0.1	0.0	0.1	4.6	3.6	0.2	2.8	0.1	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.1	3.5	0.0	4.8	8.7	1.7	0.3	6.4	0.0	0.0	22.6	0.8	2.1	0.0	0.0	0.0	9.3	0.0	0.1	54.1	29.8	0.0	0.1	0.0	0.0	1.6	0.5	0.0	0.4	0.0	0.4	0.1	0.2	0.0	4.4	24.5
USO1	"p115, TAP, VDP"	ENSG00000138768	"USO1 vesicle transport factor"	O60763	4	75724577-75814286	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 219.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010108, HPA038282, HPA038283"	Supported		Supported	"Nucleoli fibrillar center,Golgi apparatus"		NA	NA		170000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Nucleoli fibrillar center"	"CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929"	"unprognostic (9.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (7.95e-3)"	"unprognostic (4.01e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-2)"	35.0	38.7	13.1	32.3	14.7	13.0	39.0	15.6	19.0	44.3	26.1	33.9	35.6	32.3	64.2	50.1	30.1	32.0	57.4	14.9	16.1	38.7	76.8	30.4	32.5	16.7	14.4	56.9	57.5	37.7	31.5	43.7	16.4	39.9	36.9	39.2	54.7	37.5	219.2	36.2	33.7	35.7	14.9	26.3	40.8	43.1	15.6	30.7	53.4	138.7	39.7	40.2	27.6	19.2	46.8	36.0	49.5	66.7	118.6	155.8	45.5	106.2	129.4	57.2	69.2	36.2	70.4	60.6	64.0	98.0	49.2	52.8	74.9	66.5	85.6	67.2	29.3	41.8	31.4	76.3	93.0	55.8	46.2	89.2	80.6	59.8	116.4	110.6	87.1	41.7	73.7	67.9	85.8	30.9	55.4	29.5	67.9	98.2	21.3	36.3	47.2	49.2	85.5	53.1	39.4	38.3	39.1	82.4	67.3	73.6	60.6	45.1	67.4	52.2	32.2	95.8	40.7	63.6	36.6	29.5	77.6	33.1	63.2	21.9	13.1	11.9	16.4	18.7	22.2	9.8	13.6	15.7	16.8	11.2	13.9	13.8	8.1	22.2	26.9	13.4	15.1	13.7	13.1	14.7	15.6	19.0	14.9	16.1	16.7	14.4	16.4	14.9	15.6	19.2	34.5	60.9	84.5	59.1	43.2	38.0	52.8	59.6	51.2	33.3	35.0	28.4	126.9	28.6	71.7	25.8	43.8	47.9	32.6	32.0	35.2	38.4	11.1	35.7	57.5	36.4	40.1	20.8	70.9	48.6	49.0	62.7	61.2	55.0	48.8	126.2	32.9	62.0	42.8	26.9	68.7	63.7	40.7	38.0	35.1	10.9	78.6	41.3	28.4	60.9	54.8	32.8	45.3	77.4	113.7	48.5	33.4	68.4	106.9	78.2	44.3	50.4	66.4	51.2	39.5	54.0	50.5	73.8	68.2	58.7	40.3	90.6	37.8	36.3	41.9	63.8
USP25	USP21	ENSG00000155313	"Ubiquitin specific peptidase 25"	Q9UHP3	21	15730025-15880069	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 166.7;Excitatory neurons: 148.0;Late spermatids: 192.8;Oligodendrocyte precursor cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018297, HPA024142"	Approved		Supported	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA018297: AB_1858672, HPA024142: AB_1858673"	"unprognostic (6.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.34e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-2)"	25.8	12.9	13.4	16.8	20.1	26.9	17.6	12.6	17.2	18.1	12.3	15.3	12.6	26.8	18.7	21.4	16.8	12.4	28.1	16.2	4.2	21.4	20.2	24.0	20.1	4.7	4.3	14.1	15.9	14.3	7.6	29.4	4.8	17.9	16.1	9.5	17.5	24.6	120.9	13.1	13.3	36.4	4.4	19.5	13.1	54.5	4.9	25.6	15.5	75.1	19.3	15.5	17.3	11.9	31.2	23.1	21.5	3.2	38.7	57.5	25.3	22.0	21.8	16.0	20.1	20.5	17.4	33.6	31.5	34.9	24.3	16.4	16.7	29.1	22.0	33.5	19.1	27.5	23.5	15.8	64.3	36.6	12.1	37.6	34.7	25.8	74.0	41.7	57.0	30.0	35.9	61.4	29.1	13.0	42.1	7.1	26.6	12.5	20.3	31.8	20.0	25.8	43.5	8.3	4.7	12.8	31.4	26.2	20.9	25.9	14.0	21.3	54.6	24.8	16.0	26.2	12.5	17.7	11.9	26.8	16.0	16.1	18.6	0.0	1.4	1.9	1.8	1.4	2.0	1.6	1.5	3.2	1.2	1.1	1.4	2.1	2.9	1.1	1.3	1.3	2.2	0.8	13.4	20.1	12.6	17.2	16.2	4.2	4.7	4.3	4.8	4.4	4.9	11.9	30.4	57.7	29.5	47.3	21.7	17.1	18.8	9.7	15.9	6.2	17.4	11.8	55.7	15.7	24.2	22.0	4.2	39.0	21.4	20.3	5.9	9.4	166.7	24.0	19.0	19.7	9.6	21.5	148.0	13.4	8.4	19.4	17.9	34.6	6.3	14.4	17.9	18.0	13.3	5.0	98.4	12.8	8.2	24.2	16.0	192.8	19.0	24.2	16.0	86.2	23.7	4.0	23.7	150.3	72.4	13.4	8.4	12.8	15.9	22.0	11.9	15.1	23.4	6.7	19.7	26.1	17.2	11.2	5.8	22.7	19.2	33.1	26.9	18.5	11.6	20.4
USP47		ENSG00000170242	"Ubiquitin specific peptidase 47"	Q96K76	11	11841423-11961887	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029286, HPA029289"	Supported		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"	Vesicles	"HPA029286: AB_10599852, HPA029289: AB_10601675"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	15.7	14.3	11.9	11.4	15.8	19.0	15.1	17.3	12.8	14.3	10.2	19.8	10.3	17.2	15.6	16.1	13.5	12.3	23.5	12.5	14.1	13.2	23.3	16.2	13.3	14.1	12.8	15.9	16.9	22.2	13.8	16.7	15.0	16.6	12.3	25.7	14.1	15.4	59.8	18.0	14.1	17.8	14.1	11.8	16.6	15.0	12.7	19.1	14.9	33.6	13.8	16.7	14.2	20.6	26.8	15.7	30.3	13.1	21.8	23.2	12.6	31.6	22.3	20.1	22.1	16.5	22.2	29.6	13.3	28.0	23.7	17.8	23.7	15.3	30.3	27.5	20.4	18.6	30.3	12.6	21.5	25.0	23.9	22.3	22.5	12.3	29.0	26.1	21.8	21.7	35.8	23.7	25.4	10.6	21.7	14.3	7.9	28.1	12.7	21.4	30.3	9.4	24.6	29.1	9.8	21.0	25.8	19.6	19.3	18.4	14.4	20.6	24.9	27.8	16.2	22.3	19.6	7.9	18.1	25.9	19.9	15.2	20.3	14.7	5.9	11.9	11.0	7.4	14.5	7.4	10.3	11.4	7.9	6.7	13.1	11.4	2.8	18.5	11.5	4.8	8.3	7.9	11.9	15.8	17.3	12.8	12.5	14.1	14.1	12.8	15.0	14.1	12.7	20.6	41.1	70.5	63.1	116.5	46.9	71.0	68.8	28.8	45.5	67.5	41.1	30.9	222.5	40.0	56.0	23.9	47.9	69.6	57.2	30.4	25.4	39.5	40.1	49.8	63.0	44.8	59.3	34.3	122.7	38.9	33.2	69.7	44.4	134.5	54.3	52.6	32.5	53.9	28.0	63.9	136.5	32.9	24.4	27.7	39.7	30.0	44.1	41.8	24.9	96.5	40.5	79.7	68.0	171.4	315.9	44.8	31.5	50.0	55.2	65.5	29.7	21.9	48.2	52.4	52.6	85.0	68.2	92.8	55.1	46.6	87.9	125.7	65.0	41.8	35.0	58.9
USP53	KIAA1350	ENSG00000145390	"Ubiquitin specific peptidase 53"	Q70EK8	4	119212587-119295517	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 586.8;Microglial cells: 269.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 327.9;SK-MEL-30: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035844, HPA035845"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA035844: AB_10669532, HPA035845: AB_2674817"	"unprognostic (9.33e-2)"	"unprognostic (1.49e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (4.37e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.54e-6)"	"prognostic favorable (3.58e-8)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	37.8	14.4	5.6	5.7	5.8	0.9	25.3	6.1	6.2	18.5	11.8	16.3	5.7	13.1	13.1	17.0	30.6	10.2	24.0	4.9	7.3	19.9	7.3	29.4	12.4	9.4	8.1	9.4	24.6	8.1	10.3	10.5	7.3	9.2	16.1	3.4	12.7	11.5	33.5	11.7	9.7	10.2	6.5	7.2	15.1	7.8	8.6	5.4	10.5	51.7	8.0	12.7	12.0	5.5	11.4	6.8	2.4	0.0	60.5	60.4	13.6	70.6	327.9	6.2	8.1	7.4	10.4	46.1	2.5	21.1	12.1	5.5	5.5	5.3	16.1	6.1	4.5	3.1	5.2	2.6	47.2	3.9	0.7	20.3	15.0	21.9	31.0	11.7	29.8	3.0	7.3	1.7	8.4	2.5	2.9	5.2	6.7	7.0	3.8	0.9	11.4	9.2	16.4	7.2	3.8	3.0	3.9	27.5	102.4	13.3	7.0	2.7	32.3	2.0	7.0	26.3	6.4	3.3	5.2	7.8	31.4	1.7	7.9	1.3	0.0	0.0	0.4	0.0	0.5	0.7	1.0	0.8	0.1	0.7	1.9	1.0	0.2	0.9	0.0	0.3	0.9	0.3	5.6	5.8	6.1	6.2	4.9	7.3	9.4	8.1	7.3	6.5	8.6	5.5	27.6	35.3	44.5	80.6	18.5	61.8	73.6	21.2	48.3	17.8	74.1	46.6	99.0	32.9	33.9	119.5	29.2	48.4	15.1	207.8	45.0	33.4	5.6	167.2	45.9	35.7	34.6	4.8	32.4	62.7	17.3	86.0	41.8	586.8	70.8	19.8	23.9	30.5	9.3	25.2	32.5	80.4	52.9	21.3	76.4	7.3	19.0	36.5	14.2	269.8	45.6	25.0	12.3	11.6	11.9	110.6	214.5	10.9	18.6	138.6	46.0	20.1	27.3	31.5	6.6	91.8	32.9	18.0	4.0	62.6	42.3	49.8	26.8	14.8	62.6	124.8
UTP11	"CGI-94, UTP11L"	ENSG00000183520	"UTP11 small subunit processome component"	Q9Y3A2	1	38009258-38024820	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 111.4;tongue: 85.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 60.2;Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 72.6;Syncytiotrophoblasts: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045830	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045830: AB_10969917"	"unprognostic (1.95e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.44e-8)"	"unprognostic (3.51e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (1.42e-8)"	"unprognostic (1.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	15.4	18.7	11.0	15.4	11.9	16.7	13.6	11.9	15.9	11.4	10.6	18.4	11.3	15.9	13.4	18.4	12.3	12.9	19.9	11.7	11.6	12.3	17.0	11.4	14.9	12.9	12.3	11.0	15.6	12.0	7.3	14.8	12.4	13.7	13.3	7.0	14.1	12.8	111.4	14.6	9.9	19.7	12.0	10.7	14.0	15.1	11.9	13.5	11.0	85.5	17.5	19.7	11.0	14.7	37.6	22.9	38.5	36.8	27.8	37.8	34.6	41.5	39.4	55.4	50.4	32.8	44.9	62.6	37.9	34.2	27.2	31.6	44.2	37.2	68.8	47.3	39.9	72.6	27.9	28.8	37.9	72.7	45.3	35.3	23.7	61.4	53.3	34.1	44.6	47.6	84.1	32.5	63.5	26.6	56.9	75.4	92.1	41.9	29.1	49.7	80.8	57.3	36.5	36.2	49.8	41.5	36.1	30.7	67.8	40.1	28.1	44.5	33.2	36.8	45.0	40.8	80.0	31.0	65.8	52.6	49.3	79.3	46.5	18.1	27.6	15.2	23.1	30.6	24.3	15.0	18.3	19.3	27.6	17.5	16.3	20.3	8.3	32.2	36.5	26.3	23.4	20.5	11.0	11.9	11.9	15.9	11.7	11.6	12.9	12.3	12.4	12.0	11.9	14.7	37.9	35.3	43.6	0.0	5.7	0.0	0.0	0.0	0.0	0.0	29.8	27.6	0.0	0.0	21.1	25.8	0.0	54.2	23.6	0.0	39.2	60.2	0.0	23.6	43.5	31.4	0.0	0.0	0.0	67.4	51.7	23.4	0.0	24.8	25.2	19.0	0.0	0.0	52.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	19.1	0.0	0.0	0.0	0.0	72.6	0.0	0.0	3.5	0.0	0.0	49.4	25.5	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	77.8	10.5	39.1	0.0	0.0
VDAC1	"MGC111064, PORIN"	ENSG00000213585	"Voltage dependent anion channel 1"	P21796	5	133971871-134004975	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1045.7;tongue: 812.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005885, HPA030780, CAB072343"	Supported					NA	NA		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB005885: AB_2214787, CAB072343: , HPA030780: AB_2673608"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.63e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (8.49e-4)"	"prognostic unfavorable (2.87e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	96.3	129.8	104.8	96.2	113.5	53.9	106.2	112.8	137.4	62.8	149.0	154.1	265.7	54.4	196.9	172.3	61.5	90.3	403.5	116.7	122.3	200.9	206.2	79.3	89.6	113.4	105.1	60.8	99.7	181.8	63.4	104.5	118.3	82.4	166.4	316.0	132.9	72.5	1045.7	113.9	179.1	90.7	101.1	60.2	163.6	37.5	117.3	90.9	68.5	812.0	129.3	108.3	91.0	106.4	364.5	315.8	282.8	295.3	277.5	385.0	398.0	398.1	292.2	386.5	395.2	650.0	282.9	497.4	291.5	418.0	515.1	278.2	403.4	701.2	480.7	296.1	331.7	287.3	308.9	526.0	282.2	266.5	272.9	353.3	368.5	301.1	333.0	385.3	381.2	248.0	260.1	197.8	511.8	404.5	326.3	264.1	198.5	555.2	264.3	296.5	282.6	474.3	608.6	450.0	315.0	177.7	253.7	305.2	416.0	385.9	147.0	257.6	311.6	361.4	241.6	335.9	530.2	262.9	278.3	309.4	537.1	351.9	420.7	24.9	83.2	30.3	54.5	118.4	60.0	58.3	55.6	57.3	140.7	40.5	38.8	43.8	6.9	87.7	105.1	41.1	74.5	72.9	104.8	113.5	112.8	137.4	116.7	122.3	113.4	105.1	118.3	101.1	117.3	106.4	89.9	105.8	63.1	21.2	101.9	204.8	246.6	250.8	128.7	463.6	163.7	98.3	276.0	198.8	133.2	126.9	81.3	372.4	94.9	333.1	729.8	303.4	68.7	140.8	161.1	120.7	104.1	96.7	41.5	302.6	471.4	136.9	225.8	184.6	121.8	163.9	57.1	203.9	332.7	519.9	40.6	202.7	189.2	130.6	243.5	50.3	95.7	165.7	249.1	31.9	315.8	277.0	60.8	24.1	23.8	300.7	227.7	112.1	162.0	353.6	415.8	585.3	121.2	257.2	85.5	132.8	171.4	10.9	32.7	275.5	232.9	325.6	111.0	229.1	326.7	265.1
VEZT	DKFZP761C241	ENSG00000028203	"Vezatin, adherens junctions transmembrane protein"	Q9HBM0	12	95217746-95302799	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004811, HPA017066"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA004811: AB_1080563, HPA017066: AB_1858742"	"unprognostic (3.91e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.93e-5)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.02e-2)"	7.3	9.9	7.7	5.8	8.0	3.3	8.9	11.3	9.9	9.2	3.1	7.6	5.8	8.2	9.6	6.6	7.7	7.4	9.5	8.5	8.6	6.9	6.2	7.8	6.4	4.4	5.7	11.2	9.0	8.6	13.4	9.4	5.7	9.6	6.3	20.3	5.4	7.6	23.8	10.3	5.9	7.1	4.0	4.1	5.6	4.5	6.9	6.6	18.9	21.2	6.4	7.5	8.5	7.1	14.4	12.9	18.0	9.5	14.7	9.2	6.8	10.3	13.3	8.7	12.9	4.8	6.6	18.6	6.5	8.8	4.3	7.4	13.3	9.2	15.2	12.6	7.3	7.2	3.3	5.2	7.5	14.2	4.1	12.7	15.6	7.6	21.9	19.0	17.1	8.9	4.2	7.0	7.6	4.0	12.4	6.7	9.2	4.5	13.1	11.1	8.4	6.0	23.8	10.3	12.1	10.6	10.1	14.9	4.9	15.8	18.4	2.4	13.9	7.2	2.8	3.5	5.8	6.8	11.4	16.3	2.8	5.1	3.8	0.2	1.5	0.5	1.5	1.6	2.1	2.5	2.2	0.9	2.0	1.8	1.0	0.9	0.1	1.1	0.4	0.8	1.8	0.5	7.7	8.0	11.3	9.9	8.5	8.6	4.4	5.7	5.7	4.0	6.9	7.1	36.5	70.5	49.3	88.8	31.1	77.8	58.1	37.5	63.2	67.9	46.3	28.6	49.0	37.1	44.5	33.1	85.5	39.6	26.3	40.0	9.8	50.1	16.5	30.1	48.4	44.6	38.4	22.1	151.8	45.2	22.3	31.0	27.5	53.8	29.2	59.9	47.8	36.7	21.6	62.2	149.1	36.1	30.5	27.1	37.5	11.4	32.6	23.2	37.4	74.9	25.2	24.1	14.4	101.0	98.4	76.4	39.4	33.1	40.5	54.6	33.0	21.5	33.1	146.6	6.6	39.0	37.3	39.4	21.3	57.8	72.5	110.7	29.1	32.7	24.9	71.7
WIPI1	"ATG18, ATG18A, FLJ10055, WIPI49"	ENSG00000070540	"WD repeat domain, phosphoinositide interacting 1"	Q5MNZ9	17	68420948-68457513	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 127.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 165.7;Syncytiotrophoblasts: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 114.1;eosinophil: 223.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 223.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 224.3;HHSteC: 216.7;HSkMC: 180.8;SK-MEL-30: 183.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007493, CAB037230"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"CAB037230: AB_1841265, HPA007493: AB_1848642"	"unprognostic (2.83e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.32e-3)"	"unprognostic (6.56e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.89e-3)"	31.3	18.8	11.2	14.1	11.2	26.6	30.5	12.5	15.1	33.1	19.1	36.4	12.8	15.3	14.4	14.8	12.6	23.3	78.4	10.6	12.9	33.3	18.7	26.2	8.7	12.5	12.0	11.2	29.8	25.2	17.8	62.4	12.5	17.4	38.5	8.2	55.0	18.3	127.2	21.9	14.8	18.8	11.4	12.5	29.3	9.6	15.5	5.9	21.1	97.5	16.7	22.0	14.4	11.9	4.9	9.8	8.6	12.5	224.3	167.2	49.0	36.3	163.5	13.7	43.6	7.2	7.3	3.0	16.0	74.2	47.9	3.7	3.3	22.1	23.9	4.4	4.6	34.7	3.2	42.6	216.7	2.4	48.5	180.8	39.5	54.2	72.0	44.2	61.3	5.3	2.5	82.0	41.1	29.9	0.5	7.1	1.8	12.7	15.0	0.4	30.3	35.7	20.2	16.7	2.4	11.4	7.7	103.8	183.4	44.4	54.8	9.5	61.2	65.4	10.1	31.0	8.6	78.2	92.0	10.5	98.9	16.5	29.7	114.1	18.4	223.6	11.9	22.7	5.3	4.4	3.1	11.7	9.0	1.4	0.2	5.6	39.0	10.7	24.7	6.3	2.7	15.0	11.2	11.2	12.5	15.1	10.6	12.9	12.5	12.0	12.5	11.4	15.5	11.9	26.2	9.6	11.5	12.7	13.3	7.8	11.9	45.6	0.6	15.0	24.1	8.9	7.3	28.6	48.5	16.5	2.1	44.0	18.3	30.2	31.3	31.2	6.3	26.3	19.9	17.2	12.0	56.6	9.4	57.2	165.7	41.2	25.5	40.0	7.0	12.3	33.9	11.7	35.6	10.1	8.2	67.6	44.7	18.2	14.5	5.2	46.3	37.1	42.7	20.6	34.2	10.6	20.6	6.0	12.2	28.8	20.1	42.2	83.3	55.3	8.5	71.8	49.6	15.7	26.3	10.1	24.1	5.0	5.1	3.3	6.8	125.1	13.6	27.8	28.2	36.7
WNT9A	WNT14	ENSG00000143816	"Wnt family member 9A"	O14904	1	227918656-227947932	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.7;skeletal muscle: 26.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 5.1;Ionocytes: 6.1;Respiratory ciliated cells: 12.5;Urothelial cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 16.2;PC-3: 10.8;RH-30: 16.4;SCLC-21H: 14.9;SiHa: 14.7;U-2197: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (2.27e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.93e-2)"	3.3	1.4	0.4	1.1	0.6	0.1	3.0	0.6	0.8	4.1	7.7	18.7	1.3	5.3	0.4	5.8	5.5	2.1	10.1	0.7	0.9	0.9	0.2	3.9	0.3	1.2	0.9	9.8	2.8	1.2	2.8	2.1	2.1	2.5	1.1	0.0	2.4	1.0	26.3	1.1	6.0	4.3	0.5	1.0	5.9	1.5	0.7	1.1	2.0	2.8	0.3	4.9	3.4	0.5	1.0	3.3	0.4	0.1	0.4	0.7	8.1	1.1	0.9	0.1	0.0	0.0	8.8	0.0	4.7	1.5	3.3	16.2	0.4	0.8	0.0	1.6	0.6	0.0	6.0	0.2	0.4	0.0	0.5	0.1	4.0	0.1	0.1	0.3	1.0	0.0	0.0	0.1	1.8	2.2	0.0	0.0	1.0	0.0	10.8	0.2	16.4	1.7	4.6	1.1	14.9	0.0	14.7	6.6	0.0	5.2	8.4	1.8	0.6	2.1	1.3	10.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.6	0.8	0.7	0.9	1.2	0.9	2.1	0.5	0.7	0.5	0.3	3.2	0.6	0.3	0.0	0.9	1.3	3.6	0.0	0.0	3.1	1.3	1.4	0.0	4.3	1.8	0.0	0.3	0.2	0.8	0.0	0.7	0.1	2.1	2.1	0.4	3.0	0.0	0.7	1.3	0.2	5.1	1.5	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	2.9	6.1	0.0	0.4	0.1	4.4	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.9	1.1	0.0	4.5	0.1	1.8	0.1	0.1	12.5	0.0	0.0	1.3	1.1	0.0	1.8	3.9	0.3	0.0	0.2	0.1	0.1	5.3
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888480-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 202.3;skeletal muscle: 1034.1;tongue: 543.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 1907.2"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;HUVEC TERT2: 4.2;U-2197: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Nucleoplasm	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	202.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.9	0.0	0.0	8.0	0.0	1034.1	1.2	0.1	0.0	0.0	0.5	0.1	3.0	0.0	0.1	0.3	543.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1907.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	10.1	0.0	0.0	1.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	23.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.5	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.4	5.8	1.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 72.8;Inhibitory neurons: 70.8;Oligodendrocytes: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"		"HPA053768: AB_2682254"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	4.3	3.6	3.1	5.7	4.3	10.2	6.1	5.6	3.8	4.4	4.5	4.7	3.7	6.1	4.1	4.8	4.1	3.5	10.7	3.0	3.5	5.1	4.1	6.0	7.3	3.7	3.6	6.1	4.2	6.5	3.0	5.2	3.8	5.4	5.7	13.5	3.7	3.9	44.1	5.6	3.8	5.6	3.8	5.8	4.6	5.8	3.7	7.1	6.5	16.7	7.0	4.6	3.7	5.6	10.1	7.5	12.0	11.5	5.7	9.9	12.4	11.2	8.2	13.0	10.7	15.3	12.4	22.0	5.9	10.8	9.8	16.2	28.0	15.2	24.0	15.1	8.0	35.0	9.5	10.3	8.6	31.0	11.0	9.8	9.4	13.1	24.7	7.6	15.9	12.5	16.8	7.1	12.4	8.3	14.9	13.6	13.6	21.2	6.9	16.3	19.8	9.2	9.0	12.1	13.6	9.4	9.7	13.9	11.5	12.0	8.2	16.8	13.2	9.1	7.1	11.3	16.1	4.7	7.4	17.9	4.5	19.5	13.9	1.5	0.7	0.8	1.1	0.8	1.3	1.0	1.0	1.0	1.0	0.8	1.2	1.2	0.0	1.1	2.5	0.7	1.0	0.4	3.1	4.3	5.6	3.8	3.0	3.5	3.7	3.6	3.8	3.8	3.7	5.6	10.0	12.8	12.5	36.6	24.0	8.3	10.7	12.1	11.4	17.0	8.5	6.1	22.2	10.0	5.6	9.2	64.6	8.3	11.4	4.7	0.0	5.4	10.4	6.1	11.9	9.5	1.2	10.9	72.8	4.1	7.4	9.8	18.3	7.7	15.2	11.9	12.1	10.5	10.8	10.1	70.8	7.5	6.1	10.0	8.0	8.2	17.4	9.5	12.4	44.0	11.6	5.4	10.3	58.8	82.5	5.4	3.6	8.2	21.3	11.8	3.4	5.4	6.3	21.4	32.9	11.6	10.0	14.2	18.8	14.7	11.2	12.9	18.6	7.1	9.6	10.4
ZEB1	"AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a"	ENSG00000148516	"Zinc finger E-box binding homeobox 1"	P37275	10	31318495-31529814	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 287.8;Excitatory neurons: 276.1;Inhibitory neurons: 261.9;Microglial cells: 479.7;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 113.1;TIME: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027524, CAB058686, CAB079943"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Nucleoli	"CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.66e-2)"	26.6	8.6	16.4	12.9	16.2	8.6	16.8	14.0	20.1	33.2	9.9	49.2	6.0	38.7	13.4	11.7	18.6	20.0	34.8	15.2	22.8	7.5	10.4	16.0	9.6	21.1	19.2	9.3	3.8	3.4	7.9	17.5	21.2	14.5	12.3	14.8	8.0	26.9	54.4	7.0	11.8	39.9	16.8	8.1	18.1	10.1	18.2	29.9	11.2	60.5	9.7	24.4	16.4	18.5	0.1	11.1	35.1	43.9	58.4	113.1	0.0	32.7	44.9	6.6	9.3	0.2	0.1	11.3	15.6	39.6	9.3	0.0	14.9	0.0	11.8	19.1	7.9	0.0	7.0	6.3	44.4	9.8	0.3	53.4	0.1	19.6	17.6	21.4	54.9	9.5	7.5	14.4	42.7	0.1	33.7	6.2	2.3	0.0	6.6	11.6	66.0	5.1	12.9	0.0	0.9	15.6	11.1	0.0	0.0	7.2	0.0	6.7	87.7	40.8	9.4	10.0	16.7	9.1	6.3	12.8	10.9	0.0	4.2	4.9	0.0	5.4	2.4	0.0	3.2	4.1	3.2	1.7	1.3	3.1	6.8	3.5	8.5	6.6	0.0	3.1	5.0	1.6	16.4	16.2	14.0	20.1	15.2	22.8	21.1	19.2	21.2	16.8	18.2	18.5	104.4	0.0	7.7	212.9	34.6	11.2	3.0	2.0	0.6	42.7	1.4	2.8	106.3	1.5	3.6	1.8	45.9	0.3	22.0	0.0	0.0	2.1	110.1	7.2	287.8	110.6	0.0	12.2	276.1	2.7	0.5	66.1	2.0	6.5	1.3	17.0	49.6	13.4	1.2	10.1	261.9	0.0	0.0	3.8	25.6	141.8	30.7	6.3	26.6	479.7	10.7	7.2	7.2	968.6	7.3	2.5	0.0	102.0	33.2	3.7	0.0	1.6	1.5	43.4	78.9	99.2	74.2	17.4	15.7	1.1	8.7	0.7	36.2	12.0	0.0	3.8
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491141	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 392.5;tongue: 465.5"	"Cell type enriched"	"Detected in all"	9	"Cardiomyocytes: 1836.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 29.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 161.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA054267: AB_2682431"	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	32.4	11.2	20.8	14.3	29.8	24.4	17.9	19.0	28.1	18.0	109.2	19.7	10.0	15.9	17.3	18.5	12.7	17.2	175.6	23.3	22.6	16.5	8.7	20.9	17.5	23.6	29.1	15.9	10.3	17.8	10.3	12.9	22.5	20.9	13.9	22.0	12.9	14.7	392.5	11.7	13.3	23.0	20.8	17.1	12.8	14.3	27.4	15.6	13.2	465.5	18.6	14.6	9.1	27.7	27.2	15.1	29.0	33.5	86.8	68.5	16.1	21.7	22.2	19.6	20.5	33.9	7.8	17.8	19.0	27.7	22.8	31.8	28.3	23.4	29.5	29.0	13.1	34.7	37.9	13.6	23.2	43.1	20.2	55.4	17.8	28.0	32.6	19.5	32.3	23.2	43.0	2.7	36.9	11.9	16.2	13.3	11.0	26.1	15.1	15.2	54.3	10.8	12.1	31.5	16.5	10.2	45.0	22.8	28.7	23.4	20.0	30.0	42.2	20.8	32.5	26.1	32.3	14.8	32.2	76.5	18.4	33.6	37.6	86.8	63.8	27.1	15.6	52.3	13.5	21.8	13.0	13.3	35.6	26.8	11.3	10.6	161.0	12.5	66.8	36.0	13.0	18.0	20.8	29.8	19.0	28.1	23.3	22.6	23.6	29.1	22.5	20.8	27.4	27.7	58.0	134.6	107.7	46.0	49.6	38.5	57.9	41.9	44.3	58.5	50.9	46.0	1836.4	62.9	57.0	29.5	95.9	37.9	67.2	31.7	41.1	43.2	197.2	75.2	67.1	69.9	40.2	50.5	73.3	42.4	39.3	141.7	31.1	37.5	44.9	49.5	62.8	40.1	53.5	35.3	62.9	32.6	32.6	132.7	43.4	105.2	37.6	89.8	65.8	47.8	124.3	53.6	66.9	31.2	34.2	65.7	26.9	92.6	50.7	74.8	39.7	41.5	161.1	79.9	46.0	151.2	70.0	62.3	38.1	49.8	29.8	30.6	46.0	85.9	36.6	68.2
ZNF41	"MGC8941, MRX89"	ENSG00000147124	"Zinc finger protein 41"	P51814	X	47445879-47482946	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 12.6;Inhibitory neurons: 18.6;Microglial cells: 17.8;Oligodendrocytes: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA069102	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA069102: AB_2686086"	"unprognostic (9.63e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (6.87e-2)"	"prognostic favorable (8.32e-4)"	"unprognostic (3.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	4.2	3.2	3.6	6.2	3.9	1.4	6.3	5.5	5.1	6.1	4.4	6.0	4.2	5.1	3.5	4.5	4.2	4.3	9.8	3.6	3.9	5.2	4.9	5.3	6.3	3.7	3.9	5.1	3.8	8.7	3.4	4.9	3.9	4.9	7.0	9.6	4.4	4.6	19.1	4.7	4.3	5.4	3.0	6.2	5.5	2.2	4.4	7.5	7.0	16.2	7.4	5.3	3.0	4.8	6.3	6.8	5.5	14.0	6.6	7.3	3.8	8.5	7.0	7.2	8.2	3.9	6.7	8.9	4.6	11.2	9.2	9.7	12.5	5.9	9.0	14.3	4.7	2.2	9.4	2.4	4.5	9.0	7.8	5.3	7.3	8.2	10.6	6.5	6.6	7.4	6.5	9.5	9.1	9.4	9.4	4.9	9.3	5.7	10.4	8.7	7.2	9.3	5.5	10.5	7.6	7.7	12.5	9.6	4.8	6.4	10.1	4.9	10.0	7.6	5.9	15.5	6.1	6.9	10.0	9.4	6.5	17.8	8.2	0.8	2.7	2.8	3.5	3.3	4.1	2.5	3.0	3.8	3.6	4.2	3.4	3.2	0.7	3.5	1.7	2.4	2.8	2.3	3.6	3.9	5.5	5.1	3.6	3.9	3.7	3.9	3.9	3.0	4.4	4.8	3.1	3.2	3.9	9.4	3.4	0.6	2.1	1.1	4.0	3.8	1.5	1.1	4.6	0.0	1.3	0.0	0.0	0.3	2.1	2.0	1.9	1.5	0.1	1.4	2.2	2.3	0.0	3.8	12.6	1.4	0.8	3.1	3.6	2.2	1.3	1.7	3.9	1.7	1.1	0.0	18.6	1.4	2.0	1.3	1.0	0.2	0.9	2.7	1.8	17.8	1.0	1.6	2.1	8.5	16.3	1.7	2.5	0.7	5.7	1.5	2.0	0.8	2.0	3.7	0.0	1.6	2.2	1.6	1.7	4.1	0.1	0.8	4.0	2.3	1.7	2.5
ZNF438	bA330O11.1	ENSG00000183621	"Zinc finger protein 438"	Q7Z4V0	10	30820207-31031937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Excitatory neurons: 55.3;Inhibitory neurons: 74.7;Microglial cells: 76.8;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.0;U-937: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039843	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA039843: AB_10795159"	"unprognostic (1.69e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.50e-2)"	11.9	3.6	5.5	6.4	5.7	5.5	7.4	5.1	7.3	8.5	5.7	11.3	3.8	9.2	6.6	4.6	8.2	5.6	11.0	5.6	5.8	4.4	5.4	8.4	4.0	5.3	5.2	5.9	3.1	3.7	4.9	4.0	5.5	5.4	4.1	4.5	6.2	5.6	24.6	6.8	5.3	8.7	5.3	10.3	6.0	8.4	6.3	7.8	9.7	17.4	3.1	9.3	6.8	6.5	3.7	3.7	3.1	2.7	18.0	12.5	1.7	2.9	4.2	4.5	5.6	0.2	4.4	5.0	3.3	5.2	4.2	1.0	1.6	2.2	6.3	11.6	1.2	2.2	2.0	0.2	10.1	1.7	2.3	6.0	3.7	6.4	3.6	4.1	19.0	5.8	4.3	3.5	6.2	2.7	5.9	9.7	0.3	2.7	1.5	2.6	4.5	2.9	6.4	0.9	2.3	2.5	1.4	0.6	2.1	2.0	1.4	16.2	7.9	2.0	3.5	6.1	3.6	0.8	1.5	0.1	4.0	25.3	1.5	1.3	7.2	3.3	2.0	6.9	1.5	1.0	1.5	2.7	2.2	3.7	3.1	1.7	13.1	3.9	4.3	2.8	3.6	3.5	5.5	5.7	5.1	7.3	5.6	5.8	5.3	5.2	5.5	5.3	6.3	6.5	7.8	3.2	4.8	111.3	3.2	1.0	2.0	1.7	5.2	5.5	2.1	2.2	13.0	5.7	4.2	3.7	6.2	3.5	2.0	1.8	7.9	3.6	25.2	2.7	5.6	6.1	0.0	2.5	55.3	4.2	4.6	9.1	7.1	2.4	12.6	4.1	6.4	1.8	6.9	3.3	74.7	2.6	0.0	12.9	3.5	9.6	4.1	36.3	0.0	76.8	7.3	2.4	7.2	137.2	86.9	3.7	0.8	8.2	3.6	1.3	2.5	3.9	3.9	5.3	6.6	17.0	6.7	12.8	8.0	6.0	2.4	1.6	4.2	2.4	2.3	1.8
ZSWIM1	"C20orf162, dJ337O18.5"	ENSG00000168612	"Zinc finger SWIM-type containing 1"	Q9BR11	20	45881227-45885266	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041147, HPA046751"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane, Cytosol"		"HPA041147: AB_2677329, HPA046751: AB_2679785"	"unprognostic (6.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (5.47e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.64e-1)"	"unprognostic (4.29e-2)"	3.0	4.1	2.7	3.7	2.6	6.0	3.5	4.6	2.9	3.1	2.7	4.1	4.6	3.4	3.5	3.5	4.2	3.2	4.9	2.7	2.5	3.6	1.9	3.3	5.0	2.6	2.7	5.8	4.2	4.9	1.1	4.0	2.5	4.1	3.5	8.2	4.9	3.4	15.9	6.5	4.4	3.5	1.9	4.6	4.3	3.8	2.9	3.9	4.5	5.1	4.9	3.4	1.4	3.1	7.2	8.6	6.4	7.8	11.2	6.3	6.5	4.8	5.9	10.2	9.3	19.5	8.4	8.4	13.9	6.7	11.2	17.0	10.1	12.9	7.7	3.4	6.1	10.7	11.5	14.0	6.8	9.2	10.9	9.2	10.6	8.6	8.2	7.8	7.9	7.3	9.8	6.7	6.0	20.8	10.0	7.9	3.6	8.1	9.7	7.8	9.1	6.0	6.7	10.1	8.6	5.5	16.2	24.0	5.8	5.7	14.6	7.2	7.0	11.5	7.3	6.4	7.0	6.6	5.0	8.2	9.2	6.8	6.0	2.4	1.4	3.6	0.5	1.8	0.3	2.4	1.7	0.7	0.7	2.2	2.3	2.1	1.6	0.6	1.8	2.2	1.4	0.8	2.7	2.6	4.6	2.9	2.7	2.5	2.6	2.7	2.5	1.9	2.9	3.1	0.8	3.2	2.7	0.7	1.4	1.1	2.4	2.4	2.2	3.0	0.8	0.5	5.7	4.3	1.2	0.0	0.0	2.9	0.3	4.2	3.9	2.4	0.6	1.1	1.7	1.7	2.4	4.4	0.8	3.8	2.8	1.9	4.1	1.5	3.8	2.5	2.5	2.1	1.7	6.7	0.9	2.8	2.0	1.4	1.9	0.7	3.4	0.7	0.0	0.0	1.8	1.6	1.0	0.0	0.8	3.3	3.7	1.5	0.5	1.6	2.4	1.2	0.4	3.8	0.0	2.0	1.8	1.0	2.0	1.4	1.6	2.3	1.8	3.6	3.0	2.0